ESGR 10-Q Quarterly Report June 30, 2020 | Alphaminr

ESGR 10-Q Quarter ended June 30, 2020

ENSTAR GROUP LTD
10-Ks and 10-Qs
10-Q
10-K
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
esgr-20200630
Enstar Group LTD D0 true false 0001363829 2020 Q2 FALSE --12-31 us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member P10Y us-gaap:AccountingStandardsUpdate201613Member 0001363829 2020-01-01 2020-06-30 0001363829 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001363829 us-gaap:SeriesDPreferredStockMember 2020-01-01 2020-06-30 0001363829 us-gaap:SeriesEPreferredStockMember 2020-01-01 2020-06-30 xbrli:shares 0001363829 esgr:VotingCommonStockMember 2020-08-07 0001363829 us-gaap:NonvotingCommonStockMember 2020-08-07 iso4217:USD 0001363829 us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 2020-06-30 0001363829 2019-12-31 iso4217:USD xbrli:shares 0001363829 esgr:VotingCommonStockMember 2020-06-30 0001363829 esgr:VotingCommonStockMember 2019-12-31 0001363829 us-gaap:CommonClassCMember 2020-06-30 0001363829 us-gaap:CommonClassCMember 2019-12-31 0001363829 esgr:CommonClassEMember 2019-12-31 0001363829 esgr:CommonClassEMember 2020-06-30 0001363829 us-gaap:SeriesCPreferredStockMember 2019-12-31 0001363829 us-gaap:SeriesCPreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesDPreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesDPreferredStockMember 2019-12-31 0001363829 us-gaap:SeriesEPreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesEPreferredStockMember 2019-12-31 0001363829 2020-04-01 2020-06-30 0001363829 2019-04-01 2019-06-30 0001363829 2019-01-01 2019-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2020-03-31 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2019-03-31 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2019-12-31 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2018-12-31 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2020-06-30 0001363829 esgr:VotingCommonStockMember us-gaap:CommonStockMember 2019-06-30 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2020-03-31 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2020-06-30 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2019-06-30 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2019-03-31 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2019-12-31 0001363829 us-gaap:CommonClassCMember us-gaap:CommonStockMember 2018-12-31 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2020-03-31 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2020-06-30 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2019-03-31 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2019-06-30 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2019-12-31 0001363829 esgr:CommonClassEMember us-gaap:CommonStockMember 2018-12-31 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-03-31 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-06-30 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001363829 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2019-03-31 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2019-06-30 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001363829 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2019-03-31 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2019-06-30 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001363829 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001363829 us-gaap:TreasuryStockMember 2020-03-31 0001363829 us-gaap:TreasuryStockMember 2020-06-30 0001363829 us-gaap:TreasuryStockMember 2019-03-31 0001363829 us-gaap:TreasuryStockMember 2019-06-30 0001363829 us-gaap:TreasuryStockMember 2019-12-31 0001363829 us-gaap:TreasuryStockMember 2018-12-31 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2020-03-31 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2019-03-31 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2019-12-31 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2018-12-31 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2020-04-01 2020-06-30 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2019-04-01 2019-06-30 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2020-01-01 2020-06-30 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2019-01-01 2019-06-30 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2020-06-30 0001363829 esgr:JointOwnershipPlanVotingOrdinarySharesMember 2019-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001363829 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001363829 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001363829 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001363829 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001363829 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-01 2020-06-30 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-06-30 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0001363829 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-06-30 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001363829 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-04-01 2020-06-30 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-04-01 2019-06-30 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-06-30 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-06-30 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-06-30 0001363829 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001363829 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001363829 us-gaap:RetainedEarningsMember 2020-03-31 0001363829 us-gaap:RetainedEarningsMember 2019-03-31 0001363829 us-gaap:RetainedEarningsMember 2019-12-31 0001363829 us-gaap:RetainedEarningsMember 2018-12-31 0001363829 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001363829 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001363829 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001363829 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2020-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2018-12-31 0001363829 us-gaap:RetainedEarningsMember 2020-06-30 0001363829 us-gaap:RetainedEarningsMember 2019-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2020-03-31 0001363829 us-gaap:NoncontrollingInterestMember 2019-03-31 0001363829 us-gaap:NoncontrollingInterestMember 2019-12-31 0001363829 us-gaap:NoncontrollingInterestMember 2018-12-31 0001363829 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2020-06-30 0001363829 us-gaap:NoncontrollingInterestMember 2019-06-30 0001363829 2019-06-30 0001363829 2018-12-31 0001363829 2019-01-01 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001363829 us-gaap:SubsequentEventMember esgr:HannoverReMember 2020-08-06 2020-08-06 iso4217:AUD 0001363829 us-gaap:SubsequentEventMember esgr:MunichReMember 2020-07-01 2020-07-01 0001363829 esgr:AXAGroupMember 2020-06-01 2020-06-01 0001363829 esgr:AspenMember 2020-06-01 2020-06-01 0001363829 esgr:AspenMember 2020-06-01 0001363829 srt:MinimumMember esgr:AspenMember 2020-06-01 2020-06-01 0001363829 esgr:PacificValleyInsuranceCompanyMember 2020-03-31 2020-03-31 0001363829 esgr:PacificValleyInsuranceCompanyMember 2020-04-01 2020-04-30 xbrli:pure 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember esgr:StarStoneUSMember 2020-06-10 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember srt:ScenarioForecastMember esgr:StarStoneUSMember 2020-12-31 0001363829 srt:ScenarioForecastMember esgr:NewCoMember 2020-12-31 0001363829 srt:ScenarioForecastMember esgr:StarStoneUSMember 2020-07-01 2020-12-31 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2020-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2019-12-31 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2020-01-01 2020-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2019-01-01 2019-12-31 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2020-04-01 2020-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2019-04-01 2019-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember esgr:StarStoneUSMember 2019-01-01 2019-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:FundsHeldDirectlyManagedMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ShortTermInvestmentsMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:FixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember esgr:FundsHeldDirectlyManagedMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember 2020-06-30 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:FundsHeldDirectlyManagedMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:FundsHeldDirectlyManagedMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:ShortTermInvestmentsMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:FixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:CorporateDebtSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:MunicipalBondsMember us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 us-gaap:MunicipalBondsMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 us-gaap:MunicipalBondsMember esgr:FundsHeldDirectlyManagedMember 2019-12-31 0001363829 us-gaap:MunicipalBondsMember 2019-12-31 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:FundsHeldDirectlyManagedMember 2019-12-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:ShortTermInvestmentsMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:AssetBackedSecuritiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember 2019-12-31 0001363829 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2020-06-30 0001363829 us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember 2019-12-31 0001363829 esgr:SeniorSecuredDebtSecuritiesMember 2020-06-30 0001363829 esgr:SeniorSecuredDebtSecuritiesMember 2019-12-31 0001363829 esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember esgr:NotRatedMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:NotRatedMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember esgr:NotRatedMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember us-gaap:CorporateDebtSecuritiesMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 esgr:NotRatedMember us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember us-gaap:MunicipalBondsMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:MunicipalBondsMember esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:MunicipalBondsMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:MunicipalBondsMember 2020-06-30 0001363829 us-gaap:MunicipalBondsMember esgr:NotRatedMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember us-gaap:ResidentialMortgageBackedSecuritiesMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 esgr:NotRatedMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:CommercialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember esgr:NotRatedMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember us-gaap:AssetBackedSecuritiesMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:AssetBackedSecuritiesMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 esgr:NotRatedMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:PortfolioConcentrationRiskMember esgr:TradingSecuritiesandAvailableforSaleSecuritiesMember 2020-01-01 2020-06-30 0001363829 esgr:StandardPoorsFitchAAARatingMemberMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 esgr:StandardPoorsFitchAARatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-06-30 0001363829 esgr:StandardPoorsFitchBBBRatingMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-06-30 0001363829 us-gaap:ExternalCreditRatingNonInvestmentGradeMember 2020-06-30 0001363829 esgr:NotRatedMember 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:StandardPoorsFitchAAARatingMemberMember esgr:CreditRatingConcentrationRiskMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-01-01 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:StandardPoorsFitchAARatingMember esgr:CreditRatingConcentrationRiskMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-01-01 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:CreditRatingConcentrationRiskMember us-gaap:ExternalCreditRatingInvestmentGradeMember esgr:StandardPoorsFitchARatingMember 2020-01-01 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:StandardPoorsFitchBBBRatingMember esgr:CreditRatingConcentrationRiskMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2020-01-01 2020-06-30 0001363829 esgr:MarketableSecuritiesMember us-gaap:ExternalCreditRatingNonInvestmentGradeMember esgr:CreditRatingConcentrationRiskMember 2020-01-01 2020-06-30 0001363829 esgr:MarketableSecuritiesMember esgr:NotRatedMember esgr:CreditRatingConcentrationRiskMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignGovernmentDebtSecuritiesMember 2020-06-30 esgr:Security 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-03-31 0001363829 us-gaap:CorporateDebtSecuritiesMember 2020-03-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-03-31 0001363829 us-gaap:AssetBackedSecuritiesMember 2020-03-31 0001363829 2020-03-31 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2020-04-01 2020-06-30 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:CommercialMortgageBackedSecuritiesMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 esgr:OtherGovernmentAgenciesDebtSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0001363829 esgr:PublicEquityFundsMember 2020-06-30 0001363829 esgr:PublicEquityFundsMember 2019-12-31 0001363829 us-gaap:ExchangeTradedFundsMember 2020-06-30 0001363829 us-gaap:ExchangeTradedFundsMember 2019-12-31 0001363829 us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 esgr:AmTrustFinancialServicesInc.Member 2020-06-30 0001363829 esgr:AmTrustFinancialServicesInc.Member 2019-12-31 0001363829 us-gaap:HedgeFundsMember 2020-06-30 0001363829 us-gaap:HedgeFundsMember 2019-12-31 0001363829 us-gaap:FixedIncomeFundsMember 2020-06-30 0001363829 us-gaap:FixedIncomeFundsMember 2019-12-31 0001363829 us-gaap:EquityFundsMember 2020-06-30 0001363829 us-gaap:EquityFundsMember 2019-12-31 0001363829 us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 esgr:CLOEquityMember 2020-06-30 0001363829 esgr:CLOEquityMember 2019-12-31 0001363829 esgr:CLOEquityFundsMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember 2019-12-31 0001363829 esgr:PrivateCreditFundsMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember 2019-12-31 0001363829 us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 us-gaap:OtherLongTermInvestmentsMember 2019-12-31 0001363829 us-gaap:OtherInvestmentsMember 2020-01-01 2020-06-30 0001363829 esgr:RestrictionPeriodLessThanOneYearMember us-gaap:HedgeFundsMember 2020-06-30 0001363829 us-gaap:HedgeFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodTwoToThreeYearsMember us-gaap:HedgeFundsMember 2020-06-30 0001363829 esgr:RestrictionPeriodMoreThanThreeYearsMember us-gaap:HedgeFundsMember 2020-06-30 0001363829 esgr:RestrictionPeriodNotEligibleRestrictedMember us-gaap:HedgeFundsMember 2020-06-30 0001363829 esgr:RestrictionPeriodLessThanOneYearMember us-gaap:FixedIncomeFundsMember 2020-06-30 0001363829 us-gaap:FixedIncomeFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 us-gaap:FixedIncomeFundsMember esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 us-gaap:FixedIncomeFundsMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 us-gaap:FixedIncomeFundsMember esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 us-gaap:EquityFundsMember esgr:RestrictionPeriodLessThanOneYearMember 2020-06-30 0001363829 us-gaap:EquityFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 us-gaap:EquityFundsMember esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 us-gaap:EquityFundsMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 us-gaap:EquityFundsMember esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 esgr:RestrictionPeriodLessThanOneYearMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:PrivateEquityFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodTwoToThreeYearsMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:PrivateEquityFundsMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodNotEligibleRestrictedMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:RestrictionPeriodLessThanOneYearMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:RestrictionPeriodLessThanOneYearMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember esgr:RestrictionPeriodLessThanOneYearMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 esgr:PrivateCreditFundsMember esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 esgr:RestrictionPeriodLessThanOneYearMember us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 esgr:RestrictionPeriodOneToTwoYearsMember us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 esgr:RestrictionPeriodTwoToThreeYearsMember us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 esgr:RestrictionPeriodMoreThanThreeYearsMember us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 esgr:RestrictionPeriodNotEligibleRestrictedMember us-gaap:OtherLongTermInvestmentsMember 2020-06-30 0001363829 esgr:RestrictionPeriodLessThanOneYearMember 2020-06-30 0001363829 esgr:RestrictionPeriodOneToTwoYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodTwoToThreeYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodMoreThanThreeYearsMember 2020-06-30 0001363829 esgr:RestrictionPeriodNotEligibleRestrictedMember 2020-06-30 0001363829 esgr:EnhanzedReMember 2020-06-30 0001363829 esgr:EnhanzedReMember 2019-12-31 0001363829 esgr:CitcoIIILimitedMember 2020-06-30 0001363829 esgr:CitcoIIILimitedMember 2019-12-31 0001363829 esgr:MonumentMember 2020-06-30 0001363829 esgr:MonumentMember 2019-12-31 0001363829 esgr:ClearSpringMember 2020-06-30 0001363829 esgr:ClearSpringMember 2019-12-31 0001363829 esgr:OtherEquityMethodInvestmentsMember 2020-06-30 0001363829 esgr:OtherEquityMethodInvestmentsMember 2019-12-31 0001363829 us-gaap:EquityMethodInvestmentsMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedFairValueOptionMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedVariableReturnOptionMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedFairValueOptionMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedVariableReturnOptionMember 2019-12-31 0001363829 esgr:AspenMember 2020-01-01 2020-06-30 0001363829 esgr:AXAGroupMember 2020-01-01 2020-06-30 0001363829 us-gaap:FixedMaturitiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:FixedMaturitiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:FixedMaturitiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:FixedMaturitiesMember 2019-01-01 2019-06-30 0001363829 esgr:ShortTermInvestmentsAndCashEquivalentsMember 2020-04-01 2020-06-30 0001363829 esgr:ShortTermInvestmentsAndCashEquivalentsMember 2019-04-01 2019-06-30 0001363829 esgr:ShortTermInvestmentsAndCashEquivalentsMember 2020-01-01 2020-06-30 0001363829 esgr:ShortTermInvestmentsAndCashEquivalentsMember 2019-01-01 2019-06-30 0001363829 esgr:FundsHeldMember 2020-04-01 2020-06-30 0001363829 esgr:FundsHeldMember 2019-04-01 2019-06-30 0001363829 esgr:FundsHeldMember 2020-01-01 2020-06-30 0001363829 esgr:FundsHeldMember 2019-01-01 2019-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember 2020-04-01 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember 2019-04-01 2019-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember 2020-01-01 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember 2019-01-01 2019-06-30 0001363829 esgr:FixedMaturitiesandCashandCashEquivalentsMember 2020-04-01 2020-06-30 0001363829 esgr:FixedMaturitiesandCashandCashEquivalentsMember 2019-04-01 2019-06-30 0001363829 esgr:FixedMaturitiesandCashandCashEquivalentsMember 2020-01-01 2020-06-30 0001363829 esgr:FixedMaturitiesandCashandCashEquivalentsMember 2019-01-01 2019-06-30 0001363829 us-gaap:EquitySecuritiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:EquitySecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:EquitySecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:EquitySecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:OtherInvestmentsMember 2020-04-01 2020-06-30 0001363829 us-gaap:OtherInvestmentsMember 2019-04-01 2019-06-30 0001363829 us-gaap:OtherInvestmentsMember 2019-01-01 2019-06-30 0001363829 esgr:EquitiesandOtherInvestmentsMember 2020-04-01 2020-06-30 0001363829 esgr:EquitiesandOtherInvestmentsMember 2019-04-01 2019-06-30 0001363829 esgr:EquitiesandOtherInvestmentsMember 2020-01-01 2020-06-30 0001363829 esgr:EquitiesandOtherInvestmentsMember 2019-01-01 2019-06-30 0001363829 us-gaap:DebtSecuritiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:DebtSecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:DebtSecuritiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:DebtSecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2020-04-01 2020-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2019-04-01 2019-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2020-01-01 2020-06-30 0001363829 us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember 2019-01-01 2019-06-30 0001363829 us-gaap:SegmentContinuingOperationsMember 2020-04-01 2020-06-30 0001363829 us-gaap:SegmentContinuingOperationsMember 2019-04-01 2019-06-30 0001363829 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-06-30 0001363829 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-06-30 0001363829 us-gaap:AssetPledgedAsCollateralMember 2020-06-30 0001363829 us-gaap:AssetPledgedAsCollateralMember 2019-12-31 esgr:Segment 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:AUD us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember currency:GBP 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-12-31 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:AUD 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:CAD 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:EUR 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember currency:GBP 2019-01-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0001363829 us-gaap:CreditRiskContractMember 2020-06-30 0001363829 esgr:GovernmentBondFutureContractMember us-gaap:LongMember 2020-06-30 0001363829 esgr:GovernmentBondFutureContractMember us-gaap:ShortMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:LongMember 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember us-gaap:ShortMember 2020-06-30 0001363829 esgr:CreditRiskGovernmentBondFutureForeignCurrencyForwardContractsMember 2020-06-30 0001363829 esgr:GovernmentBondFutureContractMember 2020-04-01 2020-06-30 0001363829 esgr:GovernmentBondFutureContractMember 2020-01-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember 2020-04-01 2020-06-30 0001363829 us-gaap:ForeignExchangeForwardMember 2020-01-01 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2020-04-01 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2020-01-01 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2018-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2019-04-01 2019-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2019-01-01 2019-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:StockOptionMember 2019-12-31 0001363829 us-gaap:InterestRateSwapMember 2019-10-31 0001363829 us-gaap:InterestRateSwapMember 2020-04-01 2020-06-30 0001363829 us-gaap:InterestRateSwapMember 2020-01-01 2020-06-30 0001363829 us-gaap:InterestRateSwapMember 2019-10-01 2020-04-07 0001363829 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:InterestRateSwapMember 2019-12-31 0001363829 esgr:NonlifeRunoffSegmentMember 2020-06-30 0001363829 esgr:AtriumSegmentMember 2020-06-30 0001363829 esgr:StarStoneSegmentMember 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember 2019-12-31 0001363829 esgr:AtriumSegmentMember 2019-12-31 0001363829 esgr:StarStoneSegmentMember 2019-12-31 0001363829 esgr:NonLifeRunOffandStarStoneSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:AtriumSegmentMember esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:AtriumSegmentMember esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:TopTenReinsurersMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-01-01 2019-12-31 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2019-12-31 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesGreaterThanOneMillionDollarsMember 2019-01-01 2019-12-31 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2019-12-31 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:OtherReinsurersBalancesLessThanOneMillionDollarsMember 2019-01-01 2019-12-31 0001363829 esgr:NonlifeRunoffSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:AtriumSegmentMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember esgr:StarStoneSegmentMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-01-01 2019-12-31 esgr:reinsurer 0001363829 esgr:TopTenReinsurersRatedAMinusOrHigherMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:TopTenReinsurersRatedAMinusOrHigherMember us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:TopTenReinsurersNonRatedReinsurersMember 2020-06-30 0001363829 us-gaap:ReinsurerConcentrationRiskMember us-gaap:ReinsuranceRecoverableMember esgr:TopTenReinsurersNonRatedReinsurersMember 2019-12-31 0001363829 us-gaap:EquityMethodInvesteeMember esgr:HannoverRuckSEMember us-gaap:ReinsurerConcentrationRiskMember 2020-06-30 0001363829 us-gaap:EquityMethodInvesteeMember esgr:HannoverRuckSEMember us-gaap:ReinsurerConcentrationRiskMember 2019-12-31 0001363829 us-gaap:EquityMethodInvesteeMember us-gaap:ReinsurerConcentrationRiskMember esgr:LloydsSyndicateMember 2020-06-30 0001363829 us-gaap:EquityMethodInvesteeMember us-gaap:ReinsurerConcentrationRiskMember esgr:LloydsSyndicateMember 2019-12-31 0001363829 esgr:ReinsurersRatedAMinusOrAboveMember 2020-06-30 0001363829 esgr:ReinsurersRatedBelowAMinusMember us-gaap:CededCreditRiskSecuredMember 2020-06-30 0001363829 esgr:ReinsurersRatedBelowAMinusMember us-gaap:CededCreditRiskUnsecuredMember 2020-06-30 0001363829 esgr:ReinsurersRatedAMinusOrAboveMember 2019-12-31 0001363829 esgr:ReinsurersRatedBelowAMinusMember us-gaap:CededCreditRiskSecuredMember 2019-12-31 0001363829 esgr:ReinsurersRatedBelowAMinusMember us-gaap:CededCreditRiskUnsecuredMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-03-31 0001363829 2019-03-31 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2020-06-30 0001363829 esgr:CorporateAndReconcilingItemsMember 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2019-12-31 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2019-12-31 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2019-12-31 0001363829 esgr:CorporateAndReconcilingItemsMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0001363829 us-gaap:DiscontinuedOperationsHeldforsaleMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:StarStoneUSMember 2020-03-31 0001363829 esgr:NonlifeRunoffSegmentMember 2020-04-01 2020-06-30 0001363829 esgr:AtriumSegmentMember 2020-04-01 2020-06-30 0001363829 esgr:StarStoneSegmentMember 2020-04-01 2020-06-30 0001363829 esgr:CorporateAndReconcilingItemsMember 2020-04-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember 2019-04-01 2019-06-30 0001363829 esgr:AtriumSegmentMember 2019-04-01 2019-06-30 0001363829 esgr:StarStoneSegmentMember 2019-04-01 2019-06-30 0001363829 esgr:CorporateAndReconcilingItemsMember 2019-04-01 2019-06-30 0001363829 esgr:NonlifeRunoffSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:AtriumSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:StarStoneSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:CorporateAndReconcilingItemsMember 2020-01-01 2020-06-30 0001363829 esgr:NonlifeRunoffSegmentMember 2019-01-01 2019-06-30 0001363829 esgr:AtriumSegmentMember 2019-01-01 2019-06-30 0001363829 esgr:StarStoneSegmentMember 2019-01-01 2019-06-30 0001363829 esgr:CorporateAndReconcilingItemsMember 2019-01-01 2019-06-30 0001363829 esgr:NonlifeRunoffSegmentMember 2020-03-31 0001363829 esgr:NonlifeRunoffSegmentMember 2019-03-31 0001363829 esgr:NonlifeRunoffSegmentMember 2018-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:NonlifeRunoffSegmentMember 2020-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:NonlifeRunoffSegmentMember 2019-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:NonlifeRunoffSegmentMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:NonlifeRunoffSegmentMember 2018-12-31 0001363829 esgr:NonlifeRunoffSegmentMember 2019-06-30 0001363829 esgr:AtriumSegmentMember 2020-03-31 0001363829 esgr:AtriumSegmentMember 2019-03-31 0001363829 esgr:AtriumSegmentMember 2018-12-31 0001363829 esgr:AtriumSegmentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-03-31 0001363829 esgr:AtriumSegmentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-03-31 0001363829 esgr:AtriumSegmentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0001363829 esgr:AtriumSegmentMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2018-12-31 0001363829 esgr:AtriumSegmentMember 2019-06-30 0001363829 esgr:COVID19Member esgr:AtriumSegmentMember 2020-04-01 2020-06-30 0001363829 esgr:COVID19Member esgr:AtriumSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:StarStoneSegmentMember 2020-03-31 0001363829 esgr:StarStoneSegmentMember 2019-03-31 0001363829 esgr:StarStoneSegmentMember 2018-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:StarStoneSegmentMember 2020-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:StarStoneSegmentMember 2019-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:StarStoneSegmentMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember esgr:StarStoneSegmentMember 2018-12-31 0001363829 esgr:StarStoneSegmentMember 2019-06-30 0001363829 esgr:COVID19Member esgr:StarStoneSegmentMember 2020-04-01 2020-06-30 0001363829 esgr:COVID19Member esgr:StarStoneSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:DefendantAsbestosLiabilitiesMember 2020-06-30 0001363829 esgr:DefendantAsbestosLiabilitiesMember 2019-12-31 0001363829 esgr:DefendantEnvironmentalLiabilitiesMember 2020-06-30 0001363829 esgr:DefendantEnvironmentalLiabilitiesMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-03-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0001363829 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2018-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:PublicEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:PrivateCreditFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:PrivateCreditFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:PrivateCreditFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:PrivateCreditFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:PrivateCreditFundsMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember esgr:UnitedKingdomGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:DebtSecurityGovernmentOtherMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MunicipalBondsMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialMortgageBackedSecuritiesMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 esgr:FundsHeldDirectlyManagedMember us-gaap:FairValueMeasurementsRecurringMember esgr:ShortTermInvestmentsAndFixedMaturitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:PublicEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:PublicEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:ExchangeTradedFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:HedgeFundsFixedIncomeMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PrivateEquityFundsMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:CLOEquityMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember esgr:CLOEquityFundsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:OtherInvestmentsatFairValueMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ReinsuranceRecoverableForPaidAndUnpaidClaimsAndClaimsAdjustmentsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsAssetsMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2019-12-31 0001363829 us-gaap:EquitySecuritiesMember 2020-03-31 0001363829 us-gaap:OtherInvestmentsMember 2020-03-31 0001363829 us-gaap:EquitySecuritiesMember 2020-06-30 0001363829 us-gaap:OtherInvestmentsMember 2020-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember 2019-03-31 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-03-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-03-31 0001363829 us-gaap:AssetBackedSecuritiesMember 2019-03-31 0001363829 us-gaap:EquitySecuritiesMember 2019-03-31 0001363829 us-gaap:OtherInvestmentsMember 2019-03-31 0001363829 us-gaap:CorporateDebtSecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2019-06-30 0001363829 us-gaap:EquitySecuritiesMember 2019-06-30 0001363829 us-gaap:OtherInvestmentsMember 2019-06-30 0001363829 us-gaap:EquitySecuritiesMember 2019-12-31 0001363829 us-gaap:OtherInvestmentsMember 2019-12-31 0001363829 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2018-12-31 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2018-12-31 0001363829 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001363829 us-gaap:EquitySecuritiesMember 2018-12-31 0001363829 us-gaap:OtherInvestmentsMember 2018-12-31 0001363829 us-gaap:CorporateDebtSecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:ResidentialMortgageBackedSecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:CommercialMortgageBackedSecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:AssetBackedSecuritiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember esgr:ValuationTechniqueTransactionalValueMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member srt:MinimumMember us-gaap:MeasurementInputQuotedPriceMember us-gaap:PrivateEquityFundsMember esgr:ValuationTechniqueTransactionalValueMember 2020-06-30 0001363829 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputQuotedPriceMember us-gaap:PrivateEquityFundsMember esgr:ValuationTechniqueTransactionalValueMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember us-gaap:CostApproachValuationTechniqueMember 2020-06-30 0001363829 us-gaap:FairValueInputsLevel3Member us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-03-31 0001363829 us-gaap:ReinsuranceRecoverableMember 2020-03-31 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-03-31 0001363829 us-gaap:ReinsuranceRecoverableMember 2019-03-31 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-04-01 2020-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2020-04-01 2020-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-04-01 2019-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2019-04-01 2019-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2020-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2019-06-30 0001363829 esgr:MeasurementInputDurationMember 2020-04-01 2020-06-30 0001363829 esgr:MeasurementInputDurationMember 2019-04-01 2019-06-30 0001363829 esgr:MeasurementInputCorporateBondYieldMember 2020-04-01 2020-06-30 0001363829 esgr:MeasurementInputCorporateBondYieldMember 2019-04-01 2019-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-12-31 0001363829 us-gaap:ReinsuranceRecoverableMember 2019-12-31 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2018-12-31 0001363829 us-gaap:ReinsuranceRecoverableMember 2018-12-31 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2020-01-01 2020-06-30 0001363829 esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-01-01 2019-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember 2019-01-01 2019-06-30 0001363829 esgr:MeasurementInputDurationMember 2020-01-01 2020-06-30 0001363829 esgr:MeasurementInputDurationMember 2019-01-01 2019-06-30 0001363829 esgr:MeasurementInputCorporateBondYieldMember 2020-01-01 2020-06-30 0001363829 esgr:MeasurementInputCorporateBondYieldMember 2019-01-01 2019-06-30 0001363829 esgr:MeasurementInputWeightedAverageCostOfCapitalMember 2020-01-01 2020-06-30 0001363829 esgr:MeasurementInputWeightedAverageCostOfCapitalMember 2019-01-01 2019-06-30 0001363829 esgr:MeasurementInputRiskCostOfCapitalMember 2020-01-01 2020-06-30 0001363829 esgr:MeasurementInputRiskCostOfCapitalMember 2019-01-01 2019-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEntityCreditRiskMember esgr:InternalModelMember esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MeasurementInputEntityCreditRiskMember esgr:InternalModelMember esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-01-01 2019-12-31 0001363829 us-gaap:ReinsuranceRecoverableMember us-gaap:FairValueMeasurementsRecurringMember esgr:InternalModelMember 2020-01-01 2020-06-30 0001363829 us-gaap:ReinsuranceRecoverableMember us-gaap:FairValueMeasurementsRecurringMember esgr:InternalModelMember 2019-01-01 2019-12-31 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:InternalModelMember esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2020-01-01 2020-06-30 0001363829 us-gaap:FairValueMeasurementsRecurringMember esgr:InternalModelMember esgr:LossesAndLossAdjustmentExpenseLiabilitiesMember 2019-01-01 2019-12-31 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2022Member 2020-06-30 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2029Member 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2020-04-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2019-04-01 2019-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2020-01-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:NonlifeRunoffSegmentMember 2019-01-01 2019-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2020-04-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2019-04-01 2019-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2020-01-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:AtriumSegmentMember 2019-01-01 2019-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2020-04-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2019-04-01 2019-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2020-01-01 2020-06-30 0001363829 us-gaap:OperatingSegmentsMember esgr:StarStoneSegmentMember 2019-01-01 2019-06-30 0001363829 esgr:StarstoneMember 2020-04-01 2020-06-30 0001363829 esgr:StarstoneMember 2020-01-01 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:DistributionRightsMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:DistributionRightsMember 2019-12-31 0001363829 esgr:AtriumSegmentMember us-gaap:TradeDressMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:TradeDressMember 2019-12-31 0001363829 esgr:AtriumSegmentMember esgr:LloydsSyndicateCapacityMember 2020-06-30 0001363829 esgr:AtriumSegmentMember esgr:LloydsSyndicateCapacityMember 2019-12-31 0001363829 esgr:AtriumSegmentMember us-gaap:ContractBasedIntangibleAssetsMember 2020-06-30 0001363829 esgr:AtriumSegmentMember us-gaap:ContractBasedIntangibleAssetsMember 2019-12-31 0001363829 esgr:LloydsSyndicateCapacityMember esgr:StarStoneSegmentMember 2020-06-30 0001363829 esgr:LloydsSyndicateCapacityMember esgr:StarStoneSegmentMember 2019-12-31 0001363829 srt:MinimumMember 2020-01-01 2020-06-30 0001363829 srt:MaximumMember 2020-01-01 2020-06-30 0001363829 esgr:LloydsSyndicateCapacityMember esgr:StarStoneSegmentMember 2020-01-01 2020-06-30 0001363829 esgr:LloydsSyndicateCapacityMember esgr:StarStoneSegmentMember 2020-04-01 2020-06-30 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2022Member 2020-01-01 2020-06-30 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2022Member 2019-12-31 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2029Member 2020-01-01 2020-06-30 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2029Member 2019-12-31 0001363829 us-gaap:SeniorNotesMember 2020-06-30 0001363829 us-gaap:SeniorNotesMember 2019-12-31 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2020-01-01 2020-06-30 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2020-06-30 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2019-12-31 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2020-01-01 2020-06-30 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2020-06-30 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2019-12-31 0001363829 us-gaap:LineOfCreditMember 2020-01-01 2020-06-30 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2022Member 2017-03-10 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2022Member 2017-03-10 2017-03-10 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2029Member 2019-05-28 0001363829 us-gaap:SeniorNotesMember esgr:SeniorNotesDue2029Member 2019-05-28 2019-05-28 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2018-08-16 2018-08-16 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2018-08-16 0001363829 us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember esgr:A2018EGLRevolvingCreditFacilityMember 2020-08-07 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2018-12-27 2018-12-27 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2018-12-27 0001363829 us-gaap:LineOfCreditMember esgr:A2018EGLTermLoanFacilityMember 2019-01-01 2019-12-31 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:FALFacilityMember 2019-02-12 0001363829 us-gaap:LineOfCreditMember esgr:FALFacilityMember 2019-02-12 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:FALFacilityMember 2019-11-06 2019-11-06 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:FALFacilityMember 2019-12-31 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:FALFacilityMember 2020-06-30 0001363829 esgr:A2018FacilityAgreementMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2019-12-06 0001363829 esgr:A2018FacilityAgreementMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2019-12-05 0001363829 esgr:A2018FacilityAgreementMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2019-12-31 0001363829 esgr:A2018FacilityAgreementMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2020-06-30 0001363829 us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:MaidenFacilityAgreementMember 2020-08-04 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:MaidenFacilityAgreementMember 2019-12-31 0001363829 esgr:MaidenFacilityAgreementMember 2019-01-01 2019-12-31 0001363829 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:MaidenFacilityAgreementMember 2020-06-30 0001363829 us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember esgr:A2020LetterOfCreditFacilityMember 2020-08-04 0001363829 esgr:A2018FacilityAgreementMember us-gaap:SubsequentEventMember us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2020-08-04 0001363829 esgr:TridentMember srt:SubsidiariesMember 2019-12-31 0001363829 esgr:TridentMember srt:SubsidiariesMember 2020-06-30 0001363829 esgr:DowlingMember srt:SubsidiariesMember 2020-06-30 0001363829 esgr:DowlingMember srt:SubsidiariesMember 2019-12-31 0001363829 us-gaap:SeriesDPreferredStockMember 2020-02-04 2020-02-04 0001363829 us-gaap:SeriesEPreferredStockMember 2020-02-04 2020-02-04 0001363829 us-gaap:SeriesDPreferredStockMember 2020-05-05 2020-05-05 0001363829 us-gaap:SeriesEPreferredStockMember 2020-05-05 2020-05-05 0001363829 us-gaap:SubsequentEventMember us-gaap:SeriesDPreferredStockMember 2020-08-05 2020-08-05 0001363829 us-gaap:SubsequentEventMember us-gaap:SeriesEPreferredStockMember 2020-08-05 2020-08-05 0001363829 2020-03-09 0001363829 2020-03-09 2020-03-23 0001363829 srt:ChiefExecutiveOfficerMember esgr:JointShareOwnershipPlanMember 2020-01-21 2020-01-21 0001363829 esgr:JointShareOwnershipPlanMember 2020-01-21 2020-01-21 0001363829 esgr:RestrictedStockandRestrictedStockUnitsMember 2020-04-01 2020-06-30 0001363829 esgr:RestrictedStockandRestrictedStockUnitsMember 2019-04-01 2019-06-30 0001363829 esgr:RestrictedStockandRestrictedStockUnitsMember 2020-01-01 2020-06-30 0001363829 esgr:RestrictedStockandRestrictedStockUnitsMember 2019-01-01 2019-06-30 0001363829 us-gaap:PerformanceSharesMember 2020-04-01 2020-06-30 0001363829 us-gaap:PerformanceSharesMember 2019-04-01 2019-06-30 0001363829 us-gaap:PerformanceSharesMember 2020-01-01 2020-06-30 0001363829 us-gaap:PerformanceSharesMember 2019-01-01 2019-06-30 0001363829 us-gaap:StockAppreciationRightsSARSMember 2020-04-01 2020-06-30 0001363829 us-gaap:StockAppreciationRightsSARSMember 2019-04-01 2019-06-30 0001363829 us-gaap:StockAppreciationRightsSARSMember 2020-01-01 2020-06-30 0001363829 us-gaap:StockAppreciationRightsSARSMember 2019-01-01 2019-06-30 0001363829 us-gaap:EmployeeStockMember esgr:EmployeeStockPurchasePlanMember 2020-04-01 2020-06-30 0001363829 us-gaap:EmployeeStockMember esgr:EmployeeStockPurchasePlanMember 2019-04-01 2019-06-30 0001363829 us-gaap:EmployeeStockMember esgr:EmployeeStockPurchasePlanMember 2020-01-01 2020-06-30 0001363829 us-gaap:EmployeeStockMember esgr:EmployeeStockPurchasePlanMember 2019-01-01 2019-06-30 0001363829 esgr:LongTermIncentivePlansMember esgr:TimeBasedRestrictedStockMember 2020-04-01 2020-06-30 0001363829 esgr:LongTermIncentivePlansMember esgr:TimeBasedRestrictedStockMember 2019-04-01 2019-06-30 0001363829 esgr:LongTermIncentivePlansMember esgr:TimeBasedRestrictedStockMember 2020-01-01 2020-06-30 0001363829 esgr:LongTermIncentivePlansMember esgr:TimeBasedRestrictedStockMember 2019-01-01 2019-06-30 0001363829 esgr:StarStoneLongTermIncentivePlanMember esgr:TimeBasedRestrictedStockMember 2020-04-01 2020-06-30 0001363829 esgr:StarStoneLongTermIncentivePlanMember esgr:TimeBasedRestrictedStockMember 2019-04-01 2019-06-30 0001363829 esgr:StarStoneLongTermIncentivePlanMember esgr:TimeBasedRestrictedStockMember 2020-01-01 2020-06-30 0001363829 esgr:StarStoneLongTermIncentivePlanMember esgr:TimeBasedRestrictedStockMember 2019-01-01 2019-06-30 0001363829 esgr:DeferredCompensationPlanMember 2020-04-01 2020-06-30 0001363829 esgr:DeferredCompensationPlanMember 2019-04-01 2019-06-30 0001363829 esgr:DeferredCompensationPlanMember 2020-01-01 2020-06-30 0001363829 esgr:DeferredCompensationPlanMember 2019-01-01 2019-06-30 0001363829 us-gaap:EmployeeStockMember 2020-04-01 2020-06-30 0001363829 us-gaap:EmployeeStockMember 2019-04-01 2019-06-30 0001363829 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001363829 us-gaap:EmployeeStockMember 2019-01-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:TridentMember 2012-05-01 2012-07-31 0001363829 esgr:StonePointMember srt:AffiliatedEntityMember 2020-06-30 esgr:general_partner 0001363829 srt:AffiliatedEntityMember esgr:TridentMember 2013-11-06 0001363829 esgr:NorthBayMember esgr:NorthBayShareholdersMember 2018-10-01 2018-10-01 0001363829 esgr:NorthBayMember esgr:TridentMember 2018-10-01 2018-10-01 0001363829 esgr:NorthBayMember esgr:NorthBayShareholdersMember 2019-04-01 2019-04-01 0001363829 esgr:StarstoneMember 2019-10-01 2019-10-01 0001363829 2019-10-01 2019-10-01 0001363829 srt:AffiliatedEntityMember esgr:TridentMember 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:TridentMember 2019-12-31 0001363829 esgr:MitchellInternationalMember srt:AffiliatedEntityMember 2018-12-31 0001363829 esgr:SoundPointCapitalMember srt:AffiliatedEntityMember us-gaap:SeniorLoansMember 2020-06-30 0001363829 esgr:SoundPointCapitalMember srt:AffiliatedEntityMember us-gaap:SeniorLoansMember 2020-04-01 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:ShortTermInvestmentsMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:ShortTermInvestmentsMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:FixedMaturitiesMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:FixedMaturitiesMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:HedgeFundsMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:HedgeFundsMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:FixedIncomeFundsMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:FixedIncomeFundsMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:PrivateEquityFundsMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:PrivateEquityFundsMember 2019-12-31 0001363829 esgr:CLOEquityMember esgr:StonePointAndAffiliatedEntitiesMember 2020-06-30 0001363829 esgr:CLOEquityMember esgr:StonePointAndAffiliatedEntitiesMember 2019-12-31 0001363829 esgr:CLOEquityFundsMember esgr:StonePointAndAffiliatedEntitiesMember 2020-06-30 0001363829 esgr:CLOEquityFundsMember esgr:StonePointAndAffiliatedEntitiesMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember esgr:PrivateDebtMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember esgr:PrivateDebtMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:RealEstateFundsMember 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember us-gaap:RealEstateFundsMember 2019-12-31 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2020-04-01 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2019-04-01 2019-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2020-01-01 2020-06-30 0001363829 esgr:StonePointAndAffiliatedEntitiesMember 2019-01-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:HillhouseAffiliatesMember 2020-06-30 0001363829 esgr:HillhouseMember esgr:InReFundMember srt:AffiliatedEntityMember 2020-06-30 0001363829 esgr:HillhouseInReFundL.P.Member us-gaap:FixedIncomeSecuritiesMember srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001363829 esgr:NorthAmericanEquitiesMember esgr:HillhouseInReFundL.P.Member srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001363829 esgr:HillhouseInReFundL.P.Member srt:AffiliatedEntityMember esgr:InternationalEquitiesMember 2020-01-01 2020-06-30 0001363829 esgr:FinancingDerivativesAndOtherItemsMember esgr:HillhouseInReFundL.P.Member srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember esgr:HillhouseAffiliatesMember 2020-06-30 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember esgr:HillhouseAffiliatesMember 2019-12-31 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember 2020-06-30 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember 2019-12-31 0001363829 esgr:HillhouseMember esgr:InReFundMember srt:AffiliatedEntityMember 2019-12-31 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember esgr:OtherFundsMember 2020-06-30 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember esgr:OtherFundsMember 2019-12-31 0001363829 esgr:HillhouseMember 2020-06-30 0001363829 esgr:HillhouseMember 2019-12-31 0001363829 esgr:HillhouseMember srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001363829 esgr:MonumentMember 2016-10-01 2020-06-30 0001363829 esgr:MonumentMember 2016-10-01 2019-12-31 iso4217:EUR 0001363829 esgr:SubsidiaryOfMonumentMember esgr:TransferOfLifeAssurancePoliciesMember 2019-05-31 0001363829 esgr:MonumentMember 2020-04-01 2020-06-30 0001363829 esgr:MonumentMember 2020-01-01 2020-06-30 0001363829 2017-01-01 0001363829 us-gaap:EquityMethodInvesteeMember esgr:ClearSpringMember 2020-06-30 0001363829 esgr:StarstoneMember esgr:ClearSpringMember 2020-06-30 0001363829 esgr:StarstoneMember esgr:ClearSpringMember 2019-12-31 0001363829 esgr:StarstoneMember esgr:ClearSpringMember 2017-01-01 2017-01-01 0001363829 esgr:ClearSpringMember 2017-01-01 2017-01-01 0001363829 esgr:StarstoneMember us-gaap:EquityMethodInvesteeMember esgr:ClearSpringMember 2020-06-30 0001363829 esgr:StarstoneMember us-gaap:EquityMethodInvesteeMember esgr:ClearSpringMember 2019-12-31 0001363829 esgr:ClearSpringMember 2020-06-30 0001363829 esgr:ClearSpringMember 2019-12-31 0001363829 esgr:StarstoneMember srt:AffiliatedEntityMember esgr:ClearSpringMember 2020-04-01 2020-06-30 0001363829 esgr:StarstoneMember srt:AffiliatedEntityMember esgr:ClearSpringMember 2019-04-01 2019-06-30 0001363829 esgr:StarstoneMember srt:AffiliatedEntityMember esgr:ClearSpringMember 2020-01-01 2020-06-30 0001363829 esgr:StarstoneMember srt:AffiliatedEntityMember esgr:ClearSpringMember 2019-01-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:ClearSpringMember 2020-04-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:ClearSpringMember 2019-04-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:ClearSpringMember 2020-01-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:ClearSpringMember 2019-01-01 2019-06-30 0001363829 esgr:EvergreenParentL.P.Member srt:AffiliatedEntityMember 2018-11-01 2018-11-30 0001363829 esgr:AmTrustFinancialServicesInc.Member srt:AffiliatedEntityMember 2018-11-30 0001363829 esgr:EvergreenParentL.P.Member srt:AffiliatedEntityMember 2019-12-01 2019-12-31 0001363829 esgr:EvergreenParentL.P.Member srt:AffiliatedEntityMember 2019-12-31 0001363829 esgr:TridentPineMember esgr:EvergreenParentL.P.Member srt:AffiliatedEntityMember 2018-11-30 0001363829 esgr:EvergreenParentL.P.Member srt:AffiliatedEntityMember 2018-01-01 2018-12-31 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2019-12-31 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2020-04-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2019-04-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2020-01-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:AmTrustFinancialServicesInc.Member 2019-01-01 2019-06-30 0001363829 esgr:CitcoIIILimitedMember srt:AffiliatedEntityMember esgr:TridentMember 2018-06-01 2018-06-30 0001363829 esgr:CitcoIIILimitedMember srt:AffiliatedEntityMember esgr:TridentMember 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2018-12-31 0001363829 esgr:EnhanzedReMember esgr:EnstarMember 2018-12-31 0001363829 esgr:EnhanzedReMember esgr:AllianzMember 2018-12-31 0001363829 esgr:HillhouseMember esgr:EnhanzedReMember 2018-12-31 0001363829 esgr:EnhanzedReMember esgr:EnstarMember 2020-06-30 0001363829 esgr:EnhanzedReMember esgr:ZurichMember 2020-01-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2019-12-31 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2020-04-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2019-04-01 2019-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2020-01-01 2020-06-30 0001363829 srt:AffiliatedEntityMember esgr:EnhanzedReMember 2019-01-01 2019-06-30 0001363829 country:US 2020-01-01 2020-06-30 0001363829 esgr:LimitedParentalGuaranteeMember 2020-06-30 0001363829 esgr:LimitedParentalGuaranteeMember 2019-12-31 0001363829 srt:MinimumMember 2020-06-30 0001363829 srt:MaximumMember 2020-06-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
Commission File Number 001-33289
esgr-20200630_g1.jpg
ENSTAR GROUP LIMITED
(Exact name of Registrant as specified in its charter)
BERMUDA N/A
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
Windsor Place , 3rd Floor , 22 Queen Street , Hamilton HM JX , Bermuda
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: ( 441 ) 292-3645
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
Ordinary shares, par value $1.00 per share ESGR The NASDAQ Stock Market LLC
Depositary Shares, Each Representing a 1/1,000th Interest in a 7.00% ESGRP The NASDAQ Stock Market LLC
Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Share, Series D, Par Value $1.00 Per Share
Depositary Shares, Each Representing a 1/1,000th Interest in a 7.00% ESGRO The NASDAQ Stock Market LLC
Perpetual Non-Cumulative Preferred Share, Series E, Par Value $1.00 Per Share
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes No þ
As at August 7, 2020, the registrant had outstanding 18,636,497 voting ordinary shares and 3,509,682 non-voting convertible ordinary shares, each par value $1.00 per share.




Enstar Group Limited
Quarterly Report on Form 10-Q
For the Period Ended June 30, 2020

Table of Contents
Page
PART I
Item 1.
Item 2.
Item 3.
Item 4.
PART II
Item 1.
Item 1A.
Item 2.
Item 6.



PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONSOLIDATED FINANCIAL STATEMENTS Page

1


ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED BALANCE SHEETS
As of June 30, 2020 (unaudited) and December 31, 2019
June 30, 2020 December 31, 2019
(expressed in thousands of U.S. dollars, except share data)
ASSETS
Short-term investments, trading, at fair value $ 10,216 $ 51,490
Short-term investments, available-for-sale, at fair value (amortized cost: 2020 — $ 87,977 ; 2019 — $ 128,311 ; net of allowance: 2020 — $ nil )
87,770 128,335
Fixed maturities, trading, at fair value 5,365,157 6,143,335
Fixed maturities, available-for-sale, at fair value (amortized cost: 2020 — $ 2,180,684 ; 2019 — $ 1,537,815 ; net of allowance: 2020 — $ 3,673 )
2,215,211 1,538,052
Funds held - directly managed 1,168,856 1,187,552
Equities, at fair value 640,771 726,721
Other investments, at fair value 3,278,785 2,518,031
Equity method investments 362,398 326,277
Total investments ( Note 5 and Note 11 )
13,129,164 12,619,793
Cash and cash equivalents 651,855 624,472
Restricted cash and cash equivalents 336,666 346,877
Premiums receivable 541,450 491,511
Deferred tax assets ( Note 19 )
155,245 155,793
Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2020 — $ 143,653 ) ( Note 7 )
1,422,670 1,485,616
Reinsurance balances recoverable on paid and unpaid losses, at fair value ( Note 7 and Note 11 )
671,384 695,518
Insurance balances recoverable (net of allowance: 2020 — $ 8,346 ) ( Note 10 )
428,277 448,855
Funds held by reinsured companies 1,466,596 475,732
Deferred acquisition costs 93,256 116,513
Goodwill and intangible assets ( Note 13 )
178,552 191,568
Other assets 703,898 699,081
Assets held for sale ( Note 4 )
1,514,902 1,474,770
TOTAL ASSETS $ 21,293,915 $ 19,826,099
LIABILITIES
Losses and loss adjustment expenses ( Note 9 )
$ 8,138,897 $ 7,247,282
Losses and loss adjustment expenses, at fair value ( Note 9 and Note 11 )
2,454,539 2,621,122
Defendant asbestos and environmental liabilities ( Note 10 )
808,062 847,685
Unearned premiums 513,308 533,692
Insurance and reinsurance balances payable 573,089 420,546
Deferred tax liabilities ( Note 19 )
16,559 16,074
Debt obligations ( Note 14 )
1,542,022 1,191,207
Other liabilities 442,845 444,818
Liabilities held for sale ( Note 4 )
1,237,595 1,208,531
TOTAL LIABILITIES 15,726,916 14,530,957
COMMITMENTS AND CONTINGENCIES ( Note 21 )
REDEEMABLE NONCONTROLLING INTEREST ( Note 15 )
366,533 438,791
SHAREHOLDERS’ EQUITY ( Note 16 )
Ordinary shares (par value $ 1 each, issued and outstanding 2020: 22,144,399 ; 2019: 21,511,505 ):
Voting Ordinary shares (issued and outstanding 2020: 18,634,717 ; 2019: 18,001,823 )
18,635 18,002
Non-voting convertible ordinary Series C Shares (issued and outstanding 2020 and 2019: 2,599,672 )
2,600 2,600
Non-voting convertible ordinary Series E Shares (issued and outstanding 2020 and 2019: 910,010 )
910 910
Preferred Shares:
Series C Preferred Shares (issued and held in treasury 2020 and 2019: 388,571 )
389 389
Series D Preferred Shares (issued and outstanding 2020 and 2019: 16,000 )
400,000 400,000
Series E Preferred Shares (issued and outstanding 2020 and 2019: 4,400 )
110,000 110,000
Treasury shares, at cost (Series C Preferred shares 2020 and 2019: 388,571 )
( 421,559 ) ( 421,559 )
Joint Share Ownership Plan (voting ordinary shares, held in trust 2020: 565,630 )
( 566 )
Additional paid-in capital 1,835,115 1,836,778
Accumulated other comprehensive income 51,285 7,171
Retained earnings 3,190,104 2,887,892
Total Enstar Shareholders’ Equity 5,186,913 4,842,183
Noncontrolling interest ( Note 15 )
13,553 14,168
TOTAL SHAREHOLDERS’ EQUITY 5,200,466 4,856,351
TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY $ 21,293,915 $ 19,826,099
See accompanying notes to the unaudited condensed consolidated financial statements
2


ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)
For the Three and Six Months Ended June 30, 2020 and 2019
Three Months Ended
June 30,
Six Months Ended
June 30,
2020 2019 2020 2019
(expressed in thousands of U.S. dollars, except share and per share data)
INCOME
Net premiums earned $ 142,871 $ 190,962 $ 302,222 $ 442,909
Fees and commission income 10,010 6,017 17,538 12,494
Net investment income 94,443 74,271 169,157 149,922
Net realized and unrealized gains 967,608 260,669 338,547 713,429
Other income (expense) ( 1,087 ) 11,025 19,357 16,836
1,213,845 542,944 846,821 1,335,590
EXPENSES
Net incurred losses and loss adjustment expenses 186,692 146,554 229,992 402,853
Life and annuity policy benefits 2,194 2,290
Acquisition costs 49,067 51,081 95,110 128,882
General and administrative expenses 144,830 100,676 243,258 198,939
Interest expense 14,018 13,036 27,433 24,072
Net foreign exchange (gains) losses 5,158 ( 2,579 ) ( 6,781 ) ( 6,432 )
399,765 310,962 589,012 750,604
EARNINGS BEFORE INCOME TAXES 814,080 231,982 257,809 584,986
Income tax expense ( 16,652 ) ( 7,698 ) ( 11,380 ) ( 11,800 )
Earnings (loss) from equity method investments ( 8,790 ) 17,713 3,660 26,485
NET EARNINGS FROM CONTINUING OPERATIONS 788,638 241,997 250,089 599,671
NET EARNINGS (LOSS) FROM DISCONTINUED OPERATIONS, NET OF INCOME TAXES ( 1,152 ) ( 3,943 ) ( 3,221 ) 4,125
NET EARNINGS 787,486 238,054 246,868 603,796
Net loss attributable to noncontrolling interest 19,992 2,713 52,714 4,861
NET EARNINGS ATTRIBUTABLE TO ENSTAR 807,478 240,767 299,582 608,657
Dividends on preferred shares ( 8,925 ) ( 8,925 ) ( 17,850 ) ( 18,064 )
NET EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 798,553 $ 231,842 $ 281,732 $ 590,593
Earnings (loss) per ordinary share attributable to Enstar:
Basic:
Net earnings from continuing operations $ 37.06 $ 10.90 $ 13.16 $ 27.40
Net earnings (loss) from discontinued operations ( 0.03 ) ( 0.11 ) ( 0.09 ) 0.11
Net earnings per ordinary share $ 37.03 $ 10.79 $ 13.07 $ 27.51
Diluted:
Net earnings from continuing operations $ 36.68 $ 10.81 $ 13.02 $ 27.15
Net earnings (loss) from discontinued operations ( 0.03 ) ( 0.11 ) ( 0.09 ) 0.11
Net earnings per ordinary share $ 36.65 $ 10.70 $ 12.93 $ 27.26
Weighted average ordinary shares outstanding:
Basic 21,565,240 21,477,772 21,557,542 21,470,675
Diluted 21,789,242 21,675,451 21,788,331 21,661,769

See accompanying notes to the unaudited condensed consolidated financial statements
3


ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
For the Three and Six Months Ended June 30, 2020 and 2019
Three Months Ended
June 30,
Six Months Ended
June 30,
2020 2019 2020 2019
(expressed in thousands of U.S. dollars)
NET EARNINGS $ 787,486 $ 238,054 $ 246,868 $ 603,796
Other comprehensive income (loss), net of income taxes:
Unrealized holding gains on fixed income available-for-sale investments arising during the period 112,506 1,244 53,771 4,907
Reclassification adjustment for change in allowance for credit losses recognized in net earnings ( 10,762 ) 2,450
Reclassification adjustment for net realized losses included in net earnings ( 4,222 ) ( 4,218 ) ( 4,010 ) ( 4,157 )
Unrealized gains (losses) arising during the period, net of reclassification adjustments 97,522 ( 2,974 ) 52,211 750
Total cumulative currency translation adjustment ( 1,205 ) ( 1,038 ) ( 1,891 ) ( 1,839 )
Total other comprehensive income (loss) 96,317 ( 4,012 ) 50,320 ( 1,089 )
Comprehensive income 883,803 234,042 297,188 602,707
Comprehensive loss attributable to noncontrolling interest 9,616 2,642 46,508 4,706
COMPREHENSIVE INCOME ATTRIBUTABLE TO ENSTAR $ 893,419 $ 236,684 $ 343,696 $ 607,413

See accompanying notes to the unaudited condensed consolidated financial statements

4


ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED)
For the Three and Six Months Ended June 30, 2020 and 2019
Three Months Ended
June 30,
Six Months Ended
June 30,
2020 2019 2020 2019
(expressed in thousands of U.S. dollars)
Share Capital — Voting Ordinary Shares
Balance, beginning of period $ 18,610 $ 17,958 $ 18,002 $ 17,950
Issue of shares 25 17 726 25
Shares repurchased ( 93 )
Balance, end of period $ 18,635 $ 17,975 $ 18,635 $ 17,975
Share Capital — Non-Voting Convertible Ordinary Series C Shares
Balance, beginning and end of period $ 2,600 $ 2,600 $ 2,600 $ 2,600
Share Capital — Non-Voting Convertible Ordinary Series E Shares
Balance, beginning and end of period $ 910 $ 910 $ 910 $ 910
Share Capital — Series C Convertible Participating Non-Voting Preferred Shares
Balance, beginning and end of period $ 389 $ 389 $ 389 $ 389
Share Capital — Series D Preferred Shares
Balance, beginning and end of period $ 400,000 $ 400,000 $ 400,000 $ 400,000
Share Capital — Series E Preferred Shares
Balance, beginning and end of period $ 110,000 $ 110,000 $ 110,000 $ 110,000
Treasury Shares (Series C Preferred Shares)
Balance, beginning and end of period $ ( 421,559 ) $ ( 421,559 ) $ ( 421,559 ) $ ( 421,559 )
Joint Share Ownership Plan — Voting Ordinary Shares, Held in Trust
Balance, beginning of period $ ( 566 ) $ $ $
Issue of shares ( 566 )
Balance, end of period $ ( 566 ) $ $ ( 566 ) $
Additional Paid-in Capital
Balance, beginning of period $ 1,825,798 $ 1,809,107 $ 1,836,778 $ 1,804,664
Issue of voting ordinary shares ( 109 ) 455 ( 1,360 ) 921
Shares repurchased ( 12,433 )
Amortization of share-based compensation 9,426 12,640 12,130 16,617
Balance, end of period $ 1,835,115 $ 1,822,202 $ 1,835,115 $ 1,822,202
Accumulated Other Comprehensive Income (Loss)
Balance, beginning of period $ ( 34,656 ) $ 13,279 $ 7,171 $ 10,440
Currency translation adjustment
Balance, beginning of period 7,862 10,183 8,548 10,986
Change in currency translation adjustment ( 1,038 ) ( 1,036 ) ( 1,724 ) ( 1,839 )
Balance, end of period 6,824 9,147 6,824 9,147
Defined benefit pension liability
Balance, beginning and end of period ( 945 ) ( 987 ) ( 945 ) ( 987 )
Unrealized gains (losses) on available-for-sale investments
Balance, beginning of period ( 41,573 ) 4,083 ( 432 ) 441
Change in unrealized gains (losses) on available-for-sale investments 86,979 ( 3,047 ) 45,838 595
Balance, end of period 45,406 1,036 45,406 1,036
Balance, end of period $ 51,285 $ 9,196 $ 51,285 $ 9,196
Retained Earnings
Balance, beginning of period $ 2,375,073 $ 2,335,028 $ 2,887,892 $ 1,976,539
Net earnings 787,486 238,054 246,868 603,796
Net loss attributable to noncontrolling interest 19,992 2,713 52,714 4,861
Dividends on preferred shares ( 8,925 ) ( 8,925 ) ( 17,850 ) ( 18,064 )
Change in redemption value of redeemable noncontrolling interests 16,478 6,247 26,628 5,985
Cumulative effect of change in accounting principle ( 6,148 )
Balance, end of period $ 3,190,104 $ 2,573,117 $ 3,190,104 $ 2,573,117
Noncontrolling Interest (excludes Redeemable Noncontrolling Interest)
Balance, beginning of period $ 13,405 $ 12,452 $ 14,168 $ 12,056
Purchase of noncontrolling shareholders' interest in subsidiaries ( 47 ) ( 47 )
Net earnings (loss) attributable to noncontrolling interest 148 204 ( 615 ) 600
Balance, end of period $ 13,553 $ 12,609 $ 13,553 $ 12,609
Total Shareholders' Equity $ 5,200,466 $ 4,527,439 $ 5,200,466 $ 4,527,439

See accompanying notes to the unaudited condensed consolidated financial statements
5


ENSTAR GROUP LIMITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
For the Six Months Ended June 30, 2020 and 2019
Six Months Ended June 30,
2020 2019
(expressed in thousands of U.S. dollars)
OPERATING ACTIVITIES:
Net earnings $ 246,868 $ 603,796
Net loss (earnings) loss from discontinued operations, net of income taxes 3,221 ( 4,125 )
Adjustments to reconcile net earnings to cash flows provided by operating activities:
Realized gains on sale of investments ( 61,406 ) ( 25,854 )
Unrealized gains on investments ( 277,141 ) ( 687,575 )
Depreciation and other amortization 30,006 15,722
Earnings from equity method investments ( 3,660 ) ( 26,485 )
Sales and maturities of trading securities 2,165,843 2,689,095
Purchases of trading securities ( 1,175,992 ) ( 2,678,627 )
Other non-cash items 11,082 18,187
Changes in:
Reinsurance balances recoverable on paid and unpaid losses 84,827 ( 179,566 )
Funds held by reinsured companies ( 990,864 ) ( 54,188 )
Losses and loss adjustment expenses 741,100 306,509
Defendant asbestos and environmental liabilities ( 39,623 ) ( 19,056 )
Insurance and reinsurance balances payable 152,886 66,639
Unearned premiums ( 20,384 ) 58,228
Premiums receivable ( 49,939 ) 130,435
Other operating assets and liabilities 32,337 ( 91,293 )
Net cash flows provided by operating activities 849,161 121,842
INVESTING ACTIVITIES:
Acquisitions, net of cash acquired 1,071
Sales and maturities of available-for-sale securities 1,156,786 90,536
Purchase of available-for-sale securities ( 1,759,023 ) ( 147 )
Purchase of other investments ( 656,757 ) ( 284,600 )
Proceeds from other investments 136,592 85,355
Purchase of equity method investments ( 33,000 ) ( 38,202 )
Dividends from equity method investments 237
Other investing activities ( 974 ) ( 2,844 )
Net cash flows used in investing activities ( 1,156,139 ) ( 148,831 )
FINANCING ACTIVITIES:
Dividends on preferred shares ( 17,850 ) ( 18,064 )
Dividends paid to noncontrolling interest ( 11,556 )
Purchase of noncontrolling shareholders' interest in subsidiaries ( 47 )
Repurchase of shares ( 12,526 )
Receipt of loans 364,000 1,050,806
Repayment of loans ( 14,000 ) ( 415,370 )
Net cash flows provided by financing activities 319,624 605,769
EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH AND CASH EQUIVALENTS 4,526 ( 6,436 )
NET INCREASE IN CASH AND CASH EQUIVALENTS 17,172 572,344
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 971,349 901,996
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 988,521 $ 1,474,340
Supplemental Cash Flow Information:
Income taxes paid, net of refunds $ 15,450 $ 522
Interest paid $ 26,783 $ 21,246
Reconciliation to Consolidated Balance Sheets:
Cash and cash equivalents 651,855 1,032,583
Restricted cash and cash equivalents 336,666 441,757
Cash, cash equivalents and restricted cash $ 988,521 $ 1,474,340
See accompanying notes to the unaudited condensed consolidated financial statements
6


ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Tabular information expressed in thousands of U.S. dollars except share and per share data)

1. SIGNIFICANT ACCOUNTING POLICIES
Basis of Preparation
These unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, these financial statements reflect all adjustments consisting of normal recurring items considered necessary for a fair presentation under U.S. GAAP. The results of operations for any interim period are not necessarily indicative of results for the full year. These financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2019. All significant inter-company transactions and balances have been eliminated. In these notes, the terms "we," "us," "our," "Enstar," or "the Company" refer to Enstar Group Limited and its consolidated subsidiaries. Certain prior period amounts have been reclassified to conform to the current period presentation as described in further detail in Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations." These reclassifications had no impact on net earnings.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Our actual results may differ materially from these estimates. Results of changes in estimates are reflected in earnings in the period in which the change is made. Accounting policies that we believe are most dependent on assumptions and estimates are considered to be our critical accounting policies and are related to the determination of:
liability for losses and loss adjustment expenses ("LAE");
reinsurance balances recoverable on paid and unpaid losses;
defendant asbestos and environmental liabilities and related insurance balances recoverable;
valuation allowances on reinsurance balances recoverable and deferred tax assets;
impairment charges, including credit allowances on investment securities classified as available-for-sale ("AFS"), and impairments on goodwill, intangible assets and deferred charge assets;
gross and net premiums written and net premiums earned;
fair value measurements of investments;
fair value estimates associated with accounting for acquisitions;
fair value estimates associated with loss portfolio transfer reinsurance agreements for which we have elected the fair value option; and
redeemable noncontrolling interests.

Updated Accounting Policies
The following accounting policies have been updated to reflect our adoption of Accounting Standards Update ("ASU") 2016-13 - Financial Instruments - Credit losses - Measurement of Credit Losses on Financial Instruments, effective January 1, 2020 as described in detail below under "New Accounting Standards Adopted in 2020."
Short-term investments and fixed maturity investments
We perform a detailed analysis every reporting period to identify any credit losses on our investment portfolios not measured at fair value through net earnings.
7

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Some of the factors that we consider when assessing whether an allowance for credit losses is required on our debt securities include: (1) the extent to which the fair value has been less than the amortized cost; (2) the financial condition, near-term and long-term prospects of the issuer, including the relevant industry conditions and trends, and implications of rating agency actions and offering prices; (3) the likelihood of the recoverability of principal and interest; and (4) whether it is more likely than not that we will be required to sell the security prior to an anticipated recovery in value.
With effect from January 1, 2020, credit losses on our AFS debt securities are recognized through an allowance account which is deducted from the amortized cost basis of the security, with the net carrying value of the security presented on the consolidated balance sheet at the amount expected to be collected. To calculate the amount of the credit loss, we compare the present value of the expected future cash flows with the amortized cost basis of the AFS debt security, with the amount of the credit loss recognized being limited to the excess of the amortized cost basis over the fair value of the AFS debt security, effectively creating a “fair value floor”. See "New Accounting Standards Adopted in 2020" below for the discussion on our adoption of the credit losses standard.
For our AFS debt securities that we do not intend to sell or for which it is more likely than not that we will not be required to sell before an anticipated recovery in value, we separate the credit loss component of any unrealized losses from the amount related to all other factors and report the credit loss component in net realized investment gains (losses) in our consolidated statements of earnings. The unrealized losses related to non-credit factors is reported in other comprehensive income. The allowance for credit losses account is adjusted for any additional credit losses, write-offs and subsequent recoveries.
For our AFS debt securities where we record a credit loss, a determination is made as to the cause of the credit loss and whether we expect a recovery in the fair value of the security. For our AFS debt securities where we expect a recovery in fair value, the constant effective yield method is utilized, and the investment is amortized to par.
For our AFS debt securities that we intend to sell or for which it is more likely than not that we will be required to sell before an anticipated recovery in fair value, the full amount of the unrealized loss is included in net realized investment gains (losses). The new cost basis of the investment is the previous amortized cost basis less the credit loss recognized in net realized investment gains (losses). The new cost basis is not adjusted for any subsequent recoveries in fair value.
We report the investment income accrued on our AFS debt securities within other assets and therefore separately from the underlying AFS debt securities. In addition, due to the short-term period during which accrued investment income remains unpaid, which is typically six months, since the coupon on our AFS debt securities is paid semi-annually, we have elected not to establish an allowance for credit losses on our accrued investment income balances. Accrued investment income is written off through net realized investment gains (losses) at the time the issuer of the debt security defaults or is expected to default on payments.
Uncollectible debt securities are written off when we determine that no additional payments of principal or interest will be received.
Reinsurance Balances Recoverable on Paid and Unpaid Losses
Amounts recoverable from reinsurers are estimated in a manner consistent with the underlying liability for losses and loss adjustment expenses. We report our reinsurance balances recoverable on paid and unpaid losses net of an allowance for estimated uncollectible amounts. The allowance is based upon our ongoing review of the outstanding balances and reflects factors such as the duration of the collection period, credit quality, changes in reinsurer credit standing, default rates specific to the individual reinsurer, the geographical location of the reinsurer, contractual disputes with reinsurers over individual contentious claims, contract language or coverage issues, industry analyst reports and consensus economic forecasts.
A probability-of-default methodology that reflects current and forecasted economic conditions is used to estimate the allowance for uncollectible reinsurance due to credit-related factors. See "New Accounting Standards Adopted in 2020" below for the discussion on our adoption of the credit losses standard.
The allowance also includes estimated uncollectible amounts related to dispute risk with reinsurers. Amounts deemed to be uncollectible, including amounts due from known insolvent reinsurers, are written off against the allowance.
8

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Changes in the allowance, as well as any subsequent collections of amounts previously written off, are reported as part of the net incurred losses and loss adjustment expenses in our consolidated statements of earnings.
On an ongoing basis, we also evaluate and monitor the financial condition of our reinsurers under voluntary schemes of arrangement to minimize our exposure to significant losses from potential insolvencies.
Premiums Receivable and Unearned Premium Reserves
Premiums are recognized as revenues on a pro-rata basis over the coverage period. Unearned premium reserves represent the unexpired portion of policy premiums. For retrospectively rated contracts as well as those whose written premium amounts are recorded based on premium estimates at inception, accrued premiums arising from changes to these estimates are included in premium balances receivable where appropriate. Premium balances receivable are reported net of an allowance for expected credit losses as appropriate. The allowance is based upon our ongoing review of amounts outstanding, historical loss data, including delinquencies and write-offs, current and forecasted economic conditions and other relevant factors. However, the credit risk on our premiums receivable balances is substantially reduced where we have the ability to cancel the underlying policy if the policyholder does not pay the related premium.

New Accounting Standards Adopted in 2020
ASU 2020-04 – Reference Rate Reform
In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU 2020-04 – Reference Rate Reform – Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which is codified in Accounting Standards Codification ("ASC") 848 and which provides entities with temporary optional expedients and exceptions to the existing US GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Inter-bank Offered Rate ("LIBOR") and other inter-bank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate ("SOFR").
Under the provisions of this guidance, entities can elect not to apply certain modification accounting requirements to contracts affected by reference rate reform, if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Entities can also elect various optional expedients for hedging relationships affected by reference rate reform, if certain criteria are met. In addition, entities can make a one-time election to sell, transfer or both sell and transfer debt securities classified as held-to-maturity (“HTM”) that refer to a rate affected by reference rate reform, to AFS or to trading. However, such debt securities must have been classified as HTM before January 1, 2020. Once elected, the amendments in this guidance must be applied prospectively for all eligible contract modifications.
The ASU was effective upon issuance and can be applied through to December 31, 2022. We adopted the ASU upon its issuance and as we transition from LIBOR to alternative reference rates, we will elect the temporary optional expedients and exceptions to the existing US GAAP guidance on contract modifications and hedge accounting permitted by the ASU, as appropriate. The adoption of this standard did not have any impact on our consolidated financial statements and disclosures.
ASU 2020-03 – Codification Improvements to Financial Instruments
In March 2020, the FASB issued ASU 2020-03, which makes narrow-scope improvements to various topics within the codification relating to financial instruments, including the new credit losses standard. The amendments related to certain specific issues covered by the ASU were effective immediately upon the issuance of the ASU, while certain specific issues covered by the ASU and affecting the credit losses standard in ASU 2016-13 are effective in 2020 for those entities that have already adopted ASU 2016-13. We adopted the amendments in this ASU upon its issuance and that adoption did not have a material impact on our consolidated financial statements and the related disclosures.
9

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
ASUs 2016-13, 2018-19, 2019-04, 2019-05, 2019-10 and 2019-11, Financial Instruments – Credit Losses – Measurement of Credit Losses on Financial Instruments
In June 2016, the FASB issued ASU 2016-13, which is codified in ASC 326 - Financial Instruments - Credit Losses , amending the guidance on the impairment of financial instruments and significantly changing how entities measure credit losses for most financial assets and certain other financial instruments, including reinsurance balances recoverable on paid and unpaid losses that are not measured at fair value through net earnings. The ASU replaced the “incurred loss” approach that was previously applied to determine credit losses with an “expected loss” model for financial instruments measured at amortized cost. Under the "expected loss" model, the estimate of expected credit losses should consider historical information, current information, as well as reasonable and supportable forecasts, including estimates of prepayments. The expected credit losses and subsequent adjustments to such losses are recorded through an allowance account that is deducted from the amortized cost basis of the financial asset, with the net carrying value of the financial asset presented on the consolidated balance sheet at the amount expected to be collected.
ASU 2016-13 also amends the other-than-temporary impairment ("OTTI") model that was previously applicable to AFS debt securities, with the new approach now requiring the recognition of impairments relating to credit losses through an allowance account and limiting the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. This revised approach records the full effect of reversals of any credit losses in current period earnings, compared to previous guidance where this reversal was amortized over the lifetime of the security. Under this revised approach, the length of time a security has been in an unrealized loss position will no longer be considered in determining whether to record a credit loss. In addition, the historical and implied volatility of the fair value of a security and recoveries or declines in fair value after the balance sheet date will no longer be considered when making a determination of whether a credit loss exists.
We adopted ASU 2016-13 and all the related amendments on January 1, 2020 using the modified retrospective approach for our financial instruments carried at amortized cost, and prospectively for our AFS debt securities as required by the standard, resulting in an overall reduction in retained earnings of $ 6.1 million as summarized below:
A cumulative effect adjustment of $ 3.0 million relating to our financial instruments carried at amortized cost, which primarily relates to our insurance balances recoverable on paid and unpaid losses. We already carried significant specific allowances for credit losses of $ 147.6 million on our reinsurance balances recoverable on paid and unpaid losses, relating primarily to our Non-life Run-off segment and therefore the adoption of this standard did not have a material impact on our balance sheet; and
$ 3.1 million related to our AFS debt securities whose fair values were less than their amortized cost basis.

Recently Issued Accounting Pronouncements Not Yet Adopted
Note 2 - "Significant Accounting Policies" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 describes accounting pronouncements that were not adopted as of December 31, 2019. Those pronouncements have not yet been adopted unless discussed above in "New Accounting Standards Adopted in 2020."

2. ACQUISITIONS
On October 30, 2019, we completed the acquisition of Morse TEC LLC ("Morse TEC"). For further details, refer to Note 3 - "Acquisitions" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.

3. SIGNIFICANT NEW BUSINESS

Hannover Re
On August 6, 2020, we completed a novation agreement with Hannover Reück SE and an affiliate (“Hannover Re”), pursuant to which we assumed certain legacy asbestos, environmental and workers' compensation exposures. In the transaction, we assumed gross loss reserves of approximately $ 200.0 million, which was equal to the net reinsurance premium consideration received in the transaction.

10

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Munich Re
On July 1, 2020, we completed a business transfer transaction with Great Lakes Insurance SE and HSB Engineering Insurance Limited, both subsidiaries of Munich Reinsurance Company ("Munich Re"), pursuant to which we acquired certain portfolios from their Australian branches. In the transaction, we received total assets of approximately AUD$ 144.8 million (approximately $ 99.8 million) for assuming the associated net insurance reserves, which primarily relate to long tail insurance business.

AXA Group
On June 1, 2020, we completed a loss portfolio transfer reinsurance agreement with AXA XL, a division of AXA SA, to reinsure specified legacy construction general liability multi-year policies. We assumed gross loss reserves of $ 179.7 million, which was equal to the net reinsurance premium consideration received in the transaction. In addition, we provided additional collateral of $ 24.5 million to support our obligations to AXA XL per the terms of the reinsurance agreement.

Aspen
On June 1, 2020, we completed an adverse development cover reinsurance agreement with Aspen Insurance Holdings Limited. In the transaction, we assumed $ 781.6 million of gross reserves for losses incurred on or prior to December 31, 2019 on a diversified mix of property, liability and specialty lines of business across the U.S., U.K. and Europe, in exchange for reinsurance premium consideration of $ 770.0 million and recorded a deferred charge asset of $ 11.7 million. Pursuant to the agreement, we provide $ 770.0 million of cover in excess of a $ 3.8 billion retention, and an additional $ 250.0 million of cover in excess of a $ 4.8 billion retention.

Lyft
On March 31, 2020, we entered into a novation agreement with affiliates of Lyft, Inc. (“Lyft”) and certain underwriting companies of Zurich North America (“Zurich”). In the transaction, in exchange for premium consideration of $ 465.0 million, we reinsured legacy automobile business underwritten by Zurich between October 1, 2015 and September 30, 2018 and which previously had been reinsured by Lyft’s wholly owned subsidiary, Pacific Valley Insurance Company ("PVIC"). Under a separate but related agreement, PVIC provides retrocession reinsurance coverage to us in excess of an $ 816.0 million limit. The transaction was effective on March 31, 2020.

4. DIVESTITURES, HELD-FOR-SALE BUSINESSES AND DISCONTINUED OPERATIONS

Recapitalization of StarStone U.S.
On June 10, 2020, we announced an agreement to recapitalize StarStone US Holdings, Inc. and its subsidiaries ("StarStone U.S.") and appoint a new management team and Board. As part of the recapitalization, we entered into a definitive agreement to sell StarStone U.S. to Core Specialty Insurance Holdings, Inc. ("Core Specialty"), a newly formed entity with equity backing from funds managed by SkyKnight Capital, L.P., Dragoneer Investment Group and Aquiline Capital Partners LLC. We currently have a 59.0 % interest in StarStone U.S. The purchase price will be based on a $ 30.0 million premium to the GAAP tangible book value of StarStone U.S. to be determined on the month end prior to the closing date and will consist of $ 235.0 million of common shares of Core Specialty and cash. The $ 235.0 million of common shares of Core Specialty is expected to represent an estimated 26.1 % interest in Core Specialty after certain co-investments and management equity awards. Our investment in Core Specialty will be accounted for as an equity method investment. Given the proposed transaction, we have classified the StarStone U.S. results as discontinued operations for the periods presented.
In connection with the sale, one of our Non-life Run-off subsidiaries will enter into a loss portfolio transfer reinsurance agreement with StarStone U.S. pursuant to which we will reinsure all of the net loss reserves of StarStone U.S. in respect of premium earned prior to the calendar month end prior to the closing date. We will receive a reinsurance premium equal to the assumed reserves, plus approximately $ 16.0 million. The reinsurance agreement will contain an aggregate limit on our liability equal to $ 130.0 million in excess of the assumed reserves, and our subsidiary's obligations under the reinsurance agreement will be guaranteed by Enstar.
11

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The closing of the transaction is subject to regulatory approvals and other closing conditions and is expected to occur in the second half of 2020.
StarStone U.S. comprises a substantial portion of the StarStone segment. We have classified the assets and liabilities of StarStone U.S. as held-for-sale at June 30, 2020. The following table summarizes the components of assets and liabilities held-for-sale on our consolidated balance sheets as at June 30, 2020 and December 31, 2019:
June 30, 2020 December 31, 2019
ASSETS
Fixed maturities, trading, at fair value $ 156,366 $ 202,994
Fixed maturities, available-for-sale, at fair value 482,758 375,337
Equities, at fair value 4,500 3,000
Other investments, at fair value 7,097 6,389
Total investments 650,721 587,720
Cash and cash equivalents 75,900 78,613
Restricted cash and cash equivalents 9,683 5,815
Premiums receivable 110,034 99,367
Deferred tax assets 14,890 15,191
Reinsurance balances recoverable on paid and unpaid losses 484,583 530,604
Funds held by reinsured companies 30,818 35,861
Deferred acquisition costs 33,615 36,992
Goodwill and intangible assets 24,900 24,900
Other assets 79,758 59,707
TOTAL ASSETS HELD FOR SALE $ 1,514,902 $ 1,474,770
LIABILITIES
Losses and loss adjustment expenses $ 838,682 $ 836,761
Unearned premiums 221,243 218,166
Insurance and reinsurance balances payable 60,155 22,453
Other liabilities 117,515 131,151
TOTAL LIABILITIES HELD FOR SALE $ 1,237,595 $ 1,208,531
NET ASSETS HELD FOR SALE $ 277,307 $ 266,239

As of June 30, 2020 and December 31, 2019, included in the table above were restricted investments of $ 137.4 million and $ 131.0 million, respectively.
The unrealized gains (losses) on AFS investments balance in accumulated other comprehensive income (loss) ("AOCI"), a component of shareholders' equity, included $ 14.2 million and $( 1.0 ) million as at June 30, 2020 and December 31, 2019, respectively, related to StarStone U.S. Upon completion of the sale, this balance will be included in earnings as a component of the gain on sale.
12

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The StarStone U.S. business qualifies as a discontinued operation. The following table summarizes the components of net earnings (loss) from discontinued operations, net of income taxes on the consolidated statements of earnings for the three and six months ended June 30, 2020 and 2019:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
INCOME
Net premiums earned $ 65,403 $ 85,601 $ 165,949 $ 168,941
Fees and commission income 161 365
Net investment income 3,699 4,106 7,414 7,861
Net realized and unrealized gains 6,262 9,042 847 17,073
Other income 24 5 25 6
75,388 98,915 174,235 194,246
EXPENSES
Net incurred losses and loss adjustment expenses 48,115 69,784 112,709 125,889
Acquisition costs 12,251 15,774 32,794 31,761
General and administrative expenses 15,645 16,845 30,729 30,655
Interest expense 591 645 1,180 1,355
Net foreign exchange (gains) losses ( 11 ) ( 9 ) ( 2 ) ( 5 )
76,591 103,039 177,410 189,655
EARNINGS (LOSS) BEFORE INCOME TAXES ( 1,203 ) ( 4,124 ) ( 3,175 ) 4,591
Income tax benefit (expense) 51 181 ( 46 ) ( 466 )
NET EARNINGS (LOSS) FROM DISCONTINUED OPERATIONS, NET OF INCOME TAXES $ ( 1,152 ) $ ( 3,943 ) $ ( 3,221 ) $ 4,125
Net loss (earnings) from discontinued operations attributable to noncontrolling interest 473 1,617 1,321 ( 1,692 )
NET EARNINGS (LOSS) FROM DISCONTINUED OPERATIONS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ ( 679 ) $ ( 2,326 ) $ ( 1,900 ) $ 2,433

The following table presents the cash flows of StarStone U.S. for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30,
2020 2019
Operating activities $ 95,096 $ ( 26,171 )
Investing activities ( 93,940 ) ( 4,972 )
Change in cash and restricted cash of business held for sale $ 1,156 $ ( 31,143 )

13

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Intercompany transactions between StarStone U.S. (Discontinued Operations) and Continuing Operations
The table below presents a summary of the total income and expenses recognized in continuing operations for the three and six months ended June 30, 2020 and 2019, relating to intercompany transactions, primarily intragroup reinsurances, between StarStone U.S. and our other subsidiaries:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Total Income $ 3,650 $ 1,915 $ 7,363 $ 4,709
Total Expenses ( 7,239 ) 30,235 ( 14,899 ) 46,466
Net Earnings (Loss) 10,889 ( 28,320 ) 22,262 ( 41,757 )

Run-off of StarStone International (non-U.S.)
On June 10, 2020, we also announced that we are placing the StarStone non-U.S. international operations ("StarStone International") into an orderly run-off (the "StarStone International Run-Off"). The liabilities associated with the StarStone International Run-Off vary in duration, and the run-off is expected to occur over a number of years. Steps to reduce the size of StarStone International's operations have begun and will involve several phases to occur over time. As a result, we cannot anticipate with certainty the expected completion date of the StarStone International Run-Off.
We continue to evaluate additional strategic options for StarStone International's operations and business. Consequently, such options could have the effect of mitigating costs associated with placing the business into run-off. The remaining StarStone International operations will continue to serve the needs of policyholders and ensure that the companies continue to meet all regulatory requirements. The results of StarStone International are included within continuing operations in the StarStone segment.

14

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
5. INVESTMENTS
We hold: (i) trading portfolios of short-term and fixed maturity investments and equities, carried at fair value; (ii) AFS portfolios of short-term and fixed maturity investments, carried at fair value; (iii) other investments, carried at fair value; (iv) equity method investments; and (v) funds held - directly managed.

Short-Term and Fixed Maturity Investments

Asset Types
The fair values of the underlying asset categories comprising our short-term and fixed maturity investments classified as trading and AFS and the fixed maturity investments included within our funds held - directly managed balance were as follows:
June 30, 2020
Short-term investments, trading Short-term investments, AFS Fixed maturities, trading Fixed maturities, AFS Fixed maturities, funds held - directly managed Total
U.S. government and agency $ 5,924 $ 60,225 $ 166,673 $ 203,972 $ 109,677 $ 546,471
U.K. government 186 155 64,549 42,790 107,680
Other government 3,338 331 376,956 98,852 23,835 503,312
Corporate 768 27,059 3,684,722 1,251,847 600,704 5,565,100
Municipal 86,301 28,606 50,813 165,720
Residential mortgage-backed 176,347 180,138 80,347 436,832
Commercial mortgage-backed 431,610 179,932 228,825 840,367
Asset-backed 377,999 229,074 59,279 666,352
Total fixed maturity and short-term investments $ 10,216 $ 87,770 $ 5,365,157 $ 2,215,211 $ 1,153,480 $ 8,831,834
December 31, 2019
Short-term investments, trading Short-term investments, AFS Fixed maturities, trading Fixed maturities, AFS Fixed maturities, funds held - directly managed Total
U.S. government and agency $ $ 111,583 $ 208,296 $ 269,661 $ 106,537 $ 696,077
U.K. government 24,411 1,069 122,012 14,280 161,772
Other government 21,958 387 575,017 84,760 20,734 702,856
Corporate 5,121 13,915 3,959,288 866,557 603,389 5,448,270
Municipal 1,381 87,451 2,399 49,456 140,687
Residential mortgage-backed 215,521 99,188 86,205 400,914
Commercial mortgage-backed 534,357 49,046 230,343 813,746
Asset-backed 441,393 152,161 76,681 670,235
Total fixed maturity and short-term investments $ 51,490 $ 128,335 $ 6,143,335 $ 1,538,052 $ 1,173,345 $ 9,034,557

Included within residential and commercial mortgage-backed securities as of June 30, 2020 were securities issued by U.S. governmental agencies with a fair value of $ 371.1 million (December 31, 2019: $ 333.3 million). Included within corporate securities as of June 30, 2020 were senior secured loans of $ nil (December 31, 2019: $ 31.4 million).
15

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Contractual Maturities
The contractual maturities of our short-term and fixed maturity investments, classified as trading and AFS and the fixed maturity investments included within our funds held - directly managed balance are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties.
As of June 30, 2020 Amortized
Cost
Fair Value % of Total
Fair
Value
One year or less $ 411,022 $ 411,903 4.7 %
More than one year through two years 642,622 650,200 7.4 %
More than two years through five years 2,084,605 2,146,660 24.3 %
More than five years through ten years 1,931,647 2,048,533 23.2 %
More than ten years 1,466,809 1,630,987 18.5 %
Residential mortgage-backed 430,201 436,832 4.9 %
Commercial mortgage-backed 825,225 840,367 9.5 %
Asset-backed 695,528 666,352 7.5 %
$ 8,487,659 $ 8,831,834 100.0 %

Credit Ratings
The following table sets forth the credit ratings of our short-term and fixed maturity investments classified as trading and AFS and the fixed maturity investments included within our funds held - directly managed balance as of June 30, 2020:
Amortized
Cost
Fair Value % of Total AAA
Rated
AA Rated A Rated BBB
Rated
Non-
Investment
Grade
Not Rated
U.S. government and agency $ 522,106 $ 546,471 6.2 % $ 546,471 $ $ $ $ $
U.K. government 107,185 107,680 1.2 % 2,271 94,987 10,422
Other government 488,650 503,312 5.7 % 250,552 144,733 53,101 45,147 9,779
Corporate 5,268,218 5,565,100 63.0 % 194,895 593,964 2,840,810 1,663,136 262,385 9,910
Municipal 150,546 165,720 1.9 % 10,078 82,087 53,458 20,097
Residential mortgage-backed 430,201 436,832 5.0 % 430,300 31 1,807 1,881 450 2,363
Commercial mortgage-backed 825,225 840,367 9.5 % 575,005 103,238 89,254 60,203 5,625 7,042
Asset-backed 695,528 666,352 7.5 % 291,013 97,699 149,673 117,217 9,045 1,705
Total $ 8,487,659 $ 8,831,834 100.0 % $ 2,300,585 $ 1,116,739 $ 3,198,525 $ 1,907,681 $ 287,284 $ 21,020
% of total fair value 26.0 % 12.6 % 36.2 % 21.6 % 3.3 % 0.3 %
16

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Unrealized Gains and Losses on AFS Short-term and Fixed Maturity Investments
The amortized cost, unrealized gains and losses, allowance for credit losses and fair values of our short-term and fixed maturity investments classified as AFS as of June 30, 2020 were as follows:
Gross Unrealized Losses
As of June 30, 2020 Amortized Cost Gross Unrealized Gains Non-Credit Related Losses
Allowance for Credit Losses (1)
Fair Value
U.S. government and agency $ 258,996 $ 5,505 $ ( 304 ) $ $ 264,197
U.K. government 43,654 38 ( 747 ) 42,945
Other government 96,774 2,645 ( 236 ) 99,183
Corporate 1,248,862 37,470 ( 4,336 ) ( 3,090 ) 1,278,906
Municipal 27,766 840 28,606
Residential mortgage-backed 178,981 2,085 ( 928 ) 180,138
Commercial mortgage-backed 179,412 3,631 ( 2,617 ) ( 494 ) 179,932
Asset-backed 234,216 592 ( 5,645 ) ( 89 ) 229,074
$ 2,268,661 $ 52,806 $ ( 14,813 ) $ ( 3,673 ) $ 2,302,981
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details.
The amortized cost, unrealized gains and losses and fair values of our short-term and fixed maturity investments classified as AFS as of December 31, 2019 were as follows:
As of December 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses
(Non-OTTI)
Fair Value
U.S. government and agency $ 381,488 $ 78 $ ( 322 ) $ 381,244
U.K. government 15,067 282 15,349
Other government 84,116 1,119 ( 88 ) 85,147
Corporate 880,667 3,739 ( 3,934 ) 880,472
Municipal 3,770 12 ( 2 ) 3,780
Residential mortgage-backed 99,646 221 ( 679 ) 99,188
Commercial mortgage-backed 49,219 30 ( 203 ) 49,046
Asset-backed 152,153 127 ( 119 ) 152,161
$ 1,666,126 $ 5,608 $ ( 5,347 ) $ 1,666,387

Gross Unrealized Losses on AFS Short-term and Fixed Maturity Investments
The following table summarizes our short-term and fixed maturity investments classified as AFS that were in a gross unrealized loss position, for which an allowance for credit losses has not been recorded, as of June 30, 2020, aggregated by major security type and length of time in continuous unrealized loss position:
12 Months or Greater Less Than 12 Months Total
As of June 30, 2020 Fair
Value
Gross Unrealized
Losses
Fair
Value
Gross Unrealized
Losses
Fair
Value
Gross Unrealized
Losses
U.S. government and agency $ $ $ 264,197 $ ( 304 ) $ 264,197 $ ( 304 )
U.K. government 42,945 ( 747 ) 42,945 ( 747 )
Other government 169 ( 11 ) 99,014 ( 225 ) 99,183 ( 236 )
Corporate 1,798 ( 267 ) 1,175,077 ( 2,283 ) 1,176,875 ( 2,550 )
Residential mortgage-backed 180,138 ( 928 ) 180,138 ( 928 )
Commercial mortgage-backed 164,704 ( 1,345 ) 164,704 ( 1,345 )
Asset-backed 218,538 ( 5,171 ) 218,538 ( 5,171 )
Total fixed maturity and short-term investments $ 1,967 $ ( 278 ) $ 2,144,613 $ ( 11,003 ) $ 2,146,580 $ ( 11,281 )
17

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table summarizes our short-term and fixed maturity investments classified as AFS that are in a gross unrealized loss position as of December 31, 2019, aggregated by major security type and length of time in continuous unrealized loss position:
12 Months or Greater Less Than 12 Months Total
As of December 31, 2019 Fair
Value
Gross Unrealized
Losses
Fair
Value
Gross Unrealized
Losses
Fair
Value
Gross Unrealized
Losses
U.S. government and agency $ $ $ 193,574 $ ( 322 ) $ 193,574 $ ( 322 )
Other government 1,080 ( 23 ) 37,796 ( 65 ) 38,876 ( 88 )
Corporate 2,754 ( 306 ) 338,965 ( 3,628 ) 341,719 ( 3,934 )
Municipal 128 761 ( 2 ) 889 ( 2 )
Residential mortgage-backed 52,005 ( 679 ) 52,005 ( 679 )
Commercial mortgage-backed 35,777 ( 203 ) 35,777 ( 203 )
Asset-backed 101,591 ( 119 ) 101,591 ( 119 )
Total fixed maturity and short-term investments $ 3,962 $ ( 329 ) $ 760,469 $ ( 5,018 ) $ 764,431 $ ( 5,347 )
As of June 30, 2020 and December 31, 2019, the number of securities classified as AFS in an unrealized loss position for which an allowance for credit loss is not recorded was 474 and 479 , respectively. Of these securities, the number of securities that had been in an unrealized loss position for twelve months or longer was 7 and 12 , respectively.
The contractual terms of a majority of these investments do not permit the issuers to settle the securities at a price less than the amortized cost basis of the security. While credit spreads have increased, and in certain cases credit ratings were downgraded, we currently do not expect the issuers of these fixed income securities to settle them at a price less than their amortized cost basis and therefore it is expected that we will recover the entire amortized cost basis of each security. Furthermore, we do not intend to sell the securities that are currently in an unrealized loss position, and it is also not more likely than not that we will be required to sell the securities before the recovery of their amortized cost bases.

Allowance for Credit Losses on AFS Fixed Maturity Investments
We adopted ASU 2016-13 and the related amendments on January 1, 2020 prospectively, and recognized an allowance for credit losses of $ 3.1 million on initial adoption of the guidance. Our allowance for credit losses is derived based on various data sources, multiple key inputs and forecast scenarios. These include default rates specific to the individual security, vintage of the security, geography of the issuer of the security, industry analyst reports, credit ratings and consensus economic forecasts.
To determine the credit losses on our AFS securities, we use the probability of default ("PD") and loss given default ("LGD") methodology through a third-party proprietary tool which calculates the expected credit losses based on a discounted cash flow method. The tool uses effective interest rates to discount the expected cash flows associated with each AFS security to determine its fair value, which is then compared with its amortized cost basis to derive the credit loss on the security.
The methodology and inputs used to determine the credit loss by security type are as follows:
Corporate and Government: Expected cashflows are derived that are specific to each security. The PD is based on a quantitative model that converts agency ratings to term structures that vary by country, industry and the state of the credit cycle. This is used along with macroeconomic forecasts to produce scenario conditioned PDs. The LGD is based on default studies provided by a third party which we use along with macroeconomic forecasts to produce scenario conditioned LGDs.
Municipals : Expected cash flows are derived that are specific to each security. The PD model produces scenario conditioned PD output over the lifetime of the municipal security. These PDs are based on key macroeconomic and instrument specific risk factors. The LGD is derived based on a model which uses assumptions specific to the municipal securities.
18

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
For corporates, government and municipal securities, we use an explicit reversion and a three year forecast period, which we consider to be a reasonable duration during which an economic forecast could continue to be reliable.
Asset backed, Commercial and Residential mortgaged-backed: Expected cash flows are derived that are specific to each security. The PD and LGD for each security is based on a quantitative model that generates scenario conditioned PD and LGD term structures based on the underlying collateral type, waterfall and other trustee information. This model also considers prepayments. For these security types, there is no explicit reversion and the forecasts are deemed reasonable and supportable over the life of the portfolio.
Due to the short-term period during which accrued investment income remains unpaid, which is typically six months since the coupon on our debt securities is paid semi-annually, we elected not to establish an allowance for credit losses on our accrued investment income balances. Accrued investment income is written off through net realized investment gains (losses) at the time the issuer of the debt security defaults or is expected to default on payments.
The following tables provide a reconciliation of the beginning and ending allowance for credit losses on our AFS debt securities:
Three Months Ended June 30, 2020
Other
government
Corporate Commercial
mortgage
backed
Asset-backed Total
Allowance for credit losses, beginning of period $ $ ( 14,323 ) $ ( 1 ) $ $ ( 14,324 )
Allowances for credit losses on securities for which credit losses were not previously recorded ( 149 ) ( 493 ) ( 89 ) ( 731 )
Reductions for securities sold during the period 1,388 1,388
Reductions in the allowance for credit losses on securities we either intend to sell or more likely than not, we will be required to sell before the recovery of their amortized cost basis
(Increase) decrease to the allowance for credit losses on securities that had an allowance recorded in the previous period 9,994 9,994
Allowance for credit losses, end of period $ $ ( 3,090 ) $ ( 494 ) $ ( 89 ) $ ( 3,673 )
Six Months Ended June 30, 2020
Other
government
Corporate Commercial
mortgage
backed
Asset-backed Total
Allowance for credit losses, beginning of period $ $ $ $ $
Cumulative effect of change in accounting principle ( 22 ) ( 2,987 ) ( 50 ) ( 3,059 )
Allowances for credit losses on securities for which credit losses were not previously recorded ( 1,876 ) ( 444 ) ( 89 ) ( 2,409 )
Reductions for securities sold during the period 1,773 1,773
Reductions in the allowance for credit losses on securities we either intend to sell or more likely than not, we will be required to sell before the recovery of their amortized cost basis 22 22
Allowance for credit losses, end of period $ $ ( 3,090 ) $ ( 494 ) $ ( 89 ) $ ( 3,673 )
During the three and six months ended June 30, 2020 we did not have any write-offs charged against the allowance for credit losses or any recoveries of amounts previously written-off.
Our allowance for credit losses decreased during the three months ended June 30, 2020 primarily due to low interest rates and tightening credit spreads as the markets rebounded from the recent disruption in global financial markets associated with the COVID-19 pandemic. Our modeling process for determining credit losses remained the same as the prior quarter and took into account the adverse impact that the COVID-19 pandemic still has on capital markets and the global economy in general.

19

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Other-Than-Temporary Impairment on AFS Fixed Maturity Investments
For the three and six months ended June 30, 2019, we did no t recognize any other-than-temporary impairment losses on our AFS securities. We determined that no other-than-temporary credit losses existed as of December 31, 2019. A description of our other-than-temporary impairment process is included in Note 2 - "Significant Accounting Policies" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.
As discussed in detail in Note 1 - "Significant Accounting Policies" above, we adopted ASU 2016-13 and the related amendments on January 1, 2020 with this new guidance replacing the OTTI model that was previously applicable to our AFS debt securities. The new approach now requires the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value.

Equity Investments
The following table summarizes our equity investments classified as trading:
June 30, 2020 December 31, 2019
Publicly traded equity investments in common and preferred stocks $ 274,382 $ 327,875
Exchange-traded funds 95,389 133,047
Privately held equity investments in common and preferred stocks 271,000 265,799
$ 640,771 $ 726,721
Equity investments include publicly traded common and preferred stocks, exchange-traded funds and privately held common and preferred stocks. Our publicly traded equity investments in common and preferred stocks predominantly trade on major exchanges and are managed by our external advisors. Our investments in exchange-traded funds also trade on major exchanges.
Our privately held equity investments in common and preferred stocks are direct investments in companies that we believe offer attractive risk adjusted returns and/or offer other strategic advantages. Each investment may have its own unique terms and conditions and there may be restrictions on disposals. There is no active market for these investments. Included within the above balance as of June 30, 2020 and December 31, 2019 is an investment in the parent company of AmTrust Financial Services, Inc. ("AmTrust"), with a fair value of $ 245.3 million and $ 240.1 million, respectively. Refer to Note 20 - "Related Party Transactions" for further information.

Other Investments, at fair value
The following table summarizes our other investments carried at fair value:
June 30, 2020 December 31, 2019
Hedge funds $ 1,757,982 $ 1,121,904
Fixed income funds 584,607 481,039
Equity funds 368,314 410,149
Private equity funds 315,070 323,496
CLO equities 84,188 87,555
CLO equity funds 123,299 87,509
Private credit funds 38,094
Other 7,231 6,379
$ 3,278,785 $ 2,518,031

The valuation of our other investments is described in Note 11 - "Fair Value Measurements." Due to a lag in the valuations of certain funds reported by the managers, we may record changes in valuation with up to a three-month lag. We regularly review and discuss fund performance with the fund managers to corroborate the reasonableness of the reported net asset values and to assess whether any events have occurred within the lag
20

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
period that would affect the valuation of the investments. The following is a description of the nature of each of these investment categories:
Hedge funds may invest in a wide range of instruments, including debt and equity securities, and utilize various sophisticated strategies, including derivatives, to achieve their objectives. We invest in a mixture of fixed income, equity and multi-strategy hedge funds.
Fixed income funds comprise a number of positions in diversified fixed income funds that are managed by third-party managers. Underlying investments vary from high-grade corporate bonds to non-investment grade senior secured loans and bonds, in both liquid and illiquid markets. The liquid fixed income funds have regularly published prices.
Equity funds invest in a diversified portfolio of U.S. and international publicly-traded equity securities.
Private equity funds invest primarily in the financial services industry.
CLO equities comprise investments in the equity tranches of term-financed securitizations of diversified pools of corporate bank loans.
CLO equity funds invest primarily in the equity tranches of term-financed securitizations of diversified pools of corporate bank loans.
Private credit funds invest in direct senior or collateralized loans.
Others comprise various investments including real estate debt funds that invest primarily in European commercial real estate equity and a fund that provides loans to educational institutions throughout the U.S. and its territories.
The increase in our other investments carried at fair value between June 30, 2020 and December 31, 2019 was primarily attributable to unrealized gains of $ 250.5 million and net additional subscriptions of $ 520.2 million to hedge funds, fixed income funds, private credit funds, CLO equities, CLO equity funds and equity funds.
As of June 30, 2020, we had unfunded commitments of $ 544.7 million to private credit and private equity funds.
Certain of our other investments are subject to restrictions on redemptions and sales that are determined by the governing documents, which limits our ability to liquidate those investments. These restrictions may include lock-ups, redemption gates, restricted share classes or side pockets, restrictions on the frequency of redemption and notice periods. A gate is the ability to deny or delay a redemption request, whereas a side-pocket is a designated account for which the investor loses its redemption rights. Certain other investments may not have any restrictions governing their sale, but there is no active market and no guarantee that we will be able to execute a sale in a timely manner. In addition, even if certain other investments are not eligible for redemption or sales are restricted, we may still receive income distributions from those other investments. The table below details the estimated date by which proceeds would be received if we had provided notice of our intent to redeem or initiated a sales process as of June 30, 2020:
Less than 1 Year 1-2 years 2-3 years More than 3 years Not Eligible/ Restricted Total Redemption Frequency
Hedge funds $ 700,346 $ 895,057 $ $ 102,600 $ 59,979 $ 1,757,982 Monthly to Bi-annually
Fixed income funds 574,617 9,990 584,607 Daily to Quarterly
Equity funds 368,314 368,314 Daily to Quarterly
Private equity funds 315,070 315,070 N/A
CLO equities 84,188 84,188 Daily
CLO equity funds 92,180 23,549 7,570 123,299 Quarterly to Bi-annually
Private credit funds 38,094 38,094 N/A
Other 7,231 7,231 N/A
$ 1,819,645 $ 918,606 $ 7,570 $ 102,600 $ 430,364 $ 3,278,785
21

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Refer to Note 20 - "Related Party Transactions" for further information regarding certain of our other investments.
Equity Method Investments
The following table summarizes our equity method investments:
June 30, 2020 December 31, 2019
Investment Ownership % Carrying Value Investment Ownership % Carrying Value
Enhanzed Re $ 154,050 47.4 % $ 188,868 $ 154,050 47.4 % $ 182,856
Citco 50,000 31.9 % 51,815 50,000 31.9 % 51,742
Monument 59,600 26.6 % 92,117 26,600 26.6 % 60,598
Clear Spring 11,210 20.0 % 10,402 11,210 20.0 % 10,645
Other 24,963
~ 30 %
19,196 24,963
~ 30 %
20,436
$ 299,823 $ 362,398 $ 266,823 $ 326,277
Refer to Note 20 - "Related Party Transactions" for further information regarding our investments in Enhanzed Re, Citco, Monument and Clear Spring.
As of June 30, 2020, we had unfunded commitments of $ 76.5 million related to equity method investments.

Funds Held
Under funds held arrangements, the reinsured company has retained funds that would otherwise have been remitted to our reinsurance subsidiaries. We either have (i) funds held by reinsured companies, which are carried at amortized cost and on which we receive a fixed crediting rate, or (ii) funds held - directly managed, which are carried at fair value and on which we receive the underlying return on the portfolio. The investment returns on both categories of funds held are recognized in net investment income and net realized and unrealized gains (losses). The funds held balance is credited with investment income and losses payable are deducted.
Funds Held - Directly Managed
Funds held - directly managed, where we receive the underlying return on the investment portfolio, are carried at fair value, either because we elected the fair value option at the inception of the reinsurance contract, or because it represents the aggregate of funds held at amortized cost and the fair value of an embedded derivative. The embedded derivative relates to our contractual right to receive the return on the underlying investment portfolio supporting the reinsurance contract. We include the estimated fair value of these embedded derivatives in the consolidated balance sheets with the host contract in order to reflect the expected settlement of these features with the host contract. The change in the fair value of the embedded derivative is included in net unrealized gains (losses). The following table summarizes the components of the funds held - directly managed:
June 30, 2020 December 31, 2019
Fixed maturity investments, trading $ 1,153,480 $ 1,173,345
Cash and cash equivalents 8,648 10,296
Other assets 6,728 3,911
$ 1,168,856 $ 1,187,552
22

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The following table summarizes the fixed maturity investment components of funds held - directly managed:
June 30, 2020 December 31, 2019
Funds held - Directly Managed - Fair Value Option Funds held - Directly Managed - Variable Return Total Funds held - Directly Managed - Fair Value Option Funds held - Directly Managed - Variable Return Total
Fixed maturity investments, at amortized cost $ 185,446 $ 885,997 $ 1,071,443 $ 185,859 $ 940,194 $ 1,126,053
Net unrealized gains (losses):
Change in fair value - fair value option accounting 11,624 11,624 5,438 5,438
Change in fair value - embedded derivative accounting 70,413 70,413 41,854 41,854
Fixed maturity investments within funds held - directly managed, at fair value $ 197,070 $ 956,410 $ 1,153,480 $ 191,297 $ 982,048 $ 1,173,345
Refer to the sections above for details of the fixed maturity investments within our funds held - directly managed portfolios.
Funds Held by Reinsured Companies
Funds held by reinsured companies, where we received a fixed crediting rate, are carried at cost on our consolidated balance sheets. As of June 30, 2020 and December 31, 2019, we had funds held by reinsured companies of $ 1,466.6 million and $ 475.7 million, respectively. The increase related to $ 770.0 million and $ 204.2 million of additional funds held balances related to the Aspen and AXA Group transactions, respectively.

Net Investment Income
Major categories of net investment income are summarized as follows:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Fixed maturity investments $ 52,837 $ 54,835 $ 106,279 $ 109,161
Short-term investments and cash and cash equivalents 752 4,250 3,377 7,904
Funds held 24,099 2,304 24,369 8,810
Funds held - directly managed 10,685 9,611 19,501 19,361
Investment income from fixed maturities and cash and cash equivalents 88,373 71,000 153,526 145,236
Equity investments 3,762 3,422 9,725 6,802
Other investments 5,291 2,503 13,384 4,617
Investment income from equities and other investments 9,053 5,925 23,109 11,419
Gross investment income 97,426 76,925 176,635 156,655
Investment expenses ( 2,983 ) ( 2,654 ) ( 7,478 ) ( 6,733 )
Net investment income $ 94,443 $ 74,271 $ 169,157 $ 149,922

23

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net Realized and Unrealized Gains
Components of net realized and unrealized gains were as follows:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Net realized gains (losses) on sale:
Gross realized gains on fixed maturity securities, AFS $ 8,577 $ 4,445 $ 10,124 $ 4,449
Gross realized losses on fixed maturity securities, AFS ( 4,567 ) ( 227 ) ( 6,593 ) ( 292 )
Credit recoveries (losses) on fixed maturity securities, AFS 9,002 ( 2,637 )
Net realized gains (losses) on fixed maturity securities, trading 41,556 21,113 57,380 20,391
Net realized gains (losses) on funds held - directly managed 1,741 244 2,253 ( 1,362 )
Net realized gains (losses) on equity investments 1,886 120 879 2,668
Total net realized gains on sale $ 58,195 $ 25,695 $ 61,406 $ 25,854
Net unrealized gains (losses):
Fixed maturity securities, trading $ 300,948 $ 124,977 $ 44,471 $ 326,335
Fixed maturity securities in funds held - directly managed portfolios 60,107 35,267 34,805 74,229
Equity investments 37,334 13,826 ( 52,619 ) 21,209
Other Investments 511,024 60,904 250,484 265,802
Total net unrealized gains 909,413 234,974 277,141 687,575
Net realized and unrealized gains $ 967,608 $ 260,669 $ 338,547 $ 713,429

The gross realized gains and losses on AFS investments included in the table above resulted from sales of $ 678.5 million and $ 82.4 million for the three months ended June 30, 2020 and 2019, respectively, and $ 1,046.3 million and $ 83.6 million for the six months ended June 30, 2020 and 2019, respectively.

Reconciliation to Consolidated Statements of Comprehensive Income
The following table provides a reconciliation of the gross realized gains and losses and credit recoveries (losses) on our AFS fixed maturity debt securities that arose during the three and six months ended June 30, 2020 within our continuing and discontinued operations and the offsetting reclassification adjustments included within our consolidated statements of comprehensive income:
Three Months Ended
June 30,
Six Months Ended
June 30,
2020 2019 2020 2019
Included within continuing operations:
Gross realized gains on fixed maturity securities, AFS $ 8,577 $ 4,445 $ 10,124 $ 4,449
Gross realized losses on fixed maturity securities, AFS ( 4,567 ) ( 227 ) ( 6,593 ) ( 292 )
Included within discontinued operations:
Gross realized gains on fixed maturity securities, AFS 269 536
Gross realized losses on fixed maturity securities, AFS ( 57 ) ( 57 )
Total reclassification adjustment $ 4,222 $ 4,218 $ 4,010 $ 4,157
Included within continuing operations:
Credit recoveries (losses) on fixed maturity securities, AFS $ 9,002 $ $ ( 2,637 ) $
Included within discontinued operations:
Credit recoveries (losses) on fixed maturity securities, AFS 1,760 187
Total reclassification adjustment $ 10,762 $ $ ( 2,450 ) $

24

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Restricted Assets
We utilize trust accounts to collateralize business with our insurance and reinsurance counterparties. We are also required to maintain investments and cash and cash equivalents on deposit with regulatory authorities and Lloyd's to support our insurance and reinsurance operations. The investments and cash and cash equivalents on deposit are available to settle insurance and reinsurance liabilities. Collateral generally takes the form of assets held in trust, letters of credit or funds held. The assets used as collateral are primarily highly rated fixed maturity securities. The carrying value of our restricted assets, including restricted cash of $ 336.7 million and $ 346.9 million, as of June 30, 2020 and December 31, 2019, respectively, was as follows:
June 30, 2020 December 31, 2019
Collateral in trust for third party agreements $ 4,245,007 $ 4,103,847
Assets on deposit with regulatory authorities 260,998 309,659
Collateral for secured letter of credit facilities 119,709 132,670
Funds at Lloyd's (1)
574,093 639,316
$ 5,199,807 $ 5,185,492
(1) Our businesses include three Lloyd's syndicates. Lloyd's determines the required capital principally through the annual business plan of each syndicate. This capital is referred to as "Funds at Lloyd's" and will be drawn upon in the event that a syndicate has a loss that cannot be funded from other sources. We also utilize unsecured letters of credit for Funds at Lloyd's, as described in Note 14 - "Debt Obligations and Credit Facilities."

6. DERIVATIVES AND HEDGING INSTRUMENTS

Foreign Currency Hedging of Net Investments in Foreign Operations
We use foreign currency forward exchange rate contracts in qualifying hedging relationships to hedge the foreign currency exchange rate risk associated with certain of our net investments in foreign operations. As of June 30, 2020 and December 31, 2019, we had forward currency contracts in place which we had designated as hedges of our net investments in foreign operations.
The following table presents the gross notional amounts and estimated fair values recorded within other assets and other liabilities related to our qualifying foreign currency forward exchange rate contracts:
June 30, 2020 December 31, 2019
Fair Value Fair Value
Gross Notional Amount Assets Liabilities Gross Notional Amount Assets Liabilities
Foreign currency forward - AUD $ 68,913 $ $ 2,299 $ 64,620 $ 52 $ 2,033
Foreign currency forward - EUR 130,425 84 2,890 112,284 246 1,635
Foreign currency forward - GBP 278,534 31 396 318,387 344 7,784
Total qualifying hedges $ 477,872 $ 115 $ 5,585 $ 495,291 $ 642 $ 11,452

The following table presents the amounts of the net gains and losses deferred in the cumulative translation adjustment ("CTA") account, which is a component of AOCI, in shareholders' equity, relating to our foreign currency forward exchange rate contracts:
Amount of Gains (Losses) Deferred in AOCI
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Foreign currency forward - AUD $ ( 7,435 ) $ 473 $ 1,036 $ 146
Foreign currency forward - EUR ( 3,111 ) ( 1,559 ) ( 476 ) 296
Foreign currency forward - GBP 505 ( 1,591 ) 21,317 ( 1,591 )
Net gains (losses) on qualifying derivative hedges $ ( 10,041 ) $ ( 2,677 ) $ 21,877 $ ( 1,149 )

25

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Derivatives Not Designated or Not Qualifying as Net Investments Hedging Instruments
From time to time, we may also utilize foreign currency forward contracts as part of our overall foreign currency risk management strategy or to obtain exposure to a particular financial market, as well as for yield enhancement in non-qualifying hedging relationships. We may also utilize equity call option instruments either to obtain exposure to a particular equity instrument or for yield enhancement in non-qualifying hedging relationships.

Foreign Currency Forward Contracts
The following table presents the gross notional amounts and estimated fair values recorded within other assets and other liabilities related to our non-qualifying foreign currency forward hedging relationships:
June 30, 2020 December 31, 2019
Fair Value Fair Value
Gross Notional Amount Assets Liabilities Gross Notional Amount Assets Liabilities
Foreign currency forward - AUD $ 2,136 $ 849 $ 912 $ 913 $ 839 $ 892
Foreign currency forward - CAD 50,309 936 66,266 10 1,482
Foreign currency forward - EUR 14,617 9 324 74,444 507 1,440
Foreign currency forward - GBP 48,898 5 70 11,940 13 292
Total non-qualifying hedges $ 115,960 $ 863 $ 2,242 $ 153,563 $ 1,369 $ 4,106
The following table presents the amounts of the net gains (losses) included in earnings related to our non-qualifying foreign currency forward contracts:
Gains (Losses) on non-qualifying-hedges included in net earnings
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Foreign currency forward - AUD $ ( 2,978 ) $ 1,327 $ ( 445 ) $ 562
Foreign currency forward - CAD ( 2,225 ) ( 2,493 ) 2,771 ( 2,492 )
Foreign currency forward - EUR ( 224 ) ( 334 ) 952 871
Foreign currency forward - GBP 924 6,370 1,500 $ 2,311
Net gains (losses) on non-qualifying hedges $ ( 4,503 ) $ 4,870 $ 4,778 $ 1,252

Credit Default Swaps, Futures and Currency Forward Contracts
From time to time we may also utilize (i) credit default swaps to both hedge and replicate credit exposure, (ii) government bond futures contracts for interest rate management, and (iii) foreign currency forward contracts for currency hedging, to collectively manage credit and duration risk, as well as for yield enhancement on some of our fixed income portfolios.
The following table presents the gross notional amounts and estimated fair values recorded within other assets and other liabilities related to our credit default swaps, government bond futures contracts and currency forward contracts:
June 30, 2020
Fair Value
Gross Notional Amount Assets Liabilities
Credit default swaps $ 11 $ 11 $ ( 11 )
Futures contracts - long positions 39,147 30
Futures contracts - short positions ( 31,491 ) ( 197 )
Currency forward contracts - long positions 3,377 8 ( 3 )
Currency forward contracts - short positions ( 4,854 ) 32
Total $ 6,190 $ 81 $ ( 211 )
We initially entered into these credit default swaps, government bond futures contracts and currency forward contracts during the three month period ended June 30, 2020 and therefore we did not have any of these contracts in place as of December 31, 2019.
26

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents the amounts of the net gains included in earnings related to our government bond futures contracts and currency forward contracts:
Three and Six Months Ended June 30, 2020
Futures contracts
$ ( 37 )
Currency forward contracts
166
Total net gains
$ 129
There was no earnings impact arising from the credit default swap contracts during the three and six months ended June 30, 2020.
We initially entered into these credit default swaps, government bond futures contracts and currency forward contracts during the three months ended June 30, 2020 and therefore we did not have any of these contracts in place during the three and six months ended June 30, 2019.

Investments in Call Options on Equities
During the three and six months ended June 30, 2020, we recorded unrealized losses of $ nil and less than $ 0.1 million, respectively, in net earnings on the call options on equities that we had purchased in 2018 at a cost of $ 10.0 million. During the three and six months ended June 30, 2019, we had recorded unrealized gains of $ 1.7 million and $ 1.3 million, respectively, in net earnings, on these call options on equities. These call options on equities had a fair value of less than $ 0.1 million as at December 31, 2019 and expired without being exercised during the six months ended June 30, 2020.

Other Derivatives
In October 2019, we entered into a forward interest rate swap, with a notional amount of AUD$ 120.0 million, to partially mitigate the risk associated with declining interest rates until the completion of the Munich Re transaction which closed on July 1, 2020, as described in Note 3 - "Significant New Business."
During the three and six months ended June 30, 2020, we recorded unrealized gains included within net earnings of less than $ 0.1 million and $ 0.8 million, respectively, on the forward interest rate swap. This forward interest rate swap was terminated on April 7, 2020, for an inception-to-date net realized gain of $ 0.5 million. The carrying value of the forward interest rate swap, recorded in other liabilities as of December 31, 2019, was $ 0.3 million.

27

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
7. REINSURANCE BALANCES RECOVERABLE ON PAID AND UNPAID LOSSES

The following tables provide the total reinsurance balances recoverable on paid and unpaid losses:
June 30, 2020
Non-life
Run-off
Atrium StarStone Total
Recoverable from reinsurers on unpaid:
Outstanding losses $ 932,734 $ 9,497 $ 264,302 $ 1,206,533
IBNR 554,162 17,292 138,756 710,210
Fair value adjustments - acquired companies ( 12,977 ) 461 ( 1,636 ) ( 14,152 )
Fair value adjustments - fair value option ( 52,186 ) ( 52,186 )
ULAE 7,756 7,756
Total reinsurance reserves recoverable 1,429,489 27,250 401,422 1,858,161
Paid losses recoverable 151,355 1,478 83,060 235,893
Total $ 1,580,844 $ 28,728 $ 484,482 $ 2,094,054
Reconciliation to Consolidated Balance Sheet:
Reinsurance balances recoverable on paid and unpaid losses $ 909,460 $ 28,728 $ 484,482 $ 1,422,670
Reinsurance balances recoverable on paid and unpaid losses - fair value option 671,384 671,384
Total $ 1,580,844 $ 28,728 $ 484,482 $ 2,094,054
December 31, 2019
Non-life
Run-off
Atrium StarStone Total
Recoverable from reinsurers on unpaid:
Outstanding losses $ 972,293 $ 9,011 $ 264,131 $ 1,245,435
IBNR 673,059 19,286 93,185 785,530
Fair value adjustments - acquired companies ( 13,652 ) 519 ( 2,122 ) ( 15,255 )
Fair value adjustments - fair value option ( 88,086 ) ( 88,086 )
Total reinsurance reserves recoverable 1,543,614 28,816 355,194 1,927,624
Paid losses recoverable 181,375 1,541 70,594 253,510
Total $ 1,724,989 $ 30,357 $ 425,788 $ 2,181,134
Reconciliation to Consolidated Balance Sheet:
Reinsurance balances recoverable on paid and unpaid losses $ 1,029,471 $ 30,357 $ 425,788 $ 1,485,616
Reinsurance balances recoverable on paid and unpaid losses - fair value option 695,518 695,518
Total $ 1,724,989 $ 30,357 $ 425,788 $ 2,181,134

Our insurance and reinsurance run-off subsidiaries and assumed portfolios, prior to acquisition, used retrocessional agreements to reduce their exposure to the risk of insurance and reinsurance assumed. On an annual basis, both Atrium and StarStone purchase a tailored outwards reinsurance program designed to manage their risk profiles. The majority of Atrium’s and StarStone's third-party reinsurance cover is with highly rated reinsurers or is collateralized by pledged assets or letters of credit.
The fair value adjustments, determined on acquisition of insurance and reinsurance subsidiaries, are based on the estimated timing of loss and LAE recoveries and an assumed interest rate equivalent to a risk free rate for securities with similar duration to the acquired reinsurance balances recoverable on paid and unpaid losses plus a spread for credit risk, and are amortized over the estimated recovery period, as adjusted for accelerations in timing of payments as a result of commutation settlements. The determination of the fair value adjustments on the retroactive reinsurance contracts for which we have elected the fair value option is described in Note 11 - "Fair Value Measurements."
28

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
As of June 30, 2020 and December 31, 2019, we had reinsurance balances recoverable on paid and unpaid losses of $ 2.1 billion and $ 2.2 billion, respectively. The decrease of $ 87.1 million in reinsurance balances recoverable on paid and unpaid losses was primarily due to cash collections in the first six months of 2020, offset by reserve increases on StarStone, which includes estimated recoverables on losses related to the COVID-19 pandemic.

Top Ten Reinsurers
June 30, 2020
Non-life
Run-off
Atrium StarStone Total % of
Total
Top 10 reinsurers $ 1,031,132 $ 21,180 $ 351,639 $ 1,403,951 67.0 %
Other reinsurers > $1 million 530,527 7,257 131,601 669,385 32.0 %
Other reinsurers < $1 million 19,185 291 1,242 20,718 1.0 %
Total $ 1,580,844 $ 28,728 $ 484,482 $ 2,094,054 100.0 %
December 31, 2019
Non-life
Run-off
Atrium StarStone Total % of
Total
Top 10 reinsurers $ 1,154,110 $ 22,051 $ 295,443 $ 1,471,604 67.4 %
Other reinsurers > $1 million 551,636 7,761 129,335 688,732 31.6 %
Other reinsurers < $1 million 19,243 545 1,010 20,798 1.0 %
Total $ 1,724,989 $ 30,357 $ 425,788 $ 2,181,134 100.0 %
June 30, 2020 December 31, 2019
Information regarding top ten reinsurers:
Number of top 10 reinsurers rated A- or better 8 8
Number of top 10 non-rated reinsurers (1)
2 2
Reinsurers rated A- or better in top 10 $ 1,138,740 $ 1,292,207
Collateralized non-rated reinsurers in top 10 (1)
265,211 179,397
Total top 10 reinsurance recoverables $ 1,403,951 $ 1,471,604
Single reinsurers that represent 10% or more of total reinsurance balance recoverables as of June 30, 2020:
Hannover Ruck SE (2)
$ 257,980 $ 259,077
Lloyd's Syndicates (3)
$ 373,156 $ 396,246
(1) For the two non-rated reinsurers as of June 30, 2020 and two non-rated reinsurers as of December 31, 2019, we hold security in the form of pledged assets in trust or letters of credit issued to us in the full amount of the recoverable.
(2) Hannover Ruck SE is rated AA- by Standard & Poor’s and A+ by A.M. Best.
(3) Lloyd's Syndicates are rated A+ by Standard & Poor's and A by A.M. Best.

Allowance for Estimated Uncollectible Reinsurance Balances Recoverable on Paid and Unpaid Losses
We evaluate and monitor the credit risk related to our reinsurers, and an allowance for estimated uncollectible reinsurance balances recoverable on paid and unpaid losses ("allowance for estimated uncollectible reinsurance") is established for amounts considered potentially uncollectible.
29

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
With respect to our process for determining the allowances for estimated uncollectible reinsurance, we adopted ASU 2016-13 and the related amendments on January 1, 2020 and recorded a cumulative effect adjustment of $ 0.2 million to increase the opening retained earnings on the initial adoption of the guidance. Our allowance for estimated uncollectible reinsurance is derived based on various data sources, multiple key inputs and forecast scenarios. These include the duration of the collection period, credit quality, changes in reinsurer credit standing, default rates specific to the individual reinsurer, the geographical location of the reinsurer, contractual disputes with reinsurers over individual contentious claims, contract language or coverage issues, industry analyst reports and consensus economic forecasts.
To determine the allowance for estimated uncollectible reinsurance, we use the PD and LGD methodology whereby each reinsurer is allocated an appropriate PD percentage based on the expected payout duration by portfolio. This PD percentage is then multiplied by an appropriate LGD percentage to arrive at an overall credit allowance percentage which is then applied to the reinsurance balance recoverable for each reinsurer, net of any specific bad debt provisions, collateral or other contract related offsets, to arrive at the overall allowance for estimated uncollectible reinsurance by reinsurer.
The following tables show our gross and net balances recoverable from our reinsurers as well as the related allowance for estimated uncollectible reinsurance broken down by the credit ratings of our reinsurers. The majority of the allowance for estimated uncollectible reinsurance relates to the Non-life Run-off segment.
June 30, 2020
Gross Allowance for estimated uncollectible reinsurance Net Provisions as a
% of Gross
Reinsurers rated A- or above $ 1,621,395 $ 41,077 $ 1,580,318 2.5 %
Reinsurers rated below A-, secured 434,902 434,902 %
Reinsurers rated below A-, unsecured 181,410 102,576 78,834 56.5 %
Total $ 2,237,707 $ 143,653 $ 2,094,054 6.4 %
December 31, 2019
Gross Allowance for estimated uncollectible reinsurance Net Provisions as a
% of Gross
Reinsurers rated A- or above $ 1,731,270 $ 43,427 $ 1,687,843 2.5 %
Reinsurers rated below A-, secured 463,840 463,840 %
Reinsurers rated below A-, unsecured 133,663 104,212 29,451 78.0 %
Total $ 2,328,773 $ 147,639 $ 2,181,134 6.3 %

The table below provides a reconciliation of the beginning and ending allowance for estimated uncollectible reinsurance balances for the three and six months ended June 30, 2020:
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2020
Allowance for estimated uncollectible reinsurance, beginning of period $ 143,327 $ 147,639
Cumulative effect of change in accounting principle ( 195 )
Effect of exchange rate movement ( 1,446 ) ( 1,446 )
Current period change in the allowance 2,584 ( 1,533 )
Write-offs charged against the allowance ( 600 ) ( 600 )
Recoveries collected ( 212 ) ( 212 )
Allowance for estimated uncollectible reinsurance, end of period $ 143,653 $ 143,653


30

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
8. DEFERRED CHARGE ASSETS
Deferred charge assets relate to retroactive reinsurance policies providing indemnification of losses and LAE with respect to past loss events in the Non-life Run-off segment. For insurance and reinsurance contracts for which we do not elect the fair value option, a deferred charge asset is recorded for the excess, if any, of the estimated ultimate losses payable over the premiums received at the initial measurement. The premium consideration that we charge the ceding companies may be lower than the undiscounted estimated ultimate losses payable due to the time value of money. After receiving the premium consideration in full from our cedents at the inception of the contract, we invest the premium received over an extended period of time thereby generating investment income. We expect to generate profits from these retroactive reinsurance policies when taking into account the premium received and expected investment income, less contractual obligations and expenses.
Deferred charge assets are included in other assets on our consolidated balance sheets. The following table presents a reconciliation of the deferred charge assets:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Beginning carrying value $ 257,832 $ 100,154 $ 272,462 $ 86,585
Recorded during the period 11,746 2,874 11,746 23,506
Amortization ( 11,062 ) ( 3,934 ) ( 25,692 ) ( 10,997 )
Ending carrying value $ 258,516 $ 99,094 $ 258,516 $ 99,094

Deferred charge assets are amortized over the estimated claim payment period of the related contract with the periodic amortization reflected in earnings as a component of losses and LAE. Deferred charge assets amortization is adjusted at each reporting period to reflect new estimates of the amount and timing of remaining loss payments. Changes in the estimated amount and the timing of payments of unpaid losses may have an effect on the unamortized deferred charge assets and the amount of periodic amortization. Deferred charge assets are assessed at each reporting period for impairment. If the asset is determined to be impaired, it is written down in the period in which the determination is made. For the six months ended June 30, 2020, we completed our assessment for impairment of deferred charge assets and concluded that there had been no impairment of our carried deferred charge assets amount.
Further information on deferred charge assets recorded during the three and six months ended June 30, 2020 is included in Note 3 - "Significant New Business."

9. LOSSES AND LOSS ADJUSTMENT EXPENSES
The liability for losses and loss adjustment expenses ("LAE"), also referred to as loss reserves, represents our gross estimates before reinsurance for unpaid reported losses and includes losses that have been incurred but not reported ("IBNR") for our Non-life Run-off, Atrium and StarStone segments using a variety of actuarial methods. We recognize an asset for the portion of the liability that we expect to recover from reinsurers. LAE reserves include allocated loss adjustment expenses ("ALAE"), and unallocated loss adjustment expenses ("ULAE"). ALAE are linked to the settlement of an individual claim or loss, whereas ULAE are based on our estimates of future costs to administer the claims. IBNR represents reserves for loss and LAE that have been incurred but not yet reported to us. This includes amounts for unreported claims, development on known claims and reopened claims.
Our loss reserves cover multiple lines of business, which include asbestos, environmental, general casualty, workers' compensation/personal accident, marine, aviation and transit, construction defect, professional indemnity/directors and officers, motor, property and other non-life lines of business. Refer to Note 10 - "Losses and Loss Adjustment Expenses" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 for more information on establishing the liability for losses and LAE.

31

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables summarize the liability for losses and LAE by segment and for our other activities:
June 30, 2020
Non-life
Run-off
Atrium StarStone Other Total
Outstanding losses $ 4,411,962 $ 89,321 $ 693,280 $ 10,375 $ 5,204,938
IBNR 4,500,500 144,404 610,632 14,333 5,269,869
Fair value adjustments - acquired companies ( 153,658 ) 3,649 ( 403 ) ( 150,412 )
Fair value adjustments - fair value option ( 99,020 ) ( 99,020 )
ULAE 319,450 2,357 46,254 368,061
Total $ 8,979,234 $ 239,731 $ 1,349,763 $ 24,708 $ 10,593,436
Reconciliation to Consolidated Balance Sheet:
Loss and loss adjustment expenses $ 6,524,695 $ 239,731 $ 1,349,763 $ 24,708 $ 8,138,897
Loss and loss adjustment expenses, at fair value 2,454,539 2,454,539
Total $ 8,979,234 $ 239,731 $ 1,349,763 $ 24,708 $ 10,593,436
December 31, 2019
Non-life
Run-off
Atrium StarStone Other Total
Outstanding losses $ 4,407,082 $ 89,141 $ 743,829 $ 9,512 $ 5,249,564
IBNR 3,945,407 136,543 556,135 13,565 4,651,650
Fair value adjustments - acquired companies ( 170,689 ) 3,700 ( 522 ) ( 167,511 )
Fair value adjustments - fair value option ( 217,933 ) ( 217,933 )
ULAE 331,494 2,288 18,852 352,634
Total $ 8,295,361 $ 231,672 $ 1,318,294 $ 23,077 $ 9,868,404
Reconciliation to Consolidated Balance Sheet:
Loss and loss adjustment expenses $ 5,674,239 $ 231,672 $ 1,318,294 $ 23,077 $ 7,247,282
Loss and loss adjustment expenses, at fair value 2,621,122 2,621,122
Total $ 8,295,361 $ 231,672 $ 1,318,294 $ 23,077 $ 9,868,404

The overall increase in the liability for losses and LAE between December 31, 2019 and June 30, 2020 was primarily attributable to the AXA Group, Aspen and Lyft reinsurance transactions, as described in Note 3 - "Significant New Business" and net incurred losses and LAE in the period, partially offset by losses paid and foreign exchange gains in the period.
32

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The table below provides a consolidated reconciliation of the beginning and ending liability for losses and LAE:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance as of beginning of period $ 9,836,797 $ 9,679,681 $ 9,868,404 $ 9,048,796
Less: reinsurance reserves recoverable 1,902,749 1,905,329 1,927,624 1,708,272
Less: deferred charge assets on retroactive reinsurance 257,832 100,154 272,462 86,585
Less: cumulative effect of change in accounting principle on the determination of the allowance for estimated uncollectible reinsurance balances (1)
643
Net balance as of beginning of period 7,676,216 7,674,198 7,667,675 7,253,939
Net incurred losses and LAE:
Current period 119,613 139,455 235,118 301,376
Prior periods 67,079 7,099 ( 5,126 ) 101,477
Total net incurred losses and LAE 186,692 146,554 229,992 402,853
Net paid losses:
Current period ( 11,303 ) ( 43,810 ) ( 15,110 ) ( 70,946 )
Prior periods ( 369,984 ) ( 409,388 ) ( 726,003 ) ( 858,389 )
Total net paid losses ( 381,287 ) ( 453,198 ) ( 741,113 ) ( 929,335 )
Effect of exchange rate movement 40,815 ( 31,672 ) ( 105,268 ) ( 11,993 )
Acquired on purchase of subsidiaries 686 686
Assumed business 954,323 45,463 1,425,473 665,881
Net balance as of June 30 8,476,759 7,382,031 8,476,759 7,382,031
Plus: reinsurance reserves recoverable (2)
1,858,161 1,873,766 1,858,161 1,873,766
Plus: deferred charge assets on retroactive reinsurance 258,516 99,094 258,516 99,094
Balance as of June 30 $ 10,593,436 $ 9,354,891 $ 10,593,436 $ 9,354,891
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details. This amount excludes $ 0.4 million related to the adoption impact of ASU 2016-13 on StarStone US which has been classified as a discontinued operation with the related assets and liabilities disclosed as held-for-sale on our consolidated balance sheets.
(2) Net of allowance for estimated uncollectible reinsurance.

The tables below provide the components of net incurred losses and LAE by segment and for our other activities:
Three Months Ended June 30, 2020
Non-life Run-off Atrium StarStone Other Total
Net losses paid $ 283,402 $ 14,219 $ 80,667 $ 2,999 $ 381,287
Net change in case and LAE reserves ( 76,106 ) 795 ( 30,764 ) 610 ( 105,465 )
Net change in IBNR reserves ( 255,782 ) 710 ( 3,323 ) 1,584 ( 256,811 )
Increase (reduction) in estimates of net ultimate losses ( 48,486 ) 15,724 46,580 5,193 19,011
Increase (reduction) in provisions for unallocated LAE ( 12,425 ) 27,885 15,460
Amortization of deferred charge assets 11,062 11,062
Amortization of fair value adjustments 7,280 ( 132 ) ( 32 ) 7,116
Changes in fair value - fair value option 134,043 134,043
Net incurred losses and LAE $ 91,474 $ 15,592 $ 74,433 $ 5,193 $ 186,692
33

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Three Months Ended June 30, 2019
Non-life
Run-off
Atrium StarStone Other Total
Net losses paid $ 329,103 $ 17,777 $ 104,497 $ 1,821 $ 453,198
Net change in case and LAE reserves ( 119,834 ) 259 38,088 759 ( 80,728 )
Net change in IBNR reserves ( 238,232 ) ( 4,801 ) ( 23,798 ) 1,885 ( 264,946 )
Increase (reduction) in estimates of net ultimate losses ( 28,963 ) 13,235 118,787 4,465 107,524
Increase (reduction) in provisions for unallocated LAE ( 10,896 ) 540 ( 10,356 )
Amortization of deferred charge assets 3,934 3,934
Amortization of fair value adjustments 7,715 ( 187 ) ( 38 ) 7,490
Changes in fair value - fair value option 37,962 37,962
Net incurred losses and LAE $ 9,752 $ 13,048 $ 119,289 $ 4,465 $ 146,554

Six Months Ended June 30, 2020
Non-life Run-off Atrium StarStone Other Total
Net losses paid $ 542,368 $ 31,227 $ 161,473 $ 6,045 $ 741,113
Net change in case and LAE reserves ( 250,686 ) 934 ( 66,343 ) 862 ( 315,233 )
Net change in IBNR reserves ( 360,179 ) 11,841 25,611 768 ( 321,959 )
Increase (reduction) in estimates of net ultimate losses ( 68,497 ) 44,002 120,741 7,675 103,921
Increase (reduction) in provisions for unallocated LAE ( 19,904 ) 28,495 8,591
Amortization of deferred charge assets 25,692 25,692
Amortization of fair value adjustments 16,343 6 ( 367 ) 15,982
Changes in fair value - fair value option 75,806 75,806
Net incurred losses and LAE $ 29,440 $ 44,008 $ 148,869 $ 7,675 $ 229,992

Six Months Ended June 30, 2019
Non-life
Run-off
Atrium StarStone Other Total
Net losses paid $ 678,172 $ 40,090 $ 206,417 $ 4,656 $ 929,335
Net change in case and LAE reserves ( 197,535 ) ( 154 ) 31,368 1,354 ( 164,967 )
Net change in IBNR reserves ( 471,127 ) ( 10,618 ) 19,755 3,411 ( 458,579 )
Increase (reduction) in estimates of net ultimate losses 9,510 29,318 257,540 9,421 305,789
Increase (reduction) in provisions for unallocated LAE ( 26,071 ) 927 ( 25,144 )
Amortization of deferred charge assets 10,997 10,997
Amortization of fair value adjustments 16,495 944 ( 231 ) 17,208
Changes in fair value - fair value option 94,003 94,003
Net incurred losses and LAE $ 104,934 $ 30,262 $ 258,236 $ 9,421 $ 402,853
34

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Non-life Run-off Segment
The table below provides a reconciliation of the beginning and ending liability for losses and LAE for the Non-life Run-off segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance as of beginning of period $ 8,216,850 $ 8,154,974 $ 8,295,361 $ 7,540,662
Less: reinsurance reserves recoverable 1,461,008 1,579,646 1,543,614 1,366,123
Less: deferred charge assets on retroactive insurance 257,832 100,154 272,462 86,585
Plus: cumulative effect of change in accounting principal on allowance for estimated uncollectible reinsurance (1)
703
Net balance as of beginning of period 6,498,010 6,475,174 6,479,988 6,087,954
Net incurred losses and LAE:
Current period 8,086 34,375 15,935 83,446
Prior periods 83,388 ( 24,623 ) 13,505 21,488
Total net incurred losses and LAE 91,474 9,752 29,440 104,934
Net paid losses:
Current period 202 ( 20,877 ) ( 1,038 ) ( 38,891 )
Prior periods ( 283,604 ) ( 308,226 ) ( 541,330 ) ( 639,281 )
Total net paid losses ( 283,402 ) ( 329,103 ) ( 542,368 ) ( 678,172 )
Effect of exchange rate movement 30,824 ( 31,830 ) ( 101,304 ) ( 11,141 )
Acquired on purchase of subsidiaries 686 686
Assumed business 954,323 45,463 1,425,473 665,881
Net balance as of June 30 7,291,229 6,170,142 7,291,229 6,170,142
Plus: reinsurance reserves recoverable (2)
1,429,489 1,534,427 1,429,489 1,534,427
Plus: deferred charge assets on retroactive reinsurance 258,516 99,094 258,516 99,094
Balance as of June 30 $ 8,979,234 $ 7,803,663 $ 8,979,234 $ 7,803,663
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details.
(2) Net of allowance for estimated uncollectible reinsurance.

Net incurred losses and LAE in the Non-life Run-off segment were as follows:
Three Months Ended June 30,
2020 2019
Prior
Period
Current
Period
Total Prior
Period
Current
Period
Total
Net losses paid $ 283,604 $ ( 202 ) $ 283,402 $ 308,226 $ 20,877 $ 329,103
Net change in case and LAE reserves ( 75,276 ) ( 830 ) ( 76,106 ) ( 121,377 ) 1,543 ( 119,834 )
Net change in IBNR reserves ( 264,900 ) 9,118 ( 255,782 ) ( 249,923 ) 11,691 ( 238,232 )
Increase (reduction) in estimates of net ultimate losses ( 56,572 ) 8,086 ( 48,486 ) ( 63,074 ) 34,111 ( 28,963 )
Increase (reduction) in provisions for unallocated LAE ( 12,425 ) ( 12,425 ) ( 11,160 ) 264 ( 10,896 )
Amortization of deferred charge assets 11,062 11,062 3,934 3,934
Amortization of fair value adjustments 7,280 7,280 7,715 7,715
Changes in fair value - fair value option 134,043 134,043 37,962 37,962
Net incurred losses and LAE $ 83,388 $ 8,086 $ 91,474 $ ( 24,623 ) $ 34,375 $ 9,752


35

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims. Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable.
Three Months Ended June 30, 2020
The increase in net incurred losses and LAE for the three months ended June 30, 2020 of $ 91.5 million included net incurred losses and LAE of $ 8.1 million related to current period net earned premium, primarily in respect of the run-off business acquired with the AmTrust RITC transactions. Excluding current period net incurred losses and LAE of $ 8.1 million, the increase in net incurred losses and LAE relating to prior periods was $ 83.4 million, which was attributable to an increase in the fair value of liabilities of $ 134.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option primarily due to narrowing credit spreads on corporate bond yields in the period, amortization of the deferred charge assets of $ 11.1 million and amortization of fair value adjustments over the estimated payout period relating to companies acquired of $ 7.3 million, partially offset by a reduction in estimates of net ultimate losses of $ 56.6 million and a reduction in provisions for unallocated LAE of $ 12.4 million relating to 2020 run-off activity. The reduction in estimates of net ultimate losses relating to prior periods of $ 56.6 million for the three months ended June 30, 2020 included a net reduction in case and IBNR reserves of $ 340.2 million, partially offset by net losses paid of $ 283.6 million.
Three Months Ended June 30, 2019
Net incurred losses and LAE for the three months ended June 30, 2019 of $ 9.8 million included net incurred losses and LAE of $ 34.4 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions and the acquisition of Maiden Reinsurance North America, Inc. ("Maiden Re North America"). Excluding current period net incurred losses and LAE of $ 34.4 million, the reduction in net incurred losses and LAE relating to prior periods was $ 24.6 million, which was attributable to a reduction in estimates of net ultimate losses of $ 63.1 million and a reduction in provisions for unallocated LAE of $ 11.2 million relating to 2019 run-off activity, partially offset by an increase in the fair value of liabilities of $ 38.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option, amortization of fair value adjustments over the estimated payout period relating to companies acquired of $ 7.7 million and amortization of the deferred charge assets of $ 3.9 million. The reduction in estimates of net ultimate losses relating to prior periods of $ 63.1 million for the three months ended June 30, 2019 included a net reduction in case and IBNR reserves of $ 371.3 million, partially offset by net losses paid of $ 308.2 million.

Six Months Ended June 30,
2020 2019
Prior
Period
Current
Period
Total Prior
Period
Current
Period
Total
Net losses paid $ 541,330 $ 1,038 $ 542,368 $ 639,281 $ 38,891 $ 678,172
Net change in case and LAE reserves ( 251,528 ) 842 ( 250,686 ) ( 218,950 ) 21,415 ( 197,535 )
Net change in IBNR reserves ( 374,234 ) 14,055 ( 360,179 ) ( 493,738 ) 22,611 ( 471,127 )
Increase (reduction) in estimates of net ultimate losses ( 84,432 ) 15,935 ( 68,497 ) ( 73,407 ) 82,917 9,510
Increase (reduction) in provisions for unallocated LAE ( 19,904 ) ( 19,904 ) ( 26,600 ) 529 ( 26,071 )
Amortization of deferred charge assets 25,692 25,692 10,997 10,997
Amortization of fair value adjustments 16,343 16,343 16,495 16,495
Changes in fair value - fair value option 75,806 75,806 94,003 94,003
Net incurred losses and LAE $ 13,505 $ 15,935 $ 29,440 $ 21,488 $ 83,446 $ 104,934

Six Months Ended June 30, 2020
The increase in net incurred losses and LAE for the six months ended June 30, 2020 of $ 29.4 million included net incurred losses and LAE of $ 15.9 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions. Excluding current period net incurred losses and LAE of $ 15.9 million, the increase in net incurred losses and LAE liabilities relating to prior periods was $ 13.5 million, which was attributable to an increase in the fair value of liabilities of $ 75.8 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option primarily due to declining interest rates on
36

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
corporate bond yields in the period, amortization of the deferred charge assets of $ 25.7 million and amortization of fair value adjustments over the estimated payout period relating to companies acquired of $ 16.3 million, partially offset by a reduction in estimates of net ultimate losses of $ 84.4 million and a reduction in provisions for unallocated LAE of $ 19.9 million relating to 2020 run-off activity. The reduction in estimates of net ultimate losses relating to prior periods of $ 84.4 million for the six months ended June 30, 2020 included a net change in case and IBNR reserves of $ 625.8 million, partially offset by net losses paid of $ 541.3 million.
Six Months Ended June 30, 2019
The increase in net incurred losses and LAE for the six months ended June 30, 2019 of $ 104.9 million included net incurred losses and LAE of $ 83.4 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions and the acquisition of Maiden Re North America. Excluding current period net incurred losses and LAE of $ 83.4 million, the increase in net incurred losses and LAE liabilities relating to prior periods was $ 21.5 million, which was attributable to an increase in the fair value of liabilities of $ 94.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option, amortization of fair value adjustments over the estimated payout period relating to companies acquired of $ 16.5 million and amortization of the deferred charge assets of $ 11.0 million, partially offset by a reduction in estimates of net ultimate losses of $ 73.4 million and a reduction in provisions for unallocated LAE of $ 26.6 million relating to 2019 run-off activity. The reduction in estimates of net ultimate losses of $ 73.4 million for the six months ended June 30, 2019 included a net change in case and IBNR reserves of $ 712.7 million, partially offset by net losses paid of $ 639.3 million.

Atrium
The table below provides a reconciliation of the beginning and ending liability for losses and LAE for the Atrium segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance as of beginning of period $ 243,610 $ 229,380 $ 231,672 $ 241,284
Less: reinsurance reserves recoverable 33,435 31,682 28,816 38,768
Less: cumulative effect of change in accounting principal on allowance for estimated uncollectible reinsurance (1)
851
Net balance as of beginning of period 210,175 197,698 202,005 202,516
Net incurred losses and LAE:
Current period 19,042 17,859 46,946 36,096
Prior periods ( 3,450 ) ( 4,811 ) ( 2,938 ) ( 5,834 )
Total net incurred losses and LAE 15,592 13,048 44,008 30,262
Net paid losses:
Current period ( 5,002 ) ( 7,251 ) ( 9,287 ) ( 15,144 )
Prior periods ( 9,217 ) ( 10,526 ) ( 21,940 ) ( 24,946 )
Total net paid losses ( 14,219 ) ( 17,777 ) ( 31,227 ) ( 40,090 )
Effect of exchange rate movement 933 1 ( 2,305 ) 282
Net balance as of June 30 212,481 192,970 212,481 192,970
Plus: reinsurance reserves recoverable (2)
27,250 29,606 27,250 29,606
Balance as of June 30 $ 239,731 $ 222,576 $ 239,731 $ 222,576
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details.
(2) Net of allowance for estimated uncollectible reinsurance.

37

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net incurred losses and LAE in the Atrium segment were as follows:
Three Months Ended June 30,
2020 2019
Prior
Period
Current
Period
Total Prior
Period
Current
Period
Total
Net losses paid $ 9,217 $ 5,002 $ 14,219 $ 10,526 $ 7,251 $ 17,777
Net change in case and LAE reserves ( 4,191 ) 4,986 795 ( 3,830 ) 4,089 259
Net change in IBNR reserves ( 8,344 ) 9,054 710 ( 11,320 ) 6,519 ( 4,801 )
Increase (reduction) in estimates of net ultimate losses ( 3,318 ) 19,042 15,724 ( 4,624 ) 17,859 13,235
Amortization of fair value adjustments ( 132 ) ( 132 ) ( 187 ) ( 187 )
Net incurred losses and LAE $ ( 3,450 ) $ 19,042 $ 15,592 $ ( 4,811 ) $ 17,859 $ 13,048

Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims. Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable.
Three Months Ended June 30, 2020 and 2019
Net incurred losses and LAE for the three months ended June 30, 2020 and 2019 were $ 15.6 million and $ 13.0 million, respectively. Net favorable prior period loss development was $ 3.5 million for the three months ended June 30, 2020 compared to $ 4.8 million for the three months ended June 30, 2019. The current period net favorable prior period loss development was driven by favorable development across several lines of business; notably, the non-marine direct and facultative line. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2020 were $ 19.0 million and included $ 4.3 million of losses related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $ 17.9 million.

Six Months Ended June 30,
2020 2019
Prior Period Current Period Total Prior Period Current Period Total
Net losses paid $ 21,940 $ 9,287 $ 31,227 $ 24,946 $ 15,144 $ 40,090
Net change in case and LAE reserves ( 7,225 ) 8,159 934 ( 10,172 ) 10,018 ( 154 )
Net change in IBNR reserves ( 17,659 ) 29,500 11,841 ( 21,552 ) 10,934 ( 10,618 )
Increase (reduction) in estimates of net ultimate losses ( 2,944 ) 46,946 44,002 ( 6,778 ) 36,096 29,318
Amortization of fair value adjustments 6 6 944 944
Net incurred losses and LAE $ ( 2,938 ) $ 46,946 $ 44,008 $ ( 5,834 ) $ 36,096 $ 30,262

Six Months Ended June 30, 2020 and 2019
Net incurred losses and LAE for the six months ended June 30, 2020 and 2019 were $ 44.0 million and $ 30.3 million, respectively. Net favorable prior year loss development was $ 2.9 million and $ 5.8 million for the six months ended June 30, 2020 and 2019, respectively. The current period net favorable prior period loss development was driven by favorable development across several lines of business; notably, the non-marine direct and facultative line. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2020 were $ 46.9 million and included $ 12.8 million of losses related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $ 36.1 million.
38

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
StarStone
The table below provides a reconciliation of the beginning and ending liability for losses and LAE for our StarStone segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance as of beginning of period $ 1,353,824 $ 1,274,345 $ 1,318,294 $ 1,247,989
Less: reinsurance reserves recoverable 408,306 294,001 355,194 303,381
Less: cumulative effect of change in accounting principal on allowance for estimated uncollectible reinsurance (1)
495
Net balance as of beginning of period 945,518 980,344 962,605 944,608
Net incurred losses and LAE:
Current period 87,273 82,657 163,680 172,262
Prior periods ( 12,840 ) 36,632 ( 14,811 ) 85,974
Total net incurred losses and LAE 74,433 119,289 148,869 258,236
Net paid losses:
Current period ( 6,135 ) ( 15,072 ) ( 4,387 ) ( 15,971 )
Prior periods ( 74,532 ) ( 89,425 ) ( 157,086 ) ( 190,446 )
Total net paid losses ( 80,667 ) ( 104,497 ) ( 161,473 ) ( 206,417 )
Effect of exchange rate movement 9,057 157 ( 1,660 ) ( 1,134 )
Net balance as of June 30 948,341 995,293 948,341 995,293
Plus: reinsurance reserves recoverable (2)
401,422 309,733 401,422 309,733
Balance as of June 30 $ 1,349,763 $ 1,305,026 $ 1,349,763 $ 1,305,026
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details. This amount excludes $ 0.4 million related to the adoption impact of ASU 2016-13 on StarStone US which has been classified as a discontinued operation with the related assets and liabilities disclosed as held-for-sale on our consolidated balance sheets.
(2) Net of allowance for estimated uncollectible reinsurance.

Net incurred losses and LAE in the StarStone segment were as follows:
Three Months Ended June 30,
2020 2019
Prior Period Current Period Total Prior Period Current Period Total
Net losses paid $ 74,532 $ 6,135 $ 80,667 $ 89,425 $ 15,072 $ 104,497
Net change in case and LAE reserves ( 25,402 ) ( 5,362 ) ( 30,764 ) 2,648 35,440 38,088
Net change in IBNR reserves ( 62,212 ) 58,889 ( 3,323 ) ( 56,130 ) 32,332 ( 23,798 )
Increase (reduction) in estimates of net ultimate losses ( 13,082 ) 59,662 46,580 35,943 82,844 118,787
Increase (reduction) in provisions for unallocated LAE 274 27,611 27,885 727 ( 187 ) 540
Amortization of fair value adjustments ( 32 ) ( 32 ) ( 38 ) ( 38 )
Net incurred losses and LAE $ ( 12,840 ) $ 87,273 $ 74,433 $ 36,632 $ 82,657 $ 119,289

Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims. Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable.
Three Months Ended June 30, 2020 and 2019
Net incurred losses and LAE for the three months ended June 30, 2020 and 2019 were $ 74.4 million and $ 119.3 million, respectively. Net favorable prior period loss development was $ 12.8 million for the three months ended June 30, 2020 compared to net unfavorable prior period loss development of $ 36.6 million for the three months ended June 30, 2019. Net favorable prior period loss development for the three months ended June 30,
39

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
2020 was driven by favorable development in the casualty lines of business. Net adverse prior period loss development for the three months ended June 30, 2019 was primarily related to development on lines of business that we had either exited or had been subject to remediation as part of our underwriting repositioning initiatives before our decision to place StarStone International into run-off. Excluding prior period net loss development, net incurred losses and LAE for the three months ended June 30, 2020 were $ 87.3 million and included $ 28.1 million of exit costs associated with the StarStone International Run-Off and a $ 3.1 million reduction in net incurred losses and LAE related to the COVID-19 pandemic. Excluding prior period net loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $ 82.7 million.

Six Months Ended June 30,
2020 2019
Prior Period Current Period Total Prior Period Current Period Total
Net losses paid $ 157,086 $ 4,387 $ 161,473 $ 190,446 $ 15,971 $ 206,417
Net change in case and LAE reserves ( 65,730 ) ( 613 ) ( 66,343 ) ( 13,672 ) 45,040 31,368
Net change in IBNR reserves ( 105,983 ) 131,594 25,611 ( 90,096 ) 109,851 19,755
Increase (reduction) in estimates of net ultimate losses ( 14,627 ) 135,368 120,741 86,678 170,862 257,540
Increase (reduction) in provisions for unallocated LAE 183 28,312 28,495 ( 473 ) 1,400 927
Amortization of fair value adjustments ( 367 ) ( 367 ) ( 231 ) ( 231 )
Net incurred losses and LAE $ ( 14,811 ) $ 163,680 $ 148,869 $ 85,974 $ 172,262 $ 258,236

Six Months Ended June 30, 2020 and 2019
Net incurred losses and LAE for the six months ended June 30, 2020 and 2019 were $ 148.9 million and $ 258.2 million, respectively. Net favorable prior period loss development was $ 14.8 million for the six months ended June 30, 2020 compared to net unfavorable prior period loss development of $ 86.0 million for the six months ended June 30, 2019. Net favorable prior period loss development for the six months ended June 30, 2020 was driven by favorable development in the casualty lines of business. Net unfavorable prior period loss development for the six months ended June 30, 2020 was primarily related to development on lines of business that we had either exited or had been subject to remediation as part of our underwriting repositioning initiatives before our decision to place StarStone International into run-off. Excluding prior period loss development, net incurred losses and LAE for the six months ended June 30, 2020 were $ 163.7 million and included $ 28.1 million of exit costs associated with the StarStone International Run-Off and $ 21.5 million related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the six months ended June 30, 2019 were $ 172.3 million.

10. DEFENDANT ASBESTOS AND ENVIRONMENTAL LIABILITIES
We acquired DCo LLC ("DCo") on December 30, 2016, and Morse TEC on October 30, 2019, as described in Note 3 - "Acquisitions" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019. DCo and Morse TEC hold liabilities associated with personal injury asbestos claims and environmental claims arising from their legacy manufacturing operations. These companies continue to process asbestos personal injury claims in the normal course of business. Defendant asbestos liabilities on our consolidated balance sheets include amounts for loss payments and defense costs for pending and future asbestos-related claims, determined using standard actuarial techniques for asbestos exposures. Defendant environmental liabilities include estimated clean-up costs associated with the acquired companies' former operations based on engineering reports.
Insurance balances recoverable on our consolidated balance sheets include estimated insurance recoveries relating to these liabilities. The recorded asset represents our assessment of the capacity of the insurance agreements to indemnify our subsidiaries for the anticipated defense and loss payments for pending claims and projected future claims. The recognition of these recoveries is based on an assessment of the right to recover under the respective contracts and on the financial strength of the insurers. The recorded asset does not represent the limits of our insurance coverage, but rather the amount we would expect to recover if the accrued and projected loss and defense costs were paid in full.

Included within insurance balances recoverable and defendant asbestos and environmental liabilities are the
40

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
fair value adjustments that were initially recognized upon acquisition. These fair value adjustments are amortized in proportion to the actual payout of claims and recoveries. The carrying value of the asbestos and environmental liabilities, insurance recoveries, future estimated expenses and the fair value adjustments related to DCo and Morse TEC as of June 30, 2020 and December 31, 2019 were as follows:
June 30, 2020 December 31, 2019
Defendant asbestos and environmental liabilities:
Defendant asbestos liabilities $ 1,050,279 $ 1,100,593
Defendant environmental liabilities 9,483 10,279
Estimated future expenses 48,634 51,637
Fair value adjustments ( 300,334 ) ( 314,824 )
Defendant asbestos and environmental liabilities 808,062 847,685
Insurance balances recoverable:
Insurance recoveries related to defendant asbestos and environmental liabilities 523,123 549,593
Fair value adjustments ( 94,846 ) ( 100,738 )
Insurance balances recoverable 428,277 448,855
Net liabilities relating to defendant asbestos and environmental exposures $ 379,785 $ 398,830

The table below provides a consolidated reconciliation of the beginning and ending liability for defendant asbestos and environmental exposures for the three and six months ended June 30, 2020 and 2019:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance as of beginning of period $ 822,716 $ 197,511 $ 847,685 $ 203,320
Less: Insurance balances recoverable 435,613 130,431 448,855 135,808
Plus: Cumulative effect of change in accounting principle on the determination of the allowance for estimated uncollectible insurance balances (1)
3,167
Net balance as of beginning of period 387,103 67,080 401,997 67,512
Total net paid claims ( 7,495 ) ( 1,873 ) ( 914 ) 878
Amounts recorded in other (income) expense:
Change in estimate of ultimate net liabilities ( 1,978 ) ( 3,100 ) ( 26,893 ) ( 4,259 )
Increase (reduction) in estimated future expenses ( 975 ) ( 179 ) ( 3,003 ) ( 2,304 )
Amortization of fair value adjustments 3,130 100 8,598 201
Total other expense (income) 177 ( 3,179 ) ( 21,298 ) ( 6,362 )
Net balance as at June 30
379,785 62,028 379,785 62,028
Plus: Insurance balances recoverable (2)
428,277 122,236 428,277 122,236
Balance as at June 30
$ 808,062 $ 184,264 $ 808,062 $ 184,264
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details.
(2) Net of allowance for estimated uncollectible insurance balances.
For further details on the methodologies used for determining liabilities, refer to Note 11 - "Defendant Asbestos and Environmental Liabilities" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.

41

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Allowance for Estimated Uncollectible Insurance Balances Recoverable on Defendant Asbestos Liabilities
We evaluate and monitor the credit risk related to our insurers and an allowance for estimated uncollectible insurance balances recoverable on our defendant asbestos liabilities ("allowance for estimated uncollectible insurance") is established for amounts considered potentially uncollectible.
With respect to our process for determining the allowances for estimated uncollectible insurance, we adopted ASU 2016-13 and the related amendments on January 1, 2020 and recorded a cumulative effect adjustment of $ 3.2 million to reduce the opening retained earnings on the initial adoption of the guidance. Our allowance for estimated uncollectible insurance is derived based on various data sources, multiple key inputs and forecast scenarios. These include the duration of the collection period, credit quality, changes in insurer credit standing, default rates specific to the individual insurer, the geographical location of the insurer, contractual disputes with insurers over individual contentious claims, contract language or coverage issues, industry analyst reports and consensus economic forecasts.
To determine the allowance for estimated uncollectible insurance, we similarly use the PD and LGD methodology as described in Note 7 - "Reinsurance Balances Recoverable on Paid and Unpaid Losses" above.
During the three and six months ended June 30, 2020, we did not have any write-offs charged against the allowance for estimated uncollectible insurance or any recoveries of amounts previously written off. The table below provides a reconciliation of the beginning and ending allowance for estimated uncollectible insurance balances related to our defendant asbestos liabilities, for the three and six months ended June 30, 2020:
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2020
Allowance for estimated uncollectible insurance balances, beginning of period $ 6,985 $ 3,818
Cumulative effect of change in accounting principle 3,167
Current period change in the allowance 1,361 1,361
Allowance for estimated uncollectible insurance balances, end of period $ 8,346 $ 8,346

11. FAIR VALUE MEASUREMENTS

Fair Value Hierarchy
Fair value is defined as the price at which to sell an asset or transfer a liability (i.e. the "exit price") in an orderly transaction between market participants. We use a fair value hierarchy that gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The hierarchy is broken down into three levels as follows:
Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments.
Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities, etc.) or can be corroborated by observable market data.
Level 3 - Valuations based on unobservable inputs where there is little or no market activity. Unadjusted third party pricing sources or management's assumptions and internal valuation models may be used to determine the fair values.
In addition, certain of our other investments are measured at fair value using net asset value ("NAV") per share (or its equivalent) as a practical expedient and have not been classified within the fair value hierarchy above. We have categorized our assets and liabilities that are recorded at fair value on a recurring basis among levels based on the observability of inputs, or at fair value using NAV per share (or its equivalent) as follows:
42

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
June 30, 2020
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Fair Value Based on NAV as Practical Expedient Total Fair
Value
Investments:
Short-term and fixed maturity investments:
U.S. government and agency $ $ 546,471 $ $ $ 546,471
U.K. government 107,680 107,680
Other government 503,312 503,312
Corporate 5,565,100 5,565,100
Municipal 165,720 165,720
Residential mortgage-backed 436,832 436,832
Commercial mortgage-backed 840,367 840,367
Asset-backed 666,352 666,352
$ $ 8,831,834 $ $ $ 8,831,834
Other assets included within funds held - directly managed 15,376 15,376
Equities:
Publicly traded equity investments $ 254,501 $ 19,881 $ $ $ 274,382
Exchange-traded funds 95,389 95,389
Privately held equity investments 271,000 271,000
$ 349,890 $ 19,881 $ 271,000 $ $ 640,771
Other investments:
Hedge funds $ $ $ $ 1,757,982 $ 1,757,982
Fixed income funds 415,149 169,458 584,607
Equity funds 88,396 279,918 368,314
Private equity funds 315,070 315,070
CLO equities 84,188 84,188
CLO equity funds 123,299 123,299
Private credit funds 38,094 38,094
Other 314 6,917 7,231
$ $ 587,733 $ 314 $ 2,690,738 $ 3,278,785
Total Investments $ 349,890 $ 9,454,824 $ 271,314 $ 2,690,738 $ 12,766,766
Cash and cash equivalents $ 219,149 $ 48,915 $ $ $ 268,064
Reinsurance balances recoverable on paid and unpaid losses: $ $ $ 671,384 $ $ 671,384
Other Assets:
Derivatives qualifying as hedges $ $ 115 $ $ $ 115
Derivatives not qualifying as hedges 863 863
Derivative instruments $ $ 978 $ $ $ 978
Losses and LAE: $ $ $ 2,454,539 $ $ 2,454,539
Other Liabilities:
Derivatives qualifying as hedges $ $ 5,585 $ $ $ 5,585
Derivatives not qualifying as hedges 2,242 2,242
Derivative instruments $ $ 7,827 $ $ $ 7,827
43

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
December 31, 2019
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant
Other Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Fair Value Based on NAV as Practical Expedient Total Fair
Value
Investments:
Short-term and fixed maturity investments:
U.S. government and agency $ $ 696,077 $ $ $ 696,077
U.K government 161,772 161,772
Other government 702,856 702,856
Corporate 5,448,270 5,448,270
Municipal 140,687 140,687
Residential mortgage-backed 400,914 400,914
Commercial mortgage-backed 813,746 813,746
Asset-backed 670,235 670,235
$ $ 9,034,557 $ $ $ 9,034,557
Other assets included within funds held - directly managed $ $ 14,207 $ $ $ 14,207
Equities:
Publicly traded equity investments $ 297,310 $ 30,565 $ $ $ 327,875
Exchange-traded funds 133,047 133,047
Privately held equity investments 265,799 265,799
$ 430,357 $ 30,565 $ 265,799 $ $ 726,721
Other investments:
Hedge funds $ $ $ $ 1,121,904 $ 1,121,904
Fixed income funds 398,143 82,896 481,039
Equity funds 111,040 299,109 410,149
Private equity funds 323,496 323,496
CLO equities 87,555 87,555
CLO equity funds 87,509 87,509
Other 34 314 6,031 6,379
$ $ 509,217 $ 87,869 $ 1,920,945 $ 2,518,031
Total Investments $ 430,357 $ 9,588,546 $ 353,668 $ 1,920,945 $ 12,293,516
Cash and cash equivalents $ 144,984 $ 222,191 $ $ $ 367,175
Reinsurance balances recoverable on paid and unpaid losses: $ $ $ 695,518 $ $ 695,518
Other Assets:
Derivatives qualifying as hedges $ $ 642 $ $ $ 642
Derivatives not qualifying as hedges 1,369 1,369
Derivative instruments $ $ 2,011 $ $ $ 2,011
Losses and LAE: $ $ $ 2,621,122 $ $ 2,621,122
Other Liabilities:
Derivatives qualifying as hedges $ $ 11,452 $ $ $ 11,452
Derivatives not qualifying as hedges 4,106 4,106
Derivative instruments $ $ 15,558 $ $ $ 15,558
44

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Valuation Methodologies of Financial Instruments Measured at Fair Value

Short-term and Fixed Maturity Investments
The fair values for all securities in the short-term and fixed maturity investments and funds held - directly managed portfolios are independently provided by the investment accounting service providers, investment managers and investment custodians, each of which utilize internationally recognized independent pricing services. We record the unadjusted price provided by the investment accounting service providers, investment managers or investment custodians and validate this price through a process that includes, but is not limited to: (i) comparison of prices against alternative pricing sources; (ii) quantitative analysis (e.g. comparing the quarterly return for each managed portfolio to its target benchmark); (iii) evaluation of methodologies used by external parties to estimate fair value, including a review of the inputs used for pricing; and (iv) comparing the price to our knowledge of the current investment market. Our internal price validation procedures and review of fair value methodology documentation provided by independent pricing services have not historically resulted in adjustment in the prices obtained from the pricing service.
The independent pricing services used by the investment accounting service providers, investment managers and investment custodians obtain actual transaction prices for securities that have quoted prices in active markets. Where we utilize single unadjusted broker-dealer quotes, they are generally provided by market makers or broker-dealers who are recognized as market participants in the markets for which they are providing the quotes. For determining the fair value of securities that are not actively traded, in general, pricing services use "matrix pricing" in which the independent pricing service uses observable market inputs including, but not limited to, reported trades, benchmark yields, broker-dealer quotes, interest rates, prepayment speeds, default rates and other such inputs as are available from market sources to determine a reasonable fair value.
The following describes the techniques generally used to determine the fair value of our short-term and fixed maturity investments by asset class, including the investments underlying the funds held - directly managed.
U.S. government and agency securities consist of securities issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and other agencies. Non-U.S. government securities consist of bonds issued by non-U.S. governments and agencies along with supranational organizations. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades and broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values of these securities are classified as Level 2.
Corporate securities consist primarily of investment-grade debt of a wide variety of corporate issuers and industries. The fair values of these securities are determined using the spread above the risk-free yield curve, reported trades, broker-dealer quotes, benchmark yields, and industry and market indicators. These are considered observable market inputs and, therefore, the fair values of these securities are classified as Level 2. Where pricing is unavailable from pricing services, such as in periods of low trading activity or when transactions are not orderly, we obtain non-binding quotes from broker-dealers. Where significant inputs are unable to be corroborated with market observable information, we classify the securities as Level 3.
Municipal securities consist primarily of bonds issued by U.S.-domiciled state and municipal entities. The fair values of these securities are determined using the spread above the risk-free yield curve, reported trades, broker-dealer quotes and benchmark yields. These are considered observable market inputs and, therefore, the fair values of these securities are classified as Level 2.
Asset-backed securities consist primarily of investment-grade bonds backed by pools of loans with a variety of underlying collateral. Residential and commercial mortgage-backed securities include both agency and non-agency originated securities. Where pricing is unavailable from pricing services, we obtain non-binding quotes from broker-dealers. This is generally the case when there is a low volume of trading activity and current transactions are not orderly. The significant inputs used to determine the fair value of these securities include the spread above the risk-free yield curve, reported trades, benchmark yields, prepayment speeds and default rates. The fair values of these securities are classified as Level 2 if the significant inputs are market observable. Where significant inputs are unable to be corroborated with market observable information, we classify the securities as Level 3.
45

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Equities
Our investments in equities consist of a combination of publicly and privately traded investments. Our publicly traded equity investments in common and preferred stocks predominantly trade on major exchanges and are managed by our external advisors. Our exchange-traded funds also trade on major exchanges. Our publicly traded equities are widely diversified and there is no significant concentration in any specific industry. We use an internationally recognized pricing service to estimate the fair value of our publicly traded equities and exchange-traded funds. We have categorized the majority of our publicly traded equity investments, other than preferred stock, and our exchange-traded funds as Level 1 investments because the fair values of these investments are based on unadjusted quoted prices in active markets for identical assets. One equity security is trading in an inactive market and, as a result has been classified as Level 2. The fair value estimates of our investments in publicly traded preferred stock are based on observable market data and, as a result, have been categorized as Level 2.
Our privately held equity investments in common and preferred stocks are direct investments in companies that we believe offer attractive risk adjusted returns and/or offer other strategic advantages. Each investment may have its own unique terms and conditions and there may be restrictions on disposals. The market for these investments is illiquid and there is no active market. We use a combination of cost, internal models, reported values from co-investors/managers and observable inputs, such as capital raises and capital transactions between new and existing shareholders to calculate the fair value of the privately held equity investments. The fair value estimates of our investments in privately held equities are based on unobservable market data and, as a result, have been categorized as Level 3.

Other investments, at fair value
We have ongoing due diligence processes with respect to the other investments carried at fair value in which we invest and their managers. These processes are designed to assist us in assessing the quality of information provided by, or on behalf of, each fund and in determining whether such information continues to be reliable or whether further review is warranted. Certain funds do not provide full transparency of their underlying holdings; however, we obtain the audited financial statements for funds annually, and regularly review and discuss the fund performance with the fund managers to corroborate the reasonableness of the reported net asset values ("NAV").
The use of NAV as an estimate of the fair value for investments in certain entities that calculate NAV is a permitted practical expedient. Due to the time lag in the NAV reported by certain fund managers we adjust the valuation for capital calls and distributions. Other investments measured at fair value using NAV as a practical expedient have not been classified in the fair value hierarchy. Other investments for which we do not use NAV as a practical expedient have been valued using prices from independent pricing services, investment managers and broker-dealers.
The following describes the techniques generally used to determine the fair value of our other investments.
For our investments in hedge funds, we measure fair value by obtaining the most recently available NAV as advised by the external fund manager or third-party administrator. The fair values of these investments are measured using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.
Our investments in fixed income funds and equity funds are valued based on a combination of prices from independent pricing services, external fund managers or third-party administrators. For the publicly available prices we have classified the investments as Level 2. For the non-publicly available prices we are using NAV as a practical expedient and therefore these have not been categorized within the fair value hierarchy.
For our investments in private equity funds, we measure fair value by obtaining the most recently available NAV from the external fund manager or third-party administrator. The fair values of these investments are measured using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.
We measure the fair value of our direct investment in CLO equities based on valuations provided by independent pricing services, our external CLO equity manager, and valuations provided by the broker or lead underwriter of the investment (the "broker"). The fair values measured using prices provided by independent pricing services have been classified as Level 2 and fair values using prices from brokers have been classified as Level 3 due to the use of unobservable inputs in the valuation and the limited number of
46

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
relevant trades in secondary markets.
For our investments in the CLO equity funds, we measure fair value by obtaining the most recently available NAV as advised by the external fund manager or third party administrator. The fair value of these investments is measured using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.
For our investments in private credit funds, we measure fair value by obtaining the most recently available NAV from the external fund manager or third-party administrator. The fair values of these investments are measured using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.
Included within other is an investment in a real estate debt fund, for which we measure fair value by obtaining the most recently available NAV from the external fund manager or third-party administrator. The fair value of this investment is measured using the NAV as a practical expedient and therefore has not been categorized within the fair value hierarchy.

Cash and Cash Equivalents
Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and are so near their maturity that they present insignificant risk of changes in value due to changes in interest rates. Included within cash and cash equivalents are money market funds, fixed interest deposits and highly liquid fixed maturity investments purchased with an original maturity of three months or less.
The majority of our cash and cash equivalents included within the fair value hierarchy are comprised of money market and liquid reserve funds which have been categorized as Level 1. Fixed interest deposits and highly liquid fixed maturity investments with an original maturity of three months or less have been categorized as Level 2. Operating cash balances are not subject to the recurring fair value measurement guidance and are therefore excluded from the fair value hierarchy.

Insurance Contracts - Fair Value Option
The Company uses an internal model to calculate the fair value of the liability for losses and loss adjustment expenses and reinsurance balances recoverable on paid and unpaid losses for certain retroactive reinsurance contracts where we have elected the fair value option in our Non-life Run-off segment. The fair value was calculated as the aggregate of discounted cash flows plus a risk margin. The discounted cash flow approach uses (i) estimated nominal cash flows based upon an appropriate payment pattern developed in accordance with standard actuarial techniques and (ii) a discount rate based upon a high quality rated corporate bond plus a credit spread for non-performance risk. The model uses corporate bond rates across the yield curve depending on the estimated timing of the future cash flows and specific to the currency of the risk. The risk margin was calculated using the present value of the cost of capital. The cost of capital approach uses (i) projected capital requirements, (ii) multiplied by the risk cost of capital representing the return required for non-hedgeable risk based upon the weighted average cost of capital less investment income and (iii) discounted using the weighted average cost of capital.

Derivative Instruments
The fair values of our derivative instruments, as described in Note 6 - "Derivatives and Hedging Instruments" are classified as Level 2. The fair values are based upon prices in active markets for identical contracts.
47

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Level 3 Measurements and Changes in Leveling
Transfers into or out of levels are recorded at their fair values as of the end of the reporting period, consistent with the date of determination of fair value.

Investments
The following tables present a reconciliation of the beginning and ending balances for all investments measured at fair value on a recurring basis using Level 3 inputs:
Three Months Ended June 30, 2020
Privately-held Equities Other Investments Total
Beginning fair value $ 267,012 $ 314 $ 267,326
Purchases 34 34
Sales
Total realized and unrealized gains 3,954 3,954
Transfer out of Level 3 into Level 2
Ending fair value $ 271,000 $ 314 $ 271,314
Three Months Ended June 30, 2019
Fixed maturity investments Privately-held Equities Other Investments Total
Corporate Residential mortgage-backed Commercial mortgage-backed Asset-backed
Beginning fair value $ 3,172 $ $ $ 9,050 $ 228,710 $ 41,747 $ 282,679
Purchases 90 11,995 12,085
Sales ( 381 ) ( 9 ) ( 390 )
Total realized and unrealized gains (losses) ( 40 ) ( 145 ) 2 684 ( 3,290 ) ( 2,789 )
Transfer into Level 3 from Level 2 2,871 102 1,515 15,049 19,537
Transfer out of Level 3 into Level 2 ( 706 ) ( 706 )
Ending fair value $ 5,006 $ 102 $ 1,370 $ 24,092 $ 229,394 $ 50,452 $ 310,416

Six Months Ended June 30, 2020
Privately-held Equities Other Investments Total
Beginning fair value $ 265,799 $ 87,869 $ 353,668
Purchases 1,392 37,092 38,484
Sales ( 539 ) ( 539 )
Total realized and unrealized gains (losses) 3,809 ( 40,368 ) ( 36,559 )
Transfer into Level 3 from Level 2
Transfer out of Level 3 into Level 2 ( 83,740 ) ( 83,740 )
Ending fair value $ 271,000 $ 314 $ 271,314
Six Months Ended June 30, 2019
Fixed maturity investments Privately-held Equities Other Investments Total
Corporate Residential mortgage-backed Commercial mortgage-backed Asset-backed
Beginning fair value $ 37,386 $ $ 7,389 $ 9,121 $ 228,710 $ 39,367 $ 321,973
Purchases 90 11,995 12,085
Sales ( 3,041 ) ( 608 ) ( 330 ) ( 3,979 )
Total realized and unrealized gains (losses) 217 ( 83 ) 739 684 ( 910 ) 647
Transfer into Level 3 from Level 2 3,258 102 1,515 21,024 25,899
Transfer out of Level 3 into Level 2 ( 32,904 ) ( 6,843 ) ( 6,462 ) ( 46,209 )
Ending fair value $ 5,006 $ 102 $ 1,370 $ 24,092 $ 229,394 $ 50,452 $ 310,416

48

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net realized and unrealized gains related to Level 3 assets in the tables above are included in net realized and unrealized gains (losses) in our unaudited condensed consolidated statements of earnings.
The securities transferred from Level 2 to Level 3 were transferred due to insufficient market observable inputs for the valuation of the specific assets. The transfers from Level 3 to Level 2 were based upon obtaining market observable information regarding the valuations of the specific assets.

Valuations Techniques and Inputs
The table below presents the quantitative information related to the fair value measurements for our privately held equity investments measured at fair value on a recurring basis using Level 3 inputs:
Quantitative Information about Level 3 Fair Value Measurements
Fair Value as of June 30, 2020 Valuation Techniques Unobservable Input
Range (Average) (1)
(in millions of U.S. dollars)
$ 245.3 Transactional value Implied price per share at recent purchase transaction
13.50 - 13.85
$ 25.7 Cost as approximation of fair value Cost as approximation of fair value
$ 271.0
(1) The average represents the arithmetic average of the inputs and is not weighted by the relative fair value.

Insurance Contracts - Fair Value Option

The following table presents a reconciliation of the beginning and ending balances for all insurance contracts measured at fair value on a recurring basis using Level 3 inputs:
Three Months Ended June 30,
2020 2019
Liability for losses and LAE Reinsurance balances recoverable Net Liability for losses and LAE Reinsurance balances recoverable Net
Beginning fair value $ 2,345,543 $ 653,396 $ 1,692,147 $ 2,847,793 $ 735,257 $ 2,112,536
Assumed business ( 4,975 ) ( 4,975 )
Incurred losses and LAE:
Reduction in estimates of ultimate losses ( 21,075 ) ( 4,951 ) ( 16,124 ) ( 5,802 ) 5,191 ( 10,993 )
Reduction in unallocated LAE ( 3,299 ) ( 3,299 ) ( 4,011 ) ( 4,011 )
Change in fair value 175,787 41,744 134,043 54,218 16,256 37,962
Total incurred losses and LAE 151,413 36,793 114,620 44,405 21,447 22,958
Paid losses ( 62,279 ) ( 22,321 ) ( 39,958 ) ( 91,753 ) ( 9,081 ) ( 82,672 )
Effect of exchange rate movements 24,837 3,516 21,321 ( 27,944 ) ( 4,319 ) ( 23,625 )
Ending fair value $ 2,454,539 $ 671,384 $ 1,783,155 $ 2,772,501 $ 743,304 $ 2,029,197

Changes in fair value in the table above are included in net incurred losses and LAE in our consolidated statements of earnings.
49

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents the components of the net change in fair value:
Three Months Ended
June 30,
2020 2019
Changes in fair value due to changes in:
Duration $ 3,702 $ 5,839
Corporate bond yield 130,341 32,123
Change in fair value $ 134,043 $ 37,962

Six Months Ended
June 30,
2020 2019
Liability for losses and LAE Reinsurance balances recoverable on paid and unpaid losses Net Liability for losses and LAE Reinsurance balances recoverable on paid and unpaid losses Net
Beginning fair value $ 2,621,122 $ 695,518 $ 1,925,604 $ 2,874,055 $ 739,591 $ 2,134,464
Incurred losses and LAE:
Reduction in estimates of ultimate losses ( 35,514 ) ( 8,122 ) ( 27,392 ) ( 12,956 ) 1,705 ( 14,661 )
Reduction in unallocated LAE ( 9,712 ) ( 9,712 ) ( 8,352 ) ( 8,352 )
Change in fair value 110,983 35,177 75,806 131,679 37,676 94,003
Total incurred losses and LAE 65,757 27,055 38,702 110,371 39,381 70,990
Paid losses ( 143,442 ) ( 38,435 ) ( 105,007 ) ( 207,613 ) ( 36,323 ) ( 171,290 )
Effect of exchange rate movements ( 88,898 ) ( 12,754 ) ( 76,144 ) ( 4,312 ) 655 ( 4,967 )
Ending fair value $ 2,454,539 $ 671,384 $ 1,783,155 $ 2,772,501 $ 743,304 $ 2,029,197

Changes in fair value in the table above are included in net incurred losses and LAE in our consolidated statements of earnings. The following table presents the components of the net change in fair value:
Six Months Ended
June 30,
2020 2019
Changes in fair value due to changes in:
Duration $ 7,850 $ 14,886
Corporate bond yield 66,249 79,117
Weighted cost of capital ( 5,048 )
Risk cost of capital 6,755
Change in fair value $ 75,806 $ 94,003

Below is a summary of the quantitative information regarding the significant observable and unobservable inputs used in the internal model to determine fair value on a recurring basis:
June 30, 2020 December 31, 2019
Valuation Technique Unobservable (U) and Observable (O) Inputs Weighted Average Weighted Average
Internal model Corporate bond yield (O) A rated A rated
Internal model Credit spread for non-performance risk (U) 0.2 % 0.2 %
Internal model Risk cost of capital (U) 5.1 % 5.1 %
Internal model Weighted average cost of capital (U) 8.25 % 8.5 %
Internal model Duration - liability (U) 7.92 years 7.82 years
Internal model Duration - reinsurance balances recoverable (U) 8.75 years 8.68 years
50

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses may increase or decrease due to changes in the corporate bond rate, the credit spread for non-performance risk, the risk cost of capital, the weighted average cost of capital and the estimated payment pattern as described below:
An increase in the corporate bond rate or credit spread for non-performance risk would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease in the corporate bond rate or credit spread for non-performance risk would result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses.
An increase in the weighted average cost of capital would result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease in the weighted average cost of capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses.
An increase in the risk cost of capital would result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease in the risk cost of capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses.
The duration of the liability and recoverable is adjusted every period to reflect actual net payments during the period and expected future payments. An acceleration of the estimated payment pattern, a decrease in duration, would result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a deceleration of the estimated payment pattern, an increase in duration, would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses.
In addition, the estimate of the capital required to support the liabilities is based upon current industry standards for capital adequacy. If the required capital per unit of risk increases, then the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses would increase. Conversely, a decrease in required capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses.

Disclosure of Fair Values for Financial Instruments Carried at Cost
Senior Notes
As of June 30, 2020, our 4.50 % Senior Notes due 2022 (the "2022 Senior Notes") and our 4.95 % Senior Notes due 2029 (the "2029 Senior Notes" and, together with the 2022 Senior Notes, the "Senior Notes") were carried at amortized cost of $ 348.9 million and $ 493.9 million, respectively, while the fair value based on observable market pricing from a third party pricing service was $ 355.0 million and $ 526.1 million, respectively. The Senior Notes are classified as Level 2.
Insurance Contracts
Disclosure of fair value of amounts relating to insurance contracts is not required, except those for which we elected the fair value option, as described above.
Remaining Assets and Liabilities
Our remaining assets and liabilities were generally carried at cost or amortized cost, which due to their short-term nature approximates fair value as of June 30, 2020 and December 31, 2019.
51

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
12. PREMIUMS WRITTEN AND EARNED
The following table provides a summary of premiums written and earned by segment and for our other activities:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Premiums
Written
Premiums
Earned
Premiums
Written
Premiums
Earned
Premiums
Written
Premiums
Earned
Premiums
Written
Premiums
Earned
Non-life Run-off
Gross $ ( 2,155 ) $ 14,395 $ ( 4,209 ) $ 55,551 $ ( 1,828 ) $ 32,473 $ ( 25,086 ) $ 139,517
Ceded ( 1,048 ) ( 3,878 ) 800 ( 7,081 ) 801 ( 5,926 ) 2,499 ( 14,373 )
Net $ ( 3,203 ) $ 10,517 $ ( 3,409 ) $ 48,470 $ ( 1,027 ) $ 26,547 $ ( 22,587 ) $ 125,144
Atrium
Gross $ 48,631 $ 48,152 $ 43,788 $ 41,884 $ 106,468 $ 95,985 $ 97,773 $ 85,270
Ceded ( 7,739 ) ( 4,765 ) ( 6,826 ) ( 3,685 ) ( 16,878 ) ( 10,228 ) ( 14,312 ) ( 8,318 )
Net $ 40,892 $ 43,387 $ 36,962 $ 38,199 $ 89,590 $ 85,757 $ 83,461 $ 76,952
StarStone
Gross $ 86,087 $ 112,288 $ 108,902 $ 114,462 $ 241,569 $ 238,825 $ 252,766 $ 257,240
Ceded ( 9,165 ) ( 29,452 ) ( 5,495 ) ( 16,140 ) ( 57,841 ) ( 58,375 ) ( 37,703 ) ( 28,996 )
Net $ 76,922 $ 82,836 $ 103,407 $ 98,322 $ 183,728 $ 180,450 $ 215,063 $ 228,244
Other
Gross $ 6,829 $ 6,795 $ 460 $ 6,013 $ 2,944 $ 9,468 $ 1,324 $ 12,686
Ceded ( 664 ) ( 664 ) 1 ( 42 ) ( 18 ) ( 117 )
Net $ 6,165 $ 6,131 $ 461 $ 5,971 $ 2,944 $ 9,468 $ 1,306 $ 12,569
Total
Gross $ 139,392 $ 181,630 $ 148,941 $ 217,910 $ 349,153 $ 376,751 $ 326,777 $ 494,713
Ceded ( 18,616 ) ( 38,759 ) ( 11,520 ) ( 26,948 ) ( 73,918 ) ( 74,529 ) ( 49,534 ) ( 51,804 )
Total $ 120,776 $ 142,871 $ 137,421 $ 190,962 $ 275,235 $ 302,222 $ 277,243 $ 442,909

Gross premiums written for the three months ended June 30, 2020 and 2019 were $ 139.4 million and $ 148.9 million, respectively, a decrease of $ 9.5 million. The decrease was primarily due to a decrease in gross premiums written in our StarStone segment of $ 22.8 million, partially offset by increases in our Atrium and Non-life Run-off segments of $ 4.8 million and $ 2.1 million, respectively. The decrease in the StarStone segment was primarily due to underwriting restrictions put in place as a result of the COVID-19 pandemic, a policy cancellation as a result of the StarStone International Run-Off and our strategy to exit certain lines of business. The increase in the Atrium segment was driven by new opportunities to write new business and an increase in rates, partially offset by the impact of COVID-19 and underwriting actions to not renew certain contracts in the current period.
Gross premiums written for the six months ended June 30, 2020 and 2019 were $ 349.2 million and $ 326.8 million, respectively, an increase of $ 22.4 million. The increase was primarily due to a reduction in negative gross premiums written in our Non-life Run-off segment of $ 23.3 million and an increase in gross premiums written in our Atrium segment of $ 8.7 million, partially offset by a decrease in gross premiums written in our StarStone segment of $ 11.2 million. The negative gross premium written in the Non-life Run-off segment for the six months ended June 30, 2019 was due to premium adjustments on the acquired unearned premium primarily related to the run-off business assumed as a result of the AmTrust RITC transactions and the acquisition of Maiden Re North America. The increase in the Atrium segment was driven by new opportunities to write new business and an increase in rates, partially offset by the impact of COVID-19 and underwriting actions to not renew certain contracts in the current period. The decrease in the StarStone segment was driven primarily by underwriting restrictions put in place as a result of COVID-19 and our strategy to exit certain lines of business, partially off set by new business and rate improvements in certain lines.

52

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
13. GOODWILL AND INTANGIBLE ASSETS
The following table presents a reconciliation of the beginning and ending goodwill and intangible assets for the six months ended June 30, 2020:
Intangible assets
Goodwill Intangible
assets with
a definite life
Intangible
assets
with an indefinite life
Total Total
Balance as of December 31, 2019 109,807 14,630 67,131 81,761 191,568
Impairment losses (StarStone International) ( 8,000 ) ( 4,000 ) ( 4,000 ) ( 12,000 )
Amortization ( 1,016 ) ( 1,016 ) ( 1,016 )
Balance as of June 30, 2020
$ 101,807 $ 13,614 $ 63,131 $ 76,745 $ 178,552
Goodwill
The changes in the goodwill by segment was as follows for the six months ended June 30, 2020:
Non-life
Run-Off
Atrium StarStone Total
Balance as of December 31, 2019:
$ 62,959 $ 38,848 $ 8,000 $ 109,807
Impairment losses (StarStone International) ( 8,000 ) ( 8,000 )
Balance as of June 30, 2020:
Goodwill 62,959 38,848 8,000 109,807
Accumulated impairment losses ( 8,000 ) ( 8,000 )
$ 62,959 $ 38,848 $ $ 101,807
On June 10, 2020, we announced the StarStone International Run-Off. During the three and six months ended June 30, 2020, we recognized a full impairment loss of $ 8.0 million related to the goodwill allocated to StarStone International.

53

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Intangible Assets
The gross carrying value, accumulated amortization and net carrying value of intangible assets by segment and by type as of June 30, 2020 and December 31, 2019 was as follows:
June 30, 2020 December 31, 2019
Gross
carrying
value
Accumulated amortization Net
carrying
value
Gross
carrying
value
Accumulated amortization Net
carrying
value
Atrium segment:
Intangible assets with a definite life:
Distribution channel $ 20,000 $ ( 8,777 ) $ 11,223 $ 20,000 $ ( 8,111 ) $ 11,889
Brand 7,000 ( 4,609 ) 2,391 7,000 ( 4,259 ) 2,741
Intangible assets with an indefinite life:
Lloyd’s syndicate capacity 33,031 33,031 33,031 33,031
Management contract 30,100 30,100 30,100 30,100
Total Atrium segment intangible assets $ 90,131 $ ( 13,386 ) $ 76,745 $ 90,131 $ ( 12,370 ) $ 77,761
StarStone segment:
Intangible assets with an indefinite life:
Lloyd’s syndicate capacity 4,000 ( 4,000 ) 4,000 4,000
Total intangible assets $ 94,131 $ ( 17,386 ) $ 76,745 $ 94,131 $ ( 12,370 ) $ 81,761

Atrium
The definite-lived assets are amortized on a straight-line basis over a period ranging from ten to fifteen years . The following table presents the amortization recorded on the intangible assets:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Intangible asset amortization
$ 508 $ 565 $ 1,016 $ 1,130
The estimated future amortization expense related to Atrium's intangible assets is as follows:
Year Total
2020 $ 1,017
2021 2,033
2022 2,033
2023 1,975
2024 1,333
2025 and thereafter 5,223
Total future estimated amortization expense $ 13,614

StarStone
During the three and six months ended June 30, 2020, we recognized a full impairment loss of $ 4.0 million on StarStone's Lloyd's syndicate capacity following our decision to place StarStone International into run-off.
54

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
14. DEBT OBLIGATIONS AND CREDIT FACILITIES
We primarily utilize debt facilities for funding acquisitions and for significant new business, investment activities and, from time to time, for general corporate purposes. Our debt obligations were as follows:
Facility Origination Date Term June 30, 2020 December 31, 2019
4.50 % Senior Notes due 2022
March 10, 2017 5 years $ 348,886 $ 348,616
4.95 % Senior Notes due 2029
May 28, 2019 10 years 493,893 493,600
Total Senior Notes 842,779 842,216
EGL Revolving Credit Facility August 16, 2018 5 years 350,000
2018 EGL Term Loan Facility December 27, 2018 3 years 349,243 348,991
Total debt obligations $ 1,542,022 $ 1,191,207
During the six months ended June 30, 2020, we utilized $ 364.0 million and repaid $ 14.0 million under our facilities. The facilities were utilized for funding significant new business as described in Note 3 - "Significant New Business" and providing additional liquidity to the Company to maximize financial flexibility following the recent disruption in global financial markets associated with the COVID-19 pandemic.
The table below provides a summary of the total interest expense:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Interest expense on debt obligations $ 13,675 $ 12,754 $ 26,870 $ 23,207
Amortization of debt issuance costs 343 282 563 555
Funds withheld balances and other 310
Total interest expense $ 14,018 $ 13,036 $ 27,433 $ 24,072
Senior Notes
4.50 % Senior Notes due 2022
On March 10, 2017, we issued the 2022 Senior Notes for an aggregate principal amount of $ 350.0 million. The 2022 Senior Notes pay 4.5 % interest semi-annually and mature on March 10, 2022. The 2022 Senior Notes are unsecured and unsubordinated obligations that rank equal to any of our other unsecured and unsubordinated obligations, senior to any future obligations that are expressly subordinated to the 2022 Senior Notes, effectively subordinate to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness, and structurally subordinate to all liabilities of our subsidiaries.
The 2022 Senior Notes are rated BBB- and are redeemable at our option on a make whole basis at any time prior to the date that is one month prior to the maturity of the 2022 Senior Notes. On or after the date that is one month prior to the maturity of the 2022 Senior Notes, the notes are redeemable at a redemption price equal to 100 % of the principal amount of the 2022 Senior Notes to be redeemed.
We incurred costs of $ 2.9 million in issuing the 2022 Senior Notes. These costs included underwriters’ fees, legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the principal amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of the 2022 Senior Notes and are included in interest expense in our consolidated statements of earnings. The unamortized costs as of June 30, 2020 and December 31, 2019 were $ 1.1 million and $ 1.4 million, respectively.
55

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
4.95 % Senior Notes due 2029
On May 28, 2019, we issued the 2029 Senior Notes for an aggregate principal amount of $ 500.0 million. The 2029 Senior Notes pay 4.95 % interest semi-annually and mature on June 1, 2029. The 2029 Senior Notes are unsecured and unsubordinated obligations that rank equal to any of our other unsecured and unsubordinated obligations, senior to any future obligations that are expressly subordinated to the 2029 Senior Notes, effectively subordinate to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness, and contractually subordinate to all liabilities of our subsidiaries.
The 2029 Senior Notes are rated BBB- and are redeemable at our option on a make whole basis at any time prior to the date that is three months prior to the maturity of the 2029 Senior Notes. On or after the date that is three months prior to the maturity of the 2029 Senior Notes, the notes are redeemable at a redemption price equal to 100 % of the principal amount of the notes to be redeemed.
We incurred costs of $ 6.8 million in issuing the 2029 Senior Notes. These costs included underwriters’ fees, legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the principal amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of the 2029 Senior Notes and are included in interest expense in our consolidated statements of earnings. The unamortized costs as of June 30, 2020 and December 31, 2019 were $ 6.1 million and $ 6.4 million, respectively.

EGL Revolving Credit Facility
On August 16, 2018, we and certain of our subsidiaries, as borrowers and guarantors, entered into a new five-year unsecured $ 600.0 million revolving credit agreement. The revolving credit agreement expires in August 2023 and we have the option to increase the commitments under the facility by up to an aggregate amount of $ 400.0 million from the existing lenders, or through the addition of new lenders subject to the terms of the agreement. Borrowings under the facility will bear interest at a rate based on the Company's long term senior unsecured debt ratings.
As of June 30, 2020, we were permitted to borrow up to an aggregate of $ 600.0 million under the facility. As of June 30, 2020, there was $ 250.0 million of available unutilized capacity under the facility. Subsequent to June 30, 2020, we have neither borrowed nor repaid any additional amounts under the facility, as such the unutilized capacity remains at $ 250.0 million.
Interest is payable at least every month at either the alternate base rate ("ABR") or LIBOR plus a margin as set forth in the revolving credit agreement. The margin could vary based upon any change in our long term senior unsecured debt rating assigned by Standard & Poor's ("S&P") or Fitch. We also pay a commitment fee based on the average daily unutilized portion of the facility. If an event of default occurs, the interest rate may increase and the agent may, and at the request of the required lenders shall, cancel lender commitments and demand early repayment.

2018 EGL Term Loan Facility
On December 27, 2018, we entered into and fully utilized a three-year $ 500.0 million unsecured term loan (the "2018 EGL Term Loan Facility"). The proceeds were partially used to fund the acquisition of Maiden Re North America. We have the option to increase the principal amount of the term loan credit facility up to an aggregate amount of $ 150.0 million from the existing lenders or through the addition of new lenders, subject to the terms of the term loan credit agreement. During 2019, we repaid $ 150.0 million of principal on the facility, bringing the outstanding loan amount to $ 349.2 million, which includes unamortized issuance costs of $ 0.8 million, as of June 30, 2020.
Interest is payable at least every three months at either ABR or LIBOR plus a margin set forth in the term loan credit agreement. The margin could vary based upon any change in our long term senior unsecured debt rating assigned by S&P or Fitch. During the existence of an event of default, the interest rate may increase and the agent may, and at the request of the required lenders shall, demand early repayment.
56

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
We incurred costs of $ 1.5 million associated with closing the 2018 EGL Term Loan Facility. These costs included bank, legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the principal amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of the facility and are included in general and administrative expenses in our consolidated statements of earnings. The unamortized costs as of June 30, 2020 and December 31, 2019 were $ 0.8 million and $ 1.0 million, respectively.
Refer to Note 15 - "Debt Obligations and Credit Facilities" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 for further information on the terms of the above facilities.

Letters of Credit
We utilize unsecured and secured letters of credit to support certain of our insurance and reinsurance performance obligations.
Funds at Lloyd's
We have an unsecured letter of credit agreement for Funds at Lloyd's ("FAL Facility") to issue up to $ 375.0 million of letters of credit, with provision to increase the facility by an additional $ 25.0 million up to an aggregate amount of $ 400.0 million, subject to lenders approval. On November 6, 2019, we amended and restated the FAL Facility to extend its term by one year . The FAL Facility is available to satisfy our Funds at Lloyd's requirements and expires in 2023. As of June 30, 2020 and December 31, 2019, our combined Funds at Lloyd's were comprised of cash and investments of $ 574.1 million and $ 639.3 million, respectively, and unsecured letters of credit of $ 252.0 million as of both dates.
$ 120.0 million Letter of Credit Facility
We use this facility to support certain reinsurance collateral obligations of our subsidiaries. On December 6, 2019, we reduced the facility size from $ 170.0 million to $ 120.0 million. Pursuant to the facility agreement, we have the option to increase commitments under the facility by an additional $ 60.0 million. As of both June 30, 2020 and December 31, 2019, we had issued an aggregate amount of letters of credit under this facility of $ 115.3 million.
$ 800.0 million Syndicated Letter of Credit Facility
During 2019, we entered into an unsecured $ 760.0 million letter of credit facility agreement, most recently amended on June 3, 2020. On August 4, 2020, we exercised our option to increase the commitments available under the facility by an aggregate amount of $ 40.0 million, bringing the total size of the facility to $ 800.0 million. The facility is used to post letters of credit to collateralize reinsurance performance obligations to various parties, including $ 447.4 million relating to the reinsurance transaction with Maiden Reinsurance Ltd. ("Maiden Re Bermuda"). As of June 30, 2020 and December 31, 2019, we had issued an aggregate amount of letters of credit under this facility of $ 594.1 million and $ 608.0 million, respectively.
$ 65.0 million Letter of Credit Facility
On August 4, 2020, we entered into a $ 65.0 million secured letter of credit facility agreement pursuant to which we issued a letter of credit in the amount of approximately $ 61.0 million to collateralize a portion of our reinsurance performance obligations relating to our novation transaction with Hannover Re, which we completed on August 6, 2020, as discussed in Note 3 - "Significant New Business".

15. NONCONTROLLING INTERESTS
We have both redeemable noncontrolling interest ("RNCI") and noncontrolling interest ("NCI") on our consolidated balance sheets. RNCI with redemption features that are not solely within our control are classified within temporary equity in the consolidated balance sheets and carried at redemption value, which is fair value. The change in fair value is recognized through retained earnings as if the balance sheet date were also the redemption date. In addition, we also have NCI, which does not have redemption features and is classified within equity in the consolidated balance sheets.

57

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Redeemable Noncontrolling Interest
RNCI as of June 30, 2020 and December 31, 2019 comprised the ownership interests held by the Trident V Funds ("Trident") ( 39.3 %) and Dowling Capital Partners, L.P. ("Dowling") ( 1.7 %) in our subsidiary North Bay Holdings Limited ("North Bay"). North Bay owns our investments in Atrium and StarStone.
The following is a reconciliation of the beginning and ending carrying amount of the equity attributable to the RNCI:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Balance at beginning of period $ 392,773 $ 456,346 $ 438,791 $ 458,543
Dividends paid ( 11,556 ) ( 11,556 )
Net losses attributable to RNCI ( 20,140 ) ( 2,917 ) ( 52,099 ) ( 5,461 )
Accumulated other comprehensive earnings attributable to RNCI 10,543 70 6,373 155
Foreign currency translation adjustments ( 165 ) ( 165 )
Change in redemption value of RNCI ( 16,478 ) ( 6,247 ) ( 26,628 ) ( 5,985 )
Cumulative effect of change in accounting principle attributable to RNCI (1)
261
Balance at end of period $ 366,533 $ 435,696 $ 366,533 $ 435,696
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" for further details.

We carried the RNCI at its estimated redemption value, which is fair value, as of June 30, 2020 and December 31, 2019. The decrease was attributable to $ 52.1 million of net losses primarily related to StarStone during the six months ended June 30, 2020 resulting from exit costs associated with the decision to place StarStone International into run-off; and $ 26.6 million due to change in redemption value. The redemption value decreased as a result of the StarStone International Run-Off decision and the agreement to sell StarStone U.S.
Refer to Note 20 - "Related Party Transactions" and Note 21 - "Commitments and Contingencies" for additional information regarding RNCI.

Noncontrolling Interest
As of June 30, 2020 and December 31, 2019, we had $ 13.6 million and $ 14.2 million, respectively, of NCI related to external interests in three of our subsidiaries. A reconciliation of the beginning and ending carrying amount of the equity attributable to NCI is included in the unaudited condensed consolidated statement of changes in shareholders equity.
58

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
16. SHARE CAPITAL
Refer to Note 17 - "Share Capital" to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 for additional information on our share capital.
Dividends Declared and Paid
The following table details the dividends that have been declared and paid on our Series D and E Preferred Shares for the period from January 1, 2020 to August 10, 2020:
Dividend per:
Preferred Share Series Date Declared Record Date Date Paid or Payable Preferred Share Depositary Share Total dividends paid in the six months ended June 30, 2020
(in U.S. dollars) (in thousands of U.S. dollars)
Series D February 4, 2020 February 15, 2020 March 2, 2020 $ 437.50 $ 0.43750 $ 7,000
Series E February 4, 2020 February 15, 2020 March 2, 2020 $ 437.50 $ 0.43750 1,925
Series D May 5, 2020 May 15, 2020 June 1, 2020 $ 437.50 $ 0.43750 7,000
Series E May 5, 2020 May 15, 2020 June 1, 2020 $ 437.50 $ 0.43750 1,925
Series D August 5, 2020 August 15, 2020 September 1, 2020 $ 437.50 $ 0.43750
Series E August 5, 2020 August 15, 2020 September 1, 2020 $ 437.50 $ 0.43750
$ 17,850
Share Repurchases
On March 9, 2020, our Board of Directors adopted a stock trading plan for the purpose of repurchasing a limited number of our Company’s ordinary shares, not to exceed $ 150.0 million in aggregate (the "Repurchase Program"). On March 23, 2020, we suspended our Repurchase Program due to uncertainty in the global financial markets resulting from the COVID-19 pandemic. From inception to March 23, 2020, we repurchased 92,510 ordinary shares for an aggregate price of $ 12.5 million under the Repurchase Program. The average price paid per share repurchased was $ 135.40 .
Joint Share Ownership Plan
On January 21, 2020, 565,630 Voting Ordinary Shares were issued to the trustee of the Enstar Group Limited Employee Benefit Trust (the "EB Trust"). Voting rights in respect of shares held in the EB Trust have been contractually waived. We have consolidated the EB Trust, and shares held in the EB Trust are classified like treasury shares as contra-equity in our consolidated balance sheet.
The EB Trust supports awards made under our Joint Share Ownership Plan, a sub-plan to our Amended and Restated 2016 Equity Incentive Plan (the "JSOP"). An award of 565,630 shares was made to our Chief Executive Officer on January 21, 2020, which cliff-vests after 3 years from grant. The accounting for stock-settled JSOP awards is similar to options, whereby the grant date fair value of $ 13.6 million is expensed over the life of the award. To determine the grant date fair value of $ 24.13 per share, we utilized a Monte-Carlo valuation model with the following assumptions: (i) volatility of 18.66 %; (ii) dividend yield of 0.00 %; and (iii) risk-free interest rate of 1.55 %. For further information on the EB Trust and JSOP award, including the vesting conditions, refer to Note 17 - "Share Capital" and Note 19 - "Share-Based Compensation and Pensions" to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.

59

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
17. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted net earnings per ordinary share:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Numerator:
Earnings (losses) attributable to Enstar ordinary shareholders:
Net earnings from continuing operations $ 799,232 $ 234,168 $ 283,632 $ 588,160
Net earnings (loss) from discontinued operations (3)
( 679 ) ( 2,326 ) ( 1,900 ) 2,433
Net earnings attributable to Enstar ordinary shareholders: $ 798,553 $ 231,842 $ 281,732 $ 590,593
Denominator:
Weighted-average ordinary shares outstanding — basic (1)
21,565,240 21,477,772 21,557,542 21,470,675
Effect of dilutive securities:
Share-based compensation plans (2)
185,300 138,464 177,264 131,798
Warrants 38,702 59,215 53,525 59,296
Weighted-average ordinary shares outstanding — diluted 21,789,242 21,675,451 21,788,331 21,661,769
Earnings (loss) per ordinary share attributable to Enstar:
Basic:
Net earnings from continuing operations $ 37.06 $ 10.90 $ 13.16 $ 27.40
Net earnings (loss) from discontinued operations ( 0.03 ) ( 0.11 ) ( 0.09 ) 0.11
Net earnings per ordinary share $ 37.03 $ 10.79 $ 13.07 $ 27.51
Diluted:
Net earnings from continuing operations $ 36.68 $ 10.81 $ 13.02 $ 27.15
Net earnings (loss) from discontinued operations ( 0.03 ) ( 0.11 ) ( 0.09 ) 0.11
Net earnings per ordinary share $ 36.65 $ 10.70 $ 12.93 $ 27.26

(1) Weighted-average ordinary shares for basic earnings per share includes ordinary shares (voting and non-voting) but excludes ordinary shares held in the EB Trust in respect of JSOP awards.
(2) Share-based dilutive securities include restricted shares, restricted share units, and performance share units. Certain share-based compensation awards, including the ordinary shares held in the EB Trust in respect of JSOP awards, were excluded from the calculation for the three and six months ended June 30, 2020 because they were anti-dilutive.
(3) Net earnings (loss) from discontinued operations attributable to Enstar ordinary shareholders equals net earnings (loss) from discontinued operations, net of income taxes, plus net loss (earnings) from discontinued operations attributable to noncontrolling interest; refer to Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" for a breakdown by period.




60

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
18. SHARE-BASED COMPENSATION
We provide various employee benefits including share-based compensation, an employee share purchase plan and an annual incentive compensation program. These are described in Note 19 - "Share-Based Compensation and Pensions" to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.
The table below provides a summary of the compensation costs for all of our share-based compensation plans:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Share-based compensation plans:
Restricted shares and restricted share units $ 2,330 $ 1,289 $ 3,929 $ 3,132
Performance share units 5,855 11,130 5,188 12,455
Cash-settled stock appreciation rights ( 316 ) ( 267 ) ( 3,475 ) ( 211 )
Joint share ownership plan expense 1,133 2,005
Other share-based compensation plans:
Northshore incentive plan ( 25 ) 986 447 2,032
StarStone incentive plan ( 223 )
Deferred compensation and ordinary share plan for non-employee directors 93 49 959 876
Employee share purchase plan 104 104 208 207
Total share-based compensation $ 9,174 $ 13,291 $ 9,038 $ 18,491

19. INCOME TAXATION

Interim Tax Calculation Method
We use the estimated annual effective tax rate method for computing our interim tax provision. This method applies our best estimate of the effective tax rate expected for the full year to our year-to-date earnings before income taxes. We provide for income tax expense or benefit based upon our pre-tax earnings and the provisions of currently enacted tax laws. Certain items deemed to be unusual, infrequent or not reliably estimated are excluded from the estimated annual effective tax rate. In the event such items are identified, the actual tax expense or benefit is reported in the same period as the related item. Certain other items are not included in the estimated annual effective tax rate, such as changes in the assessment of valuation allowance on deferred tax assets and uncertain tax positions, if any.

Interim Tax Expense
The effective tax rates on income for the three months ended June 30, 2020 and 2019 were 2.1 % and 3.1 %, respectively. The effective tax rates on income for the six months ended June 30, 2020 and 2019 were 4.4 % and 2.0 %, respectively. The effective tax rate on income differs from the statutory rate of 0 % due to tax on foreign operations, primarily the U.S. and the U.K.
We have foreign operating subsidiaries and branch operations principally located in the U.S., U.K., Continental Europe and Australia that are subject to federal, foreign, state and local taxes in those jurisdictions. Deferred tax lia bilities have not been accrued with respect to the undistributed earnings of our foreign subsidiaries. If the earnings were to be distributed, as dividends or other distributions, withholding taxes may be imposed by the jurisdiction of the paying subsidiary. For our U.S. subsidiaries, we have not currently accrued any withholding taxes with respect to unremitted earnings as management has indefinitely reinvested these earnings. For our U.K. subsidiaries, there are no withholding taxes imposed. For our other foreign subsidiaries, it would not be practicable to compute such amounts due to a variety of factors, including the amount, timing, and manner of any repatriation. Because we operate in many jurisdictions, our net earnings are subject to risk due to changing tax laws and tax rates around the world. The current, rapidly changing economic environment may increase the likelihood of substantial changes to tax laws in the jurisdictions in which we operate.
61

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Assessment of Valuation Allowance on Deferred Tax Assets
We have estimated the future taxable income of our foreign subsidiaries and have provided a valuation allowance in respect of loss carryforwards where we do not expect to realize a benefit. We have considered all available evidence using a "more likely than not" standard in determining the amount of the valuation allowance. During the three and six months ended June 30, 2020, we have maintained a valuation allowance for deferred tax assets which management does not believe meet the "more likely than not" criteria.

Unrecognized Tax Benefits
There were no unrecognized tax benefits as of June 30, 2020 and December 31, 2019.

Tax Examinations
Our operating subsidiaries may be subject to audit by various tax authorities and may have different statutes of limitations expiration dates. With limited exceptions, our major subsidiaries that operate in the U.S., U.K. and Australia are no longer subject to tax examinations for years before 2015.

20. RELATED PARTY TRANSACTIONS

Stone Point Capital LLC

Through several private transactions occurring from May 2012 to July 2012 and an additional private transaction that closed in May 2018, investment funds managed by Stone Point Capital LLC ("Stone Point") have acquired an aggregate of 1,635,986 of our Voting Ordinary Shares (which constitutes approximately 8.8 % of our outstanding Voting Ordinary Shares). On November 6, 2013, we appointed James D. Carey to our Board of Directors. Mr. Carey is the sole member of an entity that is one of four general partners of the entities serving as general partners for Trident, is a member of the investment committees of such general partners, and is a member and senior principal of Stone Point, the manager of the Trident funds.
In addition, we have entered into certain agreements with Trident with respect to Trident’s co-investments in the Atrium, Arden, and StarStone acquisitions. These include investors’ agreements and shareholders’ agreements (most recently amended on June 14, 2020), which provide for, among other things: (i) our right to redeem Trident’s equity interest in the Atrium/Arden and StarStone transactions in cash at fair market value at any time following March 31, 2023 (the "Call Right"); and (ii) Trident’s right to have its equity co-investment interests in the Atrium/Arden and StarStone transactions redeemed by us at fair market value (which we may satisfy in either cash or our ordinary shares) following December 31, 2022 (the "Put Right").
Following the consummation of the StarStone U.S. transaction described in Note 4 – “Divestitures, Held-for-Sale Businesses and Discontinued Operations” (the “Sale Transaction”): (a) we will have the right to exercise the Call Right separately with respect to (1) Trident’s interests in North Bay, (2) Trident’s indirect interest in North Bay’s equity interest in the StarStone U.S. business received in the Sale Transaction (the “StarStone U.S. Equity Interest”) and (3) Trident’s indirect interest in the business included in the StarStone International Run-off; and (b) Trident will have the right to exercise its Put Right separately with respect to (1) its interest in North Bay, (2) its indirect interest in the StarStone U.S. Equity Interest, and (3) its indirect interest in the business included in the StarStone International Runoff.
However, if neither the Sale Transaction nor a proposed future reorganization of North Bay (the “Reorganization” and, together with the Sale Transaction, the “Transactions”) are consumed by April 1, 2021, the date associated with the Call Right and the Put Right would instead be April 1, 2021 and clauses (a)(2), (a)(3), (b)(2) and (b)(3) above would no longer apply. If the Sale Transaction is consummated, but a Reorganization transaction is not agreed and consummated by (x) December 31, 2020, then, any time after that date, Trident will have the right to require us to purchase its indirect interest in the StarStone U.S. Equity Interest or (y) April 1, 2021, then, any time after that date, we will have the right to purchase Trident’s indirect interest in the StarStone U.S. Equity Interest.
62

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Pursuant to the terms of the shareholders’ agreements, Mr. Carey serves as a Trident representative on the boards of the holding companies, including North Bay, established in connection with the Atrium/Arden and StarStone co-investment transactions. Trident also has a second representative on these boards who is a Stone Point employee.
We, in partnership with StarStone's other shareholders, have recently completed two transactions to provide capital support to StarStone in the form of:
(i) a contribution to its contributed surplus account and a loss portfolio transfer, effective October 1, 2018. To fund the transaction, the North Bay shareholders contributed an aggregate amount of $ 135.0 million to North Bay in proportion to their ownership interests. Trident’s proportionate contribution of $ 53.1 million was temporarily funded by North Bay and was reimbursed in the first quarter of 2019; and
(ii) a loss portfolio transfer, effective April 1, 2019, for which shareholders agreed to contribute an aggregate amount of $ 48.0 million.
In addition, Enstar has separately entered into a loss portfolio transfer and adverse development cover with StarStone effective October 1, 2019, whereby StarStone transferred $ 189.4 million in loss reserves and unearned premium to a wholly-owned Enstar subsidiary in exchange for premium of $ 189.4 million. Enstar also provided an additional $ 59.0 million adverse development cover in excess of the $ 189.4 million.
The RNCI on our balance sheet relating to these Trident co-investment transactions was as follows:
June 30, 2020 December 31, 2019
Redeemable Noncontrolling Interest $ 351,253 $ 420,499

As of June 30, 2020, we had the following additional relationships with Stone Point and its affiliates:
Investments in funds (carried within other investments) managed by Stone Point, with respect to which we recognized net unrealized gains (losses);
Investments in registered investment companies affiliated with entities owned by Trident or otherwise affiliated with Stone Point, with respect to which we recognized net unrealized gains (losses) and interest income;
Separate accounts managed by Eagle Point Credit Management, PRIMA Capital Advisors and SKY Harbor Capital Management, which are affiliates of entities owned by Trident, with respect to which we incurred management fees;
Investments in funds (carried within other investments) managed by Sound Point Capital, an entity in which Mr. Carey has an indirect minority ownership interest and serves as a director, with respect to which we recognized net unrealized gains (losses);
Sound Point Capital has acted as collateral manager for certain of our direct investments in CLO debt and equity securities, with respect to which we recognized net unrealized gains (losses) and interest income;
Marble Point Capital, which is an affiliate of an entity owned by Trident, has acted as collateral manager for certain of our direct investments in CLO debt and equity securities, with respect to which we recognized net unrealized gains (losses) and interest income;
A separate account managed by Sound Point Capital, with respect to which we incurred management fees in prior periods;
In the fourth quarter of 2018, we invested $ 25.0 million in Mitchell TopCo Holdings, the parent company of Mitchell International and Genex Services, as a co-investor alongside certain Trident funds; and
In the second quarter of 2020, we invested $ 10.0 million in a 2.5 year senior secured unrated floating rate term loan facility formed and managed by Sound Point Capital. The facility's borrower, Amplify U.S. Inc., is a subsidiary of Evergreen (as defined below) and has used the proceeds to purchase AmTrust preferred stock. The facility ranks senior to all other claims of the borrower, the purchased preferred stock and cash flows therefrom serve as collateral, and AmTrust has provided an unsecured guarantee for the facility. For further information on our relationships with Evergreen and AmTrust, refer to the AmTrust section below.

63

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents the amounts included in our consolidated balance sheet related to our related party transactions with Stone Point and its affiliated entities:
June 30, 2020 December 31, 2019
Short-term investments, AFS, at fair value $ 1,598 $ 1,431
Fixed maturities, trading, at fair value 207,570 269,131
Fixed maturities, AFS, at fair value 209,803 160,303
Equities, at fair value 89,069 121,794
Other investments, at fair value:
Hedge funds 17,925 18,993
Fixed income funds 325,482 381,449
Private equity funds 28,335 34,858
CLO equities 30,126 32,560
CLO equity funds 123,299 87,509
Private Debt 15,815 16,312
Real estate fund 21,586 18,106
Cash and cash equivalents 11,472 54,080
Other assets 10,574 10
Other liabilities 1,193 4,710

The following table presents the amounts included in net earnings related to our related party transactions with Stone Point and its affiliated entities:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Net investment income $ 4,793 $ 1,563 $ 8,877 $ 2,752
Net realized and unrealized (losses) gains 29,729 9,564 ( 72,787 ) 29,747
Total net (losses) earnings $ 34,522 $ 11,127 $ ( 63,910 ) $ 32,499


Hillhouse Capital

Investment funds managed by Hillhouse Capital (defined below) collectively own approximately 9.4 % of Enstar’s voting ordinary shares. These funds also own non-voting ordinary shares and warrants to purchase additional non-voting ordinary shares, which together with their voting ordinary shares, represent an approximate 16.5 % economic interest in Enstar. In February 2017, Jie Liu, a Partner of AnglePoint (defined below), was appointed to our Board.

We have made direct investments in in funds (the “Hillhouse Funds”) managed by Hillhouse Capital Management, Ltd. and Hillhouse Capital Advisors, Ltd. (together, “Hillhouse Capital”) and AnglePoint Asset Management Ltd. ("AnglePoint"). As of June 30, 2020, our carrying value of our direct investment the InRe Fund, L.P. (the "InRe Fund"), which is managed by AnglePoint, was $ 1.5 billion with the InRe Fund's assets being invested in approximately 22 % in fixed income securities, 16 % in North American equities, 54 % in international equities and 8 % in financing, derivatives and other items.
As of June 30, 2020 and December 31, 2019 our equity method investee, Enhanzed Reinsurance Ltd. ("Enhanzed Re"), had investments in a fund managed by AnglePoint, as set forth in the table below.

64

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Our consolidated balance sheet included the following balances related to transactions with Hillhouse Capital and AnglePoint (as applicable):
June 30, 2020 December 31, 2019
Investments in funds managed by AnglePoint, held by Enhanzed Re $ 522,207 $ 327,799
Our ownership of equity method investments 47.4 % 47.4 %
Our share of Investments in funds managed by AnglePoint held by Enhanzed Re (through our ownership of equity method investments) $ 247,526 $ 155,377
Investment in other funds managed by Hillhouse Capital and AnglePoint:
InRe Fund $ 1,534,329 $ 918,633
Other funds 268,353 232,968
$ 1,802,682 $ 1,151,601

The increase in the investment in the Hillhouse Funds was primarily due to additional subscriptions of $ 300.0 million and unrealized gains for the six months ended June 30, 2020. We incurred management and performance fees of approximately $ 131.7 million, included within the Hillhouse Funds' reported NAV, for the six months ended June 30, 2020 in relation to the investment in funds managed by Hillhouse Capital and AnglePoint as described above.

Monument

Monument Insurance Group Limited ("Monument") was established in October 2016 and Enstar has invested a total of $ 59.6 million in the common and preferred shares of Monument as at June 30, 2020 (December 31, 2019: $ 26.6 million) for an interest of approximately 26.6 % (December 31, 2019: 26.6 %). In connection with our investment in Monument, we entered into a Shareholders Agreement with the other shareholders. We have accounted for our equity interest in Monument as an equity method investment as we have significant influence over its operating and financial policies.
On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-owned subsidiary Alpha Insurance SA to a subsidiary of Monument. In this transaction, we transferred policy benefits for life and annuity contracts with a carrying value of € 88.8 million (or approximately $ 99.1 million) and total assets with a fair value of € 91.1 million (or approximately $ 101.6 million) to a subsidiary of Monument.

Our investment in the common and preferred shares of Monument, which is included in equity method investments on our consolidated balance sheet, was as follows:
June 30, 2020 December 31, 2019
Investment in Monument $ 92,117 $ 60,598

During the three and six months ended June 30, 2020 we received director fees from Monument of $ 0.1 million in connection with one of our representatives serving on Monument's board of directors.

Clear Spring (formerly SeaBright)

Effective January 1, 2017, we sold SeaBright Insurance Company (“SeaBright Insurance”) and its licenses to Delaware Life Insurance Company ("Delaware Life"), a subsidiary of Guggenheim Partners, LLC. Following the sale, SeaBright Insurance was renamed Clear Spring Property and Casualty Company (“Clear Spring”). Clear Spring was subsequently capitalized with $ 56.0 million of equity, with Enstar retaining a 20 % indirect equity interest in Clear Spring.
We have accounted for our equity interest in Clear Spring as an equity method investment as we have
65

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
significant influence over its operating and financial policies.
Our investment in the common shares of Clear Spring which is included in equity method investments on our consolidated balance sheet, was as follows:
June 30, 2020 December 31, 2019
Investment in Clear Spring $ 10,402 $ 10,645

Effective January 1, 2017, StarStone National Insurance Company (“StarStone National”) entered into a ceding quota share treaty with Clear Spring pursuant to which Clear Spring reinsures 33.3 % of core workers' compensation business written by StarStone National. This agreement was terminated as of December 31, 2018.
Effective January 1, 2017, we also entered into an assuming quota share treaty with Clear Spring pursuant to which an Enstar subsidiary reinsures 25 % of all workers' compensation business written by Clear Spring. This is recorded as other activities.

Our consolidated balance sheet included the following balances between us and Clear Spring:
June 30, 2020 December 31, 2019
Balances under StarStone ceding quota share included, in assets or liabilities held for sale:
Reinsurance balances recoverable $ 21,523 $ 22,812
Prepaid insurance premiums 51
Ceded payable 3,593 3,616
Ceded acquisition costs 21
Balances under assuming quota share:
Losses and LAE 4,455 6,135
Unearned reinsurance premiums 13
Funds held 7,807 8,611
Our consolidated statement of earnings included the following amounts between us and Clear Spring:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Transactions under StarStone ceding quota share, included in net earnings (loss) from discontinued operations:
Ceded premium earned $ 682 $ ( 4,271 ) $ 1 $ ( 9,756 )
Ceded incurred losses and LAE ( 2,043 ) 3,129 ( 1,289 ) 6,988
Ceded acquisition costs ( 99 ) 8 ( 27 ) 62
Transactions under assuming quota share:
Premium earned ( 170 ) 1,068 2,439
Net incurred losses and LAE 510 ( 472 ) 882 ( 1,437 )
Acquisition costs 20 23 7 9
Total net earnings (loss) $ ( 1,100 ) $ ( 515 ) $ ( 426 ) $ ( 1,695 )

66

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
AmTrust
In November 2018, pursuant to a Subscription Agreement with Evergreen Parent L.P. ("Evergreen"), K-Z Evergreen, LLC and Trident Pine Acquisition LP ("Trident Pine"), we purchased equity in Evergreen in the aggregate amount of $ 200.0 million. Evergreen is an entity formed by private equity funds managed by Stone Point and the Karfunkel-Zyskind family that acquired the approximately 45 % of the issued and outstanding shares of common stock of AmTrust that the Karfunkel-Zyskind Family and certain of its affiliates and related parties did not already own or control. The equity interest was in the form of three separate classes of equity securities issued at the same price and in the same proportion as the equity interest purchased by Trident Pine. In a second transaction in December 2019, Enstar acquired an additional $ 25.9 million of Evergreen securities from another investor.
Following the closing of the second transaction, Enstar owns approximately 8.5 % of the equity interest in Evergreen and Trident Pine owns approximately 21.8 %. Evergreen owns all of the equity interest in AmTrust. In addition, upon the successful closing of the transaction we received a fee of $ 3.3 million, half of which was payable upon closing and the other on the first anniversary of the closing. The fee was recorded in full in other income within our consolidated statements of earnings for the year ended December 31, 2018.

Our indirect investment in the shares of AmTrust, carried in equities on our consolidated balance sheet was as follows:
June 30, 2020 December 31, 2019
Investment in AmTrust $ 245,316 $ 240,115

The following table presents the amounts included in net earnings related to our related party transactions with AmTrust:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Net investment income $ 1,896 $ 1,829 $ 4,367 $ 3,650
Net realized and unrealized gains 3,954 3,809
Total net earnings $ 5,850 $ 1,829 $ 8,176 $ 3,650


Citco

In June 2018, we made a $ 50.0 million indirect investment in the shares of Citco III Limited ("Citco"), a fund administrator with global operations. Pursuant to an investment agreement and in consideration for participation therein, a related party of Hillhouse Capital provided us with investment support. In a private transaction that preceded our co-investment opportunity, certain Citco shareholders, including Trident, agreed to sell all or a portion of their interests in Citco. As of June 30, 2020, Trident owned an approximate 3.4 % interest in Citco. Mr. Carey currently serves as an observer to the board of directors of Citco in connection with Trident's investment therein.
Our indirect investment in the shares of Citco, which is included in equity method investments on our consolidated balance sheet, was as follows:
June 30, 2020 December 31, 2019
Investment in Citco $ 51,815 $ 51,742

Enhanzed Re

Enhanzed Re is a joint venture between Enstar, Allianz SE ("Allianz") and Hillhouse Capital that was capitalized in December 2018. Enhanzed Re is a Bermuda-based Class 4 and Class E reinsurer and will reinsure life, non-life run-off, and property and casualty insurance business, initially sourced from Allianz and Enstar. Enstar, Allianz and Hillhouse Capital affiliates have made equity investment commitments in aggregate of $ 470.0 million to Enhanzed Re. Enstar owns 47.4 % of the entity, Allianz owns 24.9 % and an affiliate of Hillhouse Capital owns
67

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
27.7 %. As of June 30, 2020, Enstar contributed $ 154.1 million of its total capital commitment to Enhanzed Re and had an uncalled amount of $ 68.7 million. We have accounted for our equity interest in Enhanzed Re as an equity method investment as we have significant influence over its operating and financial policies.
Enstar acts as the (re)insurance manager for Enhanzed Re, for which it receives fee income recorded within other income, AnglePoint acts as the primary investment manager, and an affiliate of Allianz provides investment management services. Enhanzed Re writes business from affiliates of its operating sponsors, Allianz SE and Enstar. It also underwrites other business to maximize diversification by risk and geography.
Our investment in the common shares of Enhanzed Re, which is included in equity method investments on our consolidated balance sheet, was as follows:
June 30, 2020 December 31, 2019
Investment in Enhanzed Re $ 188,868 $ 182,856

We have ceded 10 % of the Zurich transaction, as discussed in Note 4 - "Significant New Business" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019, to Enhanzed Re on the same terms and conditions as those received by Enstar.

Our consolidated balance sheet included the following balances between us and Enhanzed Re:
June 30, 2020 December 31, 2019
Balances under ceding quota share:
Insurance balances payables $ 1,738 $ 1,443
Reinsurance balances recoverable 55,547 59,601
Funds held 48,730 50,089
Other assets 328 1,033

Our consolidated statement of earnings included the following amounts between us and Enhanzed Re:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Amounts under ceding quota share:
Net incurred losses and LAE ( 13 ) ( 13 )
Acquisition costs $ 23
Other income/expense ( 3,172 ) 166 ( 2,881 ) 252
Total net earnings $ ( 3,185 ) $ 166 $ ( 2,871 ) $ 252

21. COMMITMENTS AND CONTINGENCIES

Concentration of Credit Risk
We believe that there are no significant concentrations of credit risk associated with our cash and cash equivalents, fixed maturity investments, or other investments. Our cash and investments are managed pursuant to guidelines that follow prudent standards of diversification and liquidity, and limit the allowable holdings of a single issue and issuers. We are also subject to custodial credit risk on our investments, which we manage by diversifying our holdings amongst large financial institutions that are highly regulated.
We have exposure to credit risk on certain of our assets pledged to ceding companies under insurance contracts. In addition, we are potentially exposed should any insurance intermediaries be unable to fulfill their contractual obligations with respect to payments of balances owed to and by us.
68

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Credit risk exists in relation to insurance and reinsurance balances recoverable on paid and unpaid losses. We remain liable to the extent that counterparties do not meet their contractual obligations and, therefore, we evaluate and monitor concentration of credit risk among our insurers and reinsurers.
We are also subject to credit risk in relation to funds held by reinsured companies. Under funds held arrangements, the reinsured company has retained funds that would otherwise have been remitted to our reinsurance subsidiaries. The funds may be placed into trust or subject to other security arrangements. However, we generally have the contractual ability to offset any shortfall in the payment of the funds held balances with amounts owed by us. As of June 30, 2020, we had a significant funds held concentration of $ 965.5 million to one reinsured company which has financial strength credit ratings of A+ from A.M. Best and AA from S&P.
We limit the amount of credit exposure to any one counterparty, and none of our counterparty credit exposures, excluding U.S. government instruments and the counterparty noted above, exceeded 10% of shareholders’ equity as of June 30, 2020. Our credit exposure to the U.S. government was $ 905.9 million as of June 30, 2020.

Legal Proceedings
We are, from time to time, involved in various legal proceedings in the ordinary course of business, including litigation and arbitration regarding claims. Estimated losses relating to claims arising in the ordinary course of business, including the anticipated outcome of any pending arbitration or litigation, are included in the liability for losses and LAE in our consolidated balance sheets. In addition to claims litigation, we may be subject to other lawsuits and regulatory actions in the normal course of business, which may involve, among other things, allegations of underwriting errors or omissions, employment claims or regulatory activity. We do not believe that the resolution of any currently pending legal proceedings, either individually or taken as a whole, will have a material effect on our business, results of operations or financial condition. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will continue to be subject to litigation and arbitration proceedings in the ordinary course of business, including litigation generally related to the scope of coverage with respect to asbestos and environmental and other claims.

Unfunded Investment Commitments
As of June 30, 2020, we had unfunded commitments of $ 544.7 million and $ 76.5 million to private equity funds and equity method investments, respectively.

Guarantees
As of June 30, 2020 and December 31, 2019, parental guarantees and capital instruments supporting subsidiaries' insurance obligations were $ 1.3 billion and $ 1.0 billion, respectively. We also guarantee the FAL facility, which is described in Note 14 - "Debt Obligations and Credit Facilities."
In connection with the sale of StarStone U.S., the net loss reserves of StarStone U.S. will be reinsured to an Enstar Non-life Run-off entity upon completion of the sale which is expected to occur in the second half of 2020. The obligations under the loss portfolio transfer reinsurance agreement will be guaranteed by Enstar. Refer to Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" for further details.

Redeemable Noncontrolling Interest
We have the right to purchase the RNCI interests from the RNCI holders at certain times in the future (each such right, a "call right") and the RNCI holders have the right to sell their RNCI interests to us at certain times in the future (each such right, a "put right"). The RNCI rights held by Trident are described in Note 20 - "Related Party Transactions." Dowling has a right to participate if Trident exercises its put right.

Leases
Our leases are all currently classified as operating leases whereby the related lease expense is recognized within general and administrative expenses in our consolidated statements of earnings on a straight-line basis over the term of the lease. We also recognize a right-of-use asset and an offsetting lease liability within other assets and other liabilities, respectively, in our consolidated balance sheets, for each operating lease that we enter into.
69

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Our leases are primarily related to office space and facilities used to conduct business operations and have remaining lease terms of one year to 37 years; some of which include options to extend the lease term for up to five years , and some of which include options to terminate the lease within one year . Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Since a majority of our leases do not provide an implicit discount rate, we use our collateralized incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of lease payments. For more information on our leasing arrangements and the related accounting, refer to Note 23 - "Commitments and Contingencies" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.
The table below provides the lease cost and other information relating to our operating leases:
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Lease cost
Operating lease cost $ 3,202 $ 3,199 $ 6,524 $ 6,686
Short-term lease cost (1)
61 119
Total lease cost 3,263 3,199 6,643 6,686
Sub-lease income (2)
( 138 ) ( 137 ) ( 276 ) ( 268 )
Total net lease cost $ 3,125 $ 3,062 $ 6,367 $ 6,418
Other information
Operating Cash paid for amounts included in the measurement of lease liabilities $ 4,145 $ 3,169 $ 7,328 $ 6,193
Non-cash activity: right-of-use assets relating to leases 191 619 263 52,228
Weighted-average remaining lease term 6.2 years 6.6 years
Weighted-average discount rate 6.3 % 6.2 %
(1) Leases with an initial lease term of twelve months or less are not recognized within our consolidated balance sheets.
(2) Sub-lease income consists of rental income received from third parties to whom we have sub-leased some of our leased office spaces and is included within other income in our consolidated statements of earnings.

The table below provides a summary of the operating leases recorded on our consolidated balance sheets:
Balance sheet classification June 30, 2020 December 31, 2019
Right-of-use assets (1)
Other assets $ 36,613 $ 46,747
Current lease liabilities Other liabilities 8,836 11,403
Non-current lease liabilities Other liabilities 29,629 34,785
(1) Following our decision to put the StarStone International operations into orderly run-off effective June 10, 2020, we recorded total impairment charges of $ 3.5 million on the right-of-use assets relating to certain StarStone International operating leases as of June 30, 2020.
The table below provides a summary of the contractual maturities of our operating lease liabilities:
June 30, 2020
2020 $ 5,923
2021 9,684
2022 7,931
2023 6,877
2024 5,151
2025 and beyond 12,195
Total lease payments (1)
47,761
Less: Imputed interest ( 9,296 )
Present value of lease liabilities $ 38,465
(1) Amount excludes short-term leases.
70

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
22. SEGMENT INFORMATION
We have three reportable segments of business that are each managed, operated and separately reported: (i) Non-life Run-off; (ii) Atrium; and (iii) StarStone. Our other activities, which do not qualify as a reportable segment, include our corporate expenses, debt servicing costs, holding company income and expenses, foreign exchange and other miscellaneous items. These segments are described in Note 1 - "Description of Business" to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.
The following tables set forth selected and unaudited condensed consolidated statement of earnings results by segment and for our other activities:
Three Months Ended June 30, 2020
Non-life
Run-off
Atrium StarStone Other Total
Gross premiums written $ ( 2,155 ) $ 48,631 $ 86,087 $ 6,829 $ 139,392
Net premiums written $ ( 3,203 ) $ 40,892 $ 76,922 $ 6,165 $ 120,776
Net premiums earned $ 10,517 $ 43,387 $ 82,836 $ 6,131 $ 142,871
Net incurred losses and LAE ( 91,474 ) ( 15,592 ) ( 74,433 ) ( 5,193 ) ( 186,692 )
Acquisition costs ( 3,589 ) ( 14,609 ) ( 30,749 ) ( 120 ) ( 49,067 )
Operating expenses ( 48,562 ) ( 2,872 ) ( 26,476 ) ( 77,910 )
Underwriting income (loss) ( 133,108 ) 10,314 ( 48,822 ) 818 ( 170,798 )
Net investment income (loss) 89,056 1,079 7,101 ( 2,793 ) 94,443
Net realized and unrealized gains 926,494 7,567 33,547 967,608
Fees and commission income 3,966 6,044 10,010
Other income (expense) ( 2,231 ) ( 2 ) 32 1,114 ( 1,087 )
Corporate expenses ( 17,400 ) ( 5,272 ) ( 35,442 ) ( 8,806 ) ( 66,920 )
Interest income (expense) ( 16,181 ) ( 654 ) 2,817 ( 14,018 )
Net foreign exchange gains (losses) ( 4,605 ) 973 ( 4,167 ) 2,641 ( 5,158 )
EARNINGS (LOSS) BEFORE INCOME TAXES 845,991 20,703 ( 48,405 ) ( 4,209 ) 814,080
Income tax expense ( 11,812 ) ( 1,536 ) ( 3,304 ) ( 16,652 )
Loss from equity method investments ( 8,790 ) ( 8,790 )
NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS 825,389 19,167 ( 51,709 ) ( 4,209 ) 788,638
NET LOSS FROM DISCONTINUED OPERATIONS, NET OF INCOME TAX EXPENSE ( 1,152 ) ( 1,152 )
NET EARNINGS (LOSS) 825,389 19,167 ( 52,861 ) ( 4,209 ) 787,486
Net loss (earnings) attributable to noncontrolling interest 936 ( 7,896 ) 26,952 19,992
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR 826,325 11,271 ( 25,909 ) ( 4,209 ) 807,478
Dividends on preferred shares ( 8,925 ) ( 8,925 )
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 826,325 $ 11,271 $ ( 25,909 ) $ ( 13,134 ) $ 798,553
Underwriting ratios:
Loss ratio
35.9 % 89.9 %
Acquisition expense ratio 33.7 % 37.1 %
Operating expense ratio 6.6 % 31.9 %
Combined ratio 76.2 % 158.9 %
71

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Three Months Ended June 30, 2019
Non-life
Run-off
Atrium StarStone Other Total
Gross premiums written $ ( 4,209 ) $ 43,788 $ 108,902 $ 460 $ 148,941
Net premiums written $ ( 3,409 ) $ 36,962 $ 103,407 $ 461 $ 137,421
Net premiums earned $ 48,470 $ 38,199 $ 98,322 $ 5,971 $ 190,962
Net incurred losses and LAE ( 9,752 ) ( 13,048 ) ( 119,289 ) ( 4,465 ) ( 146,554 )
Life and annuity policy benefits ( 2,194 ) ( 2,194 )
Acquisition costs ( 16,512 ) ( 12,815 ) ( 21,609 ) ( 145 ) ( 51,081 )
Operating expenses ( 44,208 ) ( 3,193 ) ( 16,509 ) ( 63,910 )
Underwriting income (loss) ( 22,002 ) 9,143 ( 59,085 ) ( 833 ) ( 72,777 )
Net investment income (loss) 65,857 2,053 8,807 ( 2,446 ) 74,271
Net realized and unrealized gains 241,542 1,969 12,613 4,545 260,669
Fees and commission income (expense) 4,645 1,533 ( 161 ) 6,017
Other income 9,917 35 314 759 11,025
Corporate expenses ( 18,734 ) ( 3,502 ) ( 14,530 ) ( 36,766 )
Interest income (expense) ( 15,619 ) 2,583 ( 13,036 )
Net foreign exchange gains (losses) 3,752 98 ( 1,244 ) ( 27 ) 2,579
EARNINGS (LOSS) BEFORE INCOME TAXES 269,358 11,329 ( 38,756 ) ( 9,949 ) 231,982
Income tax benefit (expense) ( 7,399 ) ( 1,023 ) 724 ( 7,698 )
Earnings from equity method investments 18,119 ( 406 ) 17,713
NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS 280,078 10,306 ( 38,438 ) ( 9,949 ) 241,997
NET LOSS FROM DISCONTINUED OPERATIONS, NET OF INCOME TAX EXPENSE ( 3,943 ) ( 3,943 )
NET EARNINGS (LOSS) 280,078 10,306 ( 42,381 ) ( 9,949 ) 238,054
Net loss (earnings) attributable to noncontrolling interest ( 2,266 ) ( 4,227 ) 9,206 2,713
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR 277,812 6,079 ( 33,175 ) ( 9,949 ) 240,767
Dividend on preferred shares ( 8,925 ) ( 8,925 )
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 277,812 $ 6,079 $ ( 33,175 ) $ ( 18,874 ) $ 231,842
Underwriting ratios:
Loss ratio 34.2 % 121.3 %
Acquisition expense ratio 33.5 % 22.0 %
Operating expense ratio 8.4 % 16.8 %
Combined ratio 76.1 % 160.1 %
72

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Six Months Ended June 30, 2020
Non-Life
Run-Off
Atrium StarStone Other Total
Gross premiums written $ ( 1,828 ) $ 106,468 $ 241,569 $ 2,944 $ 349,153
Net premiums written $ ( 1,027 ) $ 89,590 $ 183,728 $ 2,944 $ 275,235
Net premiums earned $ 26,547 $ 85,757 $ 180,450 $ 9,468 $ 302,222
Net incurred losses and LAE ( 29,440 ) ( 44,008 ) ( 148,869 ) ( 7,675 ) ( 229,992 )
Acquisition costs ( 10,496 ) ( 28,993 ) ( 55,418 ) ( 203 ) ( 95,110 )
Operating expenses ( 96,772 ) ( 5,749 ) ( 45,945 ) ( 148,466 )
Underwriting income (loss) ( 110,161 ) 7,007 ( 69,782 ) 1,590 ( 171,346 )
Net investment income (loss) 156,507 2,604 15,327 ( 5,281 ) 169,157
Net realized and unrealized gains (losses) 351,812 1,859 ( 15,124 ) 338,547
Fees and commission income 8,951 8,587 17,538
Other income (expense) 20,064 33 117 ( 857 ) 19,357
Corporate expenses ( 25,520 ) ( 8,410 ) ( 36,016 ) ( 24,846 ) ( 94,792 )
Interest income (expense) ( 32,080 ) ( 1,101 ) 5,748 ( 27,433 )
Net foreign exchange gains (losses) 10,048 ( 1,160 ) ( 4,748 ) 2,641 6,781
EARNINGS (LOSS) BEFORE INCOME TAXES 379,621 10,520 ( 111,327 ) ( 21,005 ) 257,809
Income tax expense ( 9,005 ) ( 783 ) ( 1,592 ) ( 11,380 )
Earnings from equity method investments 3,660 3,660
NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS 374,276 9,737 ( 112,919 ) ( 21,005 ) 250,089
NET LOSS FROM DISCONTINUED OPERATIONS, NET OF INCOME TAX EXPENSE ( 3,221 ) ( 3,221 )
NET EARNINGS (LOSS) 374,276 9,737 ( 116,140 ) ( 21,005 ) 246,868
Net loss (earnings) attributable to noncontrolling interest 3,023 ( 4,028 ) 53,719 52,714
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR 377,299 5,709 ( 62,421 ) ( 21,005 ) 299,582
Dividends on preferred shares ( 17,850 ) ( 17,850 )
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 377,299 $ 5,709 $ ( 62,421 ) $ ( 38,855 ) $ 281,732
Underwriting ratios:
Loss ratio 51.3 % 82.5 %
Acquisition expense ratio 33.8 % 30.7 %
Operating expense ratio 6.7 % 25.5 %
Combined ratio 91.8 % 138.7 %
73

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Six Months Ended June 30, 2019
Non-Life
Run-Off
Atrium StarStone Other Total
Gross premiums written $ ( 25,086 ) $ 97,773 $ 252,766 $ 1,324 $ 326,777
Net premiums written $ ( 22,587 ) $ 83,461 $ 215,063 $ 1,306 $ 277,243
Net premiums earned $ 125,144 $ 76,952 $ 228,244 $ 12,569 $ 442,909
Net incurred losses and LAE ( 104,934 ) ( 30,262 ) ( 258,236 ) ( 9,421 ) ( 402,853 )
Life and annuity policy benefits ( 2,290 ) ( 2,290 )
Acquisition costs ( 44,667 ) ( 26,557 ) ( 57,281 ) ( 377 ) ( 128,882 )
Operating expenses ( 88,200 ) ( 6,226 ) ( 38,692 ) ( 133,118 )
Underwriting income (loss) ( 112,657 ) 13,907 ( 125,965 ) 481 ( 224,234 )
Net investment income (loss) 132,585 3,764 17,704 ( 4,131 ) 149,922
Net realized and unrealized gains 677,728 4,882 25,240 5,579 713,429
Fees and commission income (expense) 9,477 3,382 ( 365 ) 12,494
Other income 15,421 71 373 971 16,836
Corporate expenses ( 35,304 ) ( 7,290 ) ( 23,227 ) ( 65,821 )
Interest income (expense) ( 27,735 ) ( 475 ) 4,138 ( 24,072 )
Net foreign exchange gains (losses) 7,370 923 ( 1,835 ) ( 26 ) 6,432
EARNINGS (LOSS) BEFORE INCOME TAXES 666,885 19,639 ( 85,323 ) ( 16,215 ) 584,986
Income tax benefit (expense) ( 10,119 ) ( 1,708 ) 112 ( 85 ) ( 11,800 )
Earnings (loss) from equity method investments 26,703 ( 218 ) 26,485
NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS 683,469 17,931 ( 85,429 ) ( 16,300 ) 599,671
NET EARNINGS FROM DISCONTINUED OPERATIONS, NET OF INCOME TAX EXPENSE 4,125 4,125
NET EARNINGS (LOSS) 683,469 17,931 ( 81,304 ) ( 16,300 ) 603,796
Net loss (earnings) attributable to noncontrolling interest ( 4,912 ) ( 7,355 ) 17,128 4,861
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR 678,557 10,576 ( 64,176 ) ( 16,300 ) 608,657
Dividends on preferred shares ( 18,064 ) ( 18,064 )
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 678,557 $ 10,576 $ ( 64,176 ) $ ( 34,364 ) $ 590,593
Underwriting ratios:
Loss ratio 39.3 % 113.1 %
Acquisition expense ratio 34.5 % 25.1 %
Operating expense ratio 8.1 % 17.0 %
Combined ratio 81.9 % 155.2 %
74

ENSTAR GROUP LIMITED
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Assets by Segment
Invested assets are managed on a subsidiary basis, and investment income and realized and unrealized gains (losses) on investments are recognized in each segment as earned. Our total assets by segment and for our other activities were as follows:
June 30, 2020 December 31, 2019
Assets by Segment:
Non-life Run-off $ 17,154,632 $ 15,775,407
Atrium 608,038 580,405
StarStone 4,108,324 3,985,138
Other ( 577,079 ) ( 514,851 )
Total assets $ 21,293,915 $ 19,826,099
75


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our financial condition as of June 30, 2020 and our results of operations for the three and six months ended June 30, 2020 and 2019 should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report and the audited consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2019. Some of the information contained in this discussion and analysis or included elsewhere in this quarterly report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and the timing of events could differ materially from those anticipated by these forward-looking statements as a result of many factors, including those discussed under "Cautionary Statement Regarding Forward-Looking Statements" and "Risk Factors" included in this Quarterly Report on Form 10-Q and in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019.
Table of Contents
Section Page

Business Overview
We are a multi-faceted insurance group that offers innovative capital release solutions and specialty underwriting capabilities through our network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations. Our core focus is acquiring and managing insurance and reinsurance companies and portfolios of insurance and reinsurance business in run-off. Since the formation of our Bermuda-based holding company in 2001, we have completed or announced over 100 acquisitions or portfolio transfers. The substantial majority of our acquisitions have been in the Non-life Run-off business, which generally includes property and casualty, workers’ compensation, asbestos and environmental, construction defect, marine, aviation and transit, and other closed business.
We manage our investment portfolio with the goal of achieving superior risk-adjusted returns, while growing profitability and generating long-term growth in shareholder value.
While our core focus remains acquiring and managing non-life run-off business, we own 59.0% interests in the Atrium and StarStone groups of companies, with the Trident V Funds ("Trident") owning 39.3% interests, and Dowling Capital Partners, L.P. ("Dowling") owning 1.7% interests. On June 10, 2020, we announced an agreement to sell StarStone US Holdings, Inc. and its subsidiaries ("StarStone U.S.") to a newly formed company, Core Specialty Insurance Holdings, Inc. ("Core Specialty"), in which we will retain a minority interest. In connection with the sale, a new management team and Board will be appointed for StarStone U.S. and the net loss reserves of StarStone U.S. will be reinsured to an Enstar Non-life Run-off entity upon completion of the sale. On June 10, 2020, we also announced that we are placing the StarStone non-U.S. international operations ("StarStone International") into an orderly run-off (the "StarStone International Run-Off"). For further information, refer to Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" to our unaudited condensed consolidated financial
76


statements included within Item 1 of this Quarterly Report on Form 10-Q and the "StarStone Segment" section below.
Our business strategies are discussed in "Item 1. Business - Company Overview", "- Business Strategy", "-Strategic Growth" and "- Recent Acquisitions and Significant New Business" in our Annual Report on Form 10-K for the year ended December 31, 2019.

Key Performance Indicator
Our primary corporate objective is growing our book value per share, and we believe that long-term growth in fully diluted book value per share is the most appropriate measure of our financial performance. We create growth in our book value through the execution of the strategies discussed in "Item 1. Business - Business Strategy" in our Annual Report on Form 10-K for the year ended December 31, 2019.
During the six months ended June 30, 2020, our book value per ordinary share on a fully diluted basis increased by 7.6% to $213.06 per ordinary share. The increase was primarily due to the net earnings for the six months ended June 30, 2020, which was primarily the result of net unrealized investment gains, partially offset by exit costs associated with the StarStone International Run-Off, as discussed more fully below. Also contributing to the increase was a reduction in the redemption value of RNCI.
The table below summarizes the calculation of our fully diluted book value per ordinary share:
June 30, 2020 December 31, 2019 Change
(expressed in thousands of U.S. dollars, except share and per share data)
Numerator:
Total Enstar Shareholder's Equity $ 5,186,913 $ 4,842,183 $ 344,730
Less: Series D and E Preferred Shares 510,000 510,000
Total Enstar Ordinary Shareholders' Equity (A) 4,676,913 4,332,183 344,730
Proceeds from assumed conversion of warrants (1)
20,229 20,229
Numerator for fully diluted book value per ordinary share calculations (B) $ 4,697,142 $ 4,352,412 $ 344,730
Denominator:
Ordinary shares outstanding (C) (2)
21,578,769 21,511,505 67,264
Effect of dilutive securities:
Share-based compensation plans (3)
291,121 302,565 (11,444)
Warrants (1)
175,901 175,901
Fully diluted ordinary shares outstanding (D) 22,045,791 21,989,971 55,820
Book value per ordinary share:
Basic book value per ordinary share = (A) / (C) $ 216.74 $ 201.39 $ 15.35
Fully diluted book value per ordinary share = (B) / (D) $ 213.06 $ 197.93 $ 15.13
(1) There are warrants outstanding to acquire 175,901 Series C Non-Voting Ordinary Shares for an exercise price of $115.00 per share, subject to certain adjustments (the "Warrants"). The Warrants were issued in April 2011 and expire in April 2021. The Warrant holder may, at its election, satisfy the exercise price of the Warrants on a cashless basis by surrender of shares otherwise issuable upon exercise of the Warrants in accordance with a formula set forth in the Warrants.
(2) Ordinary shares outstanding includes voting and non-voting shares but excludes ordinary shares held in the Enstar Group Limited Employee Benefit Trust (the "EB Trust") in respect of awards made under our Joint Share Ownership Plan, a sub-plan to our Amended and Restated 2016 Equity Incentive Plan (the "JSOP").
(3) Share-based dilutive securities include restricted shares, restricted share units, and performance share units ("PSUs"). The amounts for PSUs and ordinary shares held in the EB trust in respect of the JSOP are adjusted at the end of each period end to reflect the latest estimated performance multipliers for the respective awards. The JSOP shares did not have a dilutive effect as at June 30, 2020.

77


Non-GAAP Financial Measure
In addition to presenting net earnings (loss) attributable to Enstar ordinary shareholders and diluted earnings (loss) per ordinary share determined in accordance with U.S. GAAP, we believe that presenting non-GAAP operating income (loss) attributable to Enstar ordinary shareholders and non-GAAP diluted operating income (loss) per ordinary share provides investors with valuable measures of our performance.
Non-GAAP operating income (loss) attributable to Enstar ordinary shareholders is calculated by the addition or subtraction of certain items from within our consolidated statements of earnings to or from net earnings (loss) attributable to Enstar ordinary shareholders, the most directly comparable GAAP financial measure, as illustrated in the table below:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
(expressed in thousands of U.S. dollars, except share and per share data)
Net earnings attributable to Enstar ordinary shareholders $ 798,553 $ 231,842 $ 281,732 $ 590,593
Adjustments:
Net realized and unrealized (gains) on fixed maturity investments and funds held - directly managed (1)
(417,364) (185,819) (139,803) (423,750)
Change in fair value of insurance contracts for which we have elected the fair value option 134,043 37,962 75,806 94,003
Net (earnings) loss from discontinued operations 1,152 3,943 3,221 (4,125)
Tax effects of adjustments (2)
39,264 18,676 13,299 38,799
Adjustments attributable to noncontrolling interest (3)
11,994 3,082 (4,417) 12,897
Non-GAAP operating income attributable to Enstar ordinary shareholders (4)
$ 567,642 $ 109,686 $ 229,838 $ 308,417
Diluted net earnings per ordinary share $ 36.65 $ 10.70 $ 12.93 $ 27.26
Adjustments:
Net realized and unrealized (gains) on fixed maturity investments and funds held - directly managed (1)
(19.15) (8.57) (6.42) (19.56)
Change in fair value of insurance contracts for which we have elected the fair value option 6.15 1.75 3.48 4.34
Net (earnings) loss from discontinued operations 0.05 0.18 0.15 (0.19)
Tax effects of adjustments (2)
1.80 0.86 0.61 1.79
Adjustments attributable to noncontrolling interest (3)
0.55 0.14 (0.20) 0.60
Diluted non-GAAP operating income per ordinary share (4)
$ 26.05 $ 5.06 $ 10.55 $ 14.24
Weighted average ordinary shares outstanding:
Basic 21,565,240 21,477,772 21,557,542 21,470,675
Diluted 21,789,242 21,675,451 21,788,331 21,661,769
(1) Represents the net realized and unrealized gains and losses related to fixed maturity securities included in net earnings (loss). Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance. Refer to Note 5 - "Investments" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q for further details on our net realized and unrealized gains and losses.
(2) Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate.
(3) Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interest associated with the specific subsidiaries to which the adjustments relate.
(4) Non-GAAP financial measure.


78


Basis of Non-GAAP Operating Income (Loss) Financial Measure
Our non-GAAP measure shown above, as defined in Item 10(e) of Regulation S-K, enables readers of the consolidated financial statements to analyze our results in a way that is more aligned with the manner in which our management measures our underlying performance. We believe that presenting this non-GAAP financial measure, which may be defined and calculated differently by other companies, improves the understanding of our consolidated results of operations. This measure should not be viewed as a substitute for those calculated in accordance with U.S. GAAP.
Non-GAAP operating income (loss) excludes: (i) net realized and unrealized (gains) losses on fixed maturity investments and funds held - directly managed included in net earnings (loss); (ii) change in fair value of insurance contracts for which we have elected the fair value option; (iii) gain (loss) on sale of subsidiaries, if any; (iv) net earnings (loss) from discontinued operations, if any; (v) tax effect of these adjustments, where applicable; and (vi) attribution of share of adjustments to noncontrolling interest, where applicable. We eliminate the impact of net realized and unrealized (gains) losses on fixed maturity investments and funds held - directly managed and change in fair value of insurance contracts for which we have elected the fair value option because these items are subject to significant fluctuations in fair value from period to period, driven primarily by market conditions and general economic conditions, and therefore their impact on our earnings is not reflective of the performance of our core operations. When applicable, we eliminate the impact of gain (loss) on sale of subsidiaries and net earnings (loss) on discontinued operations because these are not reflective of the performance of our core operations.

Underwriting Ratios
In presenting our results for the Atrium and StarStone segments, we discuss the loss ratio, acquisition cost ratio, operating expense ratio, and the combined ratio of our active underwriting operations within these segments. Management believes that these ratios provide the most meaningful measure for understanding our underwriting profitability. These measures are not defined in GAAP, but are calculated using GAAP amounts presented on the statements of earnings for both Atrium and StarStone.
The loss ratio is calculated by dividing net incurred losses and LAE by net premiums earned. The acquisition cost ratio is calculated by dividing acquisition costs by net premiums earned. The operating expense ratio is calculated by dividing operating expenses by net premiums earned. The combined ratio is the sum of the loss ratio, the acquisition cost ratio and the operating expense ratio.
The Atrium segment also includes corporate expenses that are not directly attributable to the underwriting results in the segment. The corporate expenses include general and administrative expenses related to amortization of the definite-lived intangible assets in the holding company, and expenses relating to Atrium Underwriters Limited ("AUL") employee salaries, benefits, bonuses and current year share grant costs. The AUL general and administrative expenses are incurred in managing the syndicate. These are principally funded by the profit commission fees earned from Syndicate 609, which is a revenue item not included in the insurance ratios.
The StarStone segment also includes corporate expenses that are not directly attributable to the underwriting results in the segment and are not included in the insurance ratios. The corporate expenses include non-recurring expenses, reorganization expenses and holding company expenses.

Current Outlook
Novel Coronavirus Pandemic (“COVID-19”)
Operational Impact. The evolving COVID-19 pandemic has caused significant disruption in global financial markets and economies. Although the operational impact to us has been minimal, with virtually all of our employees working remotely, the scope, duration and magnitude of the direct and indirect effects of the COVID-19 pandemic are changing rapidly and are difficult to anticipate. As with others in our industry, we are subject to economic factors such as interest rates, foreign exchange rates, underwriting events, regulation, tax policy changes, political risks and other market risks that can impact our strategy and operations. For additional information on the risks posed by the COVID-19 pandemic, refer to "Risk Factors" included in this Quarterly Report on Form 10-Q.
Investments Impact. The value of our investment portfolio has been significantly impacted by the ongoing uncertainty and volatility in financial markets caused by the COVID-19 pandemic. For our fixed income portfolio, the COVID-19 pandemic has coincided with interest rates dropping to historically low levels which, in conjunction with credit spreads widening in the first quarter of 2020 and then tightening during the second quarter of 2020, has collectively resulted in significant unrealized gains in our fixed income portfolio for the period. As of June 30, 2020, our fixed income portfolio is well-positioned with an A+ average credit rating, but the COVID-19 pandemic has
79


increased the risk of defaults across many industries and we continue to monitor credit risk during this time of volatility. We expect interest rates and credit spreads will remain volatile in the near-term.
Our other investments, including equities, hedge funds and other non-fixed income investments, carry higher expected returns, have a longer investment time horizon, and provide diversification from our fixed income portfolio. We therefore accept that their returns may be relatively volatile over the short term. Heightened volatility in equity markets has occurred during the COVID-19 pandemic, and equity prices have generally recovered from the sharp declines experienced in the first quarter of 2020, resulting in unrealized gains in our equity and other investments during the period. We anticipate continued volatility in the global investment markets as a result of the economic conditions caused by the COVID-19 pandemic.
Our results for the three and six months ended June 30, 2020 included the impact of unrealized investment gains of $909.4 million and $277.1 million, respectively, primarily due to the disruption in financial markets resulting from the COVID-19 pandemic.
Underwriting Impact . During the three and six months ended June 30, 2020, our Non-life Run-off segment had no underwriting losses related to the COVID-19 pandemic. However, our Atrium and StarStone segments have incurred COVID-19 related net underwriting losses as follows:
Three Months Ended June 30, 2020 Six Months Ended June 30, 2020
Total Noncontrolling Interests' Share Enstar's Share Total Noncontrolling Interests' Share Enstar's Share
(in millions of U.S. dollars)
Atrium $ 4.3 $ (1.7) $ 2.5 $ 12.8 $ (5.3) $ 7.6
StarStone - International (1)
15.3 (5.6) 9.7 39.8 (12.4) 27.5
StarStone - U.S. (2)
7.5 (3.1) 4.4
Total $ 19.6 $ (7.3) $ 12.2 $ 60.1 $ (20.8) $ 39.5
(1) Includes the impact of outwards reinstatement premiums of $2.0 million and a premium deficiency provision of $16.3 million for both the three and six months ended June 30, 2020.
(2) Included within net earnings (loss) from discontinued operations, net of income taxes.
COVID-19 net incurred losses and LAE for the Atrium segment primarily included losses in the accident and health and non-marine direct and facultative lines of business, whereas losses in the StarStone segment included losses primarily in the casualty, property and marine lines of business. For a breakdown of COVID-19 net underwriting losses by segment and line of business, refer to the "Atrium Segment" and "StarStone Segment" sections below. We expect gross premiums written in certain business lines, primarily commercial lines, may be impacted due to the severely reduced business activity following government restrictions that have temporarily prevented many businesses from operating in their usual manner, which may be partially offset by improving pricing conditions and new business opportunities.
The amounts of Non-life Run-off, Atrium and StarStone losses referenced herein represent our estimate of underwriting losses related to the COVID-19 pandemic incurred through June 30, 2020. Given the uncertainties associated with the COVID-19 pandemic and its impact, and the limited information upon which our current estimates have been made, our preliminary reserves and the estimated liability for losses and LAE arising from the COVID-19 pandemic may materially change.
80


Strategic Developments with StarStone
Recapitalization of StarStone U.S.
On June 10, 2020, we announced an agreement to sell StarStone U.S. to Core Specialty, a newly formed company in which we will retain a minority interest. In connection with the sale, a new management team and Board will be appointed for StarStone U.S. and the net loss reserves of StarStone U.S. will be reinsured to one of our Non-life Run-off subsidiaries.
StarStone U.S. is a specialty property and casualty insurance group principally focused on the excess and surplus lines ("E&S") market in the U.S., marketing these insurance products in all 50 states, primarily through a network of independent insurance brokers. StarStone U.S. is organized into four separately managed business units: excess casualty, management professional liability, healthcare liability and workers’ compensation. StarStone U.S. believes that significant growth opportunities exist in the E&S segment of the P&C market due to dislocation in the overall property and casualty market.
Run-off of StarStone International (non-U.S.)
On June 10, 2020, we also announced that we are placing StarStone International into an orderly run-off. The liabilities associated with the StarStone International Run-Off vary in duration, and the run-off is expected to occur over a number of years. Steps to reduce the size of StarStone International's operations have begun and will involve several phases to occur over time. As a result, we cannot anticipate with certainty the expected completion date of the StarStone International Run-Off.
We continue to evaluate additional strategic options for StarStone International's operations and business. Consequently, such options could have the effect of mitigating costs associated with placing the business into run-off. The remaining StarStone International operations will continue to serve the needs of policyholders and ensure that the companies continue to meet all regulatory requirements.
For additional information about these strategic developments, refer to Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q and the "StarStone Segment" section below.
Non-life Run-off Business Opportunities
During 2020, our acquisition activity in the Non-life Run-off segment proceeded in the ordinary course, and we completed transactions with Hannover Re, Munich Re, AXA Group, Aspen and Lyft. Collectively, these transactions represent approximately $1.7 billion of assets and liabilities. Refer to Note 3 - "Significant New Business" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q for further details on these transactions.

81


Consolidated Results of Operations - For the Three and Six Months Ended June 30, 2020 and 2019
The following table sets forth our unaudited condensed consolidated statements of earnings for each of the periods indicated. For a discussion of the critical accounting policies that affect the results of operations, see "Critical Accounting Policies" in our Annual Report on Form 10-K for the year ended December 31, 2019, and within this Quarterly Report on Form 10-Q.
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
INCOME
Net premiums earned $ 142,871 $ 190,962 $ (48,091) $ 302,222 $ 442,909 $ (140,687)
Fees and commission income 10,010 6,017 3,993 17,538 12,494 5,044
Net investment income 94,443 74,271 20,172 169,157 149,922 19,235
Net realized and unrealized gains (1)
967,608 260,669 706,939 338,547 713,429 (374,882)
Other income (expense) (1,087) 11,025 (12,112) 19,357 16,836 2,521
1,213,845 542,944 670,901 846,821 1,335,590 (488,769)
EXPENSES
Net incurred losses and LAE 186,692 146,554 40,138 229,992 402,853 (172,861)
Life and annuity policy benefits 2,194 (2,194) 2,290 (2,290)
Acquisition costs 49,067 51,081 (2,014) 95,110 128,882 (33,772)
General and administrative expenses 144,830 100,676 44,154 243,258 198,939 44,319
Interest expense 14,018 13,036 982 27,433 24,072 3,361
Net foreign exchange (gains) losses 5,158 (2,579) 7,737 (6,781) (6,432) (349)
399,765 310,962 88,803 589,012 750,604 (161,592)
EARNINGS BEFORE INCOME TAXES 814,080 231,982 582,098 257,809 584,986 (327,177)
Income tax expense (16,652) (7,698) (8,954) (11,380) (11,800) 420
Earnings (loss) from equity method investments (8,790) 17,713 (26,503) 3,660 26,485 (22,825)
NET EARNINGS FROM CONTINUING OPERATIONS 788,638 241,997 546,641 250,089 599,671 (349,582)
NET EARNINGS (LOSS) FROM DISCONTINUED OPERATIONS, NET OF INCOME TAXES (1,152) (3,943) 2,791 (3,221) 4,125 (7,346)
NET EARNINGS 787,486 238,054 549,432 246,868 603,796 (356,928)
Net loss attributable to noncontrolling interest 19,992 2,713 17,279 52,714 4,861 47,853
NET EARNINGS ATTRIBUTABLE TO ENSTAR 807,478 240,767 566,711 299,582 608,657 (309,075)
Dividends on preferred shares (8,925) (8,925) (17,850) (18,064) 214
NET EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 798,553 $ 231,842 $ 566,711 $ 281,732 $ 590,593 $ (308,861)
(1) We have historically utilized trading accounting, where unrealized amounts are reflected in earnings. However, from October 1, 2019 we have been electing to use AFS accounting and, where permissible, as trading fixed maturity securities mature, we are reinvesting the proceeds into AFS securities for the Non-life Run-off and StarStone segments. For a breakdown between realized and unrealized gains and losses, refer to Note 5 - "Investments" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

Highlights

Consolidated Results of Operations for the Three Months Ended June 30, 2020:
Consolidated net earnings attributable to Enstar ordinary shareholders of $798.6 million and basic and diluted net earnings per ordinary share of $37.03 and $36.65, respectively.
Non-GAAP operating income attributable to Enstar ordinary shareholders of $567.6 million and diluted non-GAAP operating income per ordinary share of $26.05. For a reconciliation of non-GAAP operating income attributable to Enstar ordinary shareholders to net earnings attributable to Enstar ordinary shareholders calculated in accordance with GAAP, and diluted non-GAAP operating income per ordinary share to diluted net earnings per ordinary share calculated in accordance with GAAP, see "Non-GAAP Financial Measure" above.
82


Net earnings from our Non-life Run-off segment of $826.3 million, which included the impact of net realized and unrealized gains of $926.5 million comprising $57.0 million of net realized gains and $869.4 million of net unrealized gains driven by increases in the valuation of our other investments, fixed maturity and equity securities, primarily due to narrowing credit spreads and favorable movements in equity markets.
The current period unrealized investment gains were partially offset by net unfavorable development on losses and LAE of $91.5 million, including $134.0 million relating to fair value accounting on certain liabilities for which we had elected the fair value option primarily due to narrowing credit spreads on corporate bond yields in the period.
Combined ratio of 76.2% for our Atrium segment, with net premiums earned of $43.4 million. Excluding the estimated underwriting losses related to the COVID-19 pandemic, the combined ratio for the Atrium segment was 66.4% for the three months ended June 30, 2020.
Combined ratio of 158.9% for our StarStone segment, with net premiums earned of $82.8 million. Excluding the impact of the exit costs associated with the StarStone International Run-Off, the combined ratio for the StarStone segment was 118.9% and included net underwriting losses related to the COVID-19 pandemic of $15.3 million for the three months ended June 30, 2020.

Consolidated Results of Operations for the Six Months Ended June 30, 2020:
Consolidated net earnings attributable to Enstar ordinary shareholders of $281.7 million and basic and diluted net earnings per ordinary share of $13.07 and $12.93, respectively.
Non-GAAP operating income attributable to Enstar ordinary shareholders of $229.8 million and diluted non-GAAP operating income per ordinary share of $10.55. For a reconciliation of non-GAAP operating income attributable to Enstar ordinary shareholders to net earnings attributable to Enstar ordinary shareholders calculated in accordance with GAAP, and diluted non-GAAP operating income per ordinary share to diluted net earnings per ordinary share calculated in accordance with GAAP, see "Non-GAAP Financial Measure" above.
Net earnings from Non-life Run-off segment of $377.3 million, including net realized and unrealized gains of $351.8 million comprised of $59.1 million of net realized gains and $292.7 million of net unrealized gains driven by increases in the valuation of our other investments and fixed maturity securities, partially offset by decreases in the valuation of our equity securities, primarily due to declining interest rates, narrowing credit spreads and unfavorable movements in equity markets, respectively.
Combined ratio of 91.8% for our Atrium segment, with net premiums earned of $85.8 million. Excluding the estimated underwriting losses related to the COVID-19 pandemic, the combined ratio for the Atrium segment was 76.9% for the six months ended June 30, 2020.
Combined ratio of 138.7% for our StarStone segment, with net premiums earned of $180.5 million. Excluding the impact of the exit costs associated with the StarStone International Run-Off, the combined ratio for the StarStone segment was 120.3% and included net underwriting losses related to the COVID-19 pandemic of $39.8 million.

Consolidated Financial Condition as of June 30, 2020:
Total investments, cash and funds held of $15.6 billion.
Total reinsurance balances recoverable on paid and unpaid losses of $2.1 billion.
Total assets of $21.3 billion.
Total gross and net reserves for losses and LAE of $10.6 billion and $8.5 billion, respectively. During the six months ended June 30, 2020, our Non-life Run-off segment assumed net reserves of $1.4 billion.
Total capital under management of $7.1 billion, including common equity of $4.7 billion, preferred equity of $510.0 million, noncontrolling interests of $380.1 million and debt of $1.5 billion.
Fully diluted book value per ordinary share of $213.06, an increase of 7.6% since December 31, 2019, which was driven primarily by the impact of the changes in the fair value of our investment portfolio attributable to the recent disruption and recovery in global financial markets associated with the COVID-19 pandemic and the reduction in the redemption value of RNCI, partially offset by exit costs associated with the StarStone International Run-Off, as discussed further below.
83


Consolidated Overview - For the Three Months Ended June 30, 2020 and 2019
In addition to the exit costs associated with the StarStone International Run-Off and the impact of the COVID-19 pandemic in 2020, the comparability of our results across different periods was impacted by the acquisitions and reinsurance transactions we completed during the six months ended June 30, 2020 with AXA Group, Aspen and Lyft and in 2019 with Morse TEC, Zurich, Maiden Re, Amerisure and AmTrust. Refer to Note 3 - "Significant New Business" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q for further details on the 2020 transactions and "Item 1. Business - Recent Acquisitions and Significant New Business" in our Annual Report on Form 10-K for the year ended December 31, 2019 for further details on the 2019 transactions.
We reported consolidated earnings attributable to Enstar ordinary shareholders of $798.6 million for the three months ended June 30, 2020, an increase of $566.7 million from net earnings of $231.8 million for the three months ended June 30, 2019. The most significant drivers of our consolidated financial performance during the three months ended June 30, 2020 as compared to the three months ended June 30, 2019 included:
Non-life Run-off - Net earnings attributable to the Non-life Run-off segment were $826.3 million for the three months ended June 30, 2020 compared to $277.8 million for the three months ended June 30, 2019. The increase in net earnings of $548.5 million was primarily due to net realized and unrealized gains of $926.5 million on our investment portfolio in the current period compared to net gains of $241.5 million in the comparative period. Current period net realized and unrealized gains were driven by increases in the valuation of our other investments, fixed maturity and equity securities, primarily due to narrowing credit spreads and favorable movements in equity markets. The current period unrealized investment gains were partially offset by $134.0 million included in net incurred losses and LAE relating to fair value accounting on certain liabilities for which we had elected the fair value option primarily due to narrowing credit spreads on corporate bond yields in the period.
Atrium - Net earnings attributable to the Atrium segment were $11.3 million for the three months ended June 30, 2020 compared to $6.1 million for the three months ended June 30, 2019. The increase in net earnings was primarily due to higher net realized and unrealized gains on our investment portfolio, driven by narrowing credit spreads and higher fees and commission income in the current period.
StarStone - Net losses attributable to the StarStone segment were $25.9 million for the three months ended June 30, 2020 compared to $33.2 million for the three months ended June 30, 2019. The decrease in net losses was primarily due to net realized and unrealized gains on our investment portfolio, driven by narrowing credit spreads in the current period. These investment gains were offset by exit costs associated with the StarStone International Run-Off.
Net Realized and Unrealized Gains - Consolidated net realized and unrealized gains were $967.6 million for the three months ended June 30, 2020 compared to $260.7 million for the three months ended June 30, 2019. The net realized and unrealized gains in the current period were primarily attributable to increases in the valuation of our other investments, fixed maturity and equity securities, primarily due to narrowing credit spreads and favorable movements in equity markets.
Non-GAAP Operating Income - Our non-GAAP operating income attributable to Enstar ordinary shareholders, which excludes the impact of net realized and unrealized gains and losses on fixed maturity investments and other items, was $567.6 million for the three months ended June 30, 2020, an increase of $458.0 million from non-GAAP operating income attributable to Enstar ordinary shareholders of $109.7 million for the three months ended June 30, 2019. The increase was primarily attributable to net realized and unrealized gains on our other investments and equities of $511.0 million and $39.2 million, respectively, during the three months ended June 30, 2020. For a reconciliation of non-GAAP operating income attributable to Enstar ordinary shareholders to net earnings attributable to Enstar ordinary shareholders calculated in accordance with GAAP, see "Non-GAAP Financial Measure" above.

Consolidated Overview - For the Six Months Ended June 30, 2020 and 2019
We reported consolidated net earnings attributable to Enstar ordinary shareholders of $281.7 million for the six months ended June 30, 2020, a decrease of $308.9 million from net earnings of $590.6 million for the six months ended June 30, 2019. The most significant drivers of our consolidated financial performance during the six months ended June 30, 2020 as compared to the six months ended June 30, 2019 included:
Non-life Run-off - Net earnings attributable to the Non-life Run-off segment were $377.3 million and $678.6 million for the six months ended June 30, 2020 and 2019, respectively. The decrease in net earnings of $301.3 million was primarily due to lower net realized and unrealized gains on our investment portfolio in the current period.
84


Current period net realized and unrealized gains were driven by increases in the valuation of our other investments and fixed maturity securities primarily due to favorable movements in equity markets and declining interest rates.
Atrium - Net earnings for the six months ended June 30, 2020 and 2019 were $5.7 million and $10.6 million, respectively. The decrease was primarily due to a higher loss ratio and a lower investment return, both of which were largely driven by the COVID-19 pandemic, partially offset by higher fees and commission income in the current period.
StarStone - Net losses were $62.4 million and $64.2 million for the six months ended June 30, 2020 and 2019, respectively. The decrease in net losses was primarily driven by a lower combined ratio, partially offset by exit costs associated with the StarStone International Run-Off and net realized and unrealized losses in the period, driven by the impact of the COVID-19 pandemic on global financial markets.
Net Realized and Unrealized Gains - Net realized and unrealized gains were $338.5 million for the six months ended June 30, 2020 compared to $713.4 million for the six months ended June 30, 2019. The net realized and unrealized gains in the current period were driven by increases in the valuation of our other investments and fixed maturity securities, primarily due to declining interest rates and favorable movements in equity markets. The unrealized gains for the six months ended June 30, 2019 were primarily attributable to increases in the valuation of our fixed maturity and other investments, largely driven by tightening credit spreads and favorable movement in international equity markets.
Non-GAAP operating income - Our Non-GAAP operating income, which excludes the impact of net realized and unrealized gains and losses on fixed maturity securities and other items, was $229.8 million for the six months ended June 30, 2020, a decrease of $78.6 million from non-GAAP operating income of $308.4 million for the six months ended June 30, 2019. The decrease was primarily attributable to losses on our equity securities of $51.7 million during the six months ended June 30, 2020. For a reconciliation of non-GAAP operating income attributable to Enstar ordinary shareholders to net earnings attributable to Enstar ordinary shareholders calculated in accordance with GAAP, see "Non-GAAP Financial Measure" above.

Results of Operations by Segment - For the Three and Six Months Ended June 30, 2020 and 2019
We have three reportable segments of business that are each managed, operated and reported upon separately: (i) Non-life Run-off; (ii) Atrium; and (iii) StarStone. Our other activities, which do not qualify as a reportable segment, include our corporate expenses, debt servicing costs, holding company income and expenses, foreign exchange and other miscellaneous items. These segments are described in Note 1 - "Description of Business" to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.
The below table provides a split by operating segment and our other activities of the net earnings (loss) attributable to Enstar ordinary shareholders:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Segment split of net earnings attributable to Enstar ordinary shareholders:
Non-life Run-off $ 826,325 $ 277,812 $ 548,513 $ 377,299 $ 678,557 $ (301,258)
Atrium 11,271 6,079 5,192 5,709 10,576 (4,867)
StarStone (25,909) (33,175) 7,266 (62,421) (64,176) 1,755
Other (13,134) (18,874) 5,740 (38,855) (34,364) (4,491)
Net earnings attributable to Enstar ordinary shareholders $ 798,553 $ 231,842 $ 566,711 $ 281,732 $ 590,593 $ (308,861)

The following is a discussion of our results of operations by segment.

85


Non-life Run-off Segment
The following is a discussion and analysis of the results of operations for our Non-life Run-off segment.
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Gross premiums written $ (2,155) $ (4,209) $ 2,054 $ (1,828) $ (25,086) $ 23,258
Net premiums written $ (3,203) $ (3,409) $ 206 $ (1,027) $ (22,587) $ 21,560
Net premiums earned $ 10,517 $ 48,470 $ (37,953) $ 26,547 $ 125,144 $ (98,597)
Net incurred losses and LAE (1)
(91,474) (9,752) (81,722) (29,440) (104,934) 75,494
Acquisition costs (3,589) (16,512) 12,923 (10,496) (44,667) 34,171
Operating expenses (48,562) (44,208) (4,354) (96,772) (88,200) (8,572)
Underwriting income (loss) (1)
(133,108) (22,002) (111,106) (110,161) (112,657) 2,496
Net investment income 89,056 65,857 23,199 156,507 132,585 23,922
Net realized and unrealized gains (losses) (2)
926,494 241,542 684,952 351,812 677,728 (325,916)
Fees and commission income 3,966 4,645 (679) 8,951 9,477 (526)
Other income (expense) (2,231) 9,917 (12,148) 20,064 15,421 4,643
Corporate expenses (17,400) (18,734) 1,334 (25,520) (35,304) 9,784
Interest expense (16,181) (15,619) (562) (32,080) (27,735) (4,345)
Net foreign exchange gains (losses) (4,605) 3,752 (8,357) 10,048 7,370 2,678
EARNINGS BEFORE INCOME TAXES 845,991 269,358 576,633 379,621 666,885 (287,264)
Income tax expense (11,812) (7,399) (4,413) (9,005) (10,119) 1,114
Earnings from equity method investments (8,790) 18,119 (26,909) 3,660 26,703 (23,043)
NET EARNINGS 825,389 280,078 545,311 374,276 683,469 (309,193)
Net loss (earnings) attributable to noncontrolling interest 936 (2,266) 3,202 3,023 (4,912) 7,935
NET EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 826,325 $ 277,812 $ 548,513 $ 377,299 $ 678,557 $ (301,258)
(1) Comparability between periods is impacted by the current period net incurred losses and LAE as acquired unearned premium is earned, and by changes in fair value due to the election of the fair value option on certain business. Refer to Net Incurred Losses and LAE table for further details.
(2) We have historically utilized trading accounting, where unrealized amounts are reflected in earnings. However, from October 1, 2019, we have elected to use AFS accounting and, where permissible, as trading fixed income securities mature, we are reinvesting the proceeds into AFS securities for the Non-life Run-off segment.

Overall Results
Three Months Ended June 30: Net earnings were $826.3 million for the three months ended June 30, 2020 compared to $277.8 million for the three months ended June 30, 2019, an increase of $548.5 million. This increase was primarily due to net realized and unrealized gains of $926.5 million on our investment portfolio in the current period compared to $241.5 million in the comparative period, a change of $685.0 million. Current period net realized and unrealized gains were driven by increases in the valuation of our other investments, fixed maturity and equity securities, primarily due to narrowing credit spreads and favorable movements in equity markets.
Our underwriting result included a favorable reduction in estimates of prior period net ultimate losses of $56.6 million in the current period, compared to $63.1 million in the comparative period. Our underwriting result also includes the amortization of deferred charge assets, amortization of fair value adjustments and the change in fair value for those liabilities where we elected the fair value option, representing an aggregate expense of $152.4 million in the current period compared to $49.6 million in the comparative period.

Six Months Ended June 30: Net earnings were $377.3 million and $678.6 million for the six months ended June 30, 2020 and 2019, respectively, a decrease of $301.3 million. The decrease was primarily attributable to a decrease of $325.9 million in net realized and unrealized gains on investments. Current period net realized and unrealized gains were driven by increases in the valuation of our other investments and fixed maturity securities, partially offset by decreases in the valuation of our equity securities, primarily due to declining interest rates, narrowing credit spreads and unfavorable movements in equity markets, respectively.
86


Our underwriting result included a favorable reduction in estimates of prior period net ultimate losses of $84.4 million in the current period, compared to $73.4 million in the comparative period. Our underwriting result also includes the amortization of deferred charge assets, amortization of fair value adjustments and the change in fair value for those liabilities where we elected the fair value option, representing an aggregate expense of $117.8 million in the current period compared to $121.5 million in the comparative period.
An analysis of the components of the segment's net earnings is shown below. Investment results are separately discussed below in "Investments Results - Consolidated."

Net Premiums Earned:
The following table shows the gross and net premiums written and earned for the Non-life Run-off segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Gross premiums written $ (2,155) $ (4,209) $ 2,054 $ (1,828) $ (25,086) $ 23,258
Ceded reinsurance premiums written (1,048) 800 (1,848) 801 2,499 (1,698)
Net premiums written $ (3,203) $ (3,409) $ 206 $ (1,027) $ (22,587) $ 21,560
Gross premiums earned $ 14,395 $ 55,551 $ (41,156) $ 32,473 $ 139,517 $ (107,044)
Ceded reinsurance premiums earned (3,878) (7,081) 3,203 (5,926) (14,373) 8,447
Net premiums earned $ 10,517 $ 48,470 $ (37,953) $ 26,547 $ 125,144 $ (98,597)

As business in this segment is in run-off, our general expectation is for premiums associated with legacy business to decline in future periods. However, the actual amount in any particular period will be impacted by new transactions during the period and the run-off of premiums from transactions completed in recent years. Premiums earned in this segment are generally offset by net incurred losses and LAE related to the premiums. Premiums earned may be higher than premiums written as we may assume unearned premium without writing the premium ourselves.
Three and Six Months Ended June 30: Net premiums written in the three and six months ended June 30, 2020 of $(3.2) million and $(1.0) million, respectively, were primarily related to reductions in net written premium on legacy business for which corresponding unearned premium was also released. Net premiums earned in the three and six months ended June 30, 2020 of $10.5 million and $26.5 million, respectively, were primarily related to the run-off business assumed as a result of the AmTrust RITC transactions. Premiums written and earned in the three and six months ended June 30, 2019 were primarily related to the run-off business assumed as a result of the AmTrust RITC transactions and the acquisition of Maiden Reinsurance North America, Inc. ("Maiden Re North America").


87


Net Incurred Losses and LAE:
The following table shows the components of net incurred losses and LAE for the Non-life Run-off segment:
Three Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 283,604 $ (202) $ 283,402 $ 308,226 $ 20,877 $ 329,103
Net change in case and LAE reserves (1)
(75,276) (830) (76,106) (121,377) 1,543 (119,834)
Net change in IBNR reserves (2)
(264,900) 9,118 (255,782) (249,923) 11,691 (238,232)
Increase (reduction) in estimates of net ultimate losses (56,572) 8,086 (48,486) (63,074) 34,111 (28,963)
Increase (reduction) in provisions for unallocated LAE (12,425) (12,425) (11,160) 264 (10,896)
Amortization of deferred charge assets 11,062 11,062 3,934 3,934
Amortization of fair value adjustments 7,280 7,280 7,715 7,715
Changes in fair value - fair value option 134,043 134,043 37,962 37,962
Net incurred losses and LAE $ 83,388 $ 8,086 $ 91,474 $ (24,623) $ 34,375 $ 9,752
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.

Three Months Ended June 30: The increase in net incurred losses and LAE for the three months ended June 30, 2020 of $91.5 million included net incurred losses and LAE of $8.1 million related to current period net earned premium, primarily in respect of the run-off business acquired with the AmTrust RITC transactions. Excluding current period net incurred losses and LAE of $8.1 million, the increase in net incurred losses and LAE relating to prior periods was $83.4 million, which was attributable to an increase in the fair value of liabilities of $134.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option primarily due to narrowing credit spreads on corporate bond yields in the period, amortization of the deferred charge assets of $11.1 million and amortization of fair value adjustments over the estimated payout period relating to companies acquired of $7.3 million, partially offset by a reduction in estimates of net ultimate losses of $56.6 million and a reduction in provisions for unallocated LAE of $12.4 million relating to 2020 run-off activity. The reduction in estimates of net ultimate losses relating to prior periods of $56.6 million for the three months ended June 30, 2020 included a net reduction in case and IBNR reserves of $340.2 million, partially offset by net losses paid of $283.6 million.
Net incurred losses and LAE for the three months ended June 30, 2019 of $9.8 million included net incurred losses and LAE of $34.4 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions and the acquisition of Maiden Re North America. Excluding current period net incurred losses and LAE of $34.4 million, the reduction in net incurred losses and LAE relating to prior periods was $24.6 million, which was attributable to a reduction in estimates of net ultimate losses of $63.1 million and a reduction in provisions for unallocated LAE of $11.2 million relating to 2019 run-off activity, partially offset by an increase in the fair value of liabilities of $38.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option, amortization of fair value adjustments over the estimated payout period relating to companies acquired of $7.7 million and amortization of the deferred charge assets of $3.9 million. The reduction in estimates of net ultimate losses relating to prior periods of $63.1 million for the three months ended June 30, 2019 included a net reduction in case and IBNR reserves of $371.3 million, partially offset by net losses paid of $308.2 million.

88


The following table shows the components of net incurred losses and LAE for the Non-life Run-off segment for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 541,330 $ 1,038 $ 542,368 $ 639,281 $ 38,891 $ 678,172
Net change in case and LAE reserves (1)
(251,528) 842 (250,686) (218,950) 21,415 (197,535)
Net change in IBNR reserves (2)
(374,234) 14,055 (360,179) (493,738) 22,611 (471,127)
Increase (reduction) in estimates of net ultimate losses (84,432) 15,935 (68,497) (73,407) 82,917 9,510
Increase (reduction) in provisions for unallocated LAE (19,904) (19,904) (26,600) 529 (26,071)
Amortization of deferred charge assets 25,692 25,692 10,997 10,997
Amortization of fair value adjustments 16,343 16,343 16,495 16,495
Changes in fair value - fair value option 75,806 75,806 94,003 94,003
Net incurred losses and LAE $ 13,505 $ 15,935 $ 29,440 $ 21,488 $ 83,446 $ 104,934
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.
Six Months Ended June 30: The increase in net incurred losses and LAE for the six months ended June 30, 2020 of $29.4 million included net incurred losses and LAE of $15.9 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions. Excluding current period net incurred losses and LAE of $15.9 million, the increase in net incurred losses and LAE liabilities relating to prior periods was $13.5 million, which was attributable to an increase in the fair value of liabilities of $75.8 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option primarily due to declining interest rates on corporate bond yields in the period, amortization of the deferred charge assets of $25.7 million and amortization of fair value adjustments over the estimated payout period relating to companies acquired of $16.3 million, partially offset by a reduction in estimates of net ultimate losses of $84.4 million and a reduction in provisions for unallocated LAE of $19.9 million relating to 2020 run-off activity. The reduction in estimates of net ultimate losses relating to prior periods of $84.4 million for the six months ended June 30, 2020 included a net change in case and IBNR reserves of $625.8 million, partially offset by net losses paid of $541.3 million.
The increase in net incurred losses and LAE for the six months ended June 30, 2019 of $104.9 million included net incurred losses and LAE of $83.4 million related to current period net earned premium, primarily for the run-off business acquired with the AmTrust RITC transactions and the acquisition of Maiden Re North America. Excluding current period net incurred losses and LAE of $83.4 million, the increase in net incurred losses and LAE liabilities relating to prior periods was $21.5 million, which was attributable to an increase in the fair value of liabilities of $94.0 million related to our assumed retroactive reinsurance agreements for which we have elected the fair value option, amortization of fair value adjustments over the estimated payout period relating to companies acquired of $16.5 million and amortization of the deferred charge assets of $11.0 million, partially offset by a reduction in estimates of net ultimate losses of $73.4 million and a reduction in provisions for unallocated LAE of $26.6 million, relating to 2019 run-off activity. The reduction in estimates of net ultimate losses of $73.4 million for the six months ended June 30, 2019 included a net change in case and IBNR reserves of $712.7 million, partially offset by net losses paid of $639.3 million.


Acquisition Costs:
Three and Six Months Ended June 30: Acquisition costs were $3.6 million and $16.5 million for the three months ended June 30, 2020 and 2019, respectively, and $10.5 million and $44.7 million for the six months ended June 30, 2020 and 2019, respectively. The reduction in acquisition costs compared to the prior period was due to a lower level of net premiums earned and lower associated acquisition costs in respect of the run-off business assumed through the AmTrust RITC transactions and the acquisition of Maiden Re North America.

89


Fees and Commission Income:
Three and Six Months Ended June 30: Our management companies in the Non-life Run-off segment earned fees and commission income of $4.0 million and $4.6 million for the three months ended June 30, 2020 and 2019, respectively, and $9.0 million and $9.5 million for the six months ended June 30, 2020 and 2019, respectively.

Other Income (Expense):
Three Months Ended June 30: For the three months ended June 30, 2020, we recorded other expense of $2.2 million compared to other income of $9.9 million for the three months ended June 30, 2019, a change of $12.1 million, primarily driven by a smaller reduction in defendant asbestos and environmental net liabilities in the current period.
Six Months Ended June 30: Other income was $20.1 million for the six months ended June 30, 2020 compared to $15.4 million for the six months ended June 30, 2019, an increase of $4.6 million, primarily as a result of reductions in defendant asbestos and environmental net liabilities in the current period.

General and Administrative Expenses:
General and administrative expenses consist of operating expenses and corporate expenses.
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Operating expenses $ 48,562 $ 44,208 $ 4,354 $ 96,772 $ 88,200 $ 8,572
Corporate expenses 17,400 18,734 (1,334) 25,520 35,304 (9,784)
General and administrative expenses $ 65,962 $ 62,942 $ 3,020 $ 122,292 $ 123,504 $ (1,212)

Three and Six Months Ended June 30: General and administrative expenses were $66.0 million and $62.9 million for the three months ended June 30, 2020 and 2019, respectively, an increase of $3.0 million. This increase was primarily attributable to higher performance-based salary and benefit accruals as a result of higher earnings in the current period.
For the six months ended June 30, 2020 and 2019, general and administrative expenses were $122.3 million and $123.5 million, respectively, a decrease of $1.2 million. This decrease was primarily attributable to lower performance-based salary and benefit accruals as a result of lower earnings in the current period.

Interest Expense:
Three and Six Months Ended June 30: Interest expense was $16.2 million and $15.6 million for the three months ended June 30, 2020 and 2019, and $32.1 million and $27.7 million for the six months ended June 30, 2020 and 2019, respectively, an increase of $4.3 million in the current six-month period. The increase reflects higher debt balances in the six months ended June 30, 2020 compared to the six months ended June 30, 2019 as facilities were utilized during the three months ended March 31, 2020 to (i) provide $150.0 million of funding for significant new business and (ii) provide $200.0 million of additional liquidity to the Company to maximize financial flexibility following the recent disruption in global financial markets associated with the COVID-19 pandemic.

Net Foreign Exchange Gains (Losses):
Three and Six Months Ended June 30: Net foreign exchange losses were $4.6 million compared to net foreign exchange gains of $3.8 million for the three months ended June 30, 2020 and 2019, respectively. Net foreign exchange gains were $10.0 million and $7.4 million for the six months ended June 30, 2020 and 2019, respectively. The net foreign exchange losses for the three months ended June 30, 2020 and the net foreign exchange gains for the six months ended June 30, 2020 were primarily due to increased volatility in foreign exchange markets associated the COVID-19 pandemic and the resulting impact on non-U.S. dollar denominated investments and technical balances.

90


Income Taxes:
Three Months Ended June 30: For the three months ended June 30, 2020 income tax expense was $11.8 million compared to $7.4 million for the three months ended June 30, 2019, an increase of $4.4 million, which was primarily due to higher earnings before income taxes in the current period.
Six Months Ended June 30: For the six months ended June 30, 2020 and 2019, income tax expenses were $9.0 million and $10.1 million, respectively, a decrease of $1.1 million, which was primarily due to lower earnings before income taxes in the current period.

Earnings (Losses) from Equity Method Investments:
Three Months Ended June 30: For the three months ended June 30, 2020 and 2019, earnings (losses) from equity method investments were $(8.8) million and $18.1 million, respectively, a decrease of $26.9 million. The decrease was primarily due to the loss recognized on our equity method investment in Enhanzed Re in the current period, which is reported quarterly in arrears.
Six Months Ended June 30: For the six months ended June 30, 2020 and 2019, earnings from equity method investments were $3.7 million and $26.7 million, respectively, a decrease of $23.0 million. The decrease was primarily due to the loss recognized on our equity method investment in Monument and a reduction in gains recognized on our equity method investment in Enhanzed Re in the current period.

Noncontrolling Interest:
Three and Six Months Ended June 30: The net (earnings) loss attributable to the noncontrolling interest of our Non-life Run-off segment were $0.9 million and $(2.3) million for the three months ended June 30, 2020 and 2019, respectively, and $3.0 million and $(4.9) million for the six months ended June 30, 2020 and 2019, respectively. The changes of $3.2 million for the three months ended June 30, 2020 and $7.9 million for the six months ended June 30, 2020 were due to losses made in the current periods for those companies where there is a noncontrolling interest, compared to earnings generated by those companies in the prior periods.
91


Atrium Segment
The Atrium segment includes Atrium 5 Ltd. ("Atrium 5"), Atrium Underwriters Limited ("AUL") and Northshore Holdings Limited. Atrium 5 results represent its proportionate share of the results of Syndicate 609 for which it provides 25% of the underwriting capacity and capital. AUL results largely represent fees charged to Syndicate 609 and a 20% profit commission on the results of the syndicate less salaries and general and administrative expenses incurred in managing the syndicate. AUL also includes other Atrium Group non-syndicate fee income and associated expenses. Northshore Holdings Limited results include the amortization of intangible assets that were fair valued upon acquisition.
The following is a discussion and analysis of the results of operations for our Atrium segment.
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Gross premiums written $ 48,631 $ 43,788 $ 4,843 $ 106,468 $ 97,773 $ 8,695
Net premiums written $ 40,892 $ 36,962 $ 3,930 $ 89,590 $ 83,461 $ 6,129
Net premiums earned $ 43,387 $ 38,199 $ 5,188 $ 85,757 $ 76,952 $ 8,805
Net incurred losses and LAE (15,592) (13,048) (2,544) (44,008) (30,262) (13,746)
Acquisition costs (14,609) (12,815) (1,794) (28,993) (26,557) (2,436)
Operating expenses (2,872) (3,193) 321 (5,749) (6,226) 477
Underwriting income 10,314 9,143 1,171 7,007 13,907 (6,900)
Net investment income 1,079 2,053 (974) 2,604 3,764 (1,160)
Net realized and unrealized gains (1)
7,567 1,969 5,598 1,859 4,882 (3,023)
Fees and commission income 6,044 1,533 4,511 8,587 3,382 5,205
Other income (expense) (2) 35 (37) 33 71 (38)
Corporate expenses (5,272) (3,502) (1,770) (8,410) (7,290) (1,120)
Net foreign exchange gains (losses) 973 98 875 (1,160) 923 (2,083)
EARNINGS BEFORE INCOME TAXES 20,703 11,329 9,374 10,520 19,639 (9,119)
Income tax expense (1,536) (1,023) (513) (783) (1,708) 925
NET EARNINGS 19,167 10,306 8,861 9,737 17,931 (8,194)
Net earnings attributable to noncontrolling interest (7,896) (4,227) (3,669) (4,028) (7,355) 3,327
NET EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ 11,271 $ 6,079 $ 5,192 $ 5,709 $ 10,576 $ (4,867)
Underwriting ratios (2) :
Loss ratio 35.9 % 34.2 % 1.7 % 51.3 % 39.3 % 12.0 %
Acquisition cost ratio 33.7 % 33.5 % 0.2 % 33.8 % 34.5 % (0.7) %
Operating expense ratio 6.6 % 8.4 % (1.8) % 6.7 % 8.1 % (1.4) %
Combined ratio 76.2 % 76.1 % 0.1 % 91.8 % 81.9 % 9.9 %
(1) For the Atrium segment, we utilize trading accounting, where unrealized amounts are reflected in earnings.
(2) Refer to "Underwriting Ratios" for a description of how these ratios are calculated.

Overall Results
Three Months Ended June 30: Net earnings were $11.3 million for the three months ended June 30, 2020 compared to net earnings of $6.1 million for the three months ended June 30, 2019, an increase of $5.2 million. The increase in net earnings was primarily due to higher net realized and unrealized gains, driven by narrowing credit spreads, and fees and commission income in the current period. The combined ratio for the three months ended June 30, 2020 was 76.2%, compared to 76.1% for the prior period. Excluding the impact of losses related to the COVID-19 pandemic, the combined ratio for the three months ended June 30, 2020 was 66.4%.

92


Six Months Ended June 30: Net earnings were $5.7 million for the six months ended June 30, 2020 compared to $10.6 million for the six months ended June 30, 2019, a decrease of $4.9 million. The decrease in net earnings was primarily due to a higher loss ratio and a lower investment return, both of which were largely driven by the COVID-19 pandemic, partially offset by higher fees and commission income in the current period. The combined ratio for the six months ended June 30, 2020 was 91.8% compared to 81.9% for the prior period. Excluding the impact of the COVID-19 pandemic, the combined ratio for the six months ended June 30, 2020 was 76.9%.

An analysis of the components of the segment's net earnings before the attribution of net earnings to noncontrolling interest is shown below. Investment results are separately discussed below in "Investments Results - Consolidated."

Gross Premiums Written:
The following table provides gross premiums written by line of business for the Atrium segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Marine, Aviation and Transit $ 13,494 $ 10,656 $ 2,838 $ 29,388 $ 23,670 $ 5,718
Binding Authorities 22,113 17,073 5,040 42,401 35,648 6,753
Reinsurance 3,487 3,429 58 11,041 11,904 (863)
Accident and Health 1,454 4,537 (3,083) 9,638 13,749 (4,111)
Non-Marine Direct and Facultative 8,083 8,093 (10) 14,000 12,802 1,198
Total $ 48,631 $ 43,788 $ 4,843 $ 106,468 $ 97,773 $ 8,695

Three and Six Months Ended June 30: Gross premiums written for the Atrium segment were $48.6 million and $43.8 million for the three months ended June 30, 2020 and 2019, respectively. Gross premiums written for the Atrium segment were $106.5 million and $97.8 million for the six months ended June 30, 2020 and 2019, respectively. The increase in gross premiums written for the three and six months ended June 30, 2020 was seen predominantly across the binding authorities and marine, aviation and transit lines of business. The binding authorities line of business benefited from new opportunities to write new business, while the marine, aviation and transit line of business continues to benefit from an increase in rates. The reduction in the accident and health line of business was largely driven by the impact of the COVID-19 pandemic as well as underwriting actions to not renew certain contracts in the current period.
Net Premiums Earned:
The following table provides net premiums earned by line of business for the Atrium segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Marine, Aviation and Transit $ 10,783 $ 7,379 $ 3,404 $ 20,976 $ 15,778 $ 5,198
Binding Authorities 19,219 16,225 2,994 38,414 35,420 2,994
Reinsurance 3,367 3,598 (231) 6,392 6,662 (270)
Accident and Health 4,229 6,005 (1,776) 8,375 9,924 (1,549)
Non-Marine Direct and Facultative 5,789 4,992 797 11,600 9,168 2,432
Total $ 43,387 $ 38,199 $ 5,188 $ 85,757 $ 76,952 $ 8,805

93


Three and Six Months Ended June 30: Net premiums earned for the Atrium segment were $43.4 million and $38.2 million for the three months ended June 30, 2020 and 2019, respectively. Net premiums earned for the Atrium segment were $85.8 million and $77.0 million for the six months ended June 30, 2020 and 2019, respectively. The increase in net premiums earned for the three and six months ended June 30, 2020 was primarily due to ongoing growth in the marine, aviation and transit, binding authorities and non-marine direct and facultative lines of business.

Net Incurred Losses and LAE:
The following table shows the components of net incurred losses and LAE for the Atrium segment:
Three Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 9,217 $ 5,002 $ 14,219 $ 10,526 $ 7,251 $ 17,777
Net change in case and LAE reserves (1)
(4,191) 4,986 795 (3,830) 4,089 259
Net change in IBNR reserves (2)
(8,344) 9,054 710 (11,320) 6,519 (4,801)
Increase (reduction) in estimates of net ultimate losses (3,318) 19,042 15,724 (4,624) 17,859 13,235
Amortization of fair value adjustments (132) (132) (187) (187)
Net incurred losses and LAE $ (3,450) $ 19,042 $ 15,592 $ (4,811) $ 17,859 $ 13,048
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.

Three Months Ended June 30: Net incurred losses and LAE for the three months ended June 30, 2020 and 2019 were $15.6 million and $13.0 million, respectively. Net favorable prior period loss development was $3.5 million for the three months ended June 30, 2020 compared to $4.8 million for the three months ended June 30, 2019. The current period net favorable prior period loss development was driven by favorable development across several lines of business, notably the non-marine direct and facultative line. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2020 were $19.0 million and included $4.3 million of losses related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $17.9 million. The loss ratios were 35.9% and 34.2% for the three months ended June 30, 2020 and 2019, respectively. Excluding the impact of losses related to the COVID-19 pandemic, the loss ratio for the three months ended June 30, 2020 was 26.1%.
For the three months ended June 30, 2020, net incurred losses and LAE for the Atrium segment included $4.3 million of losses related to the COVID-19 pandemic, with Enstar's share totaling $2.5 million, as follows:
Three Months Ended June 30, 2020
Atrium Net (25% of S609) Noncontrolling Interests' Share Enstar's share of Atrium
(in thousands of U.S. dollars)
Marine, Aviation and Transit $ 114 $ (47) $ 67
Binding Authorities 889 (364) 525
Reinsurance 606 (248) 358
Accident and Health 2,038 (836) 1,202
Non-Marine Direct and Facultative 615 (252) 363
COVID-19 net incurred losses and LAE $ 4,262 $ (1,747) $ 2,515

94


The following table shows the components of net incurred losses and LAE for the Atrium segment for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 21,940 $ 9,287 $ 31,227 $ 24,946 $ 15,144 $ 40,090
Net change in case and LAE reserves (1)
(7,225) 8,159 934 (10,172) 10,018 (154)
Net change in IBNR reserves (2)
(17,659) 29,500 11,841 (21,552) 10,934 (10,618)
Increase (reduction) in estimates of net ultimate losses (2,944) 46,946 44,002 (6,778) 36,096 29,318
Amortization of fair value adjustments 6 6 944 944
Net incurred losses and LAE $ (2,938) $ 46,946 $ 44,008 $ (5,834) $ 36,096 $ 30,262
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.

Six Months Ended June 30: Net incurred losses and LAE for the six months ended June 30, 2020 and 2019 were $44.0 million and $30.3 million, respectively. Net favorable prior year loss development was $2.9 million and $5.8 million for the six months ended June 30, 2020 and 2019, respectively. The current period net favorable prior period loss development was driven by favorable development across several lines of business, notably the non-marine direct and facultative line. Excluding prior period loss development, net incurred losses and LAE for the six months ended June 30, 2020 were $46.9 million and included $12.8 million of losses related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $36.1 million. The loss ratios were 51.3% and 39.3% for the six months ended June 30, 2020 and 2019, respectively. Excluding the impact of losses related to the COVID-19 pandemic, the loss ratio for the six months ended June 30, 2020 was 36.3%.
For the six months ended June 30, 2020, net incurred losses and LAE for the Atrium segment included $12.8 million of losses related to the COVID-19 pandemic, with Enstar's share totaling $7.6 million, as follows:
Six months ended June 30, 2020
Atrium Net (25% of S609) Noncontrolling Interests' Share Enstar's share of Atrium
(in thousands of U.S. dollars)
Marine, Aviation and Transit $ 276 $ (113) $ 163
Binding Authorities 889 (364) 525
Reinsurance 606 (248) 358
Accident and Health 8,984 (3,683) 5,301
Non-Marine Direct and Facultative 2,085 (855) 1,230
COVID-19 net incurred losses and LAE $ 12,840 $ (5,263) $ 7,576


Acquisition Costs:
Three and Six Months Ended June 30: Acquisition costs were $14.6 million and $12.8 million for the three months ended June 30, 2020 and 2019, respectively, and $29.0 million and $26.6 million for the six months ended June 30, 2020 and 2019, respectively. The acquisition cost ratios were 33.7% and 33.5% for the three months ended June 30, 2020 and 2019, respectively, and 33.8% and 34.5% for the six months ended June 30, 2020 and 2019, respectively. The reduction in the acquisition cost ratio for the six months ended June 30, 2020 was primarily due to agreed reductions in brokerage rates for certain accounts.
95


Operating Expenses:
Three and Six Months Ended June 30: Operating expenses for the Atrium segment were $2.9 million and $3.2 million for the three months ended June 30, 2020 and 2019, respectively, and $5.7 million and $6.2 million for the six months ended June 30, 2020 and 2019, respectively. The operating expense ratios were 6.6% and 8.4% for the three months ended June 30, 2020 and 2019, respectively, and 6.7% and 8.1% for the six months ended June 30, 2020 and 2019, respectively. The decrease was driven primarily by the increase in net premiums earned in the current periods.

Fees and Commission Income:
Three and Six Months Ended June 30: Fees and commission income was $6.0 million and $1.5 million for the three months ended June 30, 2020 and 2019, respectively, and $8.6 million and $3.4 million for the six months ended June 30, 2020 and 2019, respectively. The fees represent profit commission fees earned in relation to AUL’s management of Syndicate 609 and other underwriting consortiums. The increase was primarily due to higher profit commissions from Syndicate 609 and the space consortium in the current periods.

Corporate Expenses:
Three and Six Months Ended June 30: Corporate expenses for the Atrium segment were $5.3 million and $3.5 million for the three months ended June 30, 2020 and 2019, respectively, and $8.4 million and $7.3 million for the six months ended June 30, 2020 and 2019, respectively. The increase in corporate expenses was primarily due to higher variable compensation costs in the three and six months ended June 30, 2020 due to improved performance in the Atrium segment for the three months ended June 30, 2020.

Noncontrolling Interest:
Three and Six Months Ended June 30: The net earnings attributable to the noncontrolling interest in the Atrium segment were $7.9 million for the three months ended June 30, 2020, compared to net earnings attributable to the noncontrolling interest of $4.2 million for the three months ended June 30, 2019. The net earnings attributable to the noncontrolling interest in the Atrium segment were $4.0 million and $7.4 million for the six months ended June 30, 2020 and 2019, respectively. The increase in the net earnings attributable to the noncontrolling interest for the three months ended June 30, 2020 was primarily due to higher earnings whereas the decrease in the net earnings attributable to the noncontrolling interest for the six months ended June 30, 2020 was primarily due to lower earnings, as discussed above.
As of June 30, 2020 and December 31, 2019, Trident and Dowling had a combined 41.0% noncontrolling interest in the Atrium segment.

96


StarStone Segment
The results of the StarStone segment include the results of StarStone Specialty Holdings Limited and subsidiaries ("StarStone Group") and intra-group reinsurance cessions, which are eliminated upon consolidation. In partnership with StarStone's other shareholders, we have previously completed a number of transactions to provide strategic and capital support to StarStone in the form of capital contributions and reinsurance. Refer to Note 3 - "Acquisitions" and Note 21 - "Related Party Transactions" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019 for further information.
Recent Strategic Developments
During the second quarter of 2020, we completed a strategic review of the StarStone segment to reassess the strategies and opportunities. Following this review, we have taken action to position StarStone U.S. and Enstar for improved profitability going forward, as further described below.
Recapitalization of StarStone U.S.
On June 10, 2020, we announced an agreement to recapitalize StarStone U.S. and appoint a new management team and Board. As part of the recapitalization, we entered into a definitive agreement to sell StarStone U.S. to Core Specialty, a newly formed entity with equity backing from funds managed by SkyKnight Capital, L.P., Dragoneer Investment Group and Aquiline Capital Partners LLC. We currently have a 59.0% interest in StarStone U.S. The purchase price will be based on a $30.0 million premium to the GAAP tangible book value of StarStone U.S. to be determined on the month end prior to the closing date and will consist of $235.0 million of common shares of Core Specialty and cash. The $235.0 million of common shares of Core Specialty is expected to represent an estimated 26.1% interest in Core Specialty after certain co-investments and management equity awards. Our investment in Core Specialty will be accounted for as an equity method investment.
In connection with the sale, one of our Non-life Run-off subsidiaries will enter into a loss portfolio transfer reinsurance agreement with StarStone U.S. pursuant to which we will reinsure all of the net loss reserves of StarStone U.S. in respect of premium earned prior to the calendar month end prior to the closing date. We will receive a reinsurance premium equal to the assumed reserves, plus approximately $16.0 million. The reinsurance agreement will contain an aggregate limit on our liability equal to $130.0 million in excess of the assumed reserves, and our subsidiary's obligations under the reinsurance agreement will be guaranteed by Enstar.
The closing of the transaction is subject to regulatory approvals and other closing conditions and is expected to occur in the second half of 2020.
Run-off of StarStone International (non-U.S.)
On June 10, 2020, we also announced that we are placing StarStone International into an orderly run-off. StarStone International has contributed renewal rights to Syndicate 609, which is managed by AUL and which is part of our Atrium segment. As a result, Atrium expects to write new business of approximately $20.0-$40.0 million in Syndicate 609, for which it provides 25% of the underwriting capacity and capital, primarily in the Marine, Energy and Terrorism lines of business.
The liabilities associated with the StarStone International Run-Off vary in duration, and the run-off is expected to occur over a number of years. For further information on the expected liability payout pattern, refer to the contractual obligations table in the liquidity and capital resources section included within Item 2 of this Quarterly Report on Form 10-Q. Steps to reduce the size of StarStone International's operations have begun and will involve several phases to occur over time. As a result, we cannot anticipate with certainty the expected completion date of the StarStone International Run-Off.
We continue to evaluate additional strategic options for StarStone International's operations and business. Consequently, such options could have the effect of mitigating costs associated with placing the business into run-off.
The remaining StarStone International operations will continue to serve the needs of policyholders and ensure that the companies continue to meet all regulatory requirements.
For further information, refer to Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
97


Discussion of Results of Operations
The following is a discussion and analysis of the results of operations for our StarStone segment. Given the impact of the strategic developments in the segment, we have updated the layout of the following tables. In previous reports, we had distinguished the results of sub-components of the segment between StarStone Group and Intra-group reinsurances, and between core and exited lines of business, which is no longer considered to be as meaningful. The table below provides the results from continuing operations (StarStone International Run-off) and Discontinued Operations (StarStone U.S.). Current and prior period results are not indicative of future results.
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars) (in thousands of U.S. dollars)
Gross premiums written $ 86,087 $ 108,902 $ (22,815) $ 241,569 $ 252,766 $ (11,197)
Net premiums written $ 76,922 $ 103,407 $ (26,485) $ 183,728 $ 215,063 $ (31,335)
Net premiums earned $ 82,836 $ 98,322 $ (15,486) $ 180,450 $ 228,244 $ (47,794)
Net incurred losses and LAE (74,433) (119,289) 44,856 (148,869) (258,236) 109,367
Acquisition costs (30,749) (21,609) (9,140) (55,418) (57,281) 1,863
Operating expenses (26,476) (16,509) (9,967) (45,945) (38,692) (7,253)
Underwriting income (loss) (48,822) (59,085) 10,263 (69,782) (125,965) 56,183
Net investment income 7,101 8,807 (1,706) 15,327 17,704 (2,377)
Net realized and unrealized gains (1)
33,547 12,613 20,934 (15,124) 25,240 (40,364)
Fees and commission expense (161) 161 (365) 365
Other income 32 314 (282) 117 373 (256)
Corporate expenses (35,442) (35,442) (36,016) (36,016)
Interest expense (654) (654) (1,101) (475) (626)
Net foreign exchange losses (4,167) (1,244) (2,923) (4,748) (1,835) (2,913)
EARNINGS (LOSS) BEFORE INCOME TAXES (48,405) (38,756) (9,649) (111,327) (85,323) (26,004)
Income tax benefit (expense) (3,304) 724 (4,028) (1,592) 112 (1,704)
Loss from equity method investments (406) 406 (218) 218
NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS (51,709) (38,438) (13,271) (112,919) (85,429) (27,490)
NET EARNINGS (LOSS) FROM DISCONTINUED OPERATIONS, NET OF INCOME TAXES (1,152) (3,943) 2,791 (3,221) 4,125 (7,346)
NET EARNINGS (LOSS) (52,861) (42,381) (10,480) (116,140) (81,304) (34,836)
Net loss attributable to noncontrolling interest 26,952 9,206 17,746 53,719 17,128 36,591
NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ (25,909) $ (33,175) $ 7,266 $ (62,421) $ (64,176) $ 1,755
Underwriting ratios (2) :
Loss ratio
89.9 % 121.3 % (31.4) % 82.5 % 113.1 % (30.6) %
Acquisition cost ratio 37.1 % 22.0 % 15.1 % 30.7 % 25.1 % 5.6 %
Operating expense ratio 31.9 % 16.8 % 15.1 % 25.5 % 17.0 % 8.5 %
Combined ratio 158.9 % 160.1 % (1.2) % 138.7 % 155.2 % (16.5) %
(1) We have historically utilized trading accounting, where unrealized amounts are reflected in earnings. However, from October 1, 2019, we have elected to use AFS accounting and, where permissible, as trading fixed income securities mature, we are reinvesting the proceeds into AFS securities for the StarStone segment.
(2) Refer to "Underwriting Ratios" for a description of how these ratios are calculated.

98


Overall Results
Three Months Ended June 30: Net losses for the StarStone segment were $25.9 million for the three months ended June 30, 2020 compared $33.2 million for the three months ended June 30, 2019, a decrease in net losses of $7.3 million. The decrease in net losses was primarily due to net realized and unrealized gains on our investment portfolio of $33.5 million in the current period, driven by narrowing credit spreads in the current period, and lower underwriting losses.
The investment gains and improved underwriting results were offset by exit costs associated with the StarStone International Run-Off of $42.5 million in the current period. The following table summarizes the financial impact of the exit costs associated with the StarStone International Run-Off, recorded in the second quarter of 2020:
Three Months Ended
June 30, 2020
Description: Results of Operations Line Item: (in millions of U.S. dollars)
Provision for unallocated LAE (run-off basis) Net incurred losses and LAE $ (28.1)
Goodwill impairment Corporate expenses (8.0)
Provision for employee severance-related costs Corporate expenses (8.0)
Capitalized software write-down Corporate expenses (7.6)
Earnings acceleration of prepaid reinsurance premiums Net premiums earned (4.1)
Intangible asset impairment Corporate expenses (4.0)
Other asset write-downs Corporate expenses (2.9)
Operating leases right-of-use asset write-down Corporate expenses (3.5)
Valuation allowance on deferred tax assets Income tax expense (2.3)
Sub-total Net loss (68.5)
Redeemable non-controlling interest Net loss attributable to noncontrolling interest 26.0
Total reduction in StarStone net earnings attributable to the StarStone International Run-Off Net loss attributable to Enstar ordinary shareholders $ (42.5)

Net underwriting losses for the StarStone segment were $48.8 million for the three months ended June 30, 2020 and included exit costs associated with the StarStone International Run-Off of $32.4 million. The StarStone segment combined ratio was 158.9% for the three months ended June 30, 2020 as compared to 160.1% for the three months ended June 30, 2019. Excluding the impact of exit costs, the combined ratio for the three months ended was 118.9% and included net underwriting losses related to the COVID-19 pandemic of $15.3 million.
For the three months ended June 30, 2020, the StarStone segment included $15.3 million of net underwriting losses related to the COVID-19 pandemic, with Enstar's share totaling $9.7 million, as follows:
Three Months Ended June 30, 2020
StarStone Segment Noncontrolling Interests' Share Enstar's share of StarStone Segment
(in thousands of U.S. dollars)
StarStone International (1)
$ 15,274 $ (5,570) $ 9,704
StarStone U.S. (Discontinued Operations)
Total StarStone Segment COVID-19 net underwriting losses $ 15,274 $ (5,570) $ 9,704
(1) Includes the impact of outwards reinstatement premiums of $2.0 million and the premium deficiency provision of $16.3 million for the three months ended June 30, 2020.

Six Months Ended June 30: Net losses for the StarStone segment were $62.4 million for the six months ended June 30, 2020 compared to $64.2 million for the six months ended June 30, 2019, a decrease in net losses of $1.8 million. The decrease in net losses was primarily driven by a reduction in underwriting losses, partially offset by exit costs associated with the StarStone International Run-Off of $42.5 million and net realized and unrealized losses of $15.1 million in the period, driven by the impact of the COVID-19 pandemic on global financial markets.
99


Net underwriting losses for the StarStone segment were $69.8 million for the six months ended June 30, 2020 and included exit costs associated with the StarStone International Run-Off of $32.4 million. The StarStone segment combined ratio was 138.7% for the six months ended June 30, 2020 as compared to 155.2% for the six months ended June 30, 2019. Excluding the impact of exit costs, the combined ratio for the six months ended was 120.3% and included net underwriting losses related to the COVID-19 pandemic of $39.8 million.
For the six months ended June 30, 2020, the StarStone segment included $47.3 million of net underwriting losses related to the COVID-19 pandemic, with Enstar's share totaling $31.9 million, as follows:
Six Months Ended June 30, 2020
StarStone Segment Noncontrolling Interests' Share Enstar's share of StarStone Segment
(in thousands of U.S. dollars)
StarStone International (1)
$ 39,824 $ (12,355) $ 27,469
StarStone U.S. (Discontinued Operations) 7,500 (3,075) 4,425
Total StarStone Segment COVID-19 net underwriting losses $ 47,324 $ (15,430) $ 31,894
(1) Includes the impact of outwards reinstatement premiums of $2.0 million and the premium deficiency provision of $16.3 million for the six months ended June 30, 2020.
An analysis of the components of the segment's net earnings before the attribution of net earnings to noncontrolling interest is shown below. Investment results are separately discussed below in "Investments Results - Consolidated."

Underwriting Impact of Exit Costs
The underwriting impact of the exit costs relating to net premiums earned and net incurred losses and LAE as shown in the table above, are summarized in the following table:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2020
Subtotal Before Exit Costs Exit Costs Total Subtotal Before Exit Costs Exit Costs Total
A B C=A+B D E F=D+E
(in thousands of U.S. dollars)
Net premiums earned $ 86,982 $ (4,146) $ 82,836 $ 184,596 $ (4,146) $ 180,450
Net incurred losses and LAE (46,320) (28,113) (74,433) (120,756) (28,113) (148,869)
Acquisition costs (30,749) (30,749) (55,418) (55,418)
Operating expenses (26,376) (100) (26,476) (45,845) (100) (45,945)
Underwriting income (loss) (16,463) (32,359) (48,822) (37,423) (32,359) (69,782)
Underwriting ratios (1) :
Loss ratio 53.3 % 89.9 % 65.4 % 82.5 %
Acquisition cost ratio 35.4 % 37.1 % 30.0 % 30.7 %
Operating expense ratio 30.2 % 31.9 % 24.9 % 25.5 %
Combined ratio 118.9 % 158.9 % 120.3 % 138.7 %
(1) Refer to "Underwriting Ratios" for a description of how these ratios are calculated.
100



Gross Premiums Written:
The following table provides gross premiums written by line of business for the StarStone segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Casualty $ 11,112 $ 19,565 $ (8,453) $ 55,842 $ 52,643 $ 3,199
Marine 39,433 45,449 (6,016) 108,358 127,958 (19,600)
Property 35,869 28,747 7,122 59,359 50,914 8,445
Aerospace (1,830) 15,141 (16,971) 16,507 21,251 (4,744)
Workers' Compensation 1,503 1,503 1,503 1,503
Total $ 86,087 $ 108,902 $ (22,815) $ 241,569 $ 252,766 $ (11,197)

Three Months Ended June 30: Gross premiums written for the StarStone segment were $86.1 million and $108.9 million for the three months ended June 30, 2020 and 2019, respectively, a decrease of $22.8 million. The decrease in the aerospace lines of business of $17.0 million was driven primarily by underwriting restrictions put in place as a result of COVID-19. The decrease in the marine lines of business of $6.0 million was due to our strategy to exit certain lines of business and underwriting restrictions put in place as a result of COVID-19. The decrease in the casualty lines of business of $8.5 million was due to a policy cancellation as a result of the StarStone International Run-Off, partially offset by new business underwritten through our European platform before we began to implement the StarStone International Run-Off. The increase in the property lines of business of $7.1 million was due to new property programs and rate improvements across all property lines.

Six Months Ended June 30: Gross premiums written were $241.6 million and $252.8 million for the six months ended June 30, 2020 and 2019, respectively, a decrease of $11.2 million. The decrease of $19.6 million in the marine lines of business was due to our strategy to exit certain lines and underwriting restrictions put in place as a result of COVID-19. The decrease in the aerospace lines of $4.7 million was driven by underwriting restrictions put in place as a result of COVID-19 in the three months ended June 30, 2020, partially offset by a new proportional quota share arrangement underwritten in the three months ended March 31, 2020. The increase in the property lines of $8.4 million was due to new property programs and rate improvements across all property lines. The increase of $3.2 million in the casualty lines of business was mainly due to new business opportunities underwritten and improving rates, partly offset by a policy cancellation.
In light of the decision to implement the StarStone International Run-off, we expect gross premiums written to decline materially in future periods.

Net Premiums Earned:
The following table provides net premiums earned by line of business for the StarStone segment:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Casualty $ 19,644 $ 17,896 $ 1,748 $ 45,948 $ 44,419 $ 1,529
Marine 32,531 49,306 (16,775) 73,592 100,795 (27,203)
Property 22,958 20,851 2,107 44,570 59,476 (14,906)
Aerospace 6,860 11,484 (4,624) 14,479 24,664 (10,185)
Workers' Compensation 843 (1,215) 2,058 1,861 (1,110) 2,971
Total $ 82,836 $ 98,322 $ (15,486) $ 180,450 $ 228,244 $ (47,794)

101


Three Months Ended June 30: Net premiums earned for the StarStone segment were $82.8 million and $98.3 million for the three months ended June 30, 2020 and 2019, respectively, a decrease of $15.5 million. The decrease in net premiums earned was mainly due to our strategy to exit certain lines of business and a policy cancellation.

Six Months Ended June 30: Net premiums earned for the StarStone segment were $180.5 million and $228.2 million for the six months ended June 30, 2020 and 2019, respectively, a decrease of $47.8 million. The decrease in net premiums earned was mainly due to our strategy to exit certain lines of business and to a lesser extent, underwriting restrictions related to COVID-19 and a policy cancellation.
As noted above with respect to gross premiums written, in light of the decision to implement the StarStone International Run-off, we expect net premiums earned to decline materially in future periods.

Net Incurred Losses and LAE:
The following table shows the components of net incurred losses and LAE for the StarStone segment:
Three Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 74,532 $ 6,135 $ 80,667 $ 89,425 $ 15,072 $ 104,497
Net change in case and LAE reserves (1)
(25,402) (5,362) (30,764) 2,648 35,440 38,088
Net change in IBNR reserves (2)
(62,212) 58,889 (3,323) (56,130) 32,332 (23,798)
Increase (reduction) in estimates of net ultimate losses (13,082) 59,662 46,580 35,943 82,844 118,787
Increase (reduction) in provisions for unallocated LAE 274 27,611 27,885 727 (187) 540
Amortization of fair value adjustments (32) (32) (38) (38)
Net incurred losses and LAE $ (12,840) $ 87,273 $ 74,433 $ 36,632 $ 82,657 $ 119,289
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.
Three Months Ended June 30: Net incurred losses and LAE for the three months ended June 30, 2020 and 2019 were $74.4 million and $119.3 million, respectively. Net favorable prior period loss development was $12.8 million for the three months ended June 30, 2020 compared to net unfavorable prior period loss development of $36.6 million for the three months ended June 30, 2019. Net favorable prior period loss development for the three months ended June 30, 2020 was driven by favorable run-off in the casualty lines of business. Net adverse prior period loss development for the three months ended June 30, 2019 was primarily related to development on lines of business that we had either exited or were subject to remediation as part of our underwriting repositioning initiatives prior to implementing the StarStone International Run-off. Excluding prior period net loss development, net incurred losses and LAE for the three months ended June 30, 2020 were $87.3 million and included $28.1 million of exit costs associated with the StarStone International Run-Off and a reduction in net incurred losses and LAE related to the COVID-19 pandemic of $3.1 million. Excluding prior period net loss development, net incurred losses and LAE for the three months ended June 30, 2019 were $82.7 million. The loss ratios for the StarStone segment were 89.9% and 121.3% for the three months ended June 30, 2020 and 2019, respectively. Excluding the impact of exit costs associated with the StarStone International Run-Off, the loss ratio for the three months ended June 30, 2020 was 53.3%.
102


For the three months ended June 30, 2020, the StarStone segment included a reduction in net incurred losses and LAE related to the COVID-19 pandemic of $3.1 million, with Enstar's share totaling $1.6 million, as follows:
Three Months Ended June 30, 2020
StarStone International Noncontrolling Interests' Share Enstar's share of StarStone International
(in thousands of U.S. dollars)
Casualty $ (900) $ 369 $ (531)
Marine 500 (205) 295
Property 200 123 323
Aerospace (2,900) 1,189 (1,711)
COVID-19 net incurred losses and LAE $ (3,100) $ 1,476 $ (1,624)

The following table shows the components of net incurred losses and LAE for the StarStone segment for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30,
2020 2019
Prior
Periods
Current
Period
Total Prior
Periods
Current
Period
Total
(in thousands of U.S. dollars)
Net losses paid $ 157,086 $ 4,387 $ 161,473 $ 190,446 $ 15,971 $ 206,417
Net change in case and LAE reserves (1)
(65,730) (613) (66,343) (13,672) 45,040 31,368
Net change in IBNR reserves (2)
(105,983) 131,594 25,611 (90,096) 109,851 19,755
Increase (reduction) in estimates of net ultimate losses (14,627) 135,368 120,741 86,678 170,862 257,540
Increase (reduction) in provisions for unallocated LAE 183 28,312 28,495 (473) 1,400 927
Amortization of fair value adjustments (367) (367) (231) (231)
Net incurred losses and LAE $ (14,811) $ 163,680 $ 148,869 $ 85,974 $ 172,262 $ 258,236
(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.
Six Months Ended June 30: Net incurred losses and LAE for the six months ended June 30, 2020 and 2019 were $148.9 million and $258.2 million, respectively. Net favorable prior period loss development was $14.8 million for the six months ended June 30, 2020 compared to net unfavorable prior period loss development of $86.0 million for the six months ended June 30, 2019. Net favorable prior period loss development for the six months ended June 30, 2020 was driven by favorable development in the casualty lines of business. Net unfavorable prior period loss development for the six months ended June 30, 2019 was primarily related to development on lines of business that we have either exited or had been subject to remediation as part of our underwriting repositioning initiatives before our decision to place StarStone International into run-off. Excluding prior period loss development, net incurred losses and LAE for the six months ended June 30, 2020 were $163.7 million and included $28.1 million of exit costs associated with the StarStone International Run-Off and $21.5 million related to the COVID-19 pandemic. Excluding prior period loss development, net incurred losses and LAE for the six months ended June 30, 2019 were $172.3 million. The loss ratios for the StarStone segment were 82.5% and 113.1% for the six months ended June 30, 2020 and 2019, respectively. Excluding the impact of exit costs associated with the StarStone International Run-Off, the loss ratio for the six months ended June 30, 2020 was 65.4% and included COVID-19 related losses of $21.5 million.
For the six months ended June 30, 2020, StarStone segment net incurred losses and LAE included $21.5 million of losses related to the COVID-19 pandemic, with Enstar's share totaling $16.1 million, as follows:
103


Six Months Ended June 30, 2020
StarStone International Noncontrolling Interests' Share Enstar's share of StarStone International
(in thousands of U.S. dollars)
Casualty $ 10,150 $ (4,161) $ 5,989
Marine 5,200 (2,132) 3,068
Property 9,000 (205) 8,795
Aerospace (2,900) 1,189 (1,711)
COVID-19 net incurred losses and LAE $ 21,450 $ (5,309) $ 16,141


Acquisition Costs:
Three Months Ended June 30: Acquisition costs for the StarStone segment were $30.7 million and $21.6 million for the three months ended June 30, 2020 and 2019, respectively, an increase of $9.1 million. The acquisition cost ratios for the three months ended June 30, 2020 and 2019 were 37.1% and 22.0%, respectively. The increase was driven by the impact of the premium deficiency provision of $13.8 million resulting from COVID-19 underwriting losses.
Six Months Ended June 30: Acquisition costs for the StarStone segment were $55.4 million and $57.3 million for the six months ended June 30, 2020 and 2019, respectively, an decrease of $1.9 million. The acquisition cost ratios for the six months ended June 30, 2020 and 2019 were 30.7% and 25.1%, respectively. The increase was driven by the impact of the premium deficiency provision of $13.8 million resulting from COVID-19 underwriting losses.

Operating Expenses:
Three Months Ended June 30: Operating expenses for the StarStone segment for the three months ended June 30, 2020 and 2019 were $26.5 million and $16.5 million, respectively. The operating expense ratios for the three months ended June 30, 2020 and 2019 were 31.9% and 16.8%. The increase was due to lower non-direct deferred acquisition costs, resulting from the impact of the premium deficiency provision of $2.5 million caused by COVID-19 underwriting losses, and lower costs in 2019 driven by the release of the restructuring provision.

Six Months Ended June 30 : Operating expenses for the StarStone segment for the six months ended June 30, 2020 and 2019 were $45.9 million and $38.7 million, respectively. The operating expense ratios for the three months ended June 30, 2020 and 2019 were 25.5% and 17.0%, respectively. The increase was primarily driven by lower non-direct deferred acquisition costs, resulting from the impact of the premium deficiency provision of $2.5 million caused by COVID-19 underwriting losses, and lower costs in 2019 driven by the release of the restructuring provision.

Corporate Expenses:
Three and Six Months Ended June 30: Corporate expenses for the StarStone segment were $35.4 million and $nil for the three months ended June 30, 2020 and 2019, respectively, and $36.0 million and $nil for the six months ended June 30, 2020 and 2019, respectively. Corporate expenses for the three and six months ended June 30, 2020, included exit costs associated with the StarStone International Run-Off of $33.8 million and are summarized above.

Income Taxes:
Three and Six Months Ended June 30: Income tax expense for the StarStone segment for the three months ended June 30, 2020 was $3.3 million compared to an income tax benefit of $0.7 million for the three months ended June 30, 2019. For the six months ended June 30, 2020, income tax expense was $1.6 million compared to an income tax benefit of $0.1 million for the six months ended June 30, 2019. The income tax benefit (expense) is generally driven by the geographical distribution of pre-tax earnings (loss) between taxable and non-taxable jurisdictions.

104


Discontinued Operations (StarStone U.S.):
Three Months Ended June 30: The net earnings (loss) from discontinued operations, net of income tax benefit (expense) for the StarStone segment for the three months ended June 30, 2020 was $(1.2) million compared to $(3.9) million for the three months ended June 30, 2019. There was no further impact from COVID-19 assessed during the three months ended June 30, 2020.
The StarStone U.S. business included in discontinued operations includes the results of intra-group reinsurance cessions, which were non-renewed as of January 1, 2018. The effect of these intra-group reinsurance cessions on net earnings (loss), net of income tax benefit (expense) for the StarStone U.S. business was as follows:
Three Months Ended
June 30,
2020 2019
(in thousands of U.S. dollars)
StarStone U.S. Group before Intra-Group Cessions $ 8,870 $ (33,357)
Intra-Group Cessions (10,022) 29,414
StarStone U.S. net earnings (loss), net of income tax benefit (expense) $ (1,152) $ (3,943)

Six Months Ended June 30: The net earnings (loss) from discontinued operations, net of income tax benefit (expense) for the six months ended June 30, 2020 was $(3.2) million compared to $4.1 million for the six months ended June 30, 2019. For the six months ended June 30, 2020, the net earnings (loss) from discontinued operations, net of income tax benefit (expense), included $7.5 million net incurred losses and LAE related to the COVID-19 pandemic, with Enstar's share totaling $4.4 million, as follows:
Six Months Ended June 30, 2020
StarStone U.S. Noncontrolling Interests' Share Enstar's share of StarStone U.S.
(in thousands of U.S. dollars)
Casualty $ 6,000 $ (2,460) $ 3,540
Marine 1,500 (615) 885
COVID-19 net incurred losses and LAE $ 7,500 $ (3,075) $ 4,425

As described above, the StarStone U.S. business included in discontinued operations includes the results of intra-group reinsurance cessions. The effect of these intra-group reinsurance cessions on net earnings (loss), net of income tax benefit (expense) for the StarStone U.S. business was as follows:
Six Months Ended
June 30,
2020 2019
(in thousands of U.S. dollars)
StarStone U.S. Group before Intra-Group Cessions $ 18,194 $ (39,656)
Intra-Group Cessions (21,415) 43,781
StarStone U.S. net earnings (loss), net of income tax benefit (expense) $ (3,221) $ 4,125

Noncontrolling Interest:
Three and Six Months Ended June 30: The net losses attributable to the noncontrolling interest in the StarStone segment were $27.0 million for the three months ended June 30, 2020, compared to $9.2 million for the three months ended June 30, 2019. The net losses attributable to the noncontrolling interest in the StarStone segment were $53.7 million and $17.1 million for the six months ended June 30, 2020 and 2019, respectively. The increases in net losses attributable to the noncontrolling interest for the three and six months ended June 30, 2020 were primarily due to higher losses, primarily related to the underwriting impact of COVID-19 and the exit costs associated with the StarStone International Run-off, as discussed above.
As of June 30, 2020 and December 31, 2019, Trident and Dowling had a combined 41.0% noncontrolling interest in the StarStone Group.
105


Other
Our other activities, which do not qualify as a reportable segment, include our corporate expenses, debt servicing costs, preferred share dividends, holding company income and expenses, foreign exchange and other miscellaneous items. On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-owned subsidiary Alpha Insurance SA to a subsidiary of Monument.
The following is a discussion and analysis of our results of operations for our other activities, which are summarized below:
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 Change 2020 2019 Change
(in thousands of U.S. dollars)
Net premiums earned $ 6,131 $ 5,971 $ 160 $ 9,468 $ 12,569 $ (3,101)
Net incurred losses and LAE (5,193) (4,465) (728) (7,675) (9,421) 1,746
Life and annuity policy benefits (2,194) 2,194 (2,290) 2,290
Acquisition costs (120) (145) 25 (203) (377) 174
Underwriting income (loss) 818 (833) 1,651 1,590 481 1,109
Net investment losses (2,793) (2,446) (347) (5,281) (4,131) (1,150)
Net realized and unrealized gains 4,545 (4,545) 5,579 (5,579)
Other income (expense) 1,114 759 355 (857) 971 (1,828)
Corporate expenses (8,806) (14,530) 5,724 (24,846) (23,227) (1,619)
Interest Income 2,817 2,583 234 5,748 4,138 1,610
Net foreign exchange gains (losses) 2,641 (27) 2,668 2,641 (26) 2,667
LOSS BEFORE INCOME TAXES (4,209) (9,949) 5,740 (21,005) (16,215) (4,790)
Income tax expense (85) 85
NET LOSS ATTRIBUTABLE TO ENSTAR (4,209) (9,949) 5,740 (21,005) (16,300) (4,705)
Dividends on preferred shares (8,925) (8,925) (17,850) (18,064) 214
NET LOSS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS $ (13,134) $ (18,874) $ 5,740 $ (38,855) $ (34,364) $ (4,491)
Overall Results:
Three Months Ended June 30: Net losses were $13.1 million for the three months ended June 30, 2020, compared to $18.9 million for the three months ended June 30, 2019, a decrease in net losses of $5.7 million, which primarily resulted from a $5.7 million decrease in corporate expenses and an increase in foreign exchange gains of $2.7 million, partially offset by a reduction in net realized and unrealized gains of $4.5 million in the current period.

Six Months Ended June 30: Net losses were $38.9 million for the six months ended June 30, 2020, compared to net losses of $34.4 million for the six months ended June 30, 2019, an increase in net losses of $4.5 million, which primarily resulted from a reduction in net realized and unrealized gains of $5.6 million, partially offset by an increase in foreign exchange gains of $2.7 million.
Investment results are separately discussed below in "Investable Assets."

Underwriting Income:
Three and Six Months Ended June 30 : Underwriting income (loss) was broadly consistent at $0.8 million compared to $(0.8) million for the three months ended June 30, 2020 and 2019, respectively, and $1.6 million and $0.5 million for the six months ended June 30, 2020 and 2019, respectively.

Corporate Expenses:
Three and Six Months Ended June 30: Corporate expenses were $8.8 million and $14.5 million for the three months ended June 30, 2020 and 2019, respectively, a decrease of $5.7 million. Corporate expenses were $24.8 million and $23.2 million for the six months ended June 30, 2020 and 2019, respectively. The decrease for the three months ended June 30, 2020 was primarily related to higher performance-related compensation in the prior period.
106



Interest Income:
Three and Six Months Ended June 30: Interest income was $2.8 million and $2.6 million for the three months ended June 30, 2020 and 2019, respectively, and $5.7 million and $4.1 million for the six months ended June 30, 2020 and 2019, respectively. The increases for the three and six months ended June 30, 2020 represent the elimination of interest expense between our reportable segments.

Net Foreign Exchange Gains (Losses):
Three and Six Months Ended June 30: Net foreign exchange gains were $2.6 million for the three and six months ended June 30, 2020, compared to nominal losses for the three and six months ended June 30, 2019.

Dividends on Preferred Shares:
Three and Six Months Ended June 30: The dividends on preferred shares were $8.9 million for the three months ended June 30, 2020 and 2019, and $17.9 million and $18.1 million for the six months ended June 30, 2020 and 2019, respectively.

107


Investable Assets
We define investable assets as the sum of total investments, cash and cash equivalents, restricted cash and cash equivalents and funds held. Investments consist primarily of investment grade, liquid, fixed maturity securities of short-to-medium duration, equities and other investments. Cash and cash equivalents and restricted cash and cash equivalents are comprised mainly of cash, high-grade fixed deposits, and other highly liquid instruments such as commercial paper with maturities of less than three months at the time of acquisition and money market funds. Funds held primarily consist of investment grade, liquid, fixed maturity securities of short-to-medium duration.
Investable assets were $15.6 billion as of June 30, 2020 as compared to $14.1 billion as of December 31, 2019, an increase of 10.8%. The increase was primarily due to assets acquired in relation to the Lyft, Aspen and AXA Group transactions and unrealized gains on investments.
A description of our investment strategies is included in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Investments" in our Annual Report on Form 10-K for the year ended December 31, 2019.

Composition of Investable Assets By Segment
Across all of our segments, we strive to structure our investments in a manner that recognizes our liquidity needs and in order to meet our obligation to pay losses. We consider the duration characteristics of our liabilities in determining the extent to which we correlate with assets of comparable duration depending on our other investment strategies and to the extent practicable. If our liquidity needs or general liability profile change unexpectedly, we may adjust the structure of our investment portfolio to meet our revised expectations. The following tables summarize the composition of total investable assets by segment, and for our other activities:
June 30, 2020
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Short-term investments, trading, at fair value $ 8,618 $ 1,598 $ $ $ 10,216
Short-term investments, AFS, at fair value 74,575 13,195 87,770
Fixed maturities, trading, at fair value 4,674,541 161,830 528,786 5,365,157
Fixed maturities, AFS, at fair value 2,017,453 11,447 186,311 2,215,211
Funds held - directly managed 1,168,856 1,168,856
Equities, at fair value 547,442 22,101 71,228 640,771
Other investments, at fair value 3,174,543 15,451 88,791 3,278,785
Equity method investments 362,398 362,398
Total investments 12,028,426 212,427 888,311 13,129,164
Cash and cash equivalents (including restricted cash) 664,025 50,453 268,391 5,652 988,521
Funds held by reinsured companies 1,336,299 28,320 93,808 8,169 1,466,596
Total investable assets $ 14,028,750 $ 291,200 $ 1,250,510 $ 13,821 $ 15,584,281
Duration (in years) (1)
5.33 2.15 2.08 4.92
Average credit rating (2)
A+ AA- AA- AAA A+

108


December 31, 2019
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Short-term investments, trading, at fair value $ 50,268 $ 1,222 $ $ $ 51,490
Short-term investments, AFS, at fair value 121,780 6,555 128,335
Fixed maturities, trading, at fair value 5,378,533 155,510 609,292 6,143,335
Fixed maturities, AFS, at fair value 1,446,912 15,310 75,830 1,538,052
Funds held - directly managed 1,187,552 1,187,552
Equities, at fair value 576,893 22,079 127,749 726,721
Other investments, at fair value 2,386,776 7,417 123,838 2,518,031
Equity method investments 326,277 326,277
Total investments 11,474,991 201,538 943,264 12,619,793
Cash and cash equivalents (including restricted cash) 666,705 58,369 241,708 4,567 971,349
Funds held by reinsured companies 336,470 27,451 103,191 8,620 475,732
Total investable assets $ 12,478,166 $ 287,358 $ 1,288,163 $ 13,187 $ 14,066,874
Duration (in years) (1)
5.24 1.86 2.07 4.86
Average credit rating (2)
A+ AA- A+ AAA A+
(1) The duration calculation includes cash and cash equivalents, short-term investments, fixed maturities and the fixed maturities within our funds held - directly managed portfolios at June 30, 2020 and December 31, 2019.
(2) The average credit ratings calculation includes cash and cash equivalents, short-term investments, fixed maturities and the fixed maturities within our funds held - directly managed portfolios at June 30, 2020 and December 31, 2019.

As of both June 30, 2020 and December 31, 2019, our investment portfolio, including funds held - directly managed, had an average credit quality rating of A+. As of June 30, 2020 and December 31, 2019, our fixed maturity investments (classified as trading and AFS and our fixed maturity investments included within funds held - directly managed) that were non-investment grade (i.e. rated lower than BBB- and non-rated securities) comprised 3.6% and 4.5% of our total fixed maturity investment portfolio, respectively. A detailed schedule of average credit ratings by asset class as of June 30, 2020 is included in Note 5 - "Investments" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
Schedules of maturities by asset class are included in Note 5 - "Investments" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

109


Composition of Investment Portfolio By Asset Class
The following tables summarize the composition of our investment portfolio by asset class:
June 30, 2020
AAA Rated AA Rated A Rated BBB Rated Non-investment Grade Not Rated Total %
(in thousands of U.S. dollars, except percentages)
Short-term and fixed maturity investments, trading and AFS and funds held - directly managed
U.S. government & agency $ 546,471 $ $ $ $ $ $ 546,471 4.2 %
U.K. government 2,271 94,987 10,422 107,680 0.8 %
Other government 250,552 144,733 53,101 45,147 9,779 503,312 3.8 %
Corporate 194,895 593,964 2,840,810 1,663,136 262,385 9,910 5,565,100 42.4 %
Municipal 10,078 82,087 53,458 20,097 165,720 1.3 %
Residential mortgage-backed 430,300 31 1,807 1,881 450 2,363 436,832 3.3 %
Commercial mortgage-backed 575,005 103,238 89,254 60,203 5,625 7,042 840,367 6.4 %
Asset-backed 291,013 97,699 149,673 117,217 9,045 1,705 666,352 5.1 %
Total 2,300,585 1,116,739 3,198,525 1,907,681 287,284 21,020 8,831,834 67.3 %
Other assets included within funds held - directly managed 15,376 0.1 %
Equities
Publicly traded equities 274,382 2.1 %
Exchange-traded funds 95,389 0.7 %
Privately held equities 271,000 2.1 %
Total 640,771 4.9 %
Other investments
Hedge funds 1,757,982 13.4 %
Fixed income funds 584,607 4.5 %
Equity funds 368,314 2.8 %
Private equity funds 315,070 2.4 %
CLO equities 84,188 0.6 %
CLO equity funds 123,299 0.9 %
Private credit funds 38,094 0.3 %
Other 7,231 0.1 %
Total 3,278,785 25.0 %
Equity method investments 362,398 2.8 %
Total investments $ 2,300,585 $ 1,116,739 $ 3,198,525 $ 1,907,681 $ 287,284 $ 21,020 $ 13,129,164 100.0 %
110


December 31, 2019
AAA Rated AA Rated A Rated BBB Rated Non-investment Grade Not Rated Total %
(in thousands of U.S. dollars, except percentages)
Fixed maturity and short-term investments, trading and AFS and funds held - directly managed
U.S. government & agency $ 696,077 $ $ $ $ $ $ 696,077 5.5 %
U.K. government 161,772 161,772 1.3 %
Other government 316,150 154,072 63,270 144,557 24,807 702,856 5.6 %
Corporate 140,889 600,081 2,759,671 1,634,572 311,167 1,890 5,448,270 43.2 %
Municipal 10,088 56,389 50,938 23,272 140,687 1.1 %
Residential mortgage-backed 310,595 47,474 2,295 1,882 34,055 4,613 400,914 3.2 %
Commercial mortgage-backed 567,453 80,517 87,081 63,565 5,556 9,574 813,746 6.4 %
Asset-backed 304,542 79,930 159,087 110,201 15,694 781 670,235 5.3 %
Total 2,345,794 1,180,235 3,122,342 1,978,049 391,279 16,858 9,034,557 71.6 %
Other assets included within funds held - directly managed 14,207 0.1 %
Equities
Publicly traded equities 327,875 2.6 %
Exchange-traded funds 133,047 1.1 %
Privately held equities 265,799 2.1 %
Total 726,721 5.8 %
Other investments
Hedge funds 1,121,904 8.9 %
Fixed income funds 481,039 3.8 %
Equity funds 410,149 3.3 %
Private equity funds 323,496 2.5 %
CLO equities 87,555 0.7 %
CLO equity funds 87,509 0.7 %
Private credit funds %
Other 6,379 %
Total 2,518,031 19.9 %
Equity method investments 326,277 2.6 %
Total investments $ 2,345,794 $ 1,180,235 $ 3,122,342 $ 1,978,049 $ 391,279 $ 16,858 $ 12,619,793 100.0 %

A description of our investment valuation processes is included in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies" of our Annual Report on Form 10-K for the year ended December 31, 2019 and Note 11 - "Fair Value Measurements" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

111


The amortized cost, unrealized gains and losses, allowance for credit losses and fair values of our short-term and fixed maturity investments as of June 30, 2020 were as follows:
Gross Unrealized Losses
As of June 30, 2020 Amortized Cost Gross Unrealized Gains Non-Credit Related Losses
Allowance for Credit Losses (1)
Fair Value
U.S. government and agency $ 522,106 $ 24,769 $ (404) $ $ 546,471
U.K. government 107,185 2,011 (1,516) 107,680
Other government 488,650 19,179 (4,517) 503,312
Corporate 5,268,218 327,484 (27,512) (3,090) 5,565,100
Municipal 150,546 15,966 (792) 165,720
Residential mortgage-backed 430,201 9,505 (2,874) 436,832
Commercial mortgage-backed 825,225 33,301 (17,665) (494) 840,367
Asset-backed 695,528 3,479 (32,566) (89) 666,352
$ 8,487,659 $ 435,694 $ (87,846) $ (3,673) $ 8,831,834
(1) The Company adopted ASU 2016-13 and the related amendments on January 1, 2020. Refer to Note 1 - "Significant Accounting Policies" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q for further details.

The amortized cost, unrealized gains and losses and fair values of our short-term and fixed maturity investments as of December 31, 2019 were as follows:
As of December 31, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses
(Non-OTTI)
Fair Value
U.S. government and agency $ 690,343 $ 6,663 $ (929) $ 696,077
U.K. government 155,261 6,628 (117) 161,772
Other government 684,116 24,994 (6,254) 702,856
Corporate 5,231,512 235,406 (18,648) 5,448,270
Municipal 131,130 9,595 (38) 140,687
Residential mortgage-backed 396,331 5,981 (1,398) 400,914
Commercial mortgage-backed 796,730 20,673 (3,657) 813,746
Asset-backed 674,250 1,806 (5,821) 670,235
$ 8,759,673 $ 311,746 $ (36,862) $ 9,034,557

We have generally accounted for our fixed maturity securities as "trading." However, from October 1, 2019, we have elected to use AFS accounting and, where permissible, as trading fixed income securities mature, we are reinvesting the proceeds into AFS securities for the Non-life Run-off and StarStone segments. The difference is that unrealized changes on investments classified as trading are recorded through earnings, whereas unrealized changes on investments classified as AFS are recorded directly to shareholders' equity. We may experience unrealized losses on our fixed maturity investments, depending on investment conditions and general economic conditions. Unrealized amounts would only become realized in the event of a sale of the specific securities prior to maturity or a credit default. For further information on the sensitivity of our portfolio to changes in interest rates, refer to the Interest Rate Risk section within "Item 3. Quantitative and Qualitative Disclosures About Market Risk", included within this Quarterly Report on Form 10-Q.

112


The following table summarizes the composition of our top ten corporate issuers included within our short-term and fixed maturity investments, classified as trading and AFS and the fixed maturity investments included within our funds held - directly managed balance as of June 30, 2020:
Fair Value Average Credit Rating
(in thousands of U.S. dollars)
Bank of America Corp $ 115,475 A
Citigroup Inc 114,733 A-
JPMorgan Chase & Co 111,934 A
Morgan Stanley 107,951 A-
Wells Fargo & Co 96,126 A
Apple Inc 94,306 AA+
Comcast Corp 79,963 A-
HSBC Holdings PLC 53,825 A-
Walmart Inc 52,240 AA
AT&T Inc 50,119 BBB
$ 876,672

Investment Results - Consolidated
In addition to the impact of the COVID-19 pandemic in 2020, the comparability of our investment results across different periods was impacted by the acquisitions and reinsurance transactions we completed during 2020 with AXA Group, Aspen and Lyft and in 2019 with Morse TEC, Zurich, Maiden Re, Amerisure and AmTrust. Refer to Note 3 - "Significant New Business" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q for further details on the 2020 transactions and "Item 1. Business - Recent Acquisitions and Significant New Business" in our Annual Report on Form 10-K for the year ended December 31, 2019 for further details on the 2019 transactions.
The following tables summarize our investment results by major investment category and by segment as well as our other activities. Additional information is included in Note 5 - "Investments" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
Three Months Ended June 30, 2020
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Net investment income:
Fixed maturities and cash and cash equivalents $ 81,075 $ 991 $ 6,305 $ 2 $ 88,373
Equity securities 3,726 21 15 3,762
Other 6,850 145 1,091 (2,795) 5,291
Gross investment income (expense) 91,651 1,157 7,411 (2,793) 97,426
Investment expenses (2,595) (78) (310) (2,983)
Net investment income (expense) $ 89,056 $ 1,079 $ 7,101 $ (2,793) $ 94,443
Net realized and unrealized gains:
Fixed maturity securities 384,994 5,867 26,503 417,364
Equity securities 35,075 1,308 2,837 39,220
Other investments 506,425 392 4,207 511,024
Net realized and unrealized gains $ 926,494 $ 7,567 $ 33,547 $ $ 967,608
Annualized income from cash and fixed maturities $ 324,300 $ 3,964 $ 25,220 $ 8 $ 353,492
Average aggregate fixed maturities and cash and cash equivalents, at cost (1)
9,526,799 255,320 1,037,474 13,175 10,832,768
Annualized Investment Book Yield 3.40 % 1.55 % 2.43 % 0.06 % 3.26 %
Total financial statement return (2)
$ 1,015,550 $ 8,646 $ 40,648 $ (2,793) $ 1,062,051
Average aggregate invested assets, at fair value (1)
12,881,483 287,738 1,191,301 13,175 14,373,697
Financial Statement Portfolio Return 7.88 % 3.00 % 3.41 % (21.20) % 7.39 %
113


Three Months Ended June 30, 2019
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Net investment income:
Fixed maturities and cash and cash equivalents $ 61,556 $ 1,735 $ 7,128 $ 581 $ 71,000
Equity securities 2,903 21 498 3,422
Other investments and other 3,594 404 1,672 (3,167) 2,503
Gross investment income 68,053 2,160 9,298 (2,586) 76,925
Investment expenses (2,196) (107) (491) 140 (2,654)
Net investment income (expense) $ 65,857 $ 2,053 $ 8,807 $ (2,446) $ 74,271
Net realized and unrealized gains:
Fixed maturity securities $ 169,494 $ 1,644 $ 10,467 $ 4,214 $ 185,819
Equity securities 13,384 191 371 13,946
Other investments 58,664 134 1,775 331 60,904
Net realized and unrealized gains $ 241,542 $ 1,969 $ 12,613 $ 4,545 $ 260,669
Annualized income from cash and fixed maturities $ 246,224 $ 6,940 $ 28,512 $ 2,324 $ 284,000
Average aggregate fixed maturities and cash and cash equivalents, at cost (1)
8,770,538 255,117 1,148,211 88,201 10,262,067
Annualized Investment Book Yield 2.81 % 2.72 % 2.48 % 2.63 % 2.77 %
Total financial statement return (2)
$ 307,399 $ 4,022 $ 21,420 $ 2,099 $ 334,940
Average aggregate invested assets, at fair value (1)
11,542,943 266,045 1,301,833 100,089 13,210,910
Financial Statement Portfolio Return 2.66 % 1.51 % 1.65 % 2.10 % 2.54 %
(1) These amounts are an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.
(2) This is the sum of net investment income and net realized and unrealized gains (losses) from our U.S. GAAP consolidated financial statements.

Net Investment Income:
Net investment income increased by $20.2 million for the three months ended June 30, 2020 compared to the three months ended June 30, 2019, primarily due to a $17.4 million increase in net investment income from fixed maturities and cash and cash equivalents, principally due to an increase of $570.7 million in our average aggregate fixed maturities and cash and cash equivalents. The increase in our average aggregate fixed maturities and cash and cash equivalents was primarily due to the Lyft, Aspen and AXA Group transactions in 2020, and the Morse TEC, Zurich, Maiden Re and Amerisure transactions in 2019. Our annualized book yield increased 50 basis points for the three months ended June 30, 2020 compared to the three months ended June 30, 2019, primarily due to interest on short-term funds held arrangements relating to the 2020 transactions.
Net Realized and Unrealized Gains (Losses):
Net realized and unrealized gains were $967.6 million for the three months ended June 30, 2020 compared to gains of $260.7 million for the three months ended June 30, 2019, an increase of $706.8 million. Included in net realized and unrealized gains (losses) are the following items:
Net realized and unrealized gains on fixed income securities, including fixed income securities within our funds held portfolios, of $417.4 million for the three months ended June 30, 2020, compared to gains of $185.8 million for the three months ended June 30, 2019, an increase of $231.5 million. Gains in the current period were primarily attributable to an increase in the valuation of our fixed maturity investments due to tighter credit spreads and lower interest rates in the current period, compared to the comparative period.
Net realized and unrealized gains on equity securities of $39.2 million for the three months ended June 30, 2020, compared to gains of $13.9 million for the three months ended June 30, 2019, an increase of $25.2 million, primarily driven by a more favorable movements in equity markets in 2020 compared to the comparative period.
114


Net realized and unrealized gains on other investments of $511.0 million for the three months ended June 30, 2020, compared to gains of $60.9 million for the three months ended June 30, 2019, representing an increase of $450.1 million. The unrealized gains for the three months ended June 30, 2020 primarily comprised of unrealized gains in our hedge funds, fixed income funds, equity funds and CLO equities and CLO equity funds principally driven by tightening credit spreads and more favorable movement in international equity markets in the current period reversing the impact of the unrealized losses associated with COVID-19 pandemic during the first quarter of 2020. The unrealized gains for the three months ended June 30, 2019 primarily comprised of unrealized gains in our hedge funds, private equity funds, fixed income funds and equity funds, partially offset by unrealized losses on CLO equities.

The following tables summarize our investment results for the six months ended June 30, 2020 and 2019:
Six Months Ended June 30, 2020
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Net investment income:
Fixed maturities and cash and cash equivalents $ 138,493 $ 2,428 $ 12,504 $ 101 $ 153,526
Equity securities 9,089 37 599 9,725
Other 15,338 281 3,147 (5,382) 13,384
Gross investment income 162,920 2,746 16,250 (5,281) 176,635
Investment expenses (6,413) (142) (923) (7,478)
Net investment income (expense) $ 156,507 $ 2,604 $ 15,327 $ (5,281) $ 169,157
Net realized and unrealized gains and losses:
Fixed maturity securities 146,714 3,047 (9,958) 139,803
Equity securities (53,625) (160) 2,045 (51,740)
Other investments 258,723 (1,028) (7,211) 250,484
Net realized and unrealized gains and losses $ 351,812 $ 1,859 $ (15,124) $ $ 338,547
Annualized income from cash and fixed maturities $ 276,986 $ 4,856 $ 25,008 $ 202 $ 307,052
Average aggregate fixed maturities and cash and cash equivalents, at cost (1)
9,344,747 255,957 1,034,472 13,179 10,648,355
Annualized Investment Book Yield 2.96 % 1.90 % 2.42 % 1.53 % 2.88 %
Total financial statement return (2)
$ 508,319 $ 4,463 $ 203 $ (5,281) $ 507,704
Average aggregate invested assets, at fair value (1)
12,655,082 287,954 1,224,865 13,179 14,181,080
Financial Statement Portfolio Return 4.02 % 1.55 % 0.02 % (40.07) % 3.58 %

115


Six Months Ended June 30, 2019
Non-life
Run-off
Atrium StarStone Other Total
(in thousands of U.S. dollars)
Net investment income:
Fixed maturities and cash and cash equivalents $ 125,805 $ 3,202 $ 15,268 $ 961 $ 145,236
Equity securities 5,781 36 985 6,802
Other investments and other 6,648 701 2,456 (5,188) 4,617
Gross investment income (expense) 138,234 3,939 18,709 (4,227) 156,655
Investment expenses (5,649) (175) (1,005) 96 (6,733)
Net investment income (expense) $ 132,585 $ 3,764 $ 17,704 $ (4,131) $ 149,922
Net realized and unrealized gains and losses:
Fixed maturity securities $ 391,771 $ 3,774 $ 24,055 $ 4,150 $ 423,750
Equity securities 25,182 547 (1,852) 23,877
Other investments 260,775 561 3,037 1,429 265,802
Net realized and unrealized gains $ 677,728 $ 4,882 $ 25,240 $ 5,579 $ 713,429
Annualized income from cash and fixed maturities $ 251,610 $ 6,404 $ 30,536 $ 1,922 $ 290,472
Average aggregate fixed maturities and cash and cash equivalents, at cost (1)
8,615,603 257,734 1,165,592 123,220 10,162,149
Annualized Investment Book Yield 2.92 % 2.48 % 2.62 % 1.56 % 2.86 %
Total financial statement return (2)
$ 810,313 $ 8,646 $ 42,944 $ 1,448 $ 863,351
Average aggregate invested assets, at fair value (1)
11,141,014 267,148 1,307,835 136,948 12,852,945
Financial Statement Portfolio Return 7.27 % 3.24 % 3.28 % 1.06 % 6.72 %
(1) These amounts are an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.
(2) This is the sum of net investment income and net realized and unrealized gains (losses) from our U.S. GAAP consolidated financial statements.
Net Investment Income:
Net investment income increased by $19.2 million for the six months ended June 30, 2020 compared to the six months ended June 30, 2019, primarily due to a $8.3 million increase in net investment income from fixed maturities and cash and cash equivalents, principally due to an increase of $486.2 million in our average aggregate fixed maturities and cash and cash equivalents. The increase in our average aggregate fixed maturities and cash and cash equivalents was primarily due to the Lyft, Aspen and AXA Group transactions in 2020 and the AmTrust RITC, Amerisure, Zurich and Maiden Re transactions in 2019. The book yield increased by 2 basis points, primarily due to interest on short-term funds held arrangements relating to the 2020 transactions.
Net Realized and Unrealized Gains (Losses):
Net realized and unrealized gains were $338.5 million for the six months ended June 30, 2020 compared to net realized and unrealized gains of $713.4 million for the six months ended June 30, 2019, a decrease of $374.9 million. Included in net realized and unrealized gains (losses) are the following items:
Net realized and unrealized gains on fixed income securities, including fixed income securities within our funds held portfolios, of $139.8 million for the six months ended June 30, 2020, compared to net realized and unrealized gains of $423.8 million for the six months ended June 30, 2019, a decrease of $283.9 million. The gains in the current period were primarily driven by low interest rates and tightening credit spreads in the second quarter of 2020, which offset the losses associated with the COVID-19 pandemic in the first quarter. The gains in 2019 were also due to tightening credit spreads;
Net realized and unrealized losses on equity securities of $51.7 million for the six months ended June 30, 2020, compared to net realized and unrealized gains $23.9 million for the six months ended June 30, 2019, a change of $75.6 million, primarily driven by the unrealized losses associated with the market volatility occurring amidst the COVID-19 pandemic during the first quarter of 2020. Gains in the prior period were primarily driven by favorable movements in international equity markets in 2019; and
116


Net realized and unrealized gains on other investments and other items of $250.5 million for the six months ended June 30, 2020, compared to realized and unrealized gains of $265.8 million for the six months ended June 30, 2019, representing a decrease of $15.3 million. The unrealized gains for the six months ended June 30, 2020 primarily comprised unrealized gains in our hedge funds and private equity funds, principally driven by declining interest rates and improving international equity markets, partially offset by unrealized losses in our equity funds, fixed income funds, CLO equities and CLO equity funds, due to recent disruption in global financial markets associated with the COVID-19 pandemic. The unrealized gains for the six months ended June 30, 2019 primarily comprised unrealized gains in our hedge funds, equity funds, fixed income funds and private equity funds, principally driven by tightening credit spreads and a more favorable movement in international equity markets in 2019.
117


Liquidity and Capital Resources

Overview
We aim to generate cash flows from our insurance operations and investments, preserve sufficient capital for future acquisitions, and develop relationships with lenders who provide borrowing capacity at competitive rates.
Our capital resources as of June 30, 2020 included ordinary shareholders' equity of $4.7 billion, preferred equity of $510.0 million, redeemable noncontrolling interest of $366.5 million classified as temporary equity, and debt obligations of $1.5 billion. The redeemable noncontrolling interest may be settled in the future in cash or our ordinary shares, at our option. Based on our current loss reserves position, our portfolios of in-force insurance and reinsurance business, and our investment positions, we believe we are well capitalized.
The following table details our capital position:
June 30, 2020 December 31, 2019 Change
(in thousands of U.S. dollars)
Ordinary shareholders' equity $ 4,676,913 $ 4,332,183 $ 344,730
Series D and E Preferred Shares 510,000 510,000
Total Enstar Shareholders' Equity (A) 5,186,913 4,842,183 344,730
Noncontrolling interest 13,553 14,168 (615)
Total Shareholders' Equity (B) 5,200,466 4,856,351 344,115
Senior Notes 842,779 842,216 563
Revolving credit facility 350,000 350,000
Term loan facility 349,243 348,991 252
Total debt (C) 1,542,022 1,191,207 350,815
Redeemable noncontrolling interest (D) 366,533 438,791 (72,258)
Total capitalization = (B) + (C) + (D) $ 7,109,021 $ 6,486,349 $ 622,672
Total capitalization attributable to Enstar = (A) + (C) $ 6,728,935 $ 6,033,390 $ 695,545
Debt to total capitalization 21.7 % 18.4 % 3.3 %
Debt and Series D and E Preferred Shares to total capitalization 28.9 % 26.2 % 2.7 %
Debt to total capitalization attributable to Enstar 22.9 % 19.7 % 3.2 %
Debt and Series D and E Preferred Shares to total capitalization available to Enstar 30.5 % 28.2 % 2.3 %
As of June 30, 2020, we had $651.9 million of cash and cash equivalents, excluding restricted cash that supports insurance operations, and included in this amount was $447.8 million held by foreign subsidiaries outside of Bermuda. Based on our group's current corporate structure with a Bermuda domiciled parent company and the jurisdictions in which we operate, if the cash and cash equivalents held by our foreign subsidiaries were to be distributed to us, as dividends or otherwise, such amounts would not be subject to incremental income taxes, however in certain circumstances withholding taxes may be imposed by some jurisdictions, including the United States. Based on existing tax laws, regulations and our current intentions, there was no accrual as of June 30, 2020 for any material withholding taxes on dividends or other distributions, as described in Note 19 - "Income Taxation" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
118


Dividends
Enstar has not historically declared a dividend on its ordinary shares.  Our strategy is to retain earnings and invest distributions from our subsidiaries back into the company. We do not currently expect to pay any dividends on our ordinary shares.
On June 28, 2018, we issued 16,000 Series D Preferred Shares with an aggregate liquidation value of $400.0 million. On November 21, 2018, we issued 4,400 Series E Preferred Shares with an aggregate liquidation value of $110.0 million. The dividends on the Series D and E Preferred Shares are non-cumulative and may be paid quarterly in arrears on the first day of March, June, September and December of each year, only when, as and if declared.
The following table details the dividends that have been declared and paid on our Series D and E Preferred Shares from January 1, 2020 to August 10, 2020:
Dividend per:
Preferred Share Series Date Declared Record Date Date Paid or Payable Preferred Share Depositary Share Total dividends paid in the six months ended June 30, 2020
(in U.S. dollars) (in thousands of U.S. dollars)
Series D February 4,
2020
February 15,
2020
March 2,
2020
$ 437.50 $ 0.43750 $ 7,000
Series E February 4,
2020
February 15,
2020
March 2,
2020
$ 437.50 $ 0.43750 1,925
Series D May 5,
2020
May 15,
2020
June 1,
2020
$ 437.50 $ 0.43750 7,000
Series E May 5,
2020
May 15,
2020
June 1,
2020
$ 437.50 $ 0.43750 1,925
Series D August 5,
2020
August 15,
2020
September 1,
2020
$ 437.50 $ 0.43750
Series E August 5,
2020
August 15,
2020
September 1,
2020
$ 437.50 $ 0.43750
$ 17,850

Any payment of common or preferred dividends must be approved by our Board of Directors. Our ability to pay common and preferred dividends is subject to certain restrictions, as described in Note 22 - "Dividend Restrictions and Statutory Financial Information" to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019.

Sources and Uses of Cash

Holding Company Liquidity
The potential sources of cash flows to Enstar as a holding company consist of cash flows from our subsidiaries including dividends, advances and loans, and interest income on loans to our subsidiaries. We also borrow under our credit and loan facilities, and we have also issued senior notes and preferred shares.
We use cash to fund new acquisitions of companies and significant new business. We also utilize cash for our operating expenses associated with being a public company and to pay dividends on our preference shares and interest and principal on loans from subsidiaries and debt obligations, including loans under our credit facilities, our 4.50% senior notes due 2022 (the “2022 Senior Notes”) and our 4.95% senior notes due 2029 (the "2029 Senior Notes” and, together with the 2022 Senior Notes, the "Senior Notes"). The Senior Notes qualify as Tier 3 capital under the eligible capital rules of the Bermuda Monetary Authority.
We may, from time to time, raise capital from the issuance of equity, debt or other securities as we continuously evaluate our strategic opportunities. We filed an automatic shelf registration statement on October 10, 2017 with the U.S. Securities and Exchange Commission ("SEC") to allow us to conduct future offerings of certain securities, if desired, including debt, equity and other securities.
119


As we are a holding company and have no substantial operations of our own, our assets consist primarily of investments in subsidiaries and our loans and advances to subsidiaries. Dividends from our insurance subsidiaries are restricted by insurance regulation, as described below.

Operating Company Liquidity
The ability of our insurance and reinsurance subsidiaries to pay dividends and make other distributions is limited by the applicable laws and regulations of the jurisdictions in which our insurance and reinsurance subsidiaries operate, including Bermuda, the United Kingdom, the United States, Australia and Continental Europe, which subject these subsidiaries to significant regulatory restrictions. These laws and regulations require, among other things, certain of our insurance and reinsurance subsidiaries to maintain minimum capital resources requirements and limit the amount of dividends and other payments that these subsidiaries can pay to us, which in turn may limit our ability to pay dividends and make other payments. For more information on these laws and regulations, see "Item 1. Business - Regulation" in our Annual Report on Form 10-K for the year ended December 31, 2019. As of June 30, 2020, all of our insurance and reinsurance subsidiaries’ capital resources levels were in excess of the minimum levels required. The ability of our subsidiaries to pay dividends is subject to certain restrictions, as described in Note 22 - "Dividend Restrictions and Statutory Financial Information" to our consolidated financial statements included within Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2019. Our subsidiaries' ability to pay dividends and make other forms of distributions may also be limited by our repayment obligations under certain of our outstanding loan facility agreements. Variability in ultimate loss payments and valuations of investments held in collateral accounts may also result in increased liquidity requirements for our subsidiaries.
In the Non-life Run-off segment, sources of funds primarily consist of cash and investment portfolios acquired on the completion of acquisitions and loss portfolio transfer reinsurance agreements. Cash balances acquired upon our purchase of insurance or reinsurance companies are classified as cash provided by investing activities. Cash acquired from loss portfolio transfer reinsurance agreements is classified as cash provided by operating activities. We expect to use funds acquired from cash and investment portfolios, collected premiums, collections from reinsurance debtors, fees and commission income, investment income and proceeds from sales and redemptions of investments to meet expected claims payments and operational expenses, with the remainder used for acquisitions and additional investments. In the Non-life Run-off segment, we generally expect negative operating cash flows to be met by positive investing cash flows; however, cash provided by operating activities was positive for the six months ended June 30, 2020 and 2019 as the proceeds from sales and maturities of trading securities exceeded cash used in the purchase of trading securities, with the net proceeds being used in the purchase of available-for-sale securities included within investing cash flows.
In the Atrium segment, we expect a net provision of cash from operations as investment income earned and collected premiums should generally be in excess of total net claim payments, losses incurred on earned premiums and operating expenses. As a result of the announcement to sell StarStone U.S. and place StarStone International into run-off, we expect net neutral cash flows from operations as net claim payments, losses incurred on earned premiums and operating expenses are met by cash inflows from investment income, collection of premium receivable and proceeds from sales and maturities of investments.
Overall, we expect our cash flows, together with our existing capital base and cash and investments acquired on the acquisition of insurance and reinsurance subsidiaries, to be sufficient to meet cash requirements and to operate our business.

120


Cash Flows
The following table summarizes our consolidated cash flows provided by (used in) operating, investing and financing activities:
Six Months Ended June 30,
2020 2019 Change
(in thousands of U.S. dollars)
Cash provided by (used in):
Operating activities $ 849,161 $ 121,842 $ 727,319
Investing activities (1,156,139) (148,831) (1,007,308)
Financing activities 319,624 605,769 (286,145)
Effect of exchange rate changes on cash 4,526 (6,436) 10,962
Net increase in cash and cash equivalents 17,172 572,344 (555,172)
Cash and cash equivalents, beginning of period 971,349 901,996 69,353
Cash and cash equivalents, end of period $ 988,521 $ 1,474,340 $ (485,819)

Details of our consolidated cash flows are included in "Item 1. Financial Statements - Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019."
Six Months Ended June 30: Cash and cash equivalents increased by $17.2 million during the six months ended June 30, 2020 compared to $572.3 million during the six months ended June 30, 2019.
For the six months ended June 30, 2020, cash and cash equivalents increased by $17.2 million, as cash provided by operating and financing activities of $849.2 million and $319.6 million, respectively, was partially offset by cash used in investing activities of $1,156.1 million. Cash provided by operations was largely the result of proceeds from net sales and maturities of trading securities. Cash provided by financing activities for the six months ended June 30, 2020 was primarily attributable to the net debt obligations drawdown of $350.0 million under the EGL Revolving Credit Facility, which was utilized to provide $150.0 million in funding for significant new business and to provide $200.0 million of additional liquidity to the Company to maximize financial flexibility following the recent disruption in global financial markets associated with the COVID-19 pandemic. During the six months ended June 30, 2020, we repurchased 92,510 shares for $12.5 million, and paid $17.9 million of dividends on preferred shares, which are cash outflows within cash provided by financing activities. Cash used in investing activities for the six months ended June 30, 2020 primarily related to the net purchases of other investments of $520.2 million and the net purchases of AFS securities of $602.2 million.
For the six months ended June 30, 2019, cash and cash equivalents increased by $572.3 million, as cash provided by operating and financing activities of $121.8 million and $605.8 million, respectively, was partially offset by cash used in investing activities of $148.8 million. Cash used in investing activities for the six months ended June 30, 2019 was primarily related to net purchases of other investments of $199.2 million. Cash provided by operations was largely a result of timing of paid losses. Cash provided by financing activities for the six months ended June 30, 2019 was primarily attributable to an increase in debt obligations of $635.4 million, which included short-term funding under the EGL Revolving Credit Facility in relation to temporary additional collateral for a Part VII transfer in the United Kingdom that was subsequently repaid in July 2019.

Investable Assets
We define investable assets as the sum of total investments, cash and cash equivalents, restricted cash and cash equivalents and funds held. Investable assets were $15.6 billion as of June 30, 2020 as compared to $14.1 billion as of December 31, 2019, an increase of 10.8%. The increase was primarily due to assets acquired in relation to the Lyft, Aspen and AXA Group transactions and unrealized gains on investments.
For information regarding our investments strategy, portfolio and results, refer to "Investable Assets" above.

Reinsurance Balances Recoverable
As of June 30, 2020 and December 31, 2019, we had reinsurance balances recoverable on paid and unpaid losses of $2.1 billion and $2.2 billion, respectively.
121


Our insurance and reinsurance run-off subsidiaries and portfolios, prior to acquisition, used retrocessional agreements to reduce their exposure to the risk of insurance and reinsurance assumed. On an annual basis, both Atrium and StarStone have purchased a tailored outwards reinsurance program designed to manage their risk profiles. The majority of Atrium’s and StarStone's third-party reinsurance cover is with highly rated reinsurers or is collateralized by letters of credit.
We remain liable to the extent that retrocessionaires do not meet their obligations under these agreements, and therefore, we evaluate and monitor concentration of credit risk among our reinsurers. Provisions are made for amounts considered potentially uncollectible.
For further information regarding our unaudited condensed reinsurance balances recoverable, refer to Note 7 - "Reinsurance Balances Recoverable on Paid and Unpaid Losses" in the notes to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

Debt Obligations
We utilize debt financing and loan facilities primarily for acquisitions, significant new business and, from time to time, for general corporate purposes. For information regarding our debt arrangements, refer to Note 14 - "Debt Obligations and Credit Facilities" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
Our debt obligations as of June 30, 2020 and December 31, 2019 were $1.5 billion and $1.2 billion, respectively, as detailed in the below table:
Facility Origination Date Term June 30, 2020 December 31, 2019
4.50% Senior Notes due 2022 March 10, 2017 5 years $ 348,886 $ 348,616
4.95% Senior Notes due 2029 May 28, 2019 10 years 493,893 493,600
Total Senior Notes 842,779 842,216
EGL Revolving Credit Facility August 16, 2018 5 years 350,000
2018 EGL Term Loan Facility December 27, 2018 3 years 349,243 348,991
Total debt obligations $ 1,542,022 $ 1,191,207

During the six months ended June 30, 2020, we utilized $364.0 million and repaid $14.0 million under our facilities. The revolving credit facility was utilized to provide funding of $150.0 million for significant new business as described in Note 3 - "Significant New Business" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q and to provide $200.0 million of additional liquidity to the Company to maximize financial flexibility following the recent disruption in global financial markets associated with the COVID-19 pandemic.
On August 16, 2018, we and certain of our subsidiaries, as borrowers and guarantors, entered into a five-year unsecured $600.0 million revolving credit agreement. The credit agreement expires in August 2023 and we have the option to increase the commitments under the facility by up to an aggregate of $400.0 million. As of June 30, 2020, there was $250.0 million of available unutilized capacity under this facility. We are in compliance with the covenants of the facility. Subsequent to June 30, 2020, we have neither borrowed nor repaid any additional amounts under the facility, leaving the unutilized capacity under this facility at $250.0 million.
On December 27, 2018, we entered into and fully utilized a three-year $500.0 million unsecured term loan (the "2018 EGL Term Loan Facility"). During 2019, we repaid $150.0 million of principal on the facility, bringing the outstanding loan amount to $349.2 million, which includes unamortized issuance costs of $0.8 million, as of June 30, 2020.
For information regarding our Senior Notes, refer to Note 14 - "Debt Obligations and Credit Facilities" in the notes to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

Letters of Credit
We utilize unsecured and secured letters of credit to support certain of our insurance and reinsurance performance obligations.
122


Funds at Lloyd's
We have an unsecured letter of credit agreement for Funds at Lloyd's (the "FAL Facility") to issue up to $375.0 million of letters of credit, with provision to increase the facility by an additional $25.0 million up to an aggregate amount of $400.0 million, subject to lenders approval. On November 6, 2019, we amended and restated the FAL Facility to extend its term by one year. The FAL Facility is available to satisfy our Funds at Lloyd's requirements and expires in 2023. As of June 30, 2020 and December 31, 2019, our combined Funds at Lloyd's were comprised of cash and investments of $574.1 million and $639.3 million, respectively, and unsecured letters of credit of $252.0 million as of both dates.
$120.0 million Letter of Credit Facility
We use this facility to support certain reinsurance collateral obligations of our subsidiaries. On December 6, 2019, we reduced the facility size from $170.0 million to $120.0 million. Pursuant to the facility agreement, we have the option to increase commitments under the facility by an additional $60.0 million. As of both June 30, 2020 and December 31, 2019, we had issued an aggregate amount of letters of credit under this facility of $115.3 million.
$800.0 million Syndicated Letter of Credit Facility
During 2019, we entered into an unsecured $760.0 million letter of credit facility agreement, most recently amended on June 3, 2020. On August 4, 2020, we exercised our option to increase the commitments available under the facility by an aggregate amount of $40.0 million, bringing the total size of the facility to $800.0 million. The facility is used to post letters of credit to collateralize reinsurance performance obligations to various parties, including $447.4 million relating to the reinsurance transaction with Maiden Reinsurance Ltd. ("Maiden Re Bermuda"). As of June 30, 2020 and December 31, 2019, we had issued an aggregate amount of letters of credit under this facility of $594.1 million and $608.0 million, respectively.
$65.0 million Letter of Credit Facility
On August 4, 2020, we entered into a $65.0 million secured letter of credit facility agreement pursuant to which we issued a letter of credit in the amount of approximately $61.0 million to collateralize a portion of our reinsurance performance obligations relating to our novation transaction with Hannover Re, which we completed on August 6, 2020, as discussed in Note 3 - "Significant New Business" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
123


Contractual Obligations
The following table summarizes, as of June 30, 2020, our future payments under contractual obligations and estimated payments for losses and LAE and policy benefits by expected payment date and updates the table on page 89 of our Annual Report on Form 10-K for the year ended December 31, 2019. The table excludes short-term liabilities and includes only obligations that are expected to be settled in cash.
Total Less than or equal to 1 year More than 1 year - less than or equal to 3 years More than 3 years - less than or equal to 5 years More than 5 years - less than or equal to 10 years More than
10 years
(in millions of U.S. dollars)
Operating Activities
Estimated gross reserves for losses and LAE (1)
Asbestos $ 1,779.9 $ 154.8 $ 267.2 $ 220.2 $ 350.9 $ 786.8
Environmental 324.0 36.4 62.5 50.0 71.2 103.9
General Casualty 1,651.4 189.8 263.3 291.5 676.9 229.9
Workers' compensation/personal accident 2,116.1 173.2 281.5 338.9 478.5 844.0
Marine, aviation and transit 390.6 117.2 121.5 57.1 50.5 44.3
Construction defect 115.9 31.9 42.0 20.7 12.5 8.8
Professional indemnity/ Directors & Officers 990.3 205.5 261.2 155.0 239.1 129.5
Motor 995.5 328.6 371.1 78.7 78.4 138.7
Property 145.1 58.2 47.3 18.3 12.3 9.0
Other 403.7 110.7 87.8 53.4 63.7 88.1
Total Non-Life Run-off 8,912.5 1,406.3 1,805.4 1,283.8 2,034.0 2,383.0
Atrium 233.7 91.9 84.8 34.3 19.0 3.7
StarStone International (Non-U.S.) 1,303.9 446.5 463.8 205.6 151.9 36.1
Other 24.7 6.0 8.0 3.2 7.5
ULAE 368.1 69.1 87.2 52.6 62.5 96.7
Estimated gross reserves for losses and LAE (1)
10,842.9 2,019.8 2,449.2 1,579.5 2,274.9 2,519.5
Held for sale liabilities: StarStone U.S. gross reserves for losses and LAE (2)
838.7 246.5 292.0 153.6 109.7 36.9
Operating lease obligations (3)
48.5 11.2 16.6 10.7 8.0 2.0
Investing Activities
Investment commitments to private equity funds 544.7 266.7 197.1 49.6 31.3
Investment commitments to equity method investments 76.5 76.5
Financing Activities
Loan repayments (including estimated interest payments) 1,834.9 53.7 782.4 399.8 599.0
Total $ 14,186.2 $ 2,674.4 $ 3,737.3 $ 2,193.2 $ 3,022.9 $ 2,558.4
(1) The reserves for losses and LAE represent management’s estimate of the ultimate cost of settling losses. The estimation of losses is based on various complex and subjective judgments. Actual losses paid may differ, perhaps significantly, from the reserve estimates reflected in our financial statements. Similarly, the timing of payment of our estimated losses is not fixed and there may be significant changes in actual payment activity. The assumptions used in estimating the likely payments due by period are based on our historical claims payment experience and industry payment patterns, but due to the inherent uncertainty in the process of estimating the timing of such payments, there is a risk that the amounts paid in any such period can be significantly different from the amounts disclosed above. The amounts in the above table represent our estimates of known liabilities as of June 30, 2020 and do not take into account corresponding reinsurance balance recoverable amounts that would be due to us. Furthermore, certain of the reserves included in the unaudited condensed consolidated financial statements as of June 30, 2020 were acquired by us and initially recorded at fair value with subsequent amortization, whereas the expected payments by period in the table above are the estimated payments at a future time and do not reflect the fair value adjustment in the amount payable.
(2) In connection with the sale of StarStone U.S. disclosed within Note 4 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations," these liabilities are classified as held-for-sale as at June 30, 2020. Our Non-life Run-off segment will be assuming these liabilities, together with the associated reinsurance asset, via a loss portfolio transfer reinsurance agreement which is expected to occur contemporaneously with the sale of StarStone U.S. in the second half of 2020, subject to regulatory and other closing conditions.
(3) The variance of $0.7 million between our operating lease obligations disclosure of $48.5 million included within our contractual obligations table above and our undiscounted total lease payments of $47.8 million disclosed within Note 21 - "Commitments and Contingencies", is attributable to lease liabilities related to our short-term leases which are not included in our lease disclosures in Note 21 and offsetting lease liabilities on premises we have sub-leased to third-parties and which are excluded from the operating lease obligations disclosure on the table above.
124


In addition to the contractual obligations in the table above, we also have the right to purchase the RNCI from the RNCI holders at certain times in the future (each such right, a "call right") and the RNCI holders have the right to sell their RNCI to us at certain times in the future (each such right, a "put right"). The RNCI rights are described in Note 20 - "Related Party Transactions" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.
For additional information relating to our commitments and contingencies, see Note 21 - "Commitments and Contingencies" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

Off-Balance Sheet Arrangements
At June 30, 2020, we did not have any off-balance sheet arrangements, as defined by Item 303(a)(4) of Regulation S-K.

Critical Accounting Policies
Our critical accounting policies are discussed in Management's Discussion and Analysis of Results of Operations and Financial Condition contained in our Annual Report on Form 10-K for the year ended December 31, 2019. Except as discussed above, in the updates included in "Note 1 - Significant Accounting Policies" to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q, our critical accounting policies have not materially changed.

Cautionary Statement Regarding Forward-Looking Statements
This quarterly report and the documents incorporated by reference herein contain statements that constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, with respect to our financial condition, results of operations, business strategies, operating efficiencies, competitive positions, growth opportunities, plans and objectives of our management, as well as the markets for our securities and the insurance and reinsurance sectors in general. Statements that include words such as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe," "would," "should," "could," "seek," "may" and similar statements of a future or forward-looking nature identify forward-looking statements for purposes of the federal securities laws or otherwise. All forward-looking statements are necessarily estimates or expectations, and not statements of historical fact, reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward looking statements should, therefore, be considered in light of various important factors, including those set forth in this quarterly report and in our Annual Report on Form 10-K for the year ended December 31, 2019. These factors include:
risks associated with implementing our business strategies and initiatives;
the adequacy of our loss reserves and the need to adjust such reserves as claims develop over time;
risks relating to our acquisitions, including our ability to evaluate opportunities, successfully price acquisitions, address operational challenges, support our planned growth and assimilate acquired companies into our internal control system in order to maintain effective internal controls, provide reliable financial reports and prevent fraud;
risks relating to our active underwriting businesses, including unpredictability and severity of catastrophic and other major loss events, failure of risk management and loss limitation methods, the risk of a ratings downgrade or withdrawal, and cyclicality of demand and pricing in the insurance and reinsurance markets;
risks relating to the performance of our investment portfolio and our ability to structure our investments in a manner that recognizes our liquidity needs;
changes and uncertainty in economic conditions, including interest rates, inflation, currency exchange rates, equity markets and credit conditions, which could affect our investment portfolio, our ability to finance future acquisitions and our profitability;
risks relating to the evolving COVID-19 global pandemic and the significant disruption and economic and financial turmoil that has taken place as a result of government measures to protect public health;
125


the risk that ongoing or future industry regulatory developments will disrupt our business, affect the ability of our subsidiaries to operate in the ordinary course or to make distributions to us, or mandate changes in industry practices in ways that increase our costs, decrease our revenues or require us to alter aspects of the way we do business;
risks relating to the variability of statutory capital requirements and the risk that we may require additional capital in the future, which may not be available or may be available only on unfavorable terms;
risks relating to the availability and collectability of our reinsurance;
losses due to foreign currency exchange rate fluctuations;
increased competitive pressures, including the consolidation and increased globalization of reinsurance providers;
emerging claim and coverage issues;
lengthy and unpredictable litigation affecting the assessment of losses and/or coverage issues;
loss of key personnel;
the ability of our subsidiaries to distribute funds to us and the resulting impact on our liquidity;
our ability to comply with covenants in our debt agreements;
changes in our plans, strategies, objectives, expectations or intentions, which may happen at any time at management’s discretion;
operational risks, including system, data security or human failures and external hazards;
risks relating to our ability to obtain regulatory approvals, including the timing, terms and conditions of any such approvals, and to satisfy other closing conditions in connection with our acquisition agreements, which could affect our ability to complete acquisitions;
risks relating to our subsidiaries with liabilities arising from legacy manufacturing operations;
tax, regulatory or legal restrictions or limitations applicable to us or the insurance and reinsurance business generally;
changes in tax laws or regulations applicable to us or our subsidiaries, or the risk that we or one of our non-U.S. subsidiaries become subject to significant, or significantly increased, income taxes in the United States or elsewhere;
changes in Bermuda law or regulation or the political stability of Bermuda; and
changes in accounting policies or practices.
The factors listed above should be not construed as exhaustive and should be read in conjunction with the Risk Factors that are included in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2019. We undertake no obligation to publicly update or review any forward looking statement, whether to reflect any change in our expectations with regard thereto, or as a result of new information, future developments or otherwise, except as required by law.
126


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The following risk management discussion and the estimated amounts generated from sensitivity analysis presented are forward-looking statements of market risk assuming certain market conditions occur. Future results may differ materially from these estimated results due to, among other things, actual developments in the global financial markets, changes in the composition of our investment portfolio, or changes in our business strategies. The results of analysis we use to assess and mitigate risk are not projections of future events or losses. See "Cautionary Statement Regarding Forward-Looking Statements" for additional information regarding our forward-looking statements.
We are principally exposed to four types of market risk: interest rate risk, credit risk, equity price risk and foreign currency risk. Our policies to address these risks in 2020 are not materially different than those used in 2019, other than as described herein, and, based on our current knowledge and expectations, we do not currently anticipate significant changes in our market risk exposures or in how we will manage those exposures in future reporting periods.

Interest Rate and Credit Spread Risk
Interest rate risk is the price sensitivity of a security to changes in interest rates. Credit spread risk is the price sensitivity of a security to changes in credit spreads. Our investment portfolio and funds held - directly managed includes fixed maturity and short-term investments, whose fair values will fluctuate with changes in interest rates and credit spreads. We attempt to maintain adequate liquidity in our fixed maturity investments portfolio with a strategy designed to emphasize the preservation of our invested assets and provide sufficient liquidity for the prompt payment of claims and contract liabilities, as well as for settlement of commutation payments. We also monitor the duration and structure of our investment portfolio.
The following table summarizes the aggregate hypothetical change in fair value from an immediate parallel shift in the treasury yield curve, assuming credit spreads remain constant, in our fixed maturity and short-term investments portfolio classified as trading and AFS, our funds held directly managed portfolio, our fixed income funds and our fixed income exchange-traded funds, and excludes investments classified as held for sale:
Interest Rate Shift in Basis Points
As of June 30, 2020 -100 -50 +50 +100
(in millions of U.S. dollars)
Total Market Value $ 10,036 $ 9,778 $ 9,512 $ 9,249 $ 9,014
Market Value Change from Base 5.5 % 2.8 % % (2.8) % (5.2) %
Change in Unrealized Value $ 524 $ 266 $ $ (263) $ (498)
As of December 31, 2019 -100 -50 +50 +100
Total Market Value $ 10,141 $ 9,893 $ 9,648 $ 9,415 $ 9,193
Market Value Change from Base 5.1 % 2.5 % % (2.4) % (4.7) %
Change in Unrealized Value $ 493 $ 245 $ $ (233) $ (455)

Actual shifts in interest rates may not change by the same magnitude across the maturity spectrum or on an individual security and, as a result, the impact on the fair value of our fixed maturity securities, short-term investments, funds held - directly managed and fixed income exchange-traded fund may be materially different from the resulting change in value indicated in the tables above.
127


The following table summarizes the aggregate hypothetical change in fair value from an immediate parallel shift in credit spreads assuming interest rates remain fixed, in our fixed maturity and short-term investments portfolio classified as trading and AFS, our funds held directly managed portfolio, our fixed income funds and our fixed income exchange-traded funds, and excludes investments classified as held for sale:
Credit Spread Shift in Basis Points
As at June 30, 2020 +50 +100
(in millions of U.S. dollars)
Total Market Value $ 9,512 $ 9,261 $ 9,022
Market Value Change from Base (2.6) % (5.2) %
Change in Unrealized Value $ (251) $ (490)
As at December 31, 2019 +50 +100
Total Market Value $ 9,648 $ 9,429 $ 9,218
Market Value Change from Base (2.3) % (4.5) %
Change in Unrealized Value $ (219) $ (430)

Credit Risk
Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with contractual terms of the instrument or contract. We are exposed to direct credit risk primarily within our portfolios of fixed maturity and short-term investments, and through customers, brokers and reinsurers in the form of premiums receivable, reinsurance balances recoverable on paid and unpaid losses, respectively, as discussed below.

Fixed Maturity and Short-Term Investments
As a holder of $8.8 billion of fixed maturity and short-term investments, we also have exposure to credit risk as a result of investment ratings downgrades or issuer defaults. In an effort to mitigate this risk, our investment portfolio consists primarily of investment grade-rated, liquid, fixed maturity investments of short-to-medium duration and mutual funds. A table of credit ratings for our fixed maturity and short-term investments is in Note 5 - "Investments" in the notes to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q. As of June 30, 2020, 38.6% of our fixed maturity and short-term investment portfolio was rated AA or higher by a major rating agency (December 31, 2019: 39.1%) with 3.3% rated lower than BBB- (December 31, 2019: 4.3%). The portfolio as a whole, including cash, restricted cash, fixed maturity and short term investments and funds held - directly managed, had an average credit quality rating of A+ as of June 30, 2020 (December 31, 2019: A+).
In addition, we manage our portfolio pursuant to guidelines that follow what we believe are prudent standards of diversification. The guidelines limit the allowable holdings of a single issue and issuers and, as a result, we believe we do not have significant concentrations of credit risk.
A summary of our fixed maturity and short-term investments by credit rating is as follows:
Credit rating June 30, 2020 December 31, 2019 Change
AAA 26.0 % 26.0 % %
AA 12.6 % 13.1 % (0.5) %
A 36.2 % 34.5 % 1.7 %
BBB 21.6 % 21.9 % (0.3) %
Non-investment grade 3.3 % 4.3 % (1.0) %
Not rated 0.3 % 0.2 % 0.1 %
Total 100.0 % 100.0 %
Average credit rating A+ A+
128


Reinsurance Balances Recoverable
We have exposure to credit risk as it relates to our reinsurance balances recoverable on paid and unpaid losses. Our insurance subsidiaries remain liable to the extent that retrocessionaires do not meet their contractual obligations and, therefore, we evaluate and monitor concentration of credit risk among our reinsurers. A discussion of our reinsurance balances recoverable is in Note 7 - "Reinsurance Balances Recoverable on Paid and Unpaid Losses" in the notes to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q.

Funds Held
Under funds held arrangements, the reinsured company has retained funds that would otherwise have been remitted to our reinsurance subsidiaries. The funds balance is credited with investment income and losses payable are deducted. We are subject to credit risk if the reinsured company is unable to honor the value of the funds held balances, such as in the event of insolvency. However, we generally have the contractual ability to offset any shortfall in the payment of the funds held balances with amounts owed by us to the reinsured for losses payable and other amounts contractually due. Our funds held are shown under two categories on the consolidated balance sheets, where funds held upon which we receive the underlying portfolio economics are shown as "Funds held - directly managed", and funds held where we receive a fixed crediting rate are shown as "Funds held by reinsured companies." Both types of funds held are subject to credit risk. We routinely monitor the creditworthiness of reinsured companies with whom we have funds held arrangements. As of June 30, 2020, we had a significant concentration of $965.5 million with one reinsured company which has financial strength credit ratings of A+ from A.M. Best and AA from Standard & Poor's.

Equity Price Risk
Our portfolio of equity investments, excluding our fixed income exchange-traded funds but including the equity funds and call options on equities included in other investments (collectively, "equities at risk"), has exposure to equity price risk, which is the risk of potential loss in fair value resulting from adverse changes in stock prices. Our fixed income exchange-traded funds are excluded from the below analysis and have been included within the interest rate and credit spread risk analysis, as the exchange-traded funds are part of our fixed income investment strategy. Our global equity portfolio is correlated with a blend of the S&P 500 and MSCI World indices, and changes in this blend of indices would approximate the impact on our portfolio. The following table summarizes the aggregate hypothetical change in fair value from a 10% decline in the overall market prices of our equities at risk:
June 30, 2020 December 31, 2019 Change
(in millions of U.S. dollars)
Publicly traded equity investments in common and preferred stocks $ 274.4 $ 327.9 $ (53.5)
Privately held equity investments in common and preferred stocks 271.0 265.8 5.2
Private equity funds 315.1 323.5 (8.4)
Equity funds 368.3 410.1 (41.8)
Call options on equity 0.1 (0.1)
Fair value of equities at risk $ 1,228.8 $ 1,327.4 $ (98.6)
Impact of 10% decline in fair value $ 122.9 $ 132.7 $ (9.8)

In addition to the above, as of June 30, 2020, we had investments of $1.8 billion (December 31, 2019: $1.1 billion) in hedge funds, included within our other investments, at fair value, that have exposure, among other items, to equity price risk.
129


Foreign Currency Risk
The table below summarizes our net exposures to foreign currencies:
AUD CAD EUR GBP Other Total
As of June 30, 2020 (in millions of U.S. dollars)
Total net foreign currency exposure $ (0.2) $ 7.3 $ (5.8) $ 30.0 $ (10.0) $ 21.3
Pre-tax impact of a 10% movement of the U.S. dollar (1)
$ $ 0.7 $ (0.6) $ 3.0 $ (1.0) $ 2.1
As of December 31, 2019
Total net foreign currency exposure $ 20.2 $ (10.6) $ 12.9 $ (11.9) $ 0.6 $ 11.2
Pre-tax impact of a 10% movement of the U.S. dollar (1)
$ 2.0 $ (1.1) $ 1.3 $ (1.2) $ 0.1 $ 1.1
(1) Assumes 10% change in the U.S. dollar relative to other currencies.

Through our subsidiaries located in various jurisdictions, we conduct our insurance and reinsurance operations in a variety of non-U.S. currencies. We have the following exposures to foreign currency risk:
Transaction Risk: The functional currency for the majority of our subsidiaries is the U.S. dollar. Within these entities, any fluctuations in foreign currency exchange rates relative to the U.S. dollar has a direct impact on the valuation of our assets and liabilities denominated in other currencies. All changes in foreign exchange rates, with the exception of non-U.S. dollar AFS investments, are recognized in our consolidated statements of earnings. Changes in foreign exchange rates relating to non-U.S. dollar AFS investments are recorded in accumulated other comprehensive income (loss) in shareholders’ equity. Our subsidiaries with non-U.S. dollar functional currencies are also exposed to fluctuations in foreign currency exchange rates relative to their own functional currency.
Translation Risk: Our net investments in certain European, British, and Australian subsidiaries have functional currencies of the Euro, British pound and Australian dollar, respectively. The foreign exchange gain or loss resulting from the translation of their financial statements from their respective functional currency into U.S. dollars is recorded in the cumulative translation adjustment account, which is a component of accumulated other comprehensive income (loss) in shareholders’ equity.
Our foreign currency policy is to broadly manage, where possible, our foreign currency risk by:
Seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies with assets that are denominated in such currencies, subject to regulatory constraints.
Selectively utilizing foreign currency forward contracts to mitigate foreign currency risk.
Borrowing to hedge the foreign currency exposure on our net investment in certain of our subsidiaries whose functional currency is denominated in non-U.S. dollars, which is referred to as a non-derivative hedge.
The instruments we use to manage foreign currency risk are discussed in Note 6 - "Derivatives and Hedging Instruments" in the notes to our unaudited condensed consolidated financial statements included within Item 1 of this Quarterly Report on Form 10-Q. To the extent our foreign currency exposure is not matched or hedged, we may experience foreign exchange losses or gains, which would be reflected in our consolidated results of operations and financial condition.

Effects of Inflation
Inflation may have a material effect on our consolidated results of operations by its effect on our assets and our liabilities. Inflation could lead to higher interest rates, resulting in a decrease in the market value of our fixed maturity portfolio. We may choose to hold our fixed maturity investments to maturity, which would result in the unrealized gains or losses accreting back over time. Inflation may also affect the value of certain of our liabilities, primarily our estimate for losses and LAE, such as our cost of claims which includes medical treatments, litigation costs and judicial awards. Although our estimate for losses and LAE is established to reflect the likely payments in the future, we would be subject to the risk that inflation could cause these amounts to be greater than the current estimate for losses and LAE. We seek to take this into account when setting reserves and pricing new business.
130


ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of June 30, 2020. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that we maintained effective disclosure controls and procedures to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and timely reported as specified in the rules and forms of the U.S. Securities and Exchange Commission and is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the six months ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
131


PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For a discussion of legal proceedings, see Note 21 - "Commitments and Contingencies" in the notes to our unaudited condensed consolidated financial statements included in Item 1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

ITEM 1A. RISK FACTORS
Our results of operations and financial condition are subject to numerous risks and uncertainties described in “Risk Factors” included in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019. The risk factors identified therein have not materially changed, except as set forth below:
The impact of COVID-19 and related risks has adversely affected our business, results of operations, financial condition, and liquidity and capital resources, and any future impact on our business is difficult to predict at this time.
The ongoing COVID-19 pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Our results of operations, financial condition, and liquidity and capital resources have been adversely impacted by the COVID-19 pandemic, and the future impact of the pandemic is difficult to predict. In particular, we believe we are subject to the following risks related to the COVID-19 pandemic:
Investments . Due in large part to the uncertainty caused by the COVID-19 pandemic in global financial markets, our investment portfolio has experienced significant volatility. In the first quarter of 2020, we experienced significant unrealized losses (largely due to widening credit spreads on fixed income investments and changes in the fair value of our equity investments), heightened credit risk, and declines in yields on our fixed income investments. Although these unrealized losses reversed during the second quarter, our investment portfolios may continue to experience significant volatility and could be adversely impacted by unfavorable market conditions caused by the COVID-19 pandemic, which could cause continued volatility in our results of operations and negatively impact our financial condition.
Debt and Equity Financing. As a result of the economic conditions caused by the COVID-19 pandemic, capital and credit markets continue to experience volatility that could negatively impact our ability to raise additional capital through the debt or equity markets or through bank or other debt financing. If we are unable obtain adequate capital on suitably attractive terms, or at all, we may be unable to implement our future growth or operating plans and our business, financial condition, and results of operations could be materially adversely affected.
Liquidity. Due to the change in fair value of our investments caused by the COVID-19 pandemic, we and our insurance and reinsurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity. Due to current market conditions, we may not be able to secure letters of credit to satisfy certain of our existing collateral obligations, including through the extension or renewal of existing facilities, or such letters of credit may only be available on unfavorable terms. In addition, we may experience a reduction in the amount of available distribution or dividend capacity from our regulated insurance and reinsurance subsidiaries, which would also reduce liquidity.
Acquisitions and New Business. O ur ability to complete acquisitions of companies and portfolios of insurance and reinsurance business in our Non-life Run-off segment may be adversely impacted by circumstances created by the COVID-19 pandemic, including as a result of the limited availability of external financing or funding to acquire new business, the willingness of counterparties to engage in transactions in light of uncertain economic conditions or financial stress, and the additional scrutiny of regulators whose approval is required to complete transactions due to the uncertain economic conditions, as well as other factors that we are unable to predict.
Active Underwriting Segments. We have experienced underwriting losses relating to the COVID-19 pandemic in our Atrium and StarStone segments across various lines of business. Although we have established reserves against these losses as of June 30, 2020, given the uncertainty surrounding the COVID-19 pandemic and its impact on the insurance industry, our preliminary estimates of losses and loss adjustment expenses and estimates of reinsurance recoverable arising from the COVID-19 pandemic may materially change. Unanticipated issues relating to claims and coverage may emerge, which could adversely affect our business by increasing the scope of coverage beyond our intent and/or increasing the frequency and severity of claims.
132


Operational Disruptions. We rely on the continued productivity of our senior executive team, our employees, and our agents, brokers, third party administrators, suppliers and outsourcing providers to carry out our operations. If any of these people are unable to continue to work productively, or at all, due to illness, government restrictions, remote working conditions, or other disruptions related to the COVID-19 pandemic, our ability to conduct our operations may be adversely affected. In addition, like many other companies, the vast majority of our employees are working remotely, and we are therefore more dependent on our information technology systems and the continued access by our employees and service providers to reliable internet and telecommunications systems. We will be adversely affected if these systems do not function effectively or are disrupted due to heightened demand, cybersecurity attacks and data security incidents, or for any other related reason. These types of operational disruptions that impact our people and/or systems and others we may not foresee, would negatively impact our ability to settle claims efficiently, complete acquisitions, integrate our acquired businesses, manage our investments, or otherwise conduct our business.
Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. We therefore may not be able to accurately predict the longer-term effects that the COVID-19 pandemic may have on our financial condition or results of operations. To the extent the COVID-19 pandemic adversely affects our financial condition or results of operations, it may also have the effect of heightening additional risks described in Part I, Item 1A, Risk Factors, of our Annual Report on Form 10-K for the year ended December 31, 2019.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table provides information about ordinary shares acquired by the Company during the three months ended June 30, 2020.
Period
Total Number of Shares Purchased (1)
Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares that May Yet be Purchased Under the Program
April 1, 2020 - April 30, 2020 $ $ $
May 1, 2020 - May 31, 2020 $ $ $
June 1, 2020 - June 30, 2020 2,163 $ 157.58 $ $
2,163 $
(1) Consists of shares withheld from employees in order to facilitate the payment of withholding taxes on restricted shares granted pursuant to our equity incentive plan. The price for the shares is their fair market value, as determined by reference to the closing price of our ordinary shares on the vesting date.

133


ITEM 6. EXHIBITS
Exhibit No. Description
Memorandum of Association of Enstar Group Limited (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-K/A filed on May 2, 2011).
Fifth Amended and Restated Bye-Laws of Enstar Group Limited (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed on June 13, 2019).
Certificate of Designations of Series C Participating Non-Voting Perpetual Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed on June 17, 2016).
Certificate of Designations of 7.00% fixed-to-floating rate perpetual non-cumulative preference shares, Series D (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K filed on June 27, 2018).
Certificate of Designations of 7.00% perpetual non-cumulative preference shares, Series E (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K filed on November 21, 2018).
Second Amendment to Letter of Credit Facility Agreement, dated as of June 3, 2020, by and among Enstar Group Limited and certain of its subsidiaries, National Australia Bank Limited, London Branch, National Australia Bank Limited, The Bank of Nova Scotia and each of the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on June 9, 2020).
Stock Purchase Agreement, dated as of June 10, 2020, by and among StarStone Finance Limited, Core Specialty Insurance Holdings, Inc. and North Bay Holdings Limited (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on June 11, 2020).
Transition Agreement, dated July 17, 2020, by and between Enstar Group Limited and Guy Bowker (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on July 17, 2020).
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Calculation Linkbase
101.LAB XBRL Taxonomy Extension Label Linkbase
101.DEF XBRL Taxonomy Extension Definition Linkbase
101.PRE XBRL Taxonomy Extension Presentation Linkbase
104 Cover page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
________________________________
*  filed herewith
** furnished herewith
134


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on August 10, 2020.
ENSTAR GROUP LIMITED
By:
/ S / GUY BOWKER
Guy Bowker
Chief Financial Officer, Authorized Signatory, Principal Financial Officer and Principal Accounting Officer

135
TABLE OF CONTENTS
Part I Financial InformationItem 1. Financial StatementsNote 21 - "commitments and Contingencies" For Additional Information Regarding RnciItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 6. Exhibits

Exhibits

3.1 Memorandum of Association of Enstar Group Limited (incorporated by reference to Exhibit 3.1 of the Companys Form 10-K/A filed on May 2, 2011). 3.2 Fifth Amended and Restated Bye-Laws of Enstar Group Limited (incorporated by reference to Exhibit 3.1 of the Companys Form 8-K filed on June 13, 2019). 3.3 Certificate of Designations of Series C Participating Non-Voting Perpetual Preferred Stock (incorporated by reference to Exhibit 3.1 of the Companys Form 8-K filed on June 17, 2016). 3.4 Certificate of Designations of 7.00% fixed-to-floating rate perpetual non-cumulative preference shares, Series D (incorporated by reference to Exhibit 4.1 of the Companys Form 8-K filed on June 27, 2018). 3.5 Certificate of Designations of 7.00% perpetual non-cumulative preference shares, Series E (incorporated by reference to Exhibit 4.1 of the Companys Form 8-K filed on November 21, 2018). 10.1 Second Amendment to Letter of Credit Facility Agreement, dated as of June 3, 2020, by and among Enstar Group Limited and certain of its subsidiaries, National Australia Bank Limited, London Branch, National Australia Bank Limited, The Bank of Nova Scotia and each of the lenders party thereto (incorporated by reference to Exhibit 10.1 of the Companys Form 8-K filed on June 9, 2020). 10.2 Stock Purchase Agreement, dated as of June 10, 2020, by and among StarStone Finance Limited, Core Specialty Insurance Holdings, Inc. and North Bay Holdings Limited (incorporated by reference to Exhibit 10.1 of the Companys Form 8-K filed on June 11, 2020). 10.3 Transition Agreement, dated July 17, 2020, by and between Enstar Group Limited and Guy Bowker (incorporated by reference to Exhibit 10.1 of the Companys Form 8-K filed on July 17, 2020). 31.1* Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002. 32.1** Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2** Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.